angiotensin ii and Cardiomegaly
angiotensin ii has been researched along with Cardiomegaly in 1148 studies
Research
Studies (1,148)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 40 (3.48) | 18.7374 |
1990's | 178 (15.51) | 18.2507 |
2000's | 304 (26.48) | 29.6817 |
2010's | 438 (38.15) | 24.3611 |
2020's | 188 (16.38) | 2.80 |
Authors
Authors | Studies |
---|---|
Guo, G; Li, K; Pan, J; Song, Z; Wang, D; Xu, C; Xu, Z; Zhong, K | 1 |
Liu, A; Shang, Z; Zhang, Y | 1 |
Cao, Y; Lai, S; Liu, C; Tao, E; Wan, L; Wang, F; Wang, Q; Wang, W; Zou, H | 1 |
Bunbupha, S; Chaihongsa, N; Iampanichakul, M; Maneesai, P; Meephat, S; Pakdeechote, P; Prasatthong, P; Wunpathe, C | 1 |
Dong, S; Li, Y; Liu, Y; Shen, T; Wang, X; Xu, X; Zhou, L | 1 |
Chang, YM; Chen, RJ; Chiu, PL; Day, CH; Huang, CY; Huang, HY; Kuo, WW; Liang-Yo, Y; Lin, HJ; Mahendran, R; Padma, VV | 1 |
Guo, X; Kong, X; Miao, J; Sun, W; Tu, J; Weng, L; Wu, T; Wu, X; Xu, T; Yang, C; Zhang, D; Zhang, J; Zhao, K; Zhou, B | 1 |
Guo, S; Han, X; Huang, F; Jiao, M; Ma, W; Mi, S; Niu, Q; Zhan, H; Zhang, K; Zhao, Z | 1 |
Chen, L; Geng, Q; Jiang, W; Li, N; Wang, B; Wang, W; Xiong, R | 1 |
Chen, T; Fan, X; He, S; Huang, CL; Jiang, F; Jiang, Q; Lei, M; Li, T; Ou, X; Tan, X; Yang, B; Zeng, X | 1 |
Ba, B; Cao, G; Guo, Y; Mayila, A; Xing, S; Xu, J | 1 |
He, Y; Li, X; Li, Y; Shi, Y; Yang, J | 1 |
Cao, JW; Gao, J; Hu, LL; Huang, ZR; Ji, Y; Song, TY; Wang, ZY; Xie, LP; Zhao, S | 1 |
Carletti, R; Castoldi, G; di Gioia, CRT; Ippolito, S; Pelucchi, S; Stella, A; Zatti, G; Zerbini, G | 1 |
Dai, H; Jia, G; Li, W; Liang, C | 1 |
Al-Hasani, J; Friede, PAP; Ghosh, S; Hecker, M; Nahar, T; Reil, JC; Sens-Albert, C; Trogisch, FA | 1 |
Ding, XL; Qian, HB; Xue, DJ; Yang, FM; Yuan, QQ; Zhu, YZ | 1 |
Diao, H; Guo, J; Hu, Y; Leng, M; Li, X; Li, Y; Rong, X; Shao, X; Sun, M; Wang, D; Wang, L; Wang, R; Yan, M; Zhang, Y | 1 |
Hu, G; Ji, M; Xu, Z; Zhang, M; Zuo, Z | 1 |
Bai, J; Li, HH; Lin, QY; Yin, L; Yu, WJ; Zhang, YL | 1 |
Ning, Z; Song, X; Song, Z; Wu, J; Zhong, X | 1 |
Chen, X; Gu, Y; Li, Y; Liu, Y; Zhang, S | 1 |
Lei, X; Lin, X; Lu, Q; Ma, A; Zhang, L; Zhang, W | 1 |
Bai, J; Chi, J; Gao, Y; Liu, J; Liu, S; Lv, Y; Yang, H; Yang, W; Yang, X; Zhan, C; Zhong, L | 1 |
Bai, Y; Deng, X; Li, D; Shen, M | 1 |
Hua, D; Li, P; Li, Y; Mao, Y; Wu, X; Yong, Y; Zhao, K; Zhou, Z | 1 |
Liu, X; Tu, Y; Warusawitharana, HK; Xia, C; Yang, Y; Zhou, H | 1 |
Chen, PP; Deng, J; Gao, Y; Gong, QH; Li, YY; Lin, HC; Luo, M; Shi, WL; Wen, ZQ; Xu, RX; Xu, SF | 1 |
Ge, J; Li, R; Li, Y; Lin, L; Shi, Y | 1 |
Guo, S; Qian, W; Shen, L; Yang, Y; Yao, Y; Zhou, G; Zhou, J | 1 |
Kulhari, U; Kumar, A; Kundu, S; Mohapatra, P; Mugale, MN; Murty, US; Ram, C; Sahu, BD; Syed, AM | 1 |
Du, J; Kong, L; Li, Y; Yang, C; Yao, R; Zhao, G | 1 |
Bai, Y; Chen, C; Gao, Z; Jiang, X; Meng, Y; Zhang, X; Zheng, C | 1 |
Cheng, Z; Feng, J; Gao, Y; Hou, L; Li, C; Wang, J; Zhou, J | 1 |
Ji, H; Peng, W; Qu, J; Yang, L | 1 |
Dong, R; Du, T; Ferrucci, L; Hu, X; Jin, Y; Liu, H; Pang, H; Sun, L; Tanaka, T; Tang, X; Tian, R; Tian, Z; Wang, H; Wang, L; Xiao, S; Xiao, Y; Yang, X; Ye, Y; Zhang, S; Zhang, Y | 1 |
Chattipakorn, N; Chen, R; Chen, Y; Dai, C; Huang, W; Liang, G; Luo, W; Shen, S; Wang, J; Wang, Z | 1 |
Alharbi, HO; Barrington, C; Cameron, AJM; Chotani, S; Clerk, A; Cook, AC; Cooper, STE; Cull, JJ; Herbert, E; Marshall, JJT; Meijles, DN; Mohun, T; Parker, PJ; Priestnall, SL; Prin, F; Rackham, OJL; Siow, B; Snoeks, T; Stuckey, DJ; Suáarez-Bonnet, A; Vanyai, H; Zaw Thin, M | 1 |
Chen, L; Liang, Q; Liu, M; Qian, L; Xu, H; Yan, J; Yang, G | 1 |
Chen, R; Das, S; Jin, B; Li, G; Li, J; Sha, Z; Wang, S; Wang, Z; Xiao, J; Xu, J; Xu, W; Yan, Y; Yang, L; Yang, T; Yao, J; Yuan, W; Zhu, X | 1 |
Cao, L; Cong, H; Du, X; Geng, J; Hu, Y; Wang, J; Zhang, R; Zhang, Y; Zhao, X; Zheng, L | 1 |
Chen, X; Hao, C; Ji, Z; Ma, G; Qu, Y; Su, Y; Yang, M; Yao, Y; Zhang, R; Zuo, W | 1 |
Gao, Y; Guo, X; Hu, L; Li, Y; Liu, Y; Ma, S; Tang, J; Wang, Z; Wei, J; Zhang, Q; Zhang, X; Zhang, Y | 1 |
Salama, G | 1 |
Chang, WT; Chen, CL; Chen, ZC; Chu, JS; Huang, TL; Lin, YW; Liu, PY; Shih, JY | 1 |
Betazza, MC; Cianciulli, TF; Fontana Estevez, FS; Gironacci, M; González, GE; Goren, N; Medina, V; Miksztowicz, V; Morales, C; Penas, F; Selser, C; Seropian, IM; Silva, MG; Touceda, V; Villaverde, A | 1 |
Dong, L; Ren, L; Yu, L | 1 |
Ji, M; Li, Y; Lin, L; Liu, Y; Xu, C; Zuo, Z | 1 |
Li, G; Liang, G; Liang, S; Luo, W; Sun, J; Wang, M; Yu, T; Zou, C | 1 |
Ding, YY; Hong, JH; Li, JM; Liu, Y; Pan, XC; Zhang, HG | 1 |
Yuan, G; Yuan, J | 1 |
Dai, S; Fan, X; Han, B; Han, J; Hong, X; Huang, W; Lin, S; Lin, W; Shi, X; Su, L; Xu, J; Ye, B; Zhong, L; Zhong, X | 1 |
Elyagon, S; Etzion, S; Etzion, Y; Kapiloff, MS; Klapper-Goldstein, H; Levitas, A; Parvari, R; Segal, L; Shahar, M | 1 |
Chen, L; Li, Y; Liu, X; Wang, Y; Xing, Y; Zhang, G | 1 |
Ding, Y; Gu, Y; Li, Y; Shang, Z; Zhang, X | 1 |
Du, Y; Guan, C; Huang, Z; Li, P; Wang, K; Zhang, Y; Zhou, M | 1 |
Chen, RL; Dang, X; Hong, YX; Hu, Y; Li, G; Li, GR; Li, YD; Mao, L; Song, F; Wang, Y; Wu, C; Zhou, XX | 1 |
Bottermann, K; Deenen, R; Fischer, JW; Gödecke, A; Grandoch, M; Harris, TE; Hemmers, A; Herebian, D; Kalfhues, L; Köhrer, K; Leitner, LM; Nederlof, R; Nemmer, J; Oenarto, V; Petzsch, P; Pfeffer, M; Raje, V; Reichert, AS; Stegbauer, J; Zabri, H | 1 |
Akiba, Y; Fukuda, K; Funahashi, A; Hashimoto, H; Katsuki, T; Kimura, M; Komuro, J; Kuoka, T; Kusumoto, D; Nakamura, T; Seki, T; Tokuoka, Y; Yamada, T; Yuasa, S | 1 |
Huang, C; Tang, Y; Wang, X; Zhao, H; Zhao, Q | 1 |
Bhullar, SK; Dhalla, NS | 1 |
Ahluwalia, A; Aziz, D; Hoa, N; Levin, ER; Moreira, D; Patel, KN; Singh, K | 1 |
Chen, J; Chen, S; Li, L; Li, T; Liao, Z; Ruan, H; Wang, X; Wei, S; Zuo, H | 1 |
Fan, H; Gao, X; Liu, D; Wang, Z; Xu, M; Zhang, L | 1 |
Cicalese, SM; Coffman, TM; Eguchi, S; Hashimoto, T; Okuno, K; Preston, K; Rizzo, V; Sparks, MA; Torimoto, K | 1 |
Fukamizu, A; Kim, JD; Kwon, C; Mori, H; Muroi, SI; Muromachi, N; Nakagawa, Y; Nakamura, K; Saito, H; Yamada, Y | 1 |
Dong, Z; Li, T; Lu, J; Sheng, S; Shi, Y; Yuan, M; Yue, L | 1 |
Li, Y; Wang, L; Wang, W; Yang, M | 1 |
Fujioka, R; Inamitsu, M; Kobayashi, S; Maruta, A; Nakamura, Y; Oda, T; Tominaga, N; Yamamoto, T; Yano, M | 1 |
Guo, X; Hong, J; Li, C; Li, Y; Mao, J; Tang, Y; Wang, Y; Xu, B; Yu, J; Zhou, M | 1 |
Chang, J; Dong, Z; Fan, C; Jiao, Y; Jin, Q; Li, X; Que, Y; Song, Q; Yang, C; Zhang, Y | 1 |
Cai, Y; Craig Wan, C; Du, R; Gao, S; Huang, C; Jiang, S; Shen, A; Xiao, Y; Yan, T; Yang, W; Zhang, X; Zheng, G | 1 |
Ates, E; Kang, MJ; Mahmud, J; Seo, HS; Thi My Ong, H | 1 |
Bai, X; Meng, Z; Su, Y; Wang, Y; Xu, L; Yang, X; Zhuo, C | 1 |
Han, X; Ji, Q; Li, C; Shang, H; Xie, X; Ye, H; Zhang, L | 1 |
Chen, H; Fu, D; Fu, Y; Li, L; Luo, J; Wen, T; Wu, Y; Xiong, W; Zhang, L | 1 |
Gao, L; Jia, M; Wang, Z; Wu, L; Xiao, L; Yao, R; Zhang, Y | 1 |
Alammari, AH; El-Kadi, AOS; Gerges, SH; Isse, FA | 1 |
Jia, B; Jia, S; Leng, M; Liu, R; Weng, L; Xiong, Y; Yan, S; Yang, F; Ye, J; Zhao, J; Zheng, M; Zhou, Y | 1 |
Hou, Y; Ji, W; Li, L; Li, T; Li, X; Li, Y; Liang, H; Lv, L; Shan, H; Yang, N; Yang, R; Yu, T; Zhang, J; Zhang, Y | 1 |
Bao, X; Feng, J; Jing, Z; Lu, Y; Wu, M; Zeng, Z | 1 |
Chen, L; Ge, F; Guo, J; He, Y; Hu, K; Jia, M; Jiang, L; Jin, J; Li, L; Li, Q; Lv, X; Ma, S; Meng, D; Osto, E; Wang, X; Wei, X; Wu, H; Wu, J; Yang, Z; Zhang, J; Zhi, X | 1 |
Chang, CC; Cheng, HC; Chou, WC; Chu, PM; Hsieh, PL; Huang, YT; Lee, SD | 1 |
Cai, L; Chen, S; Chen, X; Ding, Y; Li, J; Li, X; Li, Y; Liu, S; Lu, X; Wei, Y; Wu, X; Xu, J; Zhou, G | 1 |
Li, L; Lu, Z; Yang, J; Zheng, X; Zhou, H | 1 |
Carletti, R; Castoldi, G; Colzani, M; di Gioia, CRT; Ippolito, S; Pelucchi, S; Perseghin, G; Zatti, G; Zerbini, G | 1 |
Chen, S; Hou, J; Liu, Q; Luo, T; Wang, D; Wang, P; Wang, X; Yan, P; Yang, Y; Zhou, Y | 1 |
Hua, D; Kong, X; Li, P; Li, Y; Mao, Y; Sheng, Y; Sun, W; Wu, X; Yang, C; Zhao, K | 1 |
Abassi, Z; Aronson, D; Cohen-Segev, R; Hamoud, S; Kabala, A; Karram, T; Kinaneh, S; Nativ, O | 1 |
Chen, J; Ma, E; Peng, L; Ren, DN; Wo, D; Wu, C; Yan, H; Zhu, W | 1 |
Ding, L; Dong, H; Jia, W; Lin, S; Lin, Y; Ren, S; Wang, Y; Wei, C; Xiao, D; Yan, P; Zhang, Y; Zhao, Y | 1 |
Chen, S; Gao, Q; Hao, L; Lei, M; Li, J; Li, W; Liu, Y; Su, F; Wei, M; Zhang, C; Zhang, Y; Zheng, X | 1 |
Cho, S; Jeong, D; Lee, C | 1 |
Alcalai, R; Arad, M; Guetta, T; Hochhauser, E; Kornowski, R; Ofek, E; Petrover, Z; Seidman, CE; Seidman, J; Yadin, D | 1 |
Chen, X; Dai, J; Fang, R; Feng, M; Shen, C; Shu, T; Wang, J; Wang, S; Wu, N | 1 |
Bin, J; Chen, L; He, M; Li, M; Liao, W; Liao, Y; Lin, H; Lu, W; Ma, S; Shen, M; Xie, J; Xiu, J; Zheng, C; Zhu, Y | 1 |
Gu, A; Jin, J; Li, W; Liang, J; Liao, X; Liu, Q; Weng, Z; Xu, C; Zhou, S; Zhou, Y | 1 |
Bangwei, Z; Bin, S; Huan, P; Jiming, W; Jing, J; Jinlai, G; Shihui, L; Xiaochun, Z; Xiaoqin, Z; Xinyi, F; Yi, H; Zhouqi, L; Ziyue, L | 1 |
Liu, F; Liu, SL; Xu, ST; Ye, JT; Zhang, YX | 1 |
Geng, J; Lv, C; Meng, Y; Yuan, H; Zhou, L | 1 |
Aubdool, A; Baliga, RS; Bedi, KC; D'Amico, G; Dukinfield, M; Hobbs, A; Hodivala-Dilke, K; Maiques, O; Maniati, E; Margulies, KB; Reynolds, LE; Sanz-Moreno, V; Wang, J | 1 |
Chang, RL; Chen, RJ; Day, CH; Ho, TJ; Huang, CY; Kuo, WW; Lai, CH; Padma, VV; Pai, PY; Pandey, S | 1 |
Agbo, E; Li, MX; Massaro, J; Saahene, RO; Tian, GZ; Wang, YQ | 1 |
Boylston, J; Casin, KM; Fillmore, N; Kohr, MJ; Liu, C; Ma, H; Murphy, E; Noguchi, A; Sinha, P; Sun, J; Wang, N; Zhou, G | 1 |
Ge, LJ; Peng, XD; Sun, JC; Tan, X; Wang, WZ; Yang, RH | 1 |
Ruan, Z; Shen, Y; Song, G; Wang, R; Zhu, L | 1 |
Boini, KM; Chen, Y; Deng, M; Lu, A; Tan, Z; Wang, L; Wu, C; Yang, T; Zhang, L; Zhu, Q | 1 |
Dou, L; Guo, J; Huang, X; Li, J; Man, Y; Shen, T; Tang, W; Wang, Q; Wang, S; Yan, M; Yu, X; Zhu, K | 1 |
Chiasson, V; Guleria, RS; Gupta, S; Takano, APC | 1 |
Huang, H; Liu, YM; Lv, YG; Wu, RD; Xu, JQ; Zhu, W | 1 |
Gugerell, A; Gyöngyösi, M; Lukovic, D; Mester-Tonczar, J; Podesser, B; Spannbauer, A; Traxler, D; Winkler, J; Zlabinger, K | 1 |
Bian, R; Dai, YJ; Gong, JX | 1 |
Che, Y; Jin, YG; Meng, YY; Shen, D; Wang, SS; Wang, ZP; Wu, QQ; Yuan, Y; Zhou, H | 1 |
Bai, F; Bose, HS; James, EA; Sturdivant, K; Wang, NP; Zhang, WW; Zhao, ZQ; Zheng, RH | 1 |
Tao, L; Yang, X; Zhang, S; Zhu, J | 1 |
Han, L; Jin, L; Piao, J; Zhou, Y | 1 |
Chen, MJ; Fan, G; Wei, J | 1 |
Feng, J; Jin, X; Li, C; Yang, M; Zhang, J; Zhou, G | 1 |
Ahmed, MS; Attramadal, H; Aukrust, P; Holt, MF; Lien, E; Louwe, MC; Mollnes, TE; Nilsson, PH; Schjalm, C; Shahini, N; Yndestad, A; Øgaard, JDS | 1 |
Li, Q; Wang, F; Wei, X; Zhang, J; Zhang, W | 1 |
Alonso, J; Ballester-Servera, C; Cañes, L; Galán, M; Herraiz-Martínez, A; Hove-Madsen, L; Martí-Pàmies, I; Martínez-González, J; Muniesa, P; Nistal, JF; Osada, J; Rodríguez, C | 1 |
Guo, D; Liu, H; Zhao, Z | 1 |
Angermann, JE; Bender, A; Burnett, L; Evans, LW; Ferguson, BS; Godoy, L; Shen, Y; Staten, D; Zhou, T | 1 |
Baruscotti, M; Guo, R; Liu, H; Liu, N; Wang, Y; Zhang, H; Zhang, J; Zhao, L | 1 |
Akhondzadeh, F; Astani, A; Najjari, R; Ranjbar, AM; Rezvani, ME; Safari, F; Samadi, M; Zare, F | 1 |
Aono, T; Arimoto, T; Goto, J; Kato, S; Kutsuzawa, D; Narumi, T; Nishiyama, S; Otaki, Y; Shishido, T; Sugai, T; Takahashi, H; Takahashi, T; Tamura, H; Toshima, T; Wanezaki, M; Watanabe, K; Watanabe, M; Watanabe, T | 1 |
Jiang, F; Sun, H; Wang, H; Xu, L; Zhang, D | 1 |
Gotoh, T; Hoshizaki, M; Imai, Y; Inagaki, T; Koyota, S; Kuba, K; Minato, T; Motoyama, S; Nakahara, K; Nakaoka, Y; Natsui, M; Nirasawa, S; Ozawa, R; Penninger, JM; Sato, T; Takahashi, S; Watanabe, H; Yamaguchi, T; Yokota, S; Yoshihashi, T; Yoshiya, T; Yoshizawa-Kumagaye, K | 1 |
Chen, W; Wang, Y; Zhang, Y | 1 |
Jiang, C; Lu, Y; Zhang, S | 1 |
Deguchi, H; Enzan, N; Ide, T; Ikeda, M; Ikeda, S; Ishikita, A; Matsushima, S; Okabe, K; Sada, M; Shinohara, K; Tadokoro, T; Tsutsui, H; Yamamoto, T | 1 |
Cao, W; Chen, Y; Ge, Z; Hu, Q; Huang, S; Li, Y; Weng, Y; Zhai, C; Zhou, L | 1 |
Gao, L; Guo, S; Li, Y; Liu, Y; Shen, J; Shi, Q; Xiao, F; Xing, S; Yang, F; Zhang, W; Zhao, L | 1 |
Alammari, AH; El-Kadi, AOS; Maayah, ZH; Shoieb, SM | 1 |
Jiang, W; Lei, L; Li, Q; Ni, Y; Wan, Z; Wei, J | 1 |
Deng, S; Li, Y; Liu, H; Tian, J; Zhao, Z | 1 |
Cai, J; Chen, J; Cui, Q; Geng, B; Li, S; Meng, Y; Xiang, R; Xu, M; Yan, H; Yang, J; Yang, Y | 1 |
Gao, L; Hackfort, BT; Hu, G; Tian, C; Zucker, IH | 1 |
Cai, K; Chen, H | 1 |
An, X; Tan, A; Wang, L; Xia, Y; Xie, Y | 1 |
Li, Z; Long, Y; Wang, L | 1 |
Chen, GH; Hu, J; Li, JL; Wang, HN; Xu, T; Yao, HQ | 1 |
Gao, C; Hu, H; Jiang, X; Liang, F; Ma, W; Sun, Q; Zhan, H; Zhang, K; Zhang, X; Zhao, Z | 1 |
Cai, DF; Cai, SA; Chen, MS; Chen, XH; Cheng, CF; Hou, N; Huang, Y; Li, AQ; Li, LR; Liu, SM; Liu, XW; Luo, CF; Qiu, XX; Xie, JX; Yuan, WC; Zhao, GJ | 1 |
Cong, W; Dong, E; Feng, Y; Hu, G; Li, M; Song, Y; Wang, S; Xiao, H; Zhang, Y | 1 |
El-Kadi, AOS; Shoieb, SM | 1 |
Bao, Y; Han, Y; Li, C; Li, Y; Ren, L; Wang, W; Wu, C | 1 |
Chen, DX; Huang, DJ; Huang, HL; Huang, JH; Lin, YB | 1 |
Cao, W; Li, Y; Qian, Y; Wang, J; Zhao, P; Zhu, H | 1 |
Cai, SY; Fu, YL; Lin, Q; Peng, FH; Tao, L; Wang, Q; Zheng, NZ | 1 |
Chakraborty, K; Joy, M; Krishnan, S | 2 |
Bao, Y; Dai, Y; Jia, K; Jin, Q; Li, X; Liu, A; Lu, L; Wu, L | 1 |
Deng, KQ; Hu, F; Ji, YX; Li, H; Liu, X; Montezano, AC; Ouyang, S; She, ZG; Tian, S; Touyz, RM; Zhang, C; Zhang, P; Zhang, XJ; Zhao, CL; Zhao, GJ; Zhu, L; Zhu, XY | 1 |
Chen, F; Geng, J; Li, X; Xie, J; Xu, B; Zhao, J | 1 |
Barreto-Chaves, MLM; Senger, N; Takano, APC | 1 |
Chen, Z; He, X; Liu, X; Lu, Y; Miao, R; Wang, J | 1 |
Chao, SP; Chen, XL; Cheng, WL; Gong, FH; Song, BJ; Xiao, XQ; Yang, YS; Zhang, Q | 1 |
Hu, YH; Mei, ZL; Wang, HB; Xiong, L | 1 |
Bianchi, K; Crespo-Leiro, MG; Domenech, N; Eaton, P; Eykyn, TR; Fernandez-Caggiano, M; Francois, AA; Kamynina, A; Krasemann, S; Morales, V; Prysyazhna, O; Vieites, MG | 1 |
Cao, Y; Chen, Y; Liu, Y; Qi, H; Ren, J; Shi, P; Song, C; Sun, H; Wang, L; Zhang, S | 1 |
Huang, Z; Kong, LY; Li, YP; Tian, XY; Wang, ZM; Wu, LM; Yao, R; Zhang, DH; Zhang, JL; Zhang, YZ | 1 |
Chen, W; Gu, Y; Ma, L; Wang, G; Wang, W; Xiao, Y; Yang, F; Yu, Y; Zhang, B | 1 |
Cai, SD; Ding, YQ; Hu, YH; Li, B; Li, JY; Liu, PQ; Lu, J; Wang, PX; Ye, JT; Yu, WJ; Yue, ZB; Zhang, YH | 1 |
Du, J; Hu, H; Pei, H; Shen, Y; Xu, R; Yang, D; Yang, Y | 1 |
Gao, P; Gao, R; Ge, W; Guo, W; Guo, X; Hou, C; Li, B; Liu, Y; Song, X; Wang, J; Zhang, W; Zhao, H | 1 |
Bai, N; Li, G; Li, J; Li, L; Li, T; Li, W; Liu, G; Lou, Q; Wang, Y; Yang, W; Zhan, C; Zhang, L; Zhao, H; Zheng, M | 1 |
Abraham, DM; Bouknight, L; Coffman, TM; Crowley, SD; Diaz, E; Gurley, SB; Hoang, T; Pennathur, S; Revoori, R; Rianto, F; Ruiz, P; Sparks, MA; Stegbauer, J; Vivekanandan-Giri, A | 1 |
Badrealam, KF; Chen, RJ; Day, CH; Huang, CY; Kung, YL; Kuo, WW; Lu, CY; Lu, SY; Padma, VV; Shibu, MA | 1 |
Ge, J; Jiang, H; Su, Y; Wang, J; Wu, J; Yu, Y; Zhang, B; Zhang, L; Zou, Y | 1 |
Consegal, M; Rodríguez-Sinovas, A; Valls-Lacalle, L | 1 |
Gu, J; Ji, Y; Lu, Y; Qian, Z; Qiu, M; Sun, W | 1 |
Chuprun, JK; Coleman, R; Eguchi, A; Gao, E; Gresham, K; Ibetti, J; Koch, WJ | 1 |
Hou, L; Huo, C; Jia, X; Li, X; Liu, Y; Wang, X; Xu, R | 1 |
Chen, J; Chen, Y; Fang, L; Gao, H; Li, H; Lin, J; Lv, R; Lyu, L; Wang, W; Xu, F; Yan, T | 1 |
Cheng, Y; Gu, W; Li, Z; Sun, T; Wang, S | 1 |
Bai, W; Peng, Y; Qin, L; Wang, Z; Yu, H | 1 |
Altara, R; Booz, GW; Massoud, GP; Zouein, FA | 1 |
Chen, W; Chen, X; Li, W; Ma, L; Qiu, J; Shi, W; Tao, J; Wang, S; Zhou, N; Zou, M; Zou, R | 1 |
Cai, L; Collins, DM; Duan, Q; King, C; Kutz, LC; Lingrel, JB; Marck, PV; Pessoa, MT; Pierre, SV; Tian, J; Wang, X; Xie, JX; Xie, Z; Xu, Y; Yan, Y | 1 |
Alexis, JD; Ashton, JM; Burke, RM; Dirkx, RA; Lighthouse, JK; Mohan, A; O'Brien, M; Phipps, RP; Quijada, P; Small, EM; Woeller, CF; Wojciechowski, W | 1 |
Morishima, M; Ono, K | 1 |
Chen, RJ; Ho, TJ; Huang, CY; Kumar, VB; Kuo, CH; Lin, KH; Padma, VV; Shanmugam, T; Shibu, MA; Yeh, YL | 1 |
Bi, X; Gao, Y; Liu, Y; Meng, T; Xie, WZ; Xu, C; Zhang, P; Zhao, D; Zhao, Z | 1 |
Boen, JRA; De Keulenaer, GW; De Meyer, GRY; De Moudt, S; Guns, PDF; Hendrickx, JO; Jacobs, G; Leloup, AJA; Segers, VFM; Shakeri, H | 1 |
Chang, W; Chen, Y; Huang, S; Ke, J; Wang, L; Wang, Q; Zhou, Z | 1 |
Chen, C; Lu, Q; Shi, JY; Su, YL; Xu, X | 1 |
Cai, J; He, B; Ji, Q; Li, Y; Pan, X; Shen, L; Shen, Y; Wang, X; Xiao, Q; Yang, X; Yin, A; Yuan, R | 1 |
Gan, WQ; Hou, YF; Li, TG; Lv, SL; Wang, WQ; Yan, Z; Yang, M; Zeng, ZF; Zhang, RX | 1 |
Chu, Z; Han, B; Han, J; Lu, Q; Shi, X; Zhang, B; Zhang, X | 1 |
Jiang, Q; Li, J; Lu, M; Zhu, Z | 1 |
Chen, H; Gao, Z; Gong, M; Li, C; Li, K; Meng, Y; Wang, L; Zhang, H; Zhang, X; Zheng, C; Zheng, Y | 1 |
Hernandez, R; Lu, W; Meng, Z; Zhou, C | 1 |
Cheng, XS; Lu, P; Peng, XG; Sheng, ZY; Wu, QH; Wu, YQ; Xu, Y; Zhang, JJ; Zhu, K | 1 |
Cai, SA; Hou, N; Huang, Y; Li, LR; Liu, XW; Luo, CF; Pan, WB; Shi, YY; Yuan, WC; Zhan, HX; Zhao, GJ | 1 |
Fan, S; Niu, Y; Qin, J; Shi, Y; Wang, J; Xiong, Q; Zhang, L; Zhang, X | 1 |
Du, J; Guo, HC; Lai, YQ; Li, G; Li, Y; Ma, K; Qiao, B; Shao, Y; Zhi, Y | 1 |
Han, Q; Li, H; Shi, H; Xue, H; Zhang, F; Zhang, Y | 1 |
De Gregorio, N; Díaz-Araya, G; Espinoza, C; Espitia-Corredor, J; Lavandero, S; Olivares-Silva, F; Osorio, JM; Peiró, C; Sánchez-Ferrer, C; Silva, D; Vivar, R | 1 |
Huang, S; Jia, Z; Niu, Y; Shi, W; Wang, S; Yu, J; Zhang, A; Zhang, Y; Zhou, W | 1 |
Cheng, T; Fan, P; Hua, C; Wang, J; Xia, Q; Zhang, L; Zhao, L; Zhou, J | 1 |
Alfadda, AA; Alsalman, N; Bazighifan, A; Gul, R | 1 |
Li, JD; Wu, MP; Xu, X; Yan, C; Zhang, YS; Zhou, Q | 1 |
Chen, W; Chen, X; Huang, F; Khan, A; Li, L; Qiu, Z; Wang, L; Wang, X; Zhang, J | 1 |
Guo, L; O'Rourke, ST; Sun, C; Yin, A; Zhang, Q; Zhong, T | 1 |
Dong, ZX; Hai, X; Han, W; Hou, HL; Liu, GZ; Shi, YQ; Wan, L; Wang, RJ; Zheng, SJ | 1 |
Abdelhamid, G; El-Kadi, AOS; El-Sherbeni, AA; Elkhatali, S; Elshenawy, OH; Maayah, ZH; Shoieb, SM | 1 |
Chen, J; Chen, XM; Hou, JW; Li, G; Li, W; Li, YG; Wang, H; Wang, Q; Wang, YP; Wei, SS; Xu, WP; Zhou, Q | 1 |
Bao, Q; Chen, L; Li, J; Liu, X; Wu, S; Wu, W; Zhao, M | 1 |
Cao, TT; Chen, HH; Dong, Z; Guo, W; Lu, R; Wei, HC; Xu, YW; Zhang, C; Zhao, P | 1 |
Han, Y; Ji, Y; Liu, J; Liu, L; Liu, S; Meng, G; Song, Q; Xie, L | 1 |
Gao, L; Huang, K; Li, H; Wang, G; Wang, J; Wang, L; Wang, Z; Yang, M | 1 |
Aguiló, S; de Diego, A; Galán, M; García-Dorado, D; Guadall, A; Martínez-González, J; Navarro, MA; Navas, M; Orriols, M; Rodriguez, C; Rodríguez-Sinovas, A; Varona, S | 1 |
Burridge, PW; Eren, M; Flevaris, P; Ghosh, AK; Gupta, S; Khan, SS; Lee, DC; Schuldt, AJT; Shah, SJ; Shapiro, AD; Vaughan, DE | 1 |
Ogita, H; Sato, A; Shimizu, A; Zankov, DP | 1 |
Chen, X; Duan, W; Jin, Z; Jing, L; Li, B; Li, K; Liang, H; Liu, J; Liu, Z; Reiter, RJ; Ren, K; Yang, J; Yang, Y; Yi, D; Yi, W; Yu, B; Yu, S; Zhai, M; Zhang, B; Zhang, M | 1 |
Gao, Y; Hu, D; Li, J; Li, Y; Shang, H; Xing, Y; Zhang, Y | 1 |
Inagaki, Y; Kaneko, S; Kitano, T; Ohkura, SI; Okamoto, Y; Sugimoto, N; Takamura, M; Takashima, SI; Takuwa, N; Takuwa, Y; Usui, S; Wada, T; Yoshioka, K | 1 |
Hays, TT; Ma, B; Qiu, H; Stoll, S; Zhou, N | 1 |
Chen, RJ; Chen, YF; Chung, LC; Huang, CY; Kuo, WW; Lee, NH; Padma Viswanadha, V; Pai, PY; Rajendran, P; Shen, CY | 1 |
Chen, Y; Jiang, G; Lv, Q; Yuan, J; Zhu, J; Zou, Y | 1 |
Chen, Y; Fillmore, N; Gao, S; Harrington, J; Liu, P; Murphy, E; Springer, D; Stoehr, A; Wang, X; Yang, Y; Zhang, X; Zhu, J | 1 |
Bu, J; Gao, J; Huang, C; Huang, G; Shen, W; Sun, M; Wei, T; Wu, J | 1 |
Aroor, AR; Bender, SB; Brown, SM; Chandrasekar, B; Cleeton, HM; DeMarco, VG; Khan, M; Meininger, GA; Meuth, AI; Nistala, R; Smith, CE; Sowers, JR | 1 |
Gu, C; He, L; Huang, Z; Li, J; Pan, L; Sheng, M; Teng, L; Xu, C; Yi, C; Zhu, Z | 1 |
Gao, L; Guo, S; Li, L; Li, R; Li, Y; Liu, Y; Niu, X; Wang, S; Yan, X; Yang, H; Yao, L; Zhang, Y; Zhao, X | 1 |
Ayme-Dietrich, E; Birling, MC; Bouabout, G; Champy, MF; Fertak, LE; Herault, Y; Jacob, H; Madeira, L; Monassier, L; Mudgett, J; Pavlovic, G; Petit-Demoulière, B; Sorg, T | 1 |
Ge, L; Hoa, N; Korach, KS; Levin, ER | 1 |
Gao, H; Huang, P; Huang, X; Li, Y; Liu, H; Peng, Y; Tang, T; Wang, D | 1 |
Choi, SY; Jeong, MH; Jin, L; Kee, HJ; Kim, GR; Lin, MQ; Liu, B; Piao, ZH; Ryu, Y; Seok, YM; Sun, S | 1 |
Chen, RJ; Ho, TJ; Huang, CY; Kuo, CH; Kuo, WW; Lin, YM; Pai, PY; Tsai, FJ; Vijaya Padma, V | 1 |
Chen, WQ; Cheng, J; Ji, XP; Mao, Y; Qiao, L; Tie, YY; Xu, QB; Xu, YY; Zhai, CG; Zhang, C; Zhang, Y | 1 |
Gong, H; Lian, X; Peng, F; Wang, L; Ye, N; Zhang, H | 1 |
Gao, L; Li, AL; Lv, JB | 1 |
Cheng, M; Hu, S; Hu, Z; Huang, C; Jiang, H; Lai, X; Liu, B; Wang, S; Wu, G; Zou, Q | 1 |
Lu, Y; Wu, F | 1 |
Huang, Y; Ji, Q; Jiang, H; Lin, Y; Liu, J; Liu, L; Shi, L; Shi, Y; Wan, J; Wang, M; Wang, Z; Xu, Y; Ye, J | 1 |
Cui, LB; Jiang, S; Jiao, B; Ru, NY; Yu, ZB; Zhang, L | 1 |
Chen, D; Gao, P; Huang, J; Ji, K; Li, X; Xu, T; Yan, C; Yang, Y; Zhu, D; Zuo, C | 1 |
Alves, F; Bader, M; Guatimosim, S; Jesus, ICG; Marques, K; Rocha-Resende, C; Santos, RAS; Scalzo, S | 1 |
Bai, J; Cao, HJ; Du, J; Guan, XM; Li, HH; Lin, QY; Liu, Y; Ma, XL; Wang, L; Xia, YL; Zhang, YL | 1 |
Paradis, P; Schiffrin, EL | 1 |
Hao, Q; Li, GH; Liu, K; Wei, J; Wu, Y; Zhao, YF | 1 |
Du, B; Gao, L; Huang, Z; Li, P; Li, Y; Liang, C; Wang, Z; Wu, L; Xiao, L; Yao, R; Zhang, D; Zhang, Y | 1 |
Liu, HB; Liu, ZH; Wang, J | 1 |
Cho, S; Jeong, J; Lee, J; Lee, ME; Lim, S; Park, S; Seo, M | 1 |
Laurindo, FRM; Pescatore, LA | 1 |
Dai, F; Ma, S; Wang, Q; Yang, D; Yang, Y; Zhang, Y | 1 |
Cai, W; Hua, J; Lai, W; Liu, Z; Ren, H; Xu, D; Zeng, Q; Zhan, Q | 1 |
Liu, HQ; Liu, Y; Luo, JD; Shen, HJ; Wang, XQ; Zheng, LY | 1 |
Du, J; Hou, CL; Lai, S; Li, HH; Li, WJ; Tian, C; Wang, HX; Yang, H; Zhang, YL | 1 |
Badrealam, KF; Chen, BC; Chiang, JT; Huang, CY; Kuo, CH; Kuo, WW; Lin, YM; Shibu, MA; Viswanadha, VP | 1 |
Frank, DU; Saucerman, JJ; Sutcliffe, MD | 1 |
Guo, Z; Li, Q; Li, ZM; Liu, PQ; Lu, J; Sun, SY; Wang, LP; Wang, PX; Yang, HW; Ye, JT | 1 |
Cai, YY; Chen, HY; He, JH; Jiang, W; Lan, J; Li, H; Li, RL; Li, X; Tang, CS; Wang, W; Wang, XX; Wu, SS; Wu, Y; Xin, JJ; Xue, KY; Zhang, HY; Zhuo, CL | 1 |
Bisping, E; Heinzel, FR; Klein, O; Mhatre, KN; Pieske, B; Völkl, J; Wakula, P | 1 |
Gupta, S; Li, L | 1 |
Gopalakrishnan, K; Kumar, S; Mishra, JS; More, AS | 1 |
Chen, L; Lei, L; Li, Q; Li, T | 1 |
Jing, Y; Liu, S; Ni, B; Zhou, D | 1 |
Andrews, KL; Chin-Dusting, JPF; Dragoljevic, D; Gaspari, T; Jefferis, AM; Jennings, GL; Khan, SI; Lee, MKS; Moore, XL; Murphy, AJ; Shihata, WA; Vinh, A | 1 |
He, W; Jiang, H; Zhang, C | 1 |
Gao, L; Kong, L; Shi, H; Tian, X; Wang, Z; Xiao, L; Zhao, L | 1 |
Cheng, M; Hu, S; Hu, ZQ; Huang, CX; Jiang, H; Liu, BL; Wang, L; Wang, S; Wu, G | 1 |
Bi, HL; Lai, S; Li, HH; Shu, Q; Wang, XM; Yang, XL; Zhang, YL | 1 |
Aisicovich, M; García, SI; Landa, MS; Peres Diaz, LS; Pirola, CJ; Schuman, ML; Toblli, JE | 1 |
Deng, W; Hu, C; Liao, HH; Tang, QZ; Wang, SS; Wei, WY; Yang, Z; Zhang, N | 1 |
Cornelissen, G; El-Kilany, G; Fedacko, J; Hristova, K; Singh, RB | 1 |
Bers, DM; Fukui, G; Hamada, Y; Ishiguchi, H; Kato, T; Kobayashi, S; Kono, M; Nakamura, Y; Nanno, T; Oda, T; Okamoto, Y; Okuda, S; Uchinoumi, H; Yamamoto, T; Yano, M | 1 |
A, P; K G, R; M, PR; P, SR | 1 |
Cheng, M; Hu, S; Huang, CX; Jiang, H; Liu, BL; Tu, X; Wang, L; Wang, S; Wu, G | 1 |
Beak, JY; Bowles, DE; Huang, W; Jensen, BC; Jetten, AM; Kang, HS; Myers, PH | 1 |
Alenina, N; Bader, M | 1 |
Chen, N; Gao, L; Li, L; Liu, Y; Wang, X; Xiao, L; Yang, L; Zhang, J; Zhao, X | 1 |
Brenes-Castro, D; Castillo, EC; García-Rivas, G; Torre-Amione, G; Vázquez-Garza, E | 1 |
Gao, L; Guo, S; Liang, C; Liu, Y; Wang, X; Xiao, L | 1 |
Cheng, WP; Chua, SK; Lo, HM; Shyu, KG; Wang, BW | 1 |
Chen, C; Li, HH; Liu, Y; Xia, YL; Yan, X; Zhang, L; Zhang, YL; Zou, LX | 1 |
Shah, AM; Zoccarato, A | 1 |
Wang, DX; Xiong, T; Yang, XQ | 1 |
Armesilla, ÁL; Jiménez-Borreguero, LJ; López-Maderuelo, MD; Lozano-Vidal, N; Martínez-Martínez, S; Redondo, JM | 1 |
Chen, T; Han, J; Huang, W; Jiang, L; Li, J; Liang, G; Wang, J; Wang, Y; Xu, J; Ye, S; Zou, C | 1 |
Wang, M; Zhang, A; Zhuo, P | 1 |
Fernández-Solà, J; Ferrer-Curriu, G; Garrabou, G; Guitart-Mampel, M; Mas-Stachurska, A; Planavila, A; Redondo-Angulo, I; Ruperez, C; Sitges, M; Villarroya, F | 1 |
Avery, EG; Balogh, A; Bartolomaeus, H; Dechend, R; Eckardt, KU; Fielitz, J; Forslund, SK; Gollasch, M; Grandoch, M; Haase, N; Hering, L; Höges, S; Homann, S; Kempa, S; Kozhakhmetov, S; Kräker, K; Krannich, A; Kusche-Vihrog, K; Kushugulova, A; Maase, M; Markó, L; Müller, DN; Rump, LC; Stegbauer, J; Tsvetkov, D; Wilck, N; Wundersitz, S; Yakoub, M; Zhumadilov, Z | 1 |
Ba, L; Cao, Y; E, M; Fu, B; Qi, H; Ren, J; Shi, P; Song, C; Sun, H; Zhang, Q | 1 |
Chen, P; Deng, Y; Feng, H; Huang, L; Ouyang, W; Wang, J; Wu, J; Xian, J; Zhu, G | 1 |
Peng, L; Yan, K; Zhang, H; Zheng, N; Zhou, K | 1 |
Imai, Y; Ito, H; Kadowaki, A; Kuba, K; Sato, T; Suzuki, T; Watanabe, H | 1 |
Cao, R; Qi, B; Wang, Y; Yang, W | 1 |
Bao, P; Chen, D; Chen, M; Hu, X; Ji, C; Li, Z; Sanchis, D; Xu, Y; Yan, F; Ye, J; Zhang, M; Zhang, Y | 1 |
Chen, D; Fu, M; Gao, P; Grossfeld, P; Han, W; Ostrowski, MC; Xu, L; Ye, M | 1 |
Chen, G; Cong, W; Jin, L; Li, S; Liang, J; Liang, Y; Niu, C; Shen, Y; Wang, Y; Xue, M; Yi, X; Zhang, H; Zhao, C; Zheng, J; Zhu, Z | 1 |
Cheng, M; Guo, X; Hu, S; Huang, C; Jiang, H; Liu, B; Wang, S; Wu, G | 1 |
Chen, W; Fassett, J; Li, W; Liu, Z; Lu, Y; Qi, X; Tang, K; Weng, X; Xu, D; Xu, Y; Zhang, Y; Zhao, Y; Zheng, J | 1 |
Huang, T; Li, F; Lu, P; Sheng, Z; Wang, S; Xu, Y | 1 |
Ge, Z; Lin, J; Lin, Z; Liu, J; Wang, Y; Yuan, X; Zhang, C | 1 |
Chen, H; He, J; Jiang, W; Lan, J; Li, H; Li, R; Li, X; Tang, CS; Wang, X; Wu, S; Wu, Y; Xin, J; Xue, K; Zhuo, C | 1 |
Abboud, FM; Chapleau, MW; Cicha, MZ; Meyerholz, DK; Nunez, S; Singh, MV | 1 |
Abdisalaam, S; Asaithamby, A; Bhattacharya, S; Gillette, TG; Hill, JA; Lam, NT; Mukherjee, S; Nakada, Y; Nhi Nguyen, NU; Sadek, HA; Savla, JJ; Xiao, F | 1 |
Jiang, Y; Liu, R; Men, H; Shao, W; Shu, S; Zhang, W | 1 |
Astani, A; Jahanifar, F; Jamhiri, M; Safari, F; Shekarforoosh, S; Zarei, F | 1 |
Hu, Y; Li, J; Li, S; Li, Y; Ma, Y; Wen, J; Wu, J; Zhang, J; Zhang, L | 1 |
Abraham, D; Acar, E; Costantino, S; Gonçalves, IF; Hallström, S; Hamza, O; Kiss, A; Klein, KU; Paneni, F; Podesser, BK; Szabo, PL; Tretter, EV; Trojanek, S | 1 |
Gao, L; Lu, HQ; Qin, XP; Yan, QJ; Yang, L; Zeng, SY | 1 |
Gao, T; Wang, F; Wang, J; Xie, M; Xue, J; Ye, H | 1 |
Chen, Y; Li, W; Ni, H; Shen, G; Wang, F; Wang, Y; Xu, S; Zhuge, Y | 1 |
Azushima, K; Fujikawa, T; Haku, S; Haruhara, K; Ishigami, T; Kinguchi, S; Kobayashi, R; Koguchi, T; Matsuda, M; Minegishi, S; Ohki, K; Tamura, K; Uneda, K; Wakui, H; Yamada, T; Yamaji, T; Yamashita, A | 1 |
Ba, L; Cao, Y; Chen, Y; Dong, C; Gao, J; Guan, X; Pan, H; Qi, H; Shi, P; Song, C; Sun, H; Zhang, Q | 1 |
Chen, R; Liu, P; Lu, Y; Qiao, C; Shao, C; Song, J; Wang, L; Wang, Z; Xie, Q; Yan, J; Yang, P | 1 |
Jing, L; Li, S; Wang, J; Zhang, G | 1 |
Andrades, ME; Biolo, A; Caetano, DSL; Clausell, N; Leitão, SAT; Lopes, A; Nascimento, TG; Pinto, GH; Rohde, LEP; Soares, DDS | 1 |
Chen, X; Li, P; Liu, C; Wang, L | 1 |
Henderson, J; Krishnamurthy, P; Luong, HT; Narasimhan, G; Qin, G; Rajasekaran, NS; Zhang, J | 1 |
Jia, CH; Wang, F; Xie, ML; Zhu, ZY | 1 |
Bi, HL; Cao, HJ; Han, L; Lai, S; Li, HH; Li, N; Wang, HX; Xie, X; Zhang, YL | 1 |
Gao, Y; Ma, ZC; Tan, HL; Wang, J; Wang, NN; Wang, YG | 1 |
Arad, M; Aravot, D; Hochhauser, E; Kornwoski, R; Nudelman, V; Peterson, SJ; Shainberg, A; Waldman, M; Zemel, R | 1 |
Becirovic-Agic, M; Hultström, M; Jönsson, S | 1 |
Deng, W; Fan, D; Huang, SH; Ma, ZG; Tang, QZ; Wan, CX; Wang, HB; Wu, HM; Wu, QQ; Xu, M | 1 |
Tang, L; Wang, J; Wen, Q; Zou, X | 1 |
Li, Q; Lin, L; Liu, X; Ni, Y; Qin, S; Wei, J; Zhang, C | 1 |
Chen, Y; Liang, J; Pan, R; Wu, F; Wu, G; Wu, Z; Xu, W; Yan, W; Zhang, H; Zhang, K | 1 |
Cao, C; Chang, J; Chen, X; Gao, E; Han, D; Li, J; Shen, D; Tang, J; Wang, B; Xiao, Y; Zhang, J; Zhao, W | 1 |
Duan, MX; Huang, R; Huang, SH; Liu, LB; Ma, ZG; Tang, QZ; Wan, CX; Wang, HB; Wu, QQ; Xu, M; Yang, J | 1 |
Hong, L; Lin, C; Lin, L; Liu, GY; Pan, YX; Peng, WW; Wang, SZ; Zhao, XL | 1 |
Feng, YQ; Geng, QS; Hu, ZQ; Huang, L; Huang, YQ; Shan, ZX; Yu, XJ; Zhu, JN | 1 |
Ding, J; Han, L; Hao, M; Li, M; Lin, L; Luo, B; Tang, Q; Yu, L; Zhang, L | 1 |
Han, Q; Li, H; Qin, D; Shi, H; Wang, L; Zhang, Y | 1 |
Chao, X; Chen, J; Geng, B; Le, K; Liu, P; Liu, Z; Luo, J; Xu, S; Ye, J; Zeng, S; Zou, J | 1 |
Itoh, N; Kinoshita, H; Kito, T; Konishi, M; Kuwahara, K; Matsumoto, E; Nakao, K; Ohta, H; Sasaki, S | 1 |
Fukumoto, Y; Kudo, S; Liao, JK; Minami, T; Nochioka, K; Shiba, N; Shimokawa, H; Takai, Y; Tanaka, S; Williams, CL | 1 |
Andersen, DC; Bie, P; Eskildsen, TV; Hansen, ML; Hansen, PB; Jensen, CH; Jeppesen, PL; Marcussen, N; Nossent, AY; Rasmussen, LM; Sandberg, MB; Schneider, M; Sheikh, SP | 1 |
Hirose, M; Ishigami, A; Kobayashi, A; Kubota, I; Misaka, T; Miyata, M; Saitoh, S; Shishido, T; Suzuki, S; Takeishi, Y | 1 |
Barreto-Chaves, ML; da Silva, IB; Gomes, DA; Tavares, FM | 1 |
Carretero, OA; Dai, X; González, GE; Leung, P; Liao, TD; Liu, Y; Nakagawa, P; Rhaleb, NE; Yang, XP | 1 |
Chu, ML; Dong, H; Khan, SA; Tsuda, T; Wu, J; Zhang, H | 1 |
Cao, WW; Chen, SR; Chen, X; Gao, H; Li, Q; Liu, PQ; Luo, JN; Wang, YH; Zeng, SY; Zou, J | 1 |
Herichová, I; Mravec, B; Neupauerová, D; Šoltésová, D; Szántóová, K; Veselá, A; Zeman, M | 1 |
Bu, L; Cheng, Z; Dong, D; Huang, T; Shen, B; Tu, Y; Wan, L; Zhao, D | 1 |
Amrit, B; Chen, H; Chen, X; Deng, X; Gong, L; He, S; Liu, K; Wang, S | 1 |
Henze, M; Monasky, MM; Soergel, DG; Solaro, RJ; Taglieri, DM; Utter, MS; Violin, JD; Warren, CM | 1 |
Currie, S; Grieve, DJ; Lawan, A; Martin, TP; Paul, A; Plevin, R; Robinson, E | 1 |
Aiello, EA; Cingolani, HE; Ennis, IL; Perez, NG | 2 |
Ishigami, A; Kobayashi, A; Kubota, I; Misaka, T; Miyata, M; Saitoh, S; Shishido, T; Suzuki, S; Takeishi, Y | 1 |
Bhuiyan, MS; Fukunaga, K; Tagashira, H | 1 |
Du, J; Han, QY; Jiang, X; Li, HH; Li, N; Tian, C; Wang, HX; Yang, H | 1 |
Allen, AM; Bassi, JK; Carter, DA; Chen, D; Choong, YT; Connelly, A; Head, GA; Jancovski, N; Lukoshkova, EV; Menuet, C; Nguyen, TP | 1 |
Du, Z; Gao, X; Han, H; Hang, P; Huo, R; Jiang, Y; Liu, Y; Lu, Y; Song, H; Sun, L; Wang, C; Wang, S; Wei, L | 1 |
Gao, PJ; Jin, HY; Lu, L; Oudit, GY; Penninger, JM; Shang, QH; Song, B; Xu, YL; Zhang, ZZ; Zhong, JC; Zhou, T; Zhu, DL | 1 |
Chien, WM; Chin, MT; Liu, Y; Luchtel, DL; Medvedev, IO; Rosenfeld, ME; Weldy, CS | 1 |
Gan, XT; Karmazyn, M; Thomas, A; Zeidan, A | 1 |
Abdul-Ghani, M; Brunette, S; Dick, SA; Fernando, P; Megeney, LA; Putinski, C; Stiles, R | 1 |
Chang, SK; Guo, LR; Liu, KX; Liu, Q; Sun, CW; Xuan, CL; Yao, FR | 1 |
Dalton, JT; Levin, ER; McKinsey, TA; Narayanan, R; Pedram, A; Razandi, M | 1 |
Banach, K; Burmeister, BT; Carnegie, GK; Conklin, BR; DeSantiago, J; Johnson, KR; Monasky, MM; Spindler, MJ; Taglieri, DM | 1 |
Sadoshima, J; Zablocki, D | 1 |
Hikoso, S; Murakawa, T; Nakayama, H; Nishida, K; Oka, T; Omiya, S; Otsu, K; Oyabu, J; Shah, AM; Takeda, T; Taneike, M; Ueda, H; Yamaguchi, O; Yasui, H | 1 |
Li, ZY; Xing, L; Yang, YH | 1 |
Aiello, EA; Caldiz, CI; Ciancio, MC; De Giusti, VC; Orlowski, A | 1 |
Chen, Y; Fan, GC; Jiang, DS; Jiang, XL; Li, H; Liu, Y; Yang, Q; Zhang, R; Zhang, XD; Zhang, Y | 1 |
Caldiz, CI; Cingolani, HE; Correa, MV; de Cingolani, GE; Ennis, IL; Nolly, MB | 1 |
Kang, YM; Qi, J; Qin, DN; Su, Q; Suo, YP; Yang, Q; Yu, XJ; Yue, LY; Zhang, DM; Zhu, GQ | 1 |
Bhuiyan, MS; Fukunaga, K; Shioda, N; Tagashira, H | 1 |
Čertíková Chábová, V; Červenka, L; Husková, Z; Kompanowska-Jezierska, E; Kramer, HJ; Kujal, P; Sadowski, J; Škaroupková, P; Tesař, V; Vaněčková, I; Vernerová, Z; Walkowska, A | 1 |
Hu, C; Huang, Y; Jiang, M; Lin, J; Tang, J; Wu, D; Wu, L; Zhang, X | 1 |
Chen, K; Chen, Y; Fan, GC; Gao, L; Gong, H; Jiang, DS; Li, H; Liu, PP; Liu, Y; Peng, J; Yang, Q; Zhang, XD; Zhang, XF; Zhang, Y; Zhou, H; Zou, Y | 1 |
Ku, HC; Su, MJ | 1 |
Du, J; Li, Y; Wang, C; Wu, Y; Zhang, C | 1 |
Barreto-Torres, G; Hernández, JS; Javadov, S; Khuchua, Z; Kuznetsov, AV | 1 |
Huang, F; Huang, H; Liu, Y; Tang, W; Wang, J; Wang, MH; Wang, T; Zhang, H; Zhang, K; Zhu, X | 1 |
Chen, XJ; Du, XN; Si, M; Wang, C; Xu, JX; Zhang, HL; Zhang, HR; Zhang, XD | 1 |
Chen, S; Chen, X; Fang, W; Gao, H; Gao, S; Geng, B; Li, H; Li, Z; Liu, M; Liu, P; Ma, Y; Ye, J; Yue, Z; Zhang, L; Zou, J | 1 |
Fujishima, Y; Funahashi, T; Hirata, A; Komura, N; Maeda, N; Matsuda, K; Mori, T; Nishizawa, H; Sekimoto, R; Shimomura, I; Tsushima, Y | 1 |
Chiu, CZ; Shyu, KG; Wang, BW | 1 |
Burger, D; Chibale, K; Mahajan, A; Reudelhuber, TL; Sturrock, ED; Touyz, RM | 1 |
Li, PF; Liu, CY; Liu, F; Long, B; Sun, T; Wang, K; Wang, Y; Yuan, SM; Zhang, XJ; Zhou, LY | 1 |
Ge, J; Lin, L; Liu, X; Tang, C; Wei, W; Weng, L; Xu, J; Ye, Y; Zou, Y | 1 |
Bezzerides, VJ; Rosenzweig, A; Ryall, KA; Saucerman, JJ | 1 |
Agarwal, D; Dange, RB; Francis, J; Masson, GS; Nair, A; Vila, J; Wilson, B | 1 |
Bai, Y; Han, JY; He, K; Huo, ZJ; Li, Q; Li, ZG; Pan, CS; Tian, GH; Wang, CS; Wei, XH; Yang, L; Zhang, YY; Zhou, CM | 1 |
Basu, R; Fan, D; Kandalam, V; Kassiri, Z; Lee, J; Oudit, GY; Patel, V; Takawale, A; Wang, X | 1 |
Dechend, R; Haase, N; Müller, DN; Przybyl, L; Qadri, F; Rugor, J | 1 |
Ai, D; Hammock, BD; Li, L; Li, N; Pang, W; Zhang, X; Zhu, Y | 1 |
Fan, YY; Li, N; Li, PF; Liu, CY; Liu, F; Long, B; Murtaza, I; Wang, K; Zhou, QY | 1 |
Cheng, C; Huang, H; Huang, J; Liu, B; Liu, S; Pan, W; Sun, W; Xiong, L; Ye, J; You, X; Zhong, Y | 1 |
Prathapan, A; Raghu, KG; Vineetha, VP | 1 |
Gong, H; Wang, S; Wu, J; You, J; Zhang, L; Zou, Y | 1 |
Charles, RL; Eaton, P; Freeman, BA; Hammock, BD; Kamynina, A; Morisseau, C; Prysyazhna, O; Rudyk, O; Yang, J | 1 |
Cavasin, MA; Chen, B; Demos-Davies, KM; Ferguson, BS; Ferrara, C; Horn, TR; Jeong, MY; Mahaffey, JH; McKinsey, TA; Piroddi, N; Poggesi, C; Scellini, B; Schuetze, KB; Spiltoir, JI; Tesi, C; Williams, SM | 1 |
Chen, GW; Li, Z; Li, ZM; Liu, M; Liu, PQ; Luo, HB; Wang, LP; Ye, JT | 1 |
Heymans, S; Westermann, D | 1 |
de Boer, RA; Frenay, AR; Hillebrands, JL; Leuvenink, HG; Pasch, A; Snijder, PM; van Goor, H | 1 |
Castro-Chaves, C; Einicker-Lamas, M; Lara, LS; Luna-Leite, MA; Luzardo, R; Madeira, C; Medei, E; Monnerat-Cahli, G; Paixão, AD; Panizzutti, R; Pereira-Acácio, A; Ribeiro, VS; Sampaio, LS; Silva, PA; Vieira-Filho, LD; Vieyra, A | 1 |
Huang, K; Ke, Y; Lei, M; Lin, WK; Liu, W; Solaro, RJ; Terrar, DA; Wang, R; Wang, X; Wang, Y; Zhang, Y | 1 |
Han, F; Lou, XF; Lu, YM; Sun, MM; Wang, P; Xie, YY; Zhang, BY; Zhang, C | 1 |
Aranega, AE; Franco, D; Hernandez-Torres, F | 1 |
Caluwé, E; Dymarkowski, S; Herijgers, P; Hermans, H; Herregods, MC; Janssens, S; Pokreisz, P; Swinnen, M | 1 |
Bin, J; Cao, S; Chen, C; Huang, X; Kitakaze, M; Li, G; Li, X; Liao, Y; Shen, L; Xu, D; Xuan, W; Zhang, J | 1 |
Cao, K; Cao, T; Chen, M; Gao, Z; Gu, L; Huang, H; Li, M; Yang, B | 1 |
Hayashi, M; Horimai, C; Yamashita, M; Yoshida, T | 1 |
Dopona, EP; Furukawa, LN; Heimann, JC; Katayama, IA; Oliveira, IB; Pereira, RC; Shimizu, MH | 1 |
Beavo, JA; Blaich, A; Desch, M; Domes, K; Hofmann, F; Lukowski, R; Patrucco, E; Rybalkin, SD; Sbroggió, M; Schlossmann, J | 1 |
Feng, X; Gao, S; Liu, P; Liu, Z; Wang, J; Xu, S | 1 |
Dasgupta, M; Karnik, SS; Stark, GR; Unal, H; Willard, B; Yang, J | 1 |
Li, J; Russell, B; Tanhehco, EJ | 1 |
Lin, L; Shan, H; Tan, W; Wei, J; Yan, R; Zhang, M; Zhang, R; Zhu, Y | 1 |
Chai, E; Qi, Y; Zhang, L; Zhang, Y; Zou, J | 1 |
Carretero, OA; D'Ambrosio, MA; Dai, X; González, GE; Leung, P; Liu, Y; Nakagawa, P; Peterson, EL; Rhaleb, NE; Yang, XP | 1 |
Shen, JH; Tan, JH; Wang, H; Xu, MC; Ying, H; Zhang, DF | 1 |
Chen, D; Chen, Q; Cheng, X; Fang, M; Gao, Y; Li, L; Liang, P; Weng, X; Wu, X; Xu, H; Xu, Y; Yang, Y; Yu, L; Zhang, T; Zhou, B | 1 |
Tan, Y; Yao, F; Zhang, N; Zhang, Q | 1 |
Du, J; Han, QY; Li, HH; Li, N; Li, WJ; Wang, HX; Xia, YL; Zhang, YL | 1 |
Aoki, Y; Imaizumi, T; Kai, H; Kudo, H; Takayama, N; Yasuoka, S | 1 |
Bian, Y; Cao, Y; Ding, L; Dou, L; Li, J; Lin, Y; Lu, Y; Man, Y; Qin, W; Ruan, Y; Shen, T; Wang, S; Xi, C; Xiao, C; Zhu, Y | 1 |
Chen, Q; Dai, X; Fang, M; Li, L; Liang, P; Weng, X; Wu, X; Xu, H; Xu, Y; Yu, L; Zhou, B | 1 |
Che, W; Guo, H; Hou, L; Jie, Q; Li, G; Liu, B; The, E; Wang, D; Wei, Y | 1 |
Fukai, T; Itoh, S; Matsuda, S; Matsuzaki, M; Murata, T; Umemoto, S; Yoshimura, K | 1 |
Guo, LR; Liu, KX; O'Rourke, ST; Sun, CW; Sun, WZ; Yan, W; Zhang, Q | 1 |
Sandgren, J; Scholz, TD; Segar, JL | 1 |
Chen, Q; Fan, Z; Fang, M; Ji, Y; Li, J; Li, L; Li, Y; Liang, P; Tian, W; Weng, X; Wu, X; Xu, H; Xu, Y; Yang, G; Yu, L | 1 |
Bian, ZY; Dai, J; Deng, W; Fang, Y; Li, FF; Tang, QZ; Wu, QQ; Xu, M; Yuan, Y; Zhang, JY; Zhou, H; Zong, J | 1 |
Chang, H; Sheng, JJ; Yu, ZB | 1 |
Cha, SA; Gao, S; Kim, SH; Park, BM | 1 |
Estes, AM; Gonzalez, FJ; Kara, M; Khan, NS; Li, W; Lin, Z; Malik, KU; Pingili, AK | 1 |
Eskurza, I; Hosooka, T; Jiang, H; Kahn, BB; Kraus, BJ; Lee, SA; Michel, T; Polak, P; Sartoretto, JL; Shiroto, T | 1 |
Andrés, V; Díez, J; González-Gómez, C; Guzmán-Martínez, G; Maraver, A; Orbe, J; Rivera-Torres, J; Serrano, M; Villa-Bellosta, R | 1 |
Deng, KQ; Gao, L; Jiang, DS; Jiang, X; Li, H; Luo, Y; Zhang, P; Zhang, XF; Zhao, GN; Zhu, X | 1 |
Flockerzi, V; Freichel, M; Jacobs, G; Kecskés, M; Kerselaers, S; Menigoz, A; Syam, N; Vangheluwe, P; Vennekens, R; Voets, T | 1 |
Birnbaumer, L; Camacho Londoño, J; Camacho Londoño, JE; Dietrich, A; Flockerzi, V; Freichel, M; Hammer, K; He, T; Kaestner, L; Laufs, U; Lipp, P; Mannebach, S; Mathar, I; Oberhofer, M; Philipp, SE; Reil, JC; Schröder, L; Schweda, F; Tabellion, W; Tian, Q | 1 |
Ma, N; Mei, J; Si, Y; Zhang, Y | 1 |
Chang, L; Guo, B; Jin, X; Li, Y; Liu, S; Miao, C; Wang, Y; Yan, J; Yang, R; Zhang, H | 1 |
Bork, N; Dünnes, S; Friebe, A; Gawaz, M; Lukowski, R; Nemer, M; Nikolaev, VO; Russwurm, M; Schöttle, V; Straubinger, J; Subramanian, H | 1 |
Chen, P; Li, X; Luo, J; Patterson, AJ; Xue, Q; Zhang, G | 1 |
Chong, S; Gang, C; Lihong, L; Qiang, C; Shifen, P; Xiangli, C | 1 |
August, BK; Balijepalli, RC; Hacker, TA; Keefe, AM; Markandeya, YS; Patel, HH; Phelan, LJ; Reynolds, CR; Roth, DM; Woon, MT | 1 |
Abboud, FM; Chapleau, MW; Cicha, MZ; Meyerholz, DK; Singh, MV | 1 |
Bian, ZY; Feng, H; Liao, HH; Ma, ZG; Tang, QZ; Yang, Z; Yuan, Y; Zhang, N | 1 |
Li, Q; Liu, P; Shen, P; Zeng, S | 1 |
Chen, X; Chen, Y; Dai, W; Huang, J; Lin, Y; Ou, D; Pan, W | 1 |
Chen, Y; Dong, P; Li, D; Li, L; Meng, F; Song, J; Wang, J; Yang, B; Zhang, L; Zhang, X | 1 |
Francis, J; Sriramula, S | 1 |
de la Serna, IL; Joe, B; Kumarasamy, S; Liu, L; Mehta, G; Walsh, A; Williams, K; Wu, J | 1 |
Chilton, L; Constantinoiu, C; Haleagrahara, N; Kinobe, R; Newton, P; Phie, J; Sarnyai, Z | 1 |
Böhm, M; Devaux, Y; Fries, P; Kazakov, A; Maack, C; Müller, A; Puhl, SL; Wagner, DR | 1 |
Alitalo, K; Andersson, LC; Anisimov, A; Cenni, B; Holopainen, T; Hulmi, JJ; Kivelä, R; Mervaala, E; Räsänen, M; Tavi, P; Tuomainen, T; Tvorogov, D; Zheng, W | 1 |
Bethmann, D; Gekle, M; Heise, C; Hünerberg, M; Mildenberger, S; Offermanns, S; Rabe, S; Schreier, B; Sibilia, M | 1 |
Abdelhamid, G; El-Kadi, AO; El-Sherbeni, AA; Elkhatali, S; Elshenawy, OH | 1 |
Cui, T; Janicki, JS; Li, B; Lyu, L; Nagarkatti, M; Nagarkatti, P; Qi, L; Qin, Q; Wang, H; Wang, XL | 1 |
Ge, J; Lin, L; Liu, X; Ren, J; Weng, L; Xu, J; Zou, Y | 1 |
Benedict, C; Garikipati, VN; Gumpert, AM; Johnson, J; Khan, M; Kishore, R; Koch, WJ; Krishnamurthy, P; Nickoloff, E; Verma, SK | 1 |
Ma, N; Si, Y; Zhang, Y | 1 |
Baker, KM; Guleria, RS; Gupta, S; Li, L; Pan, J; Thakur, S; Zhang, CL | 1 |
Cao, TN; Cordero-Reyes, AM; Gupte, AA; Hamilton, DJ; Li, S; Smith, JA; Torre-Amione, G; Vedula, I; Youker, KA; Zhang, A | 1 |
Li, X; Liang, G; Liu, Z; Peng, K; Qian, Y; Skibba, M; Tian, X; Wang, J; Xu, Z; Zou, C | 1 |
Dawn, B; Samanta, A | 1 |
Cha, HN; Choi, JH; Heo, JY; Jang, BI; Kwon, WY; Lee, IK; Park, SY | 1 |
Bian, ZY; Deng, W; Guo, H; Ni, J; Tang, QZ; Yuan, Y; Zhou, H | 1 |
Cai, X; Fu, Y; Gao, X; Guan, Y; Li, Y; Su, G; Wang, L; Wang, S | 1 |
Bloch, DB; Bloch, KD; Buys, ES; Cheng, J; Ernande, L; Kolodziej, SA; Leyton, PA; Mayeur, C; Rhee, DK; Scherrer-Crosbie, M; Shahid, M; Spagnolli, E; Tainsh, RE; Thoonen, R; Wu, MX; Zapol, WM | 1 |
Chen, L; Deng, K; Huang, J; Ji, Y; Jiang, X; Li, H; Ma, G; Wang, P; Zhang, X | 1 |
Chen, YH; Guo, K; Hou, JW; Li, CY; Li, YG; Wang, YP; Yang, LC; Zhou, Q | 1 |
Bai, J; Ding, L; Gu, R; Li, Q; Li, R; Wang, B; Wang, L; Xie, J; Xu, B | 1 |
Beqqali, A; Bitsch, N; de Windt, LJ; Hermans-Beijnsberger, S; Heymans, S; Nakagawa, S; Peters, T; Prasanth, KV; Schroen, B; van Oort, RJ | 1 |
Antunes, TT; Callera, GE; He, Y; Ryazanov, AG; Ryazanova, LV; Shrier, A; Stewart, DJ; Touyz, RM; Yogi, A; Zhai, A | 1 |
Han, CG; Liu, YX; Sheng, L; Yang, X; Ye, P | 1 |
Bakker, EN; Palao, T; Rippe, C; Swärd, K; van Veen, H; VanBavel, E | 1 |
Du, YM; Luo, J; Zhang, WD | 1 |
Cheng, M; Ding, J; Meng, W; Yu, L | 1 |
Fang, J; Gong, J; Guo, JH; Ji, YX; Li, H; Liu, HY; Wei, X; Zhao, GN; Zhu, X | 1 |
An, XZ; Chen, HZ; Chen, XF; Hao, DL; Liu, DP; Luo, YX; Tang, X; Xie, XM; Zhao, X | 1 |
Bao, JZ; Cao, Y; Gao, W; Liu, ZX; Lu, X; Wang, H; Wang, LS; Yang, Q; Zhang, L | 1 |
Chu, ML; Dong, H; Joyce, J; Khan, SA; Sasaki, T; Tsuda, T | 1 |
Ding, Z; Ge, J; Gong, H; Jiang, Q; Kang, L; Li, Y; Wang, S; Wang, X; Wu, J; Ye, Y; Yin, P; Yuan, J; Zhang, W; Zou, Y | 1 |
Levin, ER; Narayanan, R; Pedram, A; Razandi, M | 1 |
Dorri Mashhadi, F; Hafizi, Z; Jamhiri, M; Safari, F; Zare Mehrjardi, F; Zavvar Reza, J | 1 |
Hirano, T; Hiromura, M; Kawashima, H; Kogure, M; Kohashi, K; Kushima, H; Mori, Y; Nakano, Y; Negoro, T; Sato, K; Shinmura, K; Terasaki, M; Tomoyasu, M; Wachi, T; Watanabe, R; Watanabe, T; Yamada, Y | 1 |
Chen, YH; Hou, JW; Li, CY; Li, YG; Wang, H; Wang, Q; Wang, YP | 1 |
Chen, S; Ding, Y; He, P; Jiang, J; Li, Z; Liu, P; Lu, X; Ma, Y; You, J; Yue, Z | 1 |
Haag, M; Miteva, K; Müller, I; Pappritz, K; Ringe, J; Sittinger, M; Spillmann, F; Stachelscheid, H; Tschöpe, C; Van Linthout, S | 1 |
Ait-Aissa, K; Belmadani, S; Gabani, M; Haddox, S; Irani, K; Kassan, M; Mali, V; Matrougui, K; Radwan, E; Trebak, M; Zhang, W | 1 |
Eguchi, S; Elliott, KJ; Forrester, SJ; Kawai, T; Kwok, HF; Nuti, E; Obama, T; Rizzo, V; Rossello, A; Scalia, R; Takayanagi, T; Tsuji, T | 1 |
Billia, F; Grothe, D; Hauck, L | 1 |
Ding, H; Ding, S; Gao, L; He, B; Pu, J; Xu, L; Yao, T; Ying, X; Yuan, A; Zhao, Y | 1 |
Chen, HZ; Cui, SS; Liu, DP; Pei, JF; Tang, X; Yan, YF; Zhang, Y; Zhang, ZQ | 1 |
De Meyer, GR; Martinet, W; Roth, L; Schrijvers, DM | 1 |
Chang, CP; Chen, HS; Cheng, W; Feng, X; Han, P; Lin, CH; Quertermous, T; Shang, C; Yang, J; Zhou, Q | 1 |
Han, X; Ma, B; Zhou, L | 1 |
Ferro, A; Gu, Y; Han, Y; Ji, Y; Liu, J; Ma, Y; Meng, G; Moore, PK; Park, CM; Tang, X; Wang, H; Wang, R; Wang, X; Xian, M; Xiao, Y; Xie, L; Yu, Y; Zhang, Z | 1 |
Rao, SL; Wang, P; Yuan, YX; Zhu, XH | 1 |
Carrón, R; Gómez-Roso, M; Montero, MJ; Sevilla, MA | 1 |
Choi, YS; de Mattos, AB; Kim, M; Kolwicz, SC; Li, T; Nabben, M; Shao, D; Tian, R; Wang, W | 1 |
Bian, ZY; Deng, W; Jin, YG; Li, H; Shen, DF; Tang, QZ; Wang, SS; Wu, QQ; Yan, L; Yang, Z; Yuan, Y; Zeng, XF; Zhou, H | 1 |
Cheng, JD; Deng, CY; Fu, YH; Hu, ZQ; Lin, QX; Liu, FZ; Shan, ZX; Tang, CM; Wu, SL; Yang, H; Zheng, XL; Zhu, JN | 1 |
Bai, H; Ben, J; Chen, Q; Fang, R; Li, J; Li, K; Li, X; Lu, Y; Wang, Z; Yang, Q; Zhang, H; Zhang, J; Zhu, X | 1 |
Bu, P; Chen, T; Guo, X; Li, J; Li, N; Liu, H; Su, H; Wang, S; Xiao, M; Yan, F; Yang, Y; Zhang, Y | 1 |
Antoniak, S; Buczek, LJ; Cardenas, JC; Church, FC; Mackman, N; Pawlinski, R | 1 |
Geng, J; Liu, Q; Lu, D; Shan, Q; Wang, K; Wang, S; Zhang, B; Zhang, Q | 1 |
Li, F; Tang, Q; Wu, Q; Yang, Z; Yuan, Y; Zhang, N; Zhou, M; Zhu, J | 1 |
A, P; K G, R; Mathew, AK; Nair, A; Nair, RH; P, SR; S, A; Varghese, MV | 1 |
Gao, Y; Han, R; He, J; Kang, L; Li, C; Li, Y; Tian, J; Wang, J | 1 |
Ji, Y; Jing, H; Wang, D; Zhai, G | 1 |
Ding, F; Gao, M; Lu, R; Lu, Y; Luo, S; Mu, W; Shu, Y; Sun, F; Xu, C; Yang, T; Zhang, G; Zhao, W; Zhou, X; Zhuang, Y | 1 |
Boldt, K; Bork, N; Deng, L; Desch, M; Feil, R; Feil, S; Just, S; Krattenmacher, D; Kuret, A; Lukowski, R; Nemer, M; Ruth, P; Straubinger, J; Ueffing, M | 1 |
Huang, H; Kong, B; Li, Q; Liu, Y; Mei, Y; Peng, J; Quan, D; Wang, G; Wang, Z; Xiong, L; Xiong, X; Zhong, P | 1 |
Du, B; Gao, L; Huang, Z; Liu, Y; Wang, Z; Wu, L; Xiao, L; Yao, R; Zhang, D; Zhang, Y | 1 |
Chen, SR; Feng, GS; He, P; Huang, Y; Li, ZM; Liu, M; Liu, PQ; Lou, LL; Wang, PX; Zhu, CG | 1 |
Deng, ZR; Guang, GC; Yan, H; Zhang, Y | 1 |
Egashira, T; Fukuda, K; Hashimoto, H; Hayashi, K; Hayashiji, N; Ito, S; Kashimura, S; Kodaira, M; Kunitomi, A; Kusumoto, D; Lachmann, M; Motoda, C; Nagai, T; Nakanishi, C; Sakata, K; Seki, T; Shimojima, M; Takei, M; Tohyama, S; Yamagishi, M; Yozu, G; Yuasa, S | 1 |
Aiello, EA; Caldiz, CI; Chiappe de Cingolani, G; Cingolani, HE; Correa, MV; Dulce, RA; Ennis, IL; Garciarena, CD; Nolly, MB; Perez, NG; Villa-Abrille, MC; Yeves, AM | 1 |
Caglayan, E; Collins, AR; Erdmann, E; Hsueh, WA; Liu, J; Lyon, CJ; Peterson, LE; Rosenkranz, S; Ross, RS; Stauber, B; Tangirala, RK; Yin, F | 1 |
Bousquet, P; de Champlain, J; Jaffré, F; Laplante, MA; Maroteaux, L; Monassier, L | 1 |
He, XX; Liang, QS; Zhan, CY; Zhou, DX | 1 |
Hosoya, T; Ikeda, K; Ishikawa, M; Kawamura, M; Nakao, K; Otsubo, C; Tajima, N; Tojo, K; Tokudome, G; Udagawa, T | 1 |
Cui, W; Du, H; Li, N; Mao, W | 1 |
Bharadwaj, KG; Goldberg, IJ; Ikeda, S; Park, TS; Yamashita, H | 1 |
Aragon, AC; Carbett, E; Goens, MB; Walker, MK | 1 |
Ebrahimian, T; Sairam, MR; Schiffrin, EL; Touyz, RM | 1 |
Busk, PK; Hansen, AH; Haunsø, S; Hinrichsen, R | 1 |
Ainscough, JF; Ball, SG; Balmforth, AJ; Brooke, DA; Drinkhill, MJ; Sedo, A; Turner, NA | 1 |
Antonello, M; Ceolotto, G; Garbisa, S; Montemurro, D; Papparella, I; Rossi, G; Semplicini, A | 1 |
Chae, JK; Gul, R; Jang, KY; Kim, SY; Kim, UH; Ko, JK; Park, JH | 1 |
Alitalo, K; Andersson, LC; Bry, M; Hassinen, IE; Helkamaa, T; Jeltsch, M; Karpanen, T; Kivelä, R; Leskinen, H; Liimatta, E; Merentie, M; Mervaala, E; Ollila, HM; Oresic, M; Paavonen, K; Seppänen-Laakso, T; Ylä-Herttuala, S | 1 |
Bader, M; Baltatu, OC; Campos, LA; Iliescu, R; Oliveira, ML; Popova, E; Rentzsch, B; Santos, RA; Todiras, M | 1 |
Nattel, S; Van Wagoner, DR | 1 |
Borges, GR; Fazan, R; Prado, CM; Rossi, MA; Salgado, HC; Silva, CA | 1 |
Aranha, AB; Bader, M; Callera, GE; Ferreira, AJ; Mercure, C; Reudelhuber, TL; Santos, RA; Touyz, RM; Walther, T; Yogi, A | 1 |
He, X; Liang, Q; Zhan, C; Zhou, D | 1 |
Epstein, JA; Levin, MD; Liu, F; Lu, MM; Patel, VV; Petrenko, NB; Stout, AL; Wang, T; Yuan, LJ | 1 |
Li, H; Li, HZ; Li, QF; Shi, S; Sun, YH; Wang, R; Xu, CQ; Zhao, YJ | 1 |
Higashikuni, Y; Hirata, Y; Koibuchi, N; Kugiyama, K; Nagai, R; Nakamura, K; Nishimatsu, H; Sata, M | 1 |
Lazartigues, E; Lucchesi, PA; Stewart, JA | 1 |
Bian, Z; Cai, J; Lan, J; Ma, WZ; Shen, D; Tang, Q; Wang, W; Wang, YX; Yan, L; Zhuang, GQ | 1 |
Gu, ZL; Guo, CY; Sheng, R; Xie, ML; Zhou, WX | 1 |
Shyu, KG | 1 |
Campbell, KP; Chang, D; Chang, YT; Chen, CC; Chen, JJ; Chen, YC; Chen, YH; Chiang, CS; Chieng, H; Huang, CH; Shin, HS | 1 |
Ai, D; Chiamvimonvat, N; Hammock, BD; Jones, PD; Li, N; Pang, W; Shyy, JY; Xu, M; Yang, J; Zhang, Y; Zhu, Y | 1 |
Caldiz, CI; Chiappe de Cingolani, GE; Ennis, IL; Garciarena, CD; Portiansky, EL | 1 |
Ehrlich, BE; Heidrich, FM | 1 |
Bian, ZY; Cai, J; Ghosh, AK; Li, A; Li, H; Shen, DF; Tang, QZ; Yan, L; Yang, L; Yang, Q; Yang, XC; Yi, FF | 1 |
Brook, RD; Chen, LC; Mikolaj, M; Rajagopalan, S; Sun, Q; Wang, A; Xu, X; Ying, Z; Yue, P; Zhong, M | 1 |
Aplin, M; Christensen, GL; Hansen, JL | 1 |
Hong, LF; Lu, ZH; Ma, YX; Wen, Y; Xu, XJ; Zhang, XJ | 1 |
Chen, CX; Gao, JP; Gu, WL; Lü, J; Wang, Y | 1 |
Dechend, R; Elitok, S; Fischer, R; Gratze, P; Kleinewietfeld, M; Kvakan, H; Luft, FC; Muller, DN; Park, JK; Plehm, R; Qadri, F; Rahn, HP; Schwarz, I; Wellner, M | 1 |
Delbridge, LM; Domenighetti, AA; Egger, M; Gusev, K; Niggli, E; Pedrazzini, T | 1 |
Ernest, R; Li, Y; Luo, J; Wu, S; Yang, Q; Yang, Y; Yin, R; Zhelyabovska, O | 1 |
Bauersachs, J; Ertl, G; Fraccarollo, D; Galuppo, P; Hansen, JM; Jones, DP; Widder, JD | 1 |
Guo, WG; Li, RY; Liu, XT; Lu, ZF; Shi, XQ; Shu, Q; Su, FF; Yang, GD; Yuan, LJ; Zheng, QS | 1 |
Gondi, CS; Gopinath, S; Rao, JS; Vanamala, SK | 1 |
Granger, JP; Stec, DE; Vera, T | 1 |
Chilton, RJ; Lindsey, ML; Zamilpa, R | 1 |
Chow, FL; Cooper, SB; Fernandez-Patron, C; Kassiri, Z; Lopaschuk, GD; Odenbach, J; Oka, T; Wang, X | 1 |
Bader, M; Bürgelová, M; Cervenka, L; Dvorák, P; Kramer, HJ; Malý, J; Opocenský, M; Thumová, M; Vanourková, Z; Zelízko, M | 1 |
Dong, YF; Fukuda, M; Kaneko, T; Kataoka, K; Kim-Mitsuyama, S; Matsuba, S; Nakagata, N; Nakamura, T; Nako, H; Ogawa, H; Tokutomi, Y; Yamamoto, E | 1 |
Bergmann, MW; de Windt, L; Dietz, R; Gehrke, C; Noack, C; Renger, A; van der Nagel, R; Zafiriou, MP; Zelarayan, L | 1 |
Anderson, RH; Berger, F; Bodhey, NK; Falkenberg, J; Fedarava, K; Kozerke, S; Kuehne, T; Lunkenheimer, PP; Reischauer, C; Rothaus, K; Schmitt, B; Schnackenburg, B; Westermann, D | 1 |
Aizawa, Y; Gurusamy, N; Kodama, M; Muslin, AJ; Suzuki, K; Tachikawa, H; Thandavarayan, RA; Watanabe, K; Zhang, S | 1 |
Alenina, N; Bader, M; Dietz, R; Erdmann, B; Geier, C; Ghadge, SK; Morano, I; Morano, RD; Ozcelik, C; Panek, AN; Perrot, A; Popova, E; Posch, MG | 1 |
Hu, SJ; Li, L; Ye, Y | 1 |
Abdullah, MH; Abdullah, NA; Anand Swarup, KR; Fathihah, B; Johns, EJ; Khan, AH; Munavvar, AS; NurJannah, MH; Raisa, NA; Rathore, HA; Salman, IM | 1 |
Kurose, H; Nakaya, M; Nishida, M; Sato, Y | 1 |
Ahmad, S; Cesana, F; Gavras, H; Lamperti, E; Yu, J | 1 |
Fan, D; Li, L; Wang, C; Wu, LL; Zhang, ZG; Zhu, Y | 1 |
Akie, Y; Aritomi, S; Nakamura, Y; Nakayama, A; Satoh, Y; Sugiyama, A; Takahara, A; Wagatsuma, H | 1 |
Du, X; Liang, Y; Mao, Z; Sun, Z | 1 |
Abe, J; Beavo, JA; Blaxall, BC; Cai, Y; Chen, YF; Florio, V; Li, JD; Miller, CL; Nagel, DJ; Oikawa, M; Rybalkin, SD; Wojtovich, AP; Xu, H; Xu, X; Yan, C | 1 |
McLemore, GR; Ryan, MJ; Stec, DE; Storm, MV; Vera, T | 1 |
Ai, D; Shyy, JY; Zhu, Y | 1 |
Born, W; Brain, SD; Clark, N; Fischer, JA; Husmann, K; Keeble, J; Liang, L; Poston, R; Pozsgai, G; Shah, A; Siow, R; Tam, CW | 1 |
Takimoto, E | 1 |
Ardanaz, N; Carretero, OA; Cifuentes, ME; Haurani, MJ; Jackson, KW; Liao, TD; Pagano, PJ; Yang, XP | 1 |
Cheng, X; Furukawa, M; Li, P; Murohara, T; Nagata, K; Ohashi, T; Ouchi, N; Shibata, R; Shimano, M; Unno, K | 1 |
Almeida, PW; Bader, M; Campagnole-Santos, MJ; Gomes, ER; Guatimosim, S; Guimarães, D; Lara, AA; Resende, RR; Santos, RA | 1 |
Hu, D; Li, Y; Liu, N; Ren, L; Sheng, Z; Tang, R | 1 |
Brower, GL; Janicki, JS; Levick, SP; Murray, DB | 1 |
Biala, A; Eriksson, O; Finckenberg, P; Kaheinen, P; Lapatto, R; Lempiäinen, J; Louhelainen, M; Luft, FC; Martonen, E; Mattila, I; Merasto, S; Mervaala, E; Muller, DN; Oresic, M | 1 |
Ahmad, S; Davidoff, KS; Desjardins, DM; Ewen, EP; Gavras, H; Kielbasa, OM; Mathew, M; McCalmon, SA; Naya, FJ; Ohashi, K; Sato, K; Snyder, CM; Walsh, K | 1 |
Adler, GK; Coutinho, P; Guo, C; Lapointe, N; Loutraris, P; Pojoga, LH; Ricchiuti, V; Romero, JR; Stone, JR; Williams, GH; Yao, TM | 1 |
Crowley, SD; Griffiths, R; Kim, HS; Lin, EE; Ruiz, P; Song, YS | 1 |
Aihara, K; Akaike, M; Ikeda, Y; Ishikawa, K; Iwase, T; Matsumoto, T; Sata, M; Soeki, T; Sumitomo-Ueda, Y; Yagi, S; Yoshida, S | 1 |
Bai, Y; Dejima, T; Hirawa, N; Horiuchi, M; Ichihara, N; Ishigami, T; Kobayashi, Y; Maeda, A; Masuda, S; Matsuda, M; Minamisawa, S; Mogi, M; Shigenaga, A; Tamura, K; Tanaka, Y; Toya, Y; Umemura, S; Wakui, H; Yabana, M | 1 |
Anwar, MM; Euler, G; Heger, J; Piper, HM; Schiegnitz, E; von Waldthausen, D | 1 |
Chappell, MC; Ferrario, CM; Gallagher, PE; Ganten, D; Groban, L; Trask, AJ; Varagic, J; Westwood, BM | 1 |
Cai, Y; Ma, CG; Pan, CS; Qi, YF; Tang, CS; Yang, JH; Zhao, J | 1 |
Abramowitz, J; Baba, HA; Birnbaumer, L; Dietrich, A; Feil, R; Feil, S; Freichel, M; Gerling, A; Klaiber, M; Kruse, M; Kuhn, M; Londoño, JE; Penninger, JM; Pongs, O; Schröter, J; Völker, K | 1 |
Hu, Z; Liu, Y; Ma, C; Shi, H; Wu, D; Zhou, J | 1 |
Chen, C; Fu, Y; Wang, W; Wang, X; Yu, W | 1 |
Apablaza, F; Chiong, M; Godoy, I; Gonzalez, L; Hernandez, C; Jalil, JE; Lavandero, S; Lopez, R; Moya, J; Novoa, U; Ocaranza, MP; Pinto, M; Varas, M; Verdejo, H | 1 |
Biala, A; Finckenberg, P; Louhelainen, M; Martonen, E; Merasto, S; Mervaala, E; Muller, DN; Shi, J; Siltanen, A; Tauriainen, E | 1 |
Berké, B; Imam, G; Kerim, P; Moore, N; Tohti, I; Umar, A; Yimin, W | 1 |
Bruneval, P; Campbell, DJ; Karam, H; Ménard, J; Mullins, JJ | 1 |
Cheng, J; Du, J; Entman, ML; Haudek, SB; Hermosillo-Rodriguez, J; Taffet, GE; Trial, J; Wang, Y | 1 |
Adrahtas, A; Bertucci, MC; Cheung, RY; Krum, H; Ma, JY; Wang, BH | 1 |
Jiang, SY; Ma, XW; Xiao, H; Xu, M; Zhang, YY | 1 |
Alvin, Z; Haddad, GE; Laurence, G; Li, C; Zhao, A | 1 |
Gai, Y; Gao, W; Li, Z; Liu, F; Liu, X; Xu, M; Zhang, Y | 1 |
Cai, WF; Hu, ZW; Lv, XX; Ma, YG; Wang, QQ; Wang, XX; Wang, ZY; Xin, BM; Yan, HM; Yan, J; Yang, HZ; Zhang, XW | 1 |
Ai, W; Bai, X; Bian, ZY; Huang, H; Li, H; Liu, C; Tang, QZ; Yan, L; Yin, L; Zhang, Y | 1 |
Ge, J; Gong, H; Li, L; Niu, Y; Sun, A; Wu, J; Zhou, N; Zou, Y | 1 |
Bers, DM; Blatter, LA; Bodi, I; DeSantiago, J; Domeier, TL; Lorenz, JN; Maillet, M; Mikoshiba, K; Molkentin, JD; Nakayama, H | 1 |
An, W; Lin, Y; Liu, J; Yang, Y; Zang, W; Zhou, J | 1 |
Aihara, K; Akaike, M; Hirata, Y; Ikeda, Y; Ise, T; Ishikawa, K; Iwase, T; Kato, S; Matsumoto, T; Sata, M; Sumitomo-Ueda, Y; Uemoto, R; Yagi, S; Yoshida, S | 1 |
Cervenka, L; Husková, Z; Kramer, HJ; Kujal, P; Mrázová, I; Rakusan, D; Thumová, M; Vanecková, I; Vanourková, Z; Vernerová, Z | 1 |
Chen, SL; Chen, YL; Dong, YG; He, JG; Huang, YY; Ma, H | 1 |
Basu, R; Byrns, S; Chow, FL; Guo, D; Kassiri, Z; Loibner, H; Oudit, GY; Penninger, JM; Schuster, M; Wang, XH; Zhong, J | 1 |
Cao, Y; Duan, H; He, L; Zhan, Y; Zhang, Y | 1 |
Bestvater, BP; Fandrich, RR; Kardami, E; Ma, X; McNaughton, LJ; Netticadan, T; Nickel, BE; Santiago, JJ; Yu, L | 1 |
Casarini, DE; Coelho, MS; Ferreira, DN; Furukawa, LN; Heimann, JC; Katayama, IA; Oliveira, IB; Rosa, KT | 1 |
Dai, W; He, W; Jiang, J; Kong, W; Shang, G; Wang, Y | 1 |
Das, K; Estes, AM; Fang, XR; Farjana, N; Gonzalez, FJ; Jennings, BL; Malik, KU; Sahan-Firat, S | 1 |
Chang, H; Che, HL; Guo, WG; Song, Z; Wang, T; Wang, YY; Xie, MJ; Yu, ZB; Zhang, L | 1 |
Cervenka, L; Chábová, VČ; Husková, Z; Kompanowska-Jezierska, E; Kopkan, L; Kramer, HJ; Kujal, P; Malý, J; Netuka, I; Opočenský, M; Rakušan, D; Sadowski, J; Schejbalová, S; Skaroupková, P; Vaněčková, I; Vaňourková, Z; Vernerová, Z; Walkowska, A | 1 |
Bai, B; Chen, GP; Hu, SJ; Li, L; Mou, Y; Ye, Y | 1 |
Bian, ZY; Chen, M; Li, H; Liu, C; Liu, PP; Moon, M; Nghiem, MP; Tang, QZ; Wang, AB; Yan, L; Zhang, Y | 1 |
Ali, NN; Földes, G; Gorelik, J; Harding, SE; Liu, AQ; Merkely, B; Mioulane, M; Novak, P; Schneider, MD; Wright, JS | 1 |
Chow, FL; Cooper, S; Fernandez-Patron, C; Kassiri, Z; Lopaschuk, G; Odenbach, J; Oka, T; Wang, X | 1 |
Arthur, HM; Borthwick, GM; Watkins, SJ | 1 |
Ge, J; Gong, H; Jiang, G; Li, L; Lin, L; Ye, Y; Zhang, G; Zhou, N; Zou, Y | 1 |
Gao, W; Guo, Y; Li, L; Mi, L; Wang, X; Yu, H | 1 |
Domenighetti, AA; Egger, M | 1 |
Kaye, DM; Kelly, RA; Smith, TW | 2 |
Etienne-Selloum, N; Kane, MO; Keravis, T; Lugnier, C; Mokni, W; Schini-Kerth, VB; Walter, A | 1 |
Hu, YE; Wu, Y | 1 |
Chen, WY; Dai, G; Leng, XY; Li, CL; Sun, XT; Tang, LL; Zeng, WT | 1 |
Abdellatif, M; Ago, T; Sadoshima, J; Yang, Y; Zhai, P | 1 |
Harding, P; He, Q; Lapointe, MC; Yang, XP | 1 |
Cui, T; Janicki, JS; Li, J; Tang, DQ; Wang, XL; Xing, Y; Yamamoto, M; Zhang, C | 1 |
Audibert, F; Boivin, A; Fouron, JC; Le Ray, C; Leduc, L; Mercanti, I; Nuyt, AM; Vlieghe, V; Wo, B | 1 |
Imai, Y; Manabe, I; Nagai, R; Nakajima, A; Ohba, Y; Osawa, T; Takaoka, A; Taniguchi, T; Tsushima, K; Yanai, H | 1 |
Ai, D; Guan, YF; Li, N; Niu, XL; Pang, W; Zhu, Y | 1 |
Sun, H; Wang, Y | 1 |
Chen, T; Chin, MT; Dai, DF; Dorn, GW; Johnson, SC; Kang, YJ; Marcinek, DJ; Nieves-Cintrón, M; Prolla, TA; Rabinovitch, PS; Santana, LF; Villarin, JJ | 1 |
Berk, BC; Blaxall, BC; Cui, Z; Jaffré, F; Lu, Y; Menon, P; Mohan, A; Nigro, P; O'Dell, MR; Oikawa, M; Satoh, K; Soe, NN; Yan, C; Zeidan, A | 1 |
Chang, MH; Chu, CH; Hu, WS; Huang, CY; Lo, JF; Lu, RB; Tsai, CH; Tsai, FJ; Tzang, BS; Weng, YS | 1 |
Alvin, Z; Coleman, BR; Haddad, GE; Hajj-Moussa, M; Laurence, GG; Zhao, A | 1 |
Booz, GW; Kurdi, M | 1 |
Dai, DF; Rabinovitch, P | 1 |
Chen, J; Entman, ML; Lin, SC; Miao, Y; Taffet, GE; Wang, Y; Xu, J | 1 |
Jing, Q; Li, Q; Qin, YW; Song, XW; Wang, GK; Xu, XD | 1 |
Böhm, M; Maack, C | 1 |
Essick, EE; Ghobrial, J; Ohashi, K; Ouchi, N; Pimentel, DR; Sam, F; Shibata, R; Wilson, RM | 1 |
Alvin, ZV; Coleman, BR; Haddad, GE; Hajj-Moussa, M; Laurence, GG; Zhao, A | 1 |
Hoit, BD; Lee, HG; Liner, A; Richardson, SL; Smith, MA; Wolfram, JA; Zhu, X | 1 |
Chatterjee, A; Dutta, D; Mir, SA; Mitra, A; Pathak, K; Sarkar, S | 1 |
Coffman, TM; Crowley, SD; Griffiths, R; Herrera, M; Ruiz, P; Zhang, J | 1 |
Hanatani, A; Iwao, H; Izumi, Y; Muro, T; Nakamura, Y; Shimada, K; Shiota, M; Yamashita, N; Yamazaki, T; Yoshiyama, M | 1 |
Li, L; Li, ZZ; Su, DF; Wang, ZB; Wei, X; Yu, YS; Zhang, LC | 1 |
Chen, CX; Huang, XY; Li, YM; Liu, Y; Wu, XM; Zhang, XM | 1 |
Jiao, X; Jin, Z; Wang, J; Zhang, G; Zhang, W; Zhi, J | 1 |
Baumann, M; Eriksson, O; Finckenberg, P; Haasio, K; Kytö, V; Lalowski, MM; Levijoki, J; Luft, FC; Merasto, S; Mervaala, E; Muller, DN; Oresic, M | 1 |
Arthur, HM; Borthwick, GM; Oakenfull, R; Robson, A; Watkins, SJ | 1 |
Cartwright, EJ; Gui, J; Jin, J; Ke, Y; Lei, M; Liu, W; Naumann, R; Neyses, L; Prehar, S; Solaro, RJ; Taglieri, DM; Tsui, H; Ulm, S; Wang, X; Xiao, RP; Zi, M | 1 |
Barrick, CJ; Caron, KM; Dackor, RT; Lenhart, PM; Nagle, E | 1 |
Ann Tallant, E; Gallagher, PE; McCollum, LT | 1 |
Huang, J; Huang, X; Jin, H; Wang, D; Zheng, J | 1 |
An, L; Guo, X; He, L; Jia, J; Wu, J; Zhao, X; Zhu, H; Zou, Y | 1 |
Galatioto, J; Kamran, H; Lazar, JM; Liu, F; Mascareno, E; Pedrazzini, T; Rozenberg, I; Salciccioli, L; Siddiqui, MA | 1 |
Bustelo, XR; Campuzano, V; Coustets, M; Francke, U; Menacho-Márquez, M; Nevado, J; Pérez-Jurado, LA; Sánchez-Rodríguez, C; Segura-Puimedon, M; Terrado, V | 1 |
Cai, Y; Chen, SR; Ji, Y; Liu, PQ; Pi, RB; Shen, XY; Ye, JT; Yu, SS | 1 |
Adiarto, S; Emoto, N; Heiden, S; Nakayama, K; Vignon-Zellweger, N; Yagi, K; Yanagisawa, M | 1 |
Kato, J; Kida, N; Kitamura, K; Komatsu, Y; Kuwasako, K; Nagata, S; Nozaki, N | 1 |
Backs, J; Dierck, F; Frank, D; Frey, N; Katus, HA; Krebs, J; Kuhn, C; Lehmann, LH; Oehl, U; Will, R | 1 |
Cai, Y; Chen, SR; Gao, S; Li, H; Liu, PQ; Pi, RB; Ye, JT; Yu, SS | 1 |
Alexander, AE; Cao, AH; Irvine, JC; Kaye, DM; Kemp-Harper, BK; Lin, EQ; Love, JE; McMullen, JR; Patel, R; Ritchie, RH | 1 |
Ding, R; Frank, GD; Inagami, T; Landon, EJ; Pandolfi, PP; Rachakonda, A; Senbonmatsu, T; Tan, Z; Wang, N | 1 |
Du, ZM; Han, HM; Hang, PZ; Jiang, YN; Liu, Y; Pan, ZW; Song, HX; Sun, LH; Wang, S | 1 |
Chandrasekar, B; Clark, RA; Siddesha, JM; Siebenlist, U; Valente, AJ | 1 |
Chuah, M; Creemers, EE; Hiller, M; Leenders, JJ; Pinto, YM; Swinnen, M; van der Made, I; Vandendriessche, T; Wijnen, WJ | 1 |
Azibani, F; Chatziantoniou, C; Delcayre, C; Fazal, L; Samuel, JL | 1 |
Basu, R; Das, SK; Kassiri, Z; Lopaschuk, GD; McLean, BA; Mori, J; Oudit, GY; Patel, VB; Wagg, CS; Zhang, L | 1 |
Aoki, H; Imaizumi, T; Kyogoku, S; Minami, T; Nagata, T; Oba, T; Ohmura, H; Ohshima, H; Sugi, Y; Yasukawa, H | 1 |
Bartolomé, MV; Cachofeiro, V; Cordova, C; Delgado, C; Gómez-Hurtado, N; Jurado-López, R; Lahera, V; Martín, R; Martínez-Martínez, E; Miana, M; Nieto, ML; San Román, JA | 1 |
Binger, KJ; Bowman, EP; Dechend, R; Fokuhl, V; Kleinewietfeld, M; Kvakan, H; Markó, L; Müller, DN; Park, JK; Qadri, F; Spallek, B | 1 |
Aiello, EA; De Giusti, VC | 1 |
Feng, Y; Hans, C; Lazartigues, E; McIlwain, E; Varner, KJ | 1 |
Chang, C; Chen, HZ; Du, XD; Han, J; He, JP; Luo, J; Shan, ZG; Su, ML; Wang, RH; Wang, WJ; Wang, Y; Wu, Q; Xu, M; Zhang, N; Zhao, BX; Zhao, WX | 1 |
Chen, C; Dong, DL; Guo, WT; Huo, R; Li, CB; Li, N; Li, Y; Liu, HB; Sheng, Y; Sun, B; Xie, X; Yang, BF; Zhu, JX | 1 |
Cai, Y; Gao, S; Geng, B; Liu, M; Liu, P; Lu, J; Ye, J; Yu, S; Zhang, L; Zou, J | 1 |
Hiroi, Y; Ito, M; Li, Y; Liao, JK; Liu, PY; Noma, K; Okamoto, R; Taniguchi, M | 1 |
Chen, GP; Hu, SJ; Mou, Y; Yang, J; Ye, Y; Zhao, CZ; Zhu, HH | 1 |
Fujita, S; Hiroe, M; Hosotani, N; Imanaka-Yoshida, K; Ishizaka, N; Kitaura, Y; Kohda, Y; Nishioka, T; Otsuka, K; Shimojo, N; Tanaka, T; Terasaki, F; Yoshida, T | 1 |
Chu, SL; Gao, PJ; Guo, SJ; Jia, N; Li, XB; Li, YQ; Niu, WQ; Zhu, DL | 1 |
Crawford, JR; Duerrschmid, C; Entman, ML; Haudek, SB; Reineke, E; Taffet, GE; Trial, J | 1 |
Fu, FY; Lei, H; Li, L; Wang, C; Wang, JY; Wu, LL; Wu, LP; Zhang, ZG; Zhu, WG | 1 |
Booz, GW; Fuseler, JW; Hall, JE; Hamza, S; Kurdi, M; Lopez-Ruiz, A; Soljancic, A; Zgheib, C; Zouein, FA | 1 |
Alrob, OA; Harris, RA; Lopaschuk, GD; Mori, J; Oudit, GY; Wagg, CS | 1 |
Ban, T; Komeda, M; Nagata, K; Nakai, A; Nishizawa, J | 1 |
Dell'Italia, LJ; Husain, A | 1 |
Ichihara, S; Iwase, M; Izawa, H; Nagasaka, T; Nagata, K; Nakashima, N; Obata, K; Odashima, M; Somura, F; Yamada, Y; Yokota, M | 1 |
Azuma, J; Baba, A; Hattori, M; Komatsu, K; Nakamura, N; Ouyang, X; Takahashi, K | 2 |
Adachi, Y; Fukamizu, A; Garbers, DL; Harada, M; Izumi, T; Kawakami, R; Kishimoto, I; Kuwahara, K; Li, Y; Nakagawa, Y; Nakanishi, M; Nakao, K; Saito, Y; Takahashi, N; Tanimoto, K | 1 |
Inagaki, K; Iwanaga, Y; Kihara, Y; Mochly-Rosen, D; Onozawa, Y; Sarai, N; Takenaka, H | 1 |
Eckhart, AD; Greene, EA; Keys, JR; Koch, WJ | 1 |
Bader, M | 1 |
Chen, LY; Chen, PM; Li, P; Wang, SW | 1 |
Kobalava, ZhD; Korovina, EP; Kotovskaia, IuV; Moiseev, VS; Nosikov, VV; Timofeeva, SG | 1 |
Altruda, F; Brancaccio, M; De Acetis, M; Fratta, L; Guazzone, S; Hirsch, E; Lembo, G; Marino, G; Notte, A; Poulet, R; Silengo, L; Tarone, G; Vecchione, C | 1 |
Fu, MG; Tang, CS | 1 |
Araujo, RC; Bader, M; Borges, JC; Gomes, MA; Leite, KM; Lomez, ES; Pesquero, JB; Pesquero, JL; Silva, JA | 1 |
Dusting, GJ; Ritchie, RH; Rosenkranz, AC; Woods, RL | 1 |
Cheng, L; Jiang, MX; Li, XH; Xia, GJ; Yao, WX | 1 |
Cheng, ZJ; Finckenberg, P; Louhelainen, M; Merasto, S; Mervaala, EM; Tikkanen, I; Vapaatalo, H | 1 |
Cristol, JP; Delbosc, S; Jover, B; Mimran, A; Rugale, C | 1 |
Matsuoka, S; Nagaoka, M; Okamoto, H; Shimazu, E; Takano, M; Yayama, K | 1 |
De Smet, HR; Menadue, MF; Oliver, JR; Phillips, PA | 1 |
Adams, MA; Angelis, E; Pak, BJ; Pang, SC; Sangaralingham, SJ; Smallegange, C; Tse, MY | 1 |
Catt, KJ; Shah, BH | 1 |
Liao, JK; Nakagami, H; Takemoto, M | 1 |
Dechend, R; Finckenberg, P; Ganten, D; Lapatto, R; Luft, FC; Mervaala, E; Müller, DN; Park, JK; Vapaatalo, H | 1 |
Bond, R; Brinsa, TA; Dell'Italia, L; Diwan, A; Evans, K; Flesch, M; Höper, A; Mann, DL; Peshock, R; Sivasubramanian, N; Spinale, FG; Wei, CC | 1 |
Sweitzer, NK | 1 |
Fu, M; Liu, N; Pang, Y; Tang, C; Xu, S; Zhang, J | 1 |
Hattori, T; Higashi, M; Hiroki, J; Ichiki, T; Morikawa, K; Mukai, Y; Shimokawa, H; Takahashi, S; Takeshita, A | 1 |
Chamorro, V; Duarte, J; O'Valle, F; Osuna, A; Sainz, J; Vargas, F; Wangensteen, R | 1 |
Bendall, JK; Byrne, JA; Cave, AC; Gove, C; Grieve, DJ; Lambeth, JD; Li, JM; Shah, AM | 1 |
Ichijo, H; Iwao, H; Izumi, Y; Izumiya, Y; Kim, S; Matsuzawa, A; Yoshida, K; Yoshiyama, M | 1 |
Grayburn, PA; Hammer, RE; Kedzierski, RM; Kisanuki, YY; Richardson, JA; Schneider, MD; Williams, CS; Yanagisawa, M | 1 |
Delbridge, LM; Domenighetti, AA; Huggins, CE; Pedrazzini, T; Pepe, S | 1 |
Capuano, V; Coulombe, A; Deroubaix, E; Ferron, L; Renaud, JF; Ruchon, Y | 1 |
Ebihara, A; Hirata, Y; Iimuro, S; Iwata, H; Nagai, R; Niu, P; Shindo, T; Suematsu, Y; Takeda, N; Zhang, Y | 1 |
Cheng, ZJ; Finckenberg, P; Helkamaa, T; Lapatto, R; Louhelainen, M; Luft, FC; Männistö, P; Merasto, S; Mervaala, EM; Müller, DN; Rauhala, P; Reenilä, I | 1 |
Ding, B; Guo, ZG; Li, YX; Zhang, SQ | 1 |
Ahn, HY; Kim, CH; Kim, EG; Kim, HS; Sachinidis, A; Song, HJ; Zheng, Y | 1 |
Athirakul, K; Coffman, TM; Francois, H; Mao, L; Rockman, H | 1 |
Chan, P; Chen, JJ; Chen, YL; Cheng, TH; Lee, HM; Lee, WS; Liu, JC; Shih, NL | 1 |
Bai, H; Liu, J; Wu, LL; Xing, DQ; Zhao, YL | 1 |
Bedigian, MP; Lu, L; Robinson, AD; Sun, Y; Weber, KT; Zhang, J | 1 |
Asanuma, M; Emori, T; Kakishita, M; Kusano, K; Matsubara, H; Morita, H; Nakamura, K; Nakamura, Y; Ogawa, N; Ohe, T; Saito, H; Sugaya, T | 1 |
Ebihara, A; Hirata, Y; Iimuro, S; Iwata, H; Kangawa, K; Nagai, R; Niu, P; Shindo, T; Suematsu, Y; Takeda, N; Zhang, Y | 1 |
Sarkar, S; Sen, S; Vellaichamy, E; Young, D | 1 |
Dusting, GJ; Huynh, LP; Kaye, DM; Ritchie, RH; Rosenkranz, AC; Stephenson, T | 1 |
Shen, FM; Su, DF; Tao, X; Zhang, SH | 1 |
Hara, Y; Imaki, T; Naruse, M; Nishikawa, T; Sato, A; Takano, K; Tanabe, A; Tsuchiya, K | 1 |
Bruemmer, D; Collins, AR; Fishbein, MC; Hsueh, WA; Kim, S; Law, RE; Nicholas, S; Ross, RS; Schnee, J; Wang, W | 1 |
Cupesi, M; Gannon, J; Huang, H; Lee, RT; MacGillivray, C; Schulze, PC; Sylvan, JD; Yoshioka, J | 1 |
Akino, M; Denhardt, D; Jia, N; Kitabatake, A; Kon, S; Liu, L; Matsui, Y; Morimoto, J; Okamoto, H; Onozuka, H; Rittling, SR; Uede, T | 1 |
Takeda, Y | 1 |
Chen, CX; Shen, YH | 1 |
Akazawa, H; Fujita, T; Fukamizu, A; Iiri, T; Iwanaga, K; Kihara, M; Komuro, I; Kudoh, S; Makita, N; Minamino, T; Nagai, T; Qin, Y; Sano, M; Takano, H; Tamura, K; Toko, H; Umemura, S; Zhu, W; Zou, Y | 1 |
Iwasaka, T; Okigaki, M | 1 |
Davisson, RL; Lazartigues, E; Sharma, RV; Zimmerman, MC | 1 |
Chau, LY; Chen, YH; Chiang, MT; Hu, CM | 1 |
Mascareno, E; Mathew, S; Siddiqui, MA | 1 |
Cattini, PA; Hirst, CJ; Jiang, ZS; Jimenez, SK; Kardami, E; Sheikh, F; Zahradka, P | 1 |
Fujita, M; Hirata, A; Hori, M; Kitakaze, M; Liao, Y; Minamino, T; Nagamachi, Y; Nakatani, T; Ogawa, S; Okada, K; Ozawa, K; Takashima, S; Tomoike, H; Tsukamoto, O; Tsukamoto, Y; Yutani, C | 1 |
Eto, T; Kato, J; Tsuruda, T | 1 |
Hasegawa, H; Komuro, I | 1 |
Gómez-Fernández, P | 1 |
Black, MJ; Jones, ES; Widdop, RE | 1 |
Chan, HW; Hannan, RD; Osborne, JE; Smith, NJ; Thomas, WG | 1 |
Hao, DL; Huang, Y; Hui, RT; Li, HL; Liang, CC; Lin, M; Liu, DP; Liu, G; Liu, YQ; Wang, AB; Wei, C; Williams, GM; Zhang, CN | 1 |
Allessie, M; Blaauw, Y; Eijsbouts, S; Neuberger, HR; Schotten, U; van Hunnik, A; Verheule, S | 1 |
Wang, YX | 1 |
Hoshijima, M; Iwata, M; Kuroda, S; Maturana, A; Okajima, T; Tanizawa, K; Tatematsu, K; Van Lint, J; Vandenheede, JR | 1 |
Finckenberg, P; Lindgren, L; Louhelainen, M; Luft, FC; Merasto, S; Mervaala, EM; Müller, DN; Vapaatalo, H | 1 |
Li Volti, G | 1 |
Callera, GE; He, Y; Javeshghani, D; Lochard, N; Mercure, C; Reudelhuber, TL; Touyz, RM; Yao, G; Yogi, A | 1 |
Goldberg, AL; Izumiya, Y; Lecker, S; Maatz, H; Pimentel, D; Razeghi, P; Sandri, M; Sato, K; Schiekofer, S; Shiojima, I; Skurk, C; Taegtmeyer, H; Walsh, K; Zeng, L | 1 |
Curl, CI; Delbridge, LM; Domenighetti, AA; Huggins, CE; Morgan, TO; Pedrazzini, T; Porrello, ER | 1 |
du Toit, EF; Lochner, A; Nabben, M | 1 |
Choy, DF; da Cunha, V; Dole, WP; Halks-Miller, M; Johns, A; Li, W; Light, DR; Mahmoudi, M; Martin-McNulty, B; Schroeder, M; Vincelette, J; Wang, YX | 1 |
de Champlain, J; Laplante, MA; Wu, R | 1 |
Baurand, A; Bergmann, MW; Dietz, R; Dunger, S; El-Jamali, A; Freund, C; Loser, P; Scheidereit, C; Schmidt-Ullrich, R; Schneider, W | 1 |
Pagliaro, P; Penna, C | 1 |
Guo, ZQ; Wang, SR; Zhu, LQ | 1 |
Madeddu, P | 1 |
Hashikabe, Y; Hattori, Y; Kase, H; Nakanishi, N; Uchida, K | 1 |
Aihara, K; Akaike, M; Azuma, H; Fujimura, M; Hashizume, S; Ikeda, Y; Izawa, Y; Kato, M; Kato, S; Kawano, H; Matsumoto, T; Sato, T; Suzaki, Y; Tamaki, T; Yagi, S; Yoshizumi, M | 1 |
Ishida, H; Ito, H; Takemori, K | 1 |
Asai, T; Fujita, H; Kanmatsuse, K; Kushiro, T | 1 |
Booz, GW | 1 |
Delbridge, LM; Domenighetti, AA; Egger, M; Pedrazzini, T; Richards, SM; Wang, Q | 1 |
Averill, DB; Brosnihan, KB; Ferrario, CM; Schiffrin, EL; Smith, RD; Yokoyama, H | 1 |
Goens, MB; Lund, AK; Nuñez, BA; Walker, MK | 1 |
Li, T; Liu, X; Sun, S; Wang, Y; Xu, F | 1 |
Arimoto, T; Konta, T; Koyama, Y; Kubota, I; Niizeki, T; Shishido, T; Takahashi, H; Takeishi, Y | 1 |
Aiqun, M; Geru, W; Tao, G; Xiaojun, B; Yutao, X | 1 |
Carretero, OA; Liao, TD; Motivala, A; Peng, H; Peterson, EL; Rhaleb, NE; Vuljaj, N | 1 |
Feng, B; He, ZY; Liu, W; Xu, J; Yang, HB | 1 |
Iwao, H; Izumi, Y; Izumiya, Y; Kim-Mitsuyama, S; Namba, M; Wake, R; Yoshida, K; Yoshiyama, M | 1 |
Kim, HH; Liao, JK; Noma, K; Oyama, N; Rikitake, Y; Satoh, M; Wang, CY | 1 |
Akimoto, K; Hattori, Y; Kasai, K; Matsuoka, H; Nishikimi, T | 1 |
Abe, J; Arimoto, T; Endoh, M; Goto, K; Koyama, Y; Kubota, I; Nakajima, O; Niizeki, T; Nishimaru, K; Nozaki, N; Shiga, R; Shishido, T; Takahashi, H; Takeishi, Y; Walsh, RA | 1 |
Ahn, Y; Bang, YJ; Epstein, JA; Jeong, MH; Kee, HJ; Kim, JK; Kim, KK; Kim, N; Kook, H; Nam, KI; Park, JE; Qian, YR; Sohn, IS; Yin, Z | 1 |
Fujioka, D; Kawabata, K; Kitta, Y; Kobayashi, T; Kodama, Y; Kugiyama, K; Nakamura, T; Obata, JE; Saito, Y; Takano, H; Umetani, K | 1 |
Cui, W; Han, C; Jia, X; Li, N; Liu, C; Liu, Z; Mao, W; Song, Y; Wang, W; Zhang, W; Zhang, X | 1 |
Han, Z; Xiang, J; Yang, Y; Zhang, K | 1 |
Ikushima, M; Ito, N; Kaibe, M; Katsuya, T; Ogihara, T; Ohishi, M; Rakugi, H; Shiota, A; Sugano, S; Takeda, S; Tatara, Y; Yamamoto, K | 1 |
Aizawa, Y; Gurusamy, N; Hirabayashi, K; Kodama, M; Ma, M; Muslin, AJ; Prakash, P; Watanabe, K; Zhang, S | 1 |
Liu, ZP; Liu, ZQ; Song, Y; Zhang, XP | 1 |
Liu, YX; Sheng, L; Ye, P | 1 |
Gupta, M; Gupta, MP; Lang, R; Pillai, JB; Rajamohan, SB; Raman, J | 1 |
Kwiatkowski, DJ; Liao, JK; Mukai, Y; Ogita, H; Satoh, M; Takeshita, K | 1 |
Böhm, M; Custodis, F; Eberl, M; Kilter, H; Laufs, U | 1 |
Adachi, S; Isobe, M; Ito, H; Kitajima, S; Maejima, Y; Morikawa-Futamatsu, K; Suzuki, J; Tamamori-Adachi, M | 1 |
Abdallah, Y; Helmig, S; Piper, HM; Schäfer, C; Schlüter, KD; Wenzel, S | 1 |
Huang, Y; Hui, RT; Li, HL; Liang, CC; Liu, DP; Liu, G; Liu, YQ; Wang, AB; Wei, C; Wei, YS; Williams, GM; Zhang, CN | 1 |
Guo, WG; Xie, MJ; Yu, ZB | 1 |
Javadov, S; Karmazyn, M; Kirshenbaum, LA; Purdham, DM; Rajapurohitam, V | 1 |
Chappell, MC; Westwood, BM; Yamaleyeva, LM | 1 |
Tian, Y; Wang, J; Yu, LJ; Zhou, YZ; Zhu, SJ; Zhu, ZM | 1 |
Kim-Mitsuyama, S | 1 |
Galeotti, J; Holle, E; Liu, J; Sadoshima, J; Wagner, T; Yu, X; Zhai, P | 1 |
Iwanaga, Y; Kihara, Y; Kita, T; Takenaka, H | 1 |
Evangelista, FS; Krieger, JE | 1 |
Berenji, K; Castrillon, DH; Cheng, J; Dey, A; Gerard, RD; Hill, JA; Lu, G; Morris, DJ; Ni, YG; Oh, M; Rothermel, BA; Sachan, N; Wang, N | 1 |
Asada, Y; Eto, T; Imamura, T; Kato, J; Kitamura, K; Masuyama, H; Stasch, JP; Tsuruda, T | 1 |
Abriel, H; Boixel, C; Cefai, D; Domenighetti, AA; Pedrazzini, T | 1 |
Inoue, R; Kobayashi, H; Kurose, H; Mori, Y; Nagao, T; Nishida, M; Onohara, N; Sato, Y; Sumimoto, H | 1 |
Coles, JG; Dai, X; Du, C; Fedak, PW; Hannigan, G; Henkelman, M; Hinek, A; Husain, M; Lau, A; Lu, H; Mongroo, PS; Yamabi, H; Zhou, YQ | 1 |
Coffman, TM; Crowley, SD; Griffiths, R; Gurley, SB; Herrera, MJ; Kim, HS; Kumar, AP; Le, TH; Ruiz, P; Smithies, O | 1 |
Bolton, TA; Grobe, JL; Katovich, MJ; Lingis, M; Machado, JM; Mecca, AP; Raizada, MK; Shenoy, V; Speth, RC | 1 |
Alvarez, BV; Casey, JR; Johnson, DE; Karmazyn, M; Light, PE; Soliman, D; Sowah, D; Xia, Y | 1 |
Bu, DF; Li, YG; Liu, BG; Pang, YZ; Tan, XR; Tang, CS; Wang, DM; Wei, RH; Zhang, YG | 1 |
Sheng, L; Wu, SM; Yang, W; Ye, P | 1 |
Griffin, AJ; Gupta, M; Kumbar, DH; Muangmingsuk, S; Ocampo, C; VanBergen, A | 1 |
Cervenka, L; Husková, Z; Kolský, A; Kramer, H; Malý, J; Opocenský, M; Skaroupková, P; Thumová, M; Vanourková, Z; Vernerová, Z | 1 |
Averill, DB; Chappell, MC; Ferrario, CM; Ganten, D; Trask, AJ | 1 |
Ahuja, P; Ehler, E; Pedrazzini, T; Perriard, E; Perriard, JC; Satoh, S | 1 |
Chen, S; Huang, H; Li, R; Liu, P; Tang, F; Wang, P; Zhang, H | 1 |
Chen, H; Feng, J; Li, S; Liang, Q; Wang, Z; Yan, L; Yang, L; Yao, S; Zheng, Z; Zhou, D; Zou, X | 1 |
Cingolani, HE; Ennis, IL | 1 |
Baurand, A; Bergmann, MW; Betney, R; Birchmeier, W; Busjahn, A; Dietz, R; Dunger, S; Gehrke, C; Huelsken, J; Noack, C; Taketo, MM; Zelarayan, L | 1 |
Dechend, R; Dietz, R; Fiebeler, A; Fischer, R; Gapelyuk, A; Gratze, P; Gruner, A; Gruner, K; Luft, FC; Muller, DN; Qadri, F; Schirdewan, A; Shagdarsuren, E; Wellner, M | 1 |
Li, HL; Li, TB; Liu, DP; She, ZG; Wang, AB; Wang, YG; Wei, YS; Yang, Q | 1 |
Anning, PB; Baalasubramanian, S; Coles, B; Lewis, R; Morgan, BP; Morton, J; O'Donnell, VB | 1 |
Chen, H; Cheng, Y; Dean, DB; Ji, R; Liu, X; Yang, J; Yue, J; Zhang, C | 1 |
Pandey, KN; Somanna, N; Vellaichamy, E; Zhao, D | 1 |
Coles, B; Fielding, CA; Jones, SA; O'Donnell, VB; Rose-John, S; Scheller, J | 1 |
Delbosc, S; Jover, B; Mimran, A; Rugale, C | 1 |
Gao, GD; Lin, YX; Liu, JJ; Xu, X; Zhou, J | 1 |
Fukunaga, K; Han, F; Kasahara, J; Lu, YM; Moriguchi, S; Qin, ZH; Shioda, N; Shirasaki, Y | 1 |
Anéas, I; Carmo, EC; Frimm, C; Hashimoto, NY; Krieger, JE; Negrão, CE; Oliveira, EM; Rocha, FL; Roque, FR; Rossoni, LV | 1 |
Bak, S; Coleman, T; Osher, E; Semenkovich, CF; Stern, N; Tordjman, KM; Vechoropoulos, M; Yudovich, R | 1 |
Ishikawa, K; Kamiyama, Y; Kimura, S; Kobayashi, A; Maruyama, Y; Matsumoto, H | 1 |
Frank, D; Frey, N; Gehring, D; Hanselmann, C; Katus, HA; Kuhn, C; Lippl, S; van Eickels, M; Will, R | 1 |
Bernstein, EA; Bernstein, KE; Campbell, DJ; Fuchs, S; Li, P; Xiao, HD | 1 |
Akazawa, H; Komuro, I; Qin, Y; Yasuda, N; Zou, Y | 1 |
Carretero, OA; Harding, P; Peng, H; Pokharel, S; Rasoul, S; Rhaleb, NE; Sharma, U | 1 |
Yang, L; Yao, SL; Zou, XJ | 1 |
Baker, KM; Kumar, R; Singh, VP | 1 |
Han, CG; Liu, YX; Sheng, L; Ye, P; Zhang, ZY | 1 |
Li, HZ; Lin, Y; Lv, YJ; Tian, Y; Wang, C; Wang, LN; Xi, YH; Xu, CQ; Yang, BF; Zhang, WH; Zhao, YJ | 1 |
An, J; Dietz, R; Endres, M; Gertz, K; Harms, C; Hauck, L; Rohne, J; von Harsdorf, R | 1 |
Balestrasse, KB; Gorzalczany, S; Noriega, GO; Polizio, AH; Taira, C; Tomaro, ML; Yannarelli, GG | 1 |
Chang, H; Kuan, P; Shyu, KG; Wang, BW | 1 |
Levin, ER; Liu, J; Lubahn, D; Pedram, A; Razandi, M; Vannan, M | 1 |
Francis, J; Haque, M; Majid, DS; Sriramula, S | 1 |
Leenen, FH; Liang, B | 1 |
Ehrlich, BE; Estrada, M; Giordano, FJ; Heidrich, FM; Huang, Y; Zhang, K | 1 |
Hou, Y; Matsuo, O; Okada, K; Okamoto, C; Ueshima, S | 1 |
Burchette, JL; Coffman, TM; Crowley, SD; Frey, CW; Gould, SK; Griffiths, R; Howell, DN; Kim, HS; Makhanova, N; Ruiz, P; Tharaux, PL; Yan, M | 1 |
Khairallah, P; Saragoca, M; Sen, S; Tarazi, RC | 1 |
Abrahams, JM; Johnston, CI; Woods, RL | 1 |
Berglund, G; Hartford, M; Ljungman, S; Wallentin, I; Wikstrand, J; Wilhelmsen, L | 1 |
Greenlees, KJ; Migally, N; Tucker, A; Wright, ML | 1 |
Hill, NS; Ou, LC | 1 |
Doussau, MP; Giudicelli, JF; Richer, C | 1 |
Ishiye, M; Nakashima, M; Uematsu, T; Umemura, K | 2 |
Lee, YA; Lindpaintner, K; Raman, VK | 1 |
Fareh, J; Schiffrin, EL; Thibault, G; Touyz, RM | 2 |
Kawamura, K; Kubota, J; Mori, T; Nishimura, H; Ueyama, M | 1 |
Fronhoffs, S; Luyken, J; Neyses, L; Nouskas, J; Oberdorf, S; Pfeifer, U; Sukhatme, VP; Vetter, H; Williams, RS | 1 |
Rabkin, SW | 1 |
Abassi, ZA; Cuda, G; Golomb, E; Keiser, HR; Panchal, VR; Stylianou, M; Trachewsky, D | 1 |
Rabkin, SW; Sunga, PS | 3 |
Dillmann, WH; Kim, NN; Lee, AA; Printz, MP; Villarreal, FJ | 1 |
Parker, TG | 1 |
Ikenouchi, H; Kinugawa, K; Kohmoto, O; Serizawa, T; Takahashi, T; Yao, A | 1 |
Izumo, S; Sadoshima, J | 3 |
Iwai, N; Kinoshita, M; Shimoike, H | 1 |
Hiroi, Y; Komuro, I; Kudoh, S; Mizuno, T; Shiojima, I; Takano, H; Tobe, K; Ueki, K; Yamazaki, T; Zou, Y | 2 |
Rao, MR; Tao, L; Wang, HX | 1 |
Lorell, BH | 3 |
Xu, S; Zhang, Y | 1 |
Chatani, F; Hamaguchi, A; Inada, Y; Ishimura, Y; Iwao, H; Kim, S; Miura, K; Ohta, K; Omura, T; Yukimura, T | 1 |
Li, JS; Schiffrin, EL | 1 |
Besse, P; Bonoron-Adèle, S; Gouverneur, G; Sempé, S; Stuyvers, B; Tariosse, L | 1 |
Chien, KR; Hunter, JJ; Lembo, G | 1 |
Bezstarosti, K; De Jonge, HW; Lamers, JM; Sharma, HS; Van Heugten, HA; Verdouw, PD | 1 |
Liu, LS; Zhang, YH | 1 |
Hamaguchi, A; Iwao, H; Kim, S; Miura, K; Ohta, K; Yukimura, T | 1 |
Bertram, JF; Black, MJ; Bobik, A; O'Sullivan, JB | 1 |
Cao, ZP; Gao, GD; Liu, J; Lu, X; Tian, B | 1 |
Pollack, PS | 1 |
Cade, JR; Fregly, MJ; Hegland, D; Rossi, F; Sun, Z; Tümer, N; Yürekli, M | 1 |
Eguchi, S; Hirata, Y; Kanno, K; Kano, H | 1 |
Dohi, K; Iwano, M; Kagoshima, T; Konishi, N; Masuda, J; Nakamura, Y; Sakaguchi, Y; Sutani, T; Tsuchihashi, M; Tsuruta, S | 1 |
Hughes, AD; Ibrahim, J; Schachter, M; Sever, PS | 1 |
Falkenhahn, M; Gohlke, P; Paul, M; Stoll, M; Unger, T | 1 |
Fish, AF | 1 |
Haneda, T; Miyata, S | 1 |
Diamant, D; Ingelfinger, JR; Lopez, JJ; Lorell, BH; Schunkert, H; Tang, SS; Weinberg, EO | 1 |
Sano, H | 1 |
Brecher, P; Chobanian, AV; Crawford, DC | 1 |
Pouleur, H | 1 |
Everett, AD; Fisher, A; Gomez, RA; Tufro-McReddie, A | 1 |
Chiu, AT; Herblin, WF; Smith, RD; Timmermans, PB; Wong, PC | 1 |
Leenen, FH; Ruzicka, M | 1 |
Izumo, S; Sadoshima, J; Slayter, HS; Xu, Y | 1 |
Dillmann, WH; Kim, NN; Printz, MP; Ungab, GD; Villarreal, FJ | 1 |
Andreasen, F; Böttcher, M; Christiansen, EH; Tian, R | 1 |
Adachi, S; Hirata, Y; Hiroe, M; Ito, H; Koike, A; Murumo, F; Nogami, A; Tanaka, M; Tsujino, M | 1 |
Inada, M; Matsubara, H; Suzuki, J; Urakami, M | 1 |
Sakata, Y | 1 |
Dzau, VJ | 1 |
Casley, DJ; Doyle, AE; Harrap, SB; Mirakian, C; Mitchell, GA | 1 |
Harmsen, E; Leenen, FH; Ruzicka, M; Yuan, B | 1 |
Dillmann, WH; Lee, AA; McCulloch, AD; Villarreal, FJ | 1 |
Komuro, I; Kudoh, S; Takano, H; Yamazaki, T; Yazaki, Y; Zou, Y | 1 |
Anderson, NH; Bohr, DF; Devlin, AM; Dominiczak, AF; Lee, WK; Reid, JL | 1 |
Adachi, S; Akimoto, H; Fujisaki, H; Hata, M; Hiroe, M; Ito, H; Lin, M; Marumo, F; Tanaka, M | 1 |
Fitzpatrick, F; Goulet, JL; Höper, M; Koller, BH; Lepley, RA; Tuder, RM; Voelkel, NF; Wade, K | 1 |
Ganten, D; Nishimura, H; Urata, H | 1 |
Damen, JE; Goutsouliak, V; Krystal, G; Rabkin, SW | 1 |
Brunner, HR; Waeber, B | 1 |
Batlouni, M | 1 |
Sesin, J; Tamargo, J | 1 |
Heagerty, AM; Hollis, S; MacDiarmaid-Gordon, A; Ohanian, V; Roffe, C | 1 |
Iyer, SN; Katovich, MJ | 1 |
Haneda, T; Kikuchi, K; Miyata, S; Osaki, J | 1 |
Baker, KM; Booz, GW | 2 |
Lee, MA; Lee, YA; Liang, CS; Lindpaintner, K | 1 |
Perryman, MB; Raynolds, MV | 1 |
Fukamizu, A; Horiguchi, H; Ishida, J; Murakami, K; Sugiyama, F; Takimoto, E | 1 |
Carl, LL; Giger, KE; Hannan, R; Watson, PA | 1 |
Kawaguchi, H; Kitabatake, A | 1 |
Komuro, I; Shiojima, I; Yamazaki, T; Yazaki, Y | 3 |
Bauer, B; Bauer, WR; Ertl, G; Hu, K | 1 |
Abe, K; Jiang, ZL; Johnston, CI; Kamimoto, M; Kanazawa, M; Kohzuki, M; Sato, T; Wu, XM; Yasujima, M; Yoshida, K | 1 |
Barry, WH; Ito, N; Kagaya, Y; Lorell, BH; Weinberg, EO | 1 |
Gallagher, AM; Klett, CP; Palmer, A; Printz, MP; Rioseco-Camacho, N | 1 |
Boddi, M; Modesti, PA; Neri Serneri, GG | 1 |
Böhm, MP; Knorr, A; Laufs, U; Nickenig, G; Paul, M; Schnabel, P | 1 |
Bertram, JF; Black, MJ; Briscoe, T; Jackson, B; Johnston, CI | 1 |
Anderson, PG; Berecek, KH; Bishop, SP; Regan, CP | 1 |
Arai, M; Iso, T; Kogure, K; Nagai, R; Suzuki, T; Wada, A | 1 |
Balcells, E; Bishop, SP; Cartee, RE; Dell'italia, LJ; Dillon, R; Hankes, GH; Machida, N; Meng, QC; Oparil, S; Schultz, D; Straeter-Knowlen, IM; Su, X | 1 |
Bezstarosti, K; Dekkers, DH; Eskildsen-Helmond, YE; Lamers, JM; van Heugten, HA | 1 |
Arnold, G; Böhm, M; Flesch, M; Hirth-Dietrich, C; Paul, M; Pinto, Y; Rosenkranz, S; Schiffer, F; Zolk, O | 1 |
Black, MJ; Bobik, A; Kanellakis, P | 1 |
Cavaillon, JM; Charlemagne, D; Corda, S; Fitting, C; Gandolfini, MP; Marotte, F; Mebazaa, A; Payen, D; Peynet, J; Rappaport, L; Samuel, JL | 1 |
Harada, M; Igaki, T; Itoh, H; Kuwahara, K; Masuda, I; Miyamoto, Y; Nakagawa, O; Nakao, K; Ogawa, E; Ogawa, Y; Saito, Y; Tanaka, I; Yamashita, J; Yoshimasa, T | 1 |
Borg, TK; Carver, W; Fu, L; Price, RL; Simpson, DG; Terracio, L; Zhao, J | 1 |
Pelech, SL; Rabkin, SW; Sanghera, JS; Sunga, PS | 1 |
Fukuda, K; Hori, S; Kodama, H; Makino, S; Ogawa, S; Pan, J; Sano, M; Takahashi, T | 1 |
Kimura, M; Nakashima, M; Ohashi, K; Umemura, K | 1 |
Iwao, H; Kim, S | 1 |
Aikawa, R; Komuro, I; Kudoh, S; Nagai, R; Uozumi, H; Yamazaki, T; Yazaki, Y; Zou, Y | 1 |
Carabello, BA; Coffman, TM; Cooper, G; DeFreyte, G; Hamawaki, M; Koide, M; Lashus, A; Oliverio, MI; Zile, MR | 1 |
Iizuka, K; Kawaguchi, H; Kitabatake, A; Murakami, T; Okamoto, H; Sano, H | 1 |
Harada, K; Kijima, K; Komuro, I; Kudoh, S; Matsubara, H; Murakami, K; Sugaya, T; Yazaki, Y; Zou, Y | 1 |
Antos, CL; Grant, SR; Lu, JR; Markham, B; Molkentin, JD; Olson, EN; Richardson, J; Robbins, J | 1 |
Dhar, M; Mascareno, E; Siddiqui, MA | 1 |
Fukamizu, A; Goto, K; Kobayashi, T; Maeda, S; Maki, S; Miyauchi, T; Murakami, K; Sakai, S; Sugishita, Y; Sugiyama, F; Takata, Y | 1 |
Harada, K; Hayashi, D; Kijima, K; Komuro, I; Kudoh, S; Matsubara, H; Mizuno, T; Murakami, K; Shiojima, I; Sugaya, T; Yazaki, Y | 1 |
Aubert, JF; Brunner, DB; Brunner, HR; Gabbiani, G; Mazzolai, L; Nussberger, J; Pedrazzini, T | 1 |
Anversa, P; Cheng, W; Kajstura, J; Leri, A; Li, B; Liu, Y; Wang, X | 1 |
Azuma, J; Azuma, M; Baba, A; Schaffer, S; Takahahsi, K | 1 |
Rao, MR; Tao, L | 1 |
Aass, H; Bishopric, N; Fowler, M; Geiran, O; Gullestad, L; Haywood, G; Kjekshus, J; Ross, H; Simonsen, S; Ueland, T; Yee, G | 1 |
Fushimi, K; Kouchi, H; Mihara, K; Miyazaki, M; Nakamura, K; Namba, M; Ohe, T | 1 |
Beardslee, MA; Beyer, EC; Darrow, BJ; Dodge, SM; Green, KG; Saffitz, JE | 1 |
LaPointe, MC; Marsh, JD; Ritchie, RH; Schiebinger, RJ | 1 |
Iwao, H; Izumi, Y; Kim, S; Yamanaka, S; Yano, M | 1 |
Baker, KM; Dostal, DE | 2 |
Gorodetskaya, EA; Kalenikova, EI; Medvedev, OS; Shechter, AB; Zacharova, NV | 1 |
Sasayama, S | 1 |
Holtz, J | 1 |
Hayashi, M; Ichihara, A; Kobori, H; Miyashita, Y; Saruta, T | 1 |
Komuro, I; Yamazaki, T; Yazaki, Y | 2 |
Fukamizu, A; Ishikawa, K; Kai, T; Kurooka, A; Murakami, K; Shimada, S; Sugimura, K; Takenaka, T | 1 |
Delbridge, LM; Morgan, TO | 1 |
Gray, MO; Kalinyak, JE; Karliner, JS; Li, HT; Long, CS | 1 |
Cardinal, R; de Champlain, J; K-Laflamme, A; Oster, L | 1 |
Meissner, A; Min, JY; Simon, R | 1 |
Aikawa, R; Kadowaki, T; Komuro, I; Kudoh, S; Yamazaki, T; Yazaki, Y; Zhu, W; Zou, Y | 1 |
Carraway, JW; Holycross, BJ; McCune, SA; Park, S; Radin, MJ | 1 |
Ishikawa, K; Kai, T; Kurooka, A; Shimada, S; Sugimura, K | 1 |
Anastasopoulos, F; Briscoe, TA; Campbell, DJ; Duncan, AM; James, GM; Kladis, A | 1 |
Khirmanov, VN; Moiseeva, OM; Pinaev, GP; Polevaia, EV; Selivanova, GV; Semenova, EG; Vlasova, TD | 1 |
Bradley, WE; Dell'Italia, LJ; Durand, J; Farrell, DM; Hageman, GR; Hankes, GH; Meng, QC; Oparil, S; Palmer, R; Wei, CC | 1 |
Aupetit-Faisant, B; Carayon, A; Delcayre, C; Heymes, C; Oubénaïssa, A; Robert, V; Silvestre, JS; Swynghedauw, B | 1 |
Fukuda, K; Kato, T; Kodama, H; Matsuzaki, J; Ogawa, S; Pan, J; Saito, M; Sano, M; Takahashi, T | 1 |
Balaev, VV; Drozdova, GA; Frolov, VA; Mustiatsa, VF; Rieger, P | 1 |
Phillips, PA | 1 |
Dusting, GJ; Ritchie, RH; Rosenkranz, AC | 1 |
Haneda, T; Kashiwagi, Y; Kawabe, J; Kikuchi, K; Nakamura, Y; Oi, S; Osaki, J | 1 |
Ghatpande, S; Goswami, S; Mascareno, E; Siddiqui, MA | 1 |
Bastien, NR; Gutkowska, J; Lambert, C; Meloche, S; Servant, MJ | 1 |
Drexler, H; Wollert, KC | 1 |
Cody, RJ; Goetze, S; Graf, K; Hsueh, WA; Kawano, H; Kawano, Y; Law, RE; Schnee, J | 1 |
Bader, M; Baltatu, O; Ganten, D; Silva, JA | 1 |
Aoki, H; Izumo, S; Sadoshima, J | 1 |
De Windt, LJ; Lim, HW; Molkentin, JD; Taigen, T | 1 |
Bader, M; Breu, V; Ganten, D; Gross, V; Haller, H; Luft, FC; Mervaala, E; Müller, DN; Park, JK; Schmidt, F | 1 |
Cingolani, HE | 1 |
Hata, T; Makino, N; Ohtsuka, S; Sawada, S; Sugano, M | 1 |
Aoki, H; Izumo, S; Richmond, M; Sadoshima, J | 1 |
Hsueh, WA; Schnee, JM | 1 |
Demura, M; Mabuchi, H; Miyamori, I; Takeda, Y; Yoneda, T | 2 |
Bristow, J; Friddle, CJ; Koga, T; Rubin, EM | 1 |
Fukuda, K; Kato, T; Kodama, H; Makino, S; Matsuzaki, J; Ogawa, S; Pan, J; Saito, M; Sano, M; Takahashi, T | 1 |
Ferrario, CM; Gelband, CH; Katovich, MJ; Pachori, AS; Raizada, MK; Wang, H | 1 |
Oriji, GK | 1 |
Gerdes, AM; Harris, J; Lu, W; Said, S; Tamura, T | 1 |
Fu, M; Liu, N; Pang, Y; Su, J; Tang, C; Xu, S; Zhang, J | 1 |
Breu, V; Dechend, R; Ganten, D; Genersch, E; Haller, H; Löffler, BM; Luft, FC; Mervaala, EM; Muller, DN; Park, JK; Schmidt, F; Schneider, W | 1 |
Azuma, J; Lombardini, JB; Schaffer, SW | 1 |
Abe, S; Adachi, S; Hiroe, M; Ito, H; Marumo, F; Nozato, T; Tamamori, M | 1 |
Azuma, J; Azuma, M; Fukuda, T; Iwao, H; Kim, S; Ohyabu, Y; Schaffer, SW; Takahashi, K; Yamamoto, I | 1 |
Boer, P; Braam, B; Gröne, H; Hohbach, J; Joles, JA; Koomans, HA; Verhagen, AM | 1 |
Belabbas, H; Herizi, A; Jover, B; Mimran, A | 1 |
Bandinelli, B; Bertolozzi, I; Boddi, M; Cecioni, I; Galanti, G; Liguori, P; Modesti, PA; Paniccia, R; Perna, A; Polidori, G; Serneri, GG; Vanni, S | 1 |
Aubert, JF; Brunner, HR; Pedrazzini, T; Pellieux, C; Sauthier, T | 1 |
Leenen, FH; Van Huysse, J; White, R; Zhao, X | 1 |
Brunner, HR; Murat, A; Pedrazzini, T; Pellieux, C | 1 |
Iwao, H; Izumi, Y; Kim, S; Namba, M; Yasumoto, H; Zhan, Y | 1 |
Braunwald, E; Bristow, MR | 1 |
Dixon, IM; Hao, J; Jassal, DS; Jones, SC; Wang, B | 1 |
Mascareno, E; Siddiqui, MA | 1 |
Aikawa, R; Komuro, I; Nagai, R; Yazaki, Y | 1 |
Anversa, P; Chimenti, C; Frustaci, A; Jakoniuk, I; Kajstura, J; Leri, A; Maseri, A; Nadal-Ginard, B | 1 |
Brede, M; Hein, L | 1 |
Beyersdorf, F; Breyer, T; Burkard, T; Dohrmann, U; Dragu, A; Füchtbauer, EM; Holubarsch, CJ; Radicke, D; Schmidt-Schweda, S; Wakili, R; Wiese, S | 1 |
Harada, M; Hosoya, T; Ikeda, K; Nakao, K; Tojo, K; Tokudome, G | 1 |
Chen, YF; Dell'Italia, LJ; Lucchesi, P; Mori, T; Oparil, S; Perry, GJ; Wei, CC; Xu, XY | 1 |
Hayashi, M; Nakaya, H; Saruta, T; Sasamura, H | 1 |
Ruwhof, C; Schrier, PI; van der Laarse, A; van der Valk-Kokshoom, LE; van Wamel, AJ | 1 |
He, KL; Li, TC; Mu, SC; Pang, YZ; Tang, CS; Zheng, QF | 1 |
DiDonato, JA; Lin, A; Mercurio, F; Purcell, NH; Tang, G; Yu, C | 1 |
Lorell, BH; Schneider, MD | 1 |
Pan, JY; Wang, TH; Zhan, CD | 1 |
Fu, MG; Jiang, ZS; Liu, NK; Pang, YZ; Tang, CS; Wang, XH | 1 |
Piper, HM; Schlüter, KD; Taimor, G; Wenzel, S | 1 |
Paull, JR; Widdop, RE | 1 |
Basso, N; González Bosc, LV; Kurnjek, ML; Müller, A; Terragno, NA | 1 |
Ikeda, U; Lee, RT; Ohki, R; Shimada, K; Yamamoto, K | 1 |
Aubert, JF; Brunner, H; Morgan, T | 1 |
Buikema, H; Ganten, D; Hoffmann, S; Inagami, T; Krause, T; Lindschau, C; Pagel, I; Paul, M; Pinto, YM; Urata, H; van Geel, PP; van Gilst, WH; Willenbrock, R | 1 |
Bedell, KA; Dalshaug, GB; Scholz, TD; Segar, JL; Smith, OM | 1 |
Leenen, FH; White, R; Yuan, B | 1 |
Wang, Y | 1 |
Grimm, M; Kitakaze, M; Liao, JK; Liao, Y; Nakagami, H; Node, K; Takemoto, M; Takemoto, Y | 1 |
Inagami, T; Senbonmatsu, T | 1 |
Aubert, JF; Beermann, F; Brunner, HR; Foletti, A; Nussberger, J; Pedrazzini, T; Peduto, G; Pellieux, C | 1 |
Chen, L; Gu, ZL; Qin, TC; Yu, LX | 1 |
Eskelinen, S; Luodonpää, M; Ruskoaho, H; Vuolteenaho, O | 1 |
Buttrick, PM; Geenen, DL; Goldspink, PH; Kimball, VA; McKinney, RD | 1 |
Asakura, M; Asanuma, H; Beppu, S; Higashiyama, S; Hori, M; Ishiguro, H; Ishikura, F; Kitakaze, M; Liao, Y; Matsumura, Y; Node, K; Ohmoto, H; Sanada, S; Tada, M; Takashima, S; Takeda, H; Yoshinaka, T; Yoshino, K | 1 |
Bishop, SP; Dell'Italia, LJ; Dillon, AR; Hankes, GH; Ideker, R; Powell, P; Rynders, P; Schultz, D; Spinale, FG; Su, X; Walcott, G; Wei, CC | 1 |
Cristol, JP; Delbosc, S; Jover, B; Mimran, A | 1 |
Bendall, JK; Cave, AC; Gall, N; Heymes, C; Shah, AM | 1 |
Piper, M; Ruf, S; Schlüter, KD | 1 |
Greenberg, B | 1 |
Force, T; Haq, S; Kilter, H; Michael, A | 1 |
Higuchi, Y; Hirotani, S; Hori, M; Mano, T; Matsumura, Y; Morita, T; Nakayama, H; Nishida, K; Otsu, K; Tada, M; Ueno, H; Yamaguchi, O | 1 |
Barta, P; Dechend, R; Dietz, R; Fiebeler, A; Ganten, D; Haller, H; Luft, FC; Muller, DN; Park, JK; Theuer, J | 1 |
Eskelinen, S; Kerkelä, R; Majalahti-Palviainen, T; Pikkarainen, S; Pöntinen, J; Ruskoaho, H; Tokola, H; Vuolteenaho, O | 1 |
Asakawa, M; Hasegawa, H; Kadowaki, T; Komuro, I; Kubota, N; Masuda, Y; Nagai, T; Saito, T; Takano, H; Uozumi, H | 1 |
Schneider, MD | 1 |
Doetschman, T; Glascock, BJ; Kimball, TR; Nieman, ML; Nix, SL; Reiser, PJ; Schultz, Jel J; Witt, SA | 1 |
Morgan, T | 1 |
Doi, H; Katoh, M; Kurosawa, Y; Narita, H | 1 |
Böhm, M; Kilter, H; Konkol, C; Laufs, U; Nickenig, G; Wassmann, S | 1 |
Agabiti-Rosei, E; Cotecchia, S; Frati, G; Fratta, L; Guelfi, D; Lembo, G; Mulvany, MJ; Notte, A; Porteri, E; Poulet, R; Rizzoni, D; Trimarco, B; Trimarco, V; Vecchione, C | 1 |
Liu, PQ; Lu, W; Pan, JY; Wang, TH | 1 |
Wang, HJ; Yao, T; Zhu, YC | 1 |
Bikhazi, AB; Birbari, AE; Bitar, KM; El-Sabban, ME; Hassan, KA | 1 |
Akazawa, H; Komuro, I; Mizukami, M; Nagai, T; Takano, H; Zou, Y | 1 |
Guo, Z; Lai, W; Li, J; Li, S; Liu, Y; Wu, P; Xiu, JC; Xu, JP; Zhang, Y | 1 |
Liu, PQ; Lu, W; Pan, JY | 1 |
Bhatnagar, RK; Lund, DD; McNamara, RF; Schmid, PG; Schmidt, JA | 1 |
Alexander, JK; Gaasch, WH; Quinones, MA; Thiel, HG; Waisser, E | 1 |
Coleman, TG; Cowley, AW; DeClue, JW; Guyton, AC; Hall, JE; Young, DB | 1 |
Hollander, W | 1 |
Abboud, FM; Heistad, DD; Mark, AL; Mayer, HE; Schmid, PG | 1 |
Arakawa, K; Doi, Y; Hiroki, T; Kanaya, H | 1 |
McMurtry, IF; Petrun, MD; Reeves, JT; Tucker, A | 1 |
Bumpus, FM; Sen, S; Tarazi, RC | 1 |
Bumpus, FM | 1 |
Linz, W; Schölkens, BA | 1 |
Adachi, S; Hirata, Y; Hiroe, M; Ito, H; Marumo, F; Tujino, M | 1 |
Fernandez-Alfonso, MS; Ganten, D; Paul, M | 1 |
Paul, M; Schunkert, H | 1 |
Ganten, D; Paul, M | 1 |
Fukuchi, S; Hashimoto, S; Mizuno, K; Niimura, S; Ohtsuki, M; Sanada, H; Tani, M; Watanabe, H | 1 |
Folkow, B; Lever, AF; Lyall, F; Morton, JJ | 1 |
Bobik, A; Dilley, RJ; Oddie, CJ | 1 |
Brilla, CG; Weber, KT | 1 |
Higaki, J; Higashimori, K; Mikami, H; Nagano, M; Nagano, N; Nakamura, F; Ogihara, T | 1 |
Brilla, C; Tan, LB; Weber, KT | 1 |
Higaki, J; Higashimori, K; Katahira, K; Mikami, H; Moriguchi, A; Nagano, M; Nakamaru, M; Nakamura, F; Ogihara, T; Tabuchi, Y | 1 |
Casley, D; Johnston, CI; Katopothis, A; Mooser, V | 1 |
Brilla, CG; Janicki, JS; Pick, R; Tan, LB; Weber, KT | 1 |
Baker, KM; Morgan, HE | 1 |
Bann, J; Baur, LH; Bruschke, AV; Buis, B; Manger Cats, V; Schipperheyn, JJ; van der Laarse, A; van der Wall, EE; van Dijk, AD | 1 |
Jalil, JE; Janicki, JS; Pick, R; Tan, LB; Weber, KT | 1 |
Fregly, MJ | 1 |
Higaki, J; Higashimori, K; Katahira, K; Mikami, H; Morishita, R; Nagano, M; Nakamura, F; Ogihara, T | 1 |
Henning, R; Linz, W; Schölkens, BA | 1 |
Neyses, L; Vetter, H | 2 |
Gohlke, P; Unger, T | 1 |
Fouad, FM; Hanna, MK; Khairallah, PA; Upsher, ME; Yoshida, K | 1 |
Ganten, D; Linz, W; Schölkens, BA | 1 |
Honda, M; Ishinaga, Y; Kobayashi, S; Matsuno, Y; Morioka, S; Moriyama, K; Murakami, Y; Ohoka, M; Tanabe, K; Yamada, S | 1 |
Honda, M; Morioka, S; Moriyama, K; Ohoka, M; Yamada, S; Yamori, Y | 1 |
Fernandes, A | 1 |
Chobanian, AV; Herrera, VL; Ruiz-Opazo, N | 1 |
Ganten, D; Gohlke, P; Lang, RE; Unger, T | 1 |
Ganey, PE; Hadley, KB; Roth, RA; Sprugel, KH | 1 |
Altiere, RJ; Gillespie, MN; O'Connor, WN; Olson, JW; Reinsel, CN | 1 |
Fregly, MJ; Lockley, OE; Sumners, C | 1 |
Khairallah, PA; Upsher, ME | 1 |
Cody, RJ; Devereux, RB; Laragh, JH; Pickering, TG | 1 |
Tatsumi, S | 1 |
Krovetz, LJ; McLoughlin, TG; Schiebler, GL | 1 |
Davis, JO; Hartroft, PM; Johnston, CI; Robb, CA | 1 |
Barold, SS; Hildner, FJ; Linhart, JW; Samet, P | 1 |
Gomez, J; McCabe, RE; Zintel, HA | 1 |
Chiavaro, A; Cosentino, F; Gambelli, G; Saponaro, A; Strano, A | 1 |
Baum, GL; Castillo, C; Llamas, R; Schwartz, A | 1 |
Dabels, J; Kochan, E; Sievers, P; Wendel, H | 1 |
Frohlich, ED | 1 |
Bumpus, FM; Khairallah, PA; Sen, S; Tarazi, RC | 1 |
Branche, G; Chiles, B; Garnier, C; Kilcoyne, MM; Soland, T; Thomson, GE; Williams, M | 1 |
Jorgensen, H; Sundsfjord, JA | 1 |
Reviews
88 review(s) available for angiotensin ii and Cardiomegaly
Article | Year |
---|---|
Angiotensin II-Induced Signal Transduction Mechanisms for Cardiac Hypertrophy.
Topics: Angiotensin II; Cardiomegaly; Fibroblasts; Humans; Myocytes, Cardiac; Signal Transduction | 2022 |
The endocrinological component and signaling pathways associated to cardiac hypertrophy.
Topics: Angiotensin II; Animals; Cardiomegaly; Disease Progression; Endocrine System; Humans; Insulin; Signal Transduction; Thyroid Hormones | 2020 |
The role of Thymosin β4 in angiotensin II-induced cardiomyocytes growth.
Topics: Angiotensin II; Animals; Animals, Newborn; Cardiomegaly; Cell Differentiation; Cell Proliferation; Humans; Myocytes, Cardiac; Rats; Signal Transduction; Thymosin | 2018 |
Chronic heart failure: a disease of the brain.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Baroreflex; Brain; Cardiomegaly; Chronic Disease; Heart; Heart Failure; Humans; Inflammation; Natriuretic Peptide, Brain; Neuroimmunomodulation; Norepinephrine; Oxidative Stress; Paraventricular Hypothalamic Nucleus; Peptide Fragments; Renin-Angiotensin System; Sympathetic Nervous System; Vagus Nerve Stimulation | 2019 |
ACE2 in Brain Physiology and Pathophysiology: Evidence from Transgenic Animal Models.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Animals, Genetically Modified; Brain; Brain Diseases; Cardiomegaly; Models, Animal; Peptide Fragments; Peptidyl-Dipeptidase A; Phenotype; Serotonin; Stress, Psychological; Tryptophan | 2019 |
Temporal Frame of Immune Cell Infiltration during Heart Failure Establishment: Lessons from Animal Models.
Topics: Angiotensin II; Animals; Aorta; B-Lymphocytes; Cardiomegaly; Cell Movement; Constriction, Pathologic; Cytokines; Disease Models, Animal; Endomyocardial Fibrosis; Heart Failure; Humans; Hypertension; Mice; Monocytes; T-Lymphocytes; Time Factors; Ventricular Dysfunction, Left | 2018 |
The autocrine/paracrine loop after myocardial stretch: mineralocorticoid receptor activation.
Topics: Angiotensin II; Autocrine Communication; Calcium; Cardiomegaly; Cardiovascular Diseases; Heart Failure; Humans; Myocardial Contraction; Myocardium; Paracrine Communication; Reactive Oxygen Species; Receptors, Mineralocorticoid; Sodium-Calcium Exchanger; Sodium-Hydrogen Exchangers; Thyroid Hormones | 2013 |
Insights into the activation and inhibition of angiotensin II type 1 receptor in the mechanically loaded heart.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Arrestin; Cardiomegaly; Humans; Myocardial Contraction; Myocardium; Receptor, Angiotensin, Type 1 | 2014 |
Molecular mechanism of aggravation of hypertensive organ damages by short-term blood pressure variability.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Cardiomegaly; Disease Models, Animal; Fibrosis; Humans; Hypertension; Myocarditis; Myocardium; Rats; Receptors, Mineralocorticoid; Renin-Angiotensin System; Risk Factors; Signal Transduction; Time Factors; Ventricular Dysfunction | 2014 |
The role of autophagy in angiotensin II-induced pathological cardiac hypertrophy.
Topics: Adiponectin; Angiotensin II; Animals; Autophagosomes; Autophagy; Autophagy-Related Proteins; Cardiomegaly; Humans; MicroRNAs; Oxidative Stress; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Signal Transduction; TOR Serine-Threonine Kinases | 2016 |
Early signals after stretch leading to cardiac hypertrophy. Key role of NHE-1.
Topics: Adult; Angiotensin II; Biomechanical Phenomena; Cardiomegaly; Heart Ventricles; Humans; Hypertrophy, Right Ventricular; Obesity; Pressoreceptors; Reactive Oxygen Species; Signal Transduction; Sodium-Hydrogen Exchangers; Ventricular Function | 2008 |
Pharmacologic perspectives of functional selectivity by the angiotensin II type 1 receptor.
Topics: Aldosterone; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Cardiomegaly; Cardiovascular Diseases; Feasibility Studies; GTP-Binding Proteins; Humans; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Signal Transduction | 2008 |
Role of 14-3-3 protein and oxidative stress in diabetic cardiomyopathy.
Topics: 14-3-3 Proteins; Angiotensin II; Animals; Apoptosis; Cardiomegaly; Cardiomyopathies; Diabetes Complications; Fibrosis; Humans; Myocardium; Oxidative Stress; Signal Transduction | 2009 |
Regulation of cardiac hypertrophy by the formation of G protein-coupled receptor--TRPC channel protein complex.
Topics: Angiotensin II; Animals; Calcium; Calcium Signaling; Cardiomegaly; Diglycerides; Drug Design; Heart Failure; Humans; Multiprotein Complexes; Receptors, G-Protein-Coupled; TRPC Cation Channels; TRPC6 Cation Channel | 2009 |
Linking an insect enzyme to hypertension: angiotensin II-epoxide hydrolase interactions.
Topics: Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Down-Regulation; Epoxide Hydrolases; Insecta; Vasoconstriction | 2010 |
Insulin signaling: a possible pathogenesis of cardiac hypertrophy.
Topics: Angiotensin II; Animals; Cardiomegaly; Humans; Insulin; Myocardium; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Signal Transduction | 2010 |
Adaptive and maladaptive remodeling of cardiomyocyte excitation-contraction coupling by angiotensin II.
Topics: Adaptation, Physiological; Angiotensin II; Animals; Cardiomegaly; Excitation Contraction Coupling; Heart Failure; Humans; Mice; Mice, Knockout; Myocytes, Cardiac; Renin-Angiotensin System; Ventricular Remodeling | 2010 |
Cytokines and cardiac hypertrophy: roles of angiotensin II and basic fibroblast growth factor.
Topics: Angiotensin II; Animals; Cardiomegaly; Cytokines; Fibroblast Growth Factor 2; Heart; Humans; Myocardium; Myocytes, Cardiac | 1996 |
Role of autocrine/paracrine mechanisms in response to myocardial strain.
Topics: Angiotensin II; Animals; Autocrine Communication; Calcium; Cardiomegaly; Endothelins; ErbB Receptors; Humans; Myocardial Contraction; Myocardium; Paracrine Communication; Reactive Oxygen Species; Signal Transduction; Sodium-Calcium Exchanger; Sodium-Hydrogen Exchangers; Stress, Mechanical | 2011 |
Regulation of the cardiac sodium/bicarbonate cotransporter by angiotensin II: potential Contribution to structural, ionic and electrophysiological myocardial remodelling.
Topics: Angiotensin II; Calcium; Cardiomegaly; Electrophysiological Phenomena; Heart; Heart Diseases; Humans; Sodium; Sodium-Bicarbonate Symporters; Ventricular Remodeling | 2013 |
Dissecting the role of chymase in angiotensin II formation and heart and blood vessel diseases.
Topics: Angiotensin I; Angiotensin II; Arteriosclerosis; Cardiomegaly; Cardiovascular Diseases; Chymases; Heart Diseases; Heart Failure; Humans; Hypertension; Peptidyl-Dipeptidase A; Serine Endopeptidases | 2002 |
Role of the local renin-angiotensin system in cardiac damage: a minireview focussing on transgenic animal models.
Topics: Angiotensin II; Animals; Animals, Genetically Modified; Cardiomegaly; Fibrosis; Heart; Hypertension; Mice; Mice, Knockout; Mice, Transgenic; Models, Biological; Myocardial Infarction; Myocardium; Organ Specificity; Peptidyl-Dipeptidase A; Rats; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Renin-Angiotensin System; Stress, Mechanical; Ventricular Remodeling | 2002 |
[Signal transduction pathways in cardiac myocyte hypertrophy].
Topics: Angiotensin II; Animals; Calcium; Cardiomegaly; Catecholamines; Endothelial Growth Factors; Humans; Signal Transduction | 2000 |
A central role of EGF receptor transactivation in angiotensin II -induced cardiac hypertrophy.
Topics: Angiotensin II; Animals; Cardiomegaly; ErbB Receptors; Gene Expression Regulation; Humans; Transcriptional Activation | 2003 |
[The bioactivity of angiotensin II and the effects of related Chinese Herbs].
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Cardiomegaly; Drugs, Chinese Herbal; Heart Failure; Humans; Hypertension; Myocardial Reperfusion Injury; Plants, Medicinal; Receptor, Angiotensin, Type 2 | 2003 |
[Involvement of angiotensin II in pathogenesis of hypertension and target organ damage].
Topics: Angioplasty, Balloon, Coronary; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Arteriosclerosis; Cardiomegaly; Clinical Trials as Topic; Coronary Restenosis; Humans; Hypertension; Hypertension, Renal; Insulin Resistance; Losartan; Ramipril; Receptor, Angiotensin, Type 1 | 2004 |
Fibroblast growth factor 2 isoforms and cardiac hypertrophy.
Topics: Angiotensin II; Animals; Cardiomegaly; Fibroblast Growth Factor 2; Humans; Myocardium; Protein Isoforms; Signal Transduction | 2004 |
[Effect of adrenomedullin on cardiac myocytes and fibroblasts].
Topics: Adrenomedullin; Angiotensin II; Animals; Apoptosis; Calcium; Cardiomegaly; Cell Division; Cyclic AMP; Endothelin-1; Heart Failure; Humans; Myoblasts, Cardiac; Myocardial Contraction; Myocytes, Cardiac; Nitric Oxide; Peptides; Protein Kinase C; Signal Transduction; Tumor Necrosis Factor-alpha; Ventricular Remodeling | 2004 |
[Role of endothelin in the development of cardiac hypertrophy].
Topics: Angiotensin II; Animals; Cardiomegaly; Cell Communication; Endothelin-1; GTP-Binding Protein alpha Subunits, Gq-G11; Hemodynamics; Humans; Receptor, Endothelin A; Stress, Mechanical; Ventricular Remodeling | 2004 |
[Modulation of renin-angiotensin system for vascular protection in hypertensive patients and in patients with diabetic nephropathy].
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Cardiomegaly; Coronary Artery Disease; Diabetic Nephropathies; Humans; Hypertension; Renin | 2004 |
Hijacking epidermal growth factor receptors by angiotensin II: new possibilities for understanding and treating cardiac hypertrophy.
Topics: Angiotensin II; Animals; Cardiomegaly; ErbB Receptors; Humans; Reactive Oxygen Species; Signal Transduction; Transcriptional Activation | 2004 |
Cardiovascular functional phenotypes and pharmacological responses in apolipoprotein E deficient mice.
Topics: Angiotensin II; Animals; Aortic Diseases; Apolipoproteins E; Arteriosclerosis; Cardiac Output, High; Cardiomegaly; Cardiovascular System; Enzyme Inhibitors; Estradiol; Hypercholesterolemia; Hyperglycemia; Mice; Mice, Knockout; NG-Nitroarginine Methyl Ester; Phenotype; Simvastatin | 2005 |
Rethinking the renin-angiotensin system and its role in cardiovascular regulation.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiomegaly; Cardiovascular System; Humans; Peptidyl-Dipeptidase A; Renin-Angiotensin System; Signal Transduction | 2005 |
[Role of renin-angiotensin system in cardiovascular remodeling].
Topics: Angiotensin II; Animals; Cardiomegaly; Humans; Hypertension; JNK Mitogen-Activated Protein Kinases; MAP Kinase Kinase Kinase 5; Oxidative Stress; Reactive Oxygen Species; Renin-Angiotensin System; Transcription Factor AP-1; Ventricular Remodeling | 2006 |
Sodium-hydrogen exchanger, cardiac overload, and myocardial hypertrophy.
Topics: Amiloride; Angiotensin II; Animals; Calcium Signaling; Carbonic Anhydrase II; Cardiomegaly; Cation Transport Proteins; Cells, Cultured; Endothelins; Heart Failure; Hormones; Humans; Hydrogen; Hydrogen-Ion Concentration; Hypertrophy, Left Ventricular; MAP Kinase Signaling System; Mice; Mitochondria, Heart; Models, Cardiovascular; Myocytes, Cardiac; Phosphorylation; Protein Processing, Post-Translational; Rabbits; Rats; Rats, Inbred SHR; Reactive Oxygen Species; Signal Transduction; Sodium; Sodium-Hydrogen Exchanger 1; Sodium-Hydrogen Exchangers; Stress, Mechanical; Swine | 2007 |
A novel mechanism of mechanical stress-induced angiotensin II type 1-receptor activation without the involvement of angiotensin II.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Cardiomegaly; Drug Inverse Agonism; Extracellular Signal-Regulated MAP Kinases; Humans; Receptor, Angiotensin, Type 1; Stress, Mechanical; Tetrazoles | 2008 |
The intracellular renin-angiotensin system: implications in cardiovascular remodeling.
Topics: Angiotensin II; Animals; Cardiomegaly; Cardiovascular Agents; Extracellular Fluid; Fibrosis; Humans; Intracellular Fluid; Myocardium; Renin-Angiotensin System; Signal Transduction; Ventricular Remodeling | 2008 |
The multifactorial role of catecholamines in hypertensive cardiac hypertrophy.
Topics: Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Catecholamines; Coronary Circulation; Heart Ventricles; Humans; Hypertension; Myocardial Contraction; Norepinephrine; Rats; Rats, Inbred Strains | 1982 |
The cardiac renin-angiotensin-aldosterone system and hypertensive cardiac hypertrophy.
Topics: Adaptation, Physiological; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Cardiomegaly; Humans; Hypertension; Myocardial Infarction; Myocardium; Renin-Angiotensin System | 1995 |
Molecular biology of myocardial hypertrophy and failure: gene expression and trophic signaling.
Topics: Angiotensin II; Animals; Calcium; Cardiomegaly; Fibroblast Growth Factors; Gene Expression; Heart Failure; Hemodynamics; Humans; Muscle Proteins; Proto-Oncogenes; Signal Transduction; Transcription Factors; Transforming Growth Factors | 1995 |
Signaling pathways for cardiac growth and hypertrophy. Recent advances and prospects for growth factor therapy.
Topics: Angiotensin II; Animals; Cardiomegaly; Endothelins; Growth Substances; Heart; Humans; Insulin-Like Growth Factor I; Signal Transduction; Transforming Growth Factor beta | 1995 |
Proto-oncogenes and the cardiovascular system.
Topics: Angiotensin II; Animals; Cardiomegaly; Cardiovascular Physiological Phenomena; Gene Expression; Heart; Hemodynamics; Humans; Myocardium; Proto-Oncogenes | 1995 |
The renin-angiotensin system in the heart and vascular wall: new therapeutic aspects.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiomegaly; Coronary Disease; Endothelium, Vascular; Heart Failure; Humans; Hypertension; Myocardial Infarction; Myocardium; Peptidyl-Dipeptidase A; Renin-Angiotensin System | 1994 |
Angiotensin converting enzyme inhibitors: inhibition of growth, a novel mechanism of action.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Cardiomegaly; Coronary Disease; Heart; Humans; Hyperplasia; Hypertension; Muscle Development; Muscle, Smooth, Vascular; Tunica Intima | 1994 |
Role of neurohormones in ventricular adaptation and failure.
Topics: Adaptation, Physiological; Aldosterone; Angiotensin II; Animals; Cardiomegaly; Disease Models, Animal; Hormones; Humans; Myocardial Infarction; Ventricular Function, Left | 1994 |
New perspectives in angiotensin system control.
Topics: Amino Acid Sequence; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Biphenyl Compounds; Blood Pressure; Cardiomegaly; Hemodynamics; Humans; Imidazoles; Losartan; Molecular Sequence Data; Pyridines; Renin-Angiotensin System; Tetrazoles | 1993 |
Local expression and pathophysiological role of renin-angiotensin in the blood vessels and heart.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiomegaly; Endothelium, Vascular; Heart; Humans; Muscle, Smooth, Vascular; Myocardial Infarction; Peptidyl-Dipeptidase A; Renin-Angiotensin System | 1993 |
Mechanisms of angiotensin II formation in humans.
Topics: Angiotensin II; Animals; Cardiomegaly; Cardiovascular System; Chymases; Heart Failure; Hemodynamics; Homeostasis; Humans; Peptidyl-Dipeptidase A; Renin-Angiotensin System; Serine Endopeptidases; Species Specificity; Tissue Distribution | 1995 |
Cardiovascular hypertrophy: role of angiotensin II and bradykinin.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Cardiomegaly; Humans; Hypertension; Rats | 1996 |
The role of genetic variants in angiotensin I converting enzyme, angiotensinogen and the angiotensin II type-1 receptor in the pathophysiology of heart muscle disease.
Topics: Angiotensin II; Angiotensinogen; Bradykinin; Cardiac Output, Low; Cardiomegaly; Genetic Variation; Heart Diseases; Humans; Peptidyl-Dipeptidase A; Receptors, Angiotensin; Renin-Angiotensin System | 1995 |
The role of the renin-angiotensin system in the pathophysiology of cardiac remodeling.
Topics: Angiotensin II; Animals; Cardiomegaly; Cell Division; Cells, Cultured; Humans; Renin-Angiotensin System | 1996 |
The renin-angiotensin system and cardiac hypertrophy.
Topics: Angiotensin II; Animals; Cardiomegaly; Cells, Cultured; Heart; Myocardium; Rats; Renin-Angiotensin System; Signal Transduction | 1996 |
The renin-angiotensin system and coronary vasomotion.
Topics: Angiotensin I; Angiotensin II; Animals; Blood Flow Velocity; Cardiomegaly; Coronary Vessels; Dogs; Humans; Hypoxia; In Vitro Techniques; Myocardial Ischemia; Peptidyl-Dipeptidase A; Rats; Renin-Angiotensin System; Swine | 1996 |
Cytokines and cardiac hypertrophy: roles of angiotensin II and basic fibroblast growth factor.
Topics: Angiotensin II; Animals; Cardiomegaly; Epidermal Growth Factor; Fibroblast Growth Factors; Heart; Heparin; Heparin-binding EGF-like Growth Factor; Intercellular Signaling Peptides and Proteins; Molecular Weight; Myocardium; Phenotype; Receptors, Angiotensin | 1996 |
[The cardiac autocrine-paracrine system in the development of hypertrophy].
Topics: Angiotensin II; Animals; Cardiomegaly; Endothelin-1; Heart; Humans; Renin-Angiotensin System | 1997 |
Involvement of angiotensin II in cardiovascular and renal injury: effects of an AT1-receptor antagonist on gene expression and the cellular phenotype.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Cardiomegaly; Fibronectins; Gene Expression; Humans; Hypertension; Nephrosclerosis; Proto-Oncogene Proteins; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; RNA, Messenger; Tetrazoles | 1997 |
[Mechanism involved in the onset of heart failure].
Topics: Angiotensin II; Animals; Calcium; Cardiomegaly; Endothelin-1; Heart Failure; Humans; Interleukin-1; Neurotransmitter Agents; Receptors, Adrenergic, beta; Ventricular Remodeling | 1998 |
Role of ACE inhibition or AT1 blockade in the remodeling following myocardial infarction.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Apoptosis; Cardiomegaly; Humans; Myocardial Infarction; Myocardium; Renin-Angiotensin System | 1998 |
Signalling pathways for cardiac hypertrophy.
Topics: Angiotensin II; Animals; Cardiomegaly; Heart; Humans; Phosphorylation; Signal Transduction | 1998 |
Angiotensin blocking drugs and the heart beyond 2000.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Bradykinin; Cardiomegaly; Forecasting; Hypertension; Rats; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin-Angiotensin System | 1999 |
The molecular mechanism of cardiac hypertrophy and failure.
Topics: Angiotensin II; Animals; Cardiac Output, Low; Cardiomegaly; Endothelin-1; Hypertension; Myocardium; Renin-Angiotensin System; Signal Transduction; Sodium-Hydrogen Exchangers; Stress, Mechanical | 1999 |
Signal transduction and transcriptional adaptation in embryonic heart development and during myocardial hypertrophy.
Topics: Adaptation, Physiological; Angiotensin II; Animals; Cardiomegaly; Gene Expression Regulation, Developmental; Heart; Humans; Signal Transduction; Transcription, Genetic | 1999 |
The renin-angiotensin system and experimental heart failure.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Aortic Valve Stenosis; Cardiomegaly; Coronary Disease; Heart Failure; Mice; Mice, Transgenic; Myocardium; Rats; Receptors, Angiotensin; Renin-Angiotensin System; Signal Transduction | 1999 |
Na+/H+ exchange hyperactivity and myocardial hypertrophy: are they linked phenomena?
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Antiporters; Cardiomegaly; Erythrocytes; Humans; Hydrogen-Ion Concentration; Hypertension; Myocardium; Signal Transduction; Sodium-Hydrogen Exchangers | 1999 |
Role of the renin-angiotensin system in cardiac hypertrophy.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Cardiomegaly; Cell Division; Cells, Cultured; Hydralazine; Hypertension; Mitogen-Activated Protein Kinases; Myocardium; Protein-Tyrosine Kinases; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Renin-Angiotensin System; Signal Transduction; Sodium-Hydrogen Exchangers; Tetrazoles | 1999 |
Role of angiotensin AT1, and AT2 receptors in cardiac hypertrophy and disease.
Topics: Angiotensin II; Animals; Aortic Valve Stenosis; Cardiomegaly; Cell Division; Humans; Hypertension; Myocardium; Proto-Oncogene Mas; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Signal Transduction | 1999 |
Angiotensin II, adhesion, and cardiac fibrosis.
Topics: Angiotensin II; Animals; Cardiomegaly; Cell Adhesion; Extracellular Matrix; Fibrosis; Humans; Integrins; Myocardium; Osteopontin; Sialoglycoproteins | 2000 |
Interaction between the actions of taurine and angiotensin II.
Topics: Angiotensin II; Animals; Calcium; Cardiomegaly; Cell Size; Diuretics; Heart Failure; Humans; MAP Kinase Signaling System; Myocardium; Receptors, Angiotensin; Sodium-Calcium Exchanger; Taurine | 2000 |
The role of Jak/STAT signaling in heart tissue renin-angiotensin system.
Topics: Angiotensin II; Animals; Cardiomegaly; DNA-Binding Proteins; Heart; Heart Diseases; Humans; Myocardium; Protein-Tyrosine Kinases; Signal Transduction; Trans-Activators | 2000 |
Transgenic mouse models of angiotensin receptor subtype function in the cardiovascular system.
Topics: Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Cardiovascular System; Kidney; Mice; Mice, Transgenic; Receptors, Angiotensin; Signal Transduction | 2001 |
Signal transduction in cardiac hypertrophy--dissecting compensatory versus pathological pathways utilizing a transgenic approach.
Topics: Angiotensin II; Animals; Animals, Genetically Modified; Antigens, CD; Calcineurin; Calcium-Calmodulin-Dependent Protein Kinases; Cardiomegaly; Cytokine Receptor gp130; GTP-Binding Protein alpha Subunits, Gq-G11; Heart Failure; Heterotrimeric GTP-Binding Proteins; Membrane Glycoproteins; Mitogen-Activated Protein Kinases; Monomeric GTP-Binding Proteins; Myocardial Contraction; Protein Kinase C; Receptor Protein-Tyrosine Kinases; Receptors, Angiotensin; Signal Transduction; Transcription, Genetic | 2001 |
Dual effects of angiotensin II type 2 receptor on cardiovascular hypertrophy.
Topics: Angiotensin II; Animals; Cardiomegaly; Forecasting; Humans; Mice; Receptors, Angiotensin; Renin-Angiotensin System; Ventricular Remodeling | 2001 |
Molecular and cellular mechanisms of mechanical stress-induced cardiac hypertrophy.
Topics: Angiotensin II; Calcineurin; Calcium; Cardiomegaly; Endothelin-1; Hemodynamics; Humans; Protein Kinases; Signal Transduction; Stress, Mechanical | 2002 |
Integration and control of circulatory function.
Topics: Angiotensin II; Animals; Blood Circulation; Blood Pressure; Blood Volume; Body Fluids; Cardiac Output; Cardiomegaly; Cardiovascular Physiological Phenomena; Cardiovascular System; Dogs; Hemodynamics; Homeostasis; Humans; Kidney; Oxygen Consumption; Reflex; Regional Blood Flow; Renin | 1976 |
Role of hypertension in atherosclerosis and cardiovascular disease.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Arteriosclerosis; Blood Platelets; Capillary Permeability; Cardiomegaly; Cardiovascular Diseases; Cerebrovascular Disorders; Coronary Disease; Death, Sudden; Endothelium; Histamine; Humans; Hypertension; Lipids; Lysosomes; Muscle, Smooth; Renin; Serotonin; Thrombosis | 1976 |
Mechanisms and sites of action of newer angiotensin agonists and antagonists in terms of activity and receptor.
Topics: Adrenal Glands; Angiotensin II; Angiotensin III; Angiotensin Receptor Antagonists; Blood Pressure; Cardiomegaly; Catecholamines; Protein Biosynthesis; Protein Conformation; Receptors, Angiotensin; Receptors, Cell Surface; Structure-Activity Relationship | 1977 |
Role of bradykinin in the cardiac effects of angiotensin-converting enzyme inhibitors.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Cardiomegaly; Epoprostenol; Heart; Kallikrein-Kinin System; Nitric Oxide; Renin-Angiotensin System; Reperfusion Injury | 1992 |
Mechanisms of cardiac growth. The role of the renin-angiotensin system.
Topics: Angiotensin II; Animals; Cardiomegaly; Humans; Hypertension; Myocardium; Renin-Angiotensin System | 1992 |
Diastolic dysfunction in pressure-overload hypertrophy and its modification by angiotensin II: current concepts.
Topics: Angiotensin II; Animals; Cardiomegaly; Diastole; Enzyme Activation; Heart; Humans; Hypertension; Myocardium; Peptidyl-Dipeptidase A | 1992 |
The molecular basis of cardiovascular hypertrophy: the role of the renin-angiotensin system.
Topics: Angiotensin II; Animals; Blood Vessels; Cardiomegaly; Cell Division; Cells, Cultured; Gene Expression; Growth Substances; Hypertension; Hypertrophy; Muscle, Smooth, Vascular; Proto-Oncogenes; Renin-Angiotensin System | 1992 |
Angiotensin II, vascular structure and blood pressure.
Topics: Angiotensin II; Animals; Blood Pressure; Blood Vessels; Cardiomegaly; Growth Substances; Hypertension; Hypertrophy; Models, Cardiovascular; Rats | 1992 |
Prevention of structural changes in the heart in hypertension by angiotensin converting enzyme inhibition.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiomegaly; Diastole; Heart Failure; Humans; Hypertension; Myocardium; Rats; Rats, Inbred SHR | 1992 |
Cardiac hypertrophy. Mechanical, neural, and endocrine dependence.
Topics: Angiotensin II; Animals; Cardiomegaly; Heart; Humans; Myocardial Contraction; Receptors, Adrenergic; Signal Transduction; Stress, Mechanical; Thyroid Hormones | 1991 |
Tissue renin-angiotensin systems in the heart and vasculature: possible involvement in the cardiovascular actions of converting enzyme inhibitors.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Cardiomegaly; Cardiovascular Physiological Phenomena; Cardiovascular System; Heart Failure; Humans; Peptidyl-Dipeptidase A; Renin-Angiotensin System | 1990 |
[Physiopathology of arterial hypertension. Significance of the renin-angiotensin-aldosterone system and structural changes].
Topics: Angiotensin II; Cardiomegaly; Coronary Disease; Humans; Hypertension; Hypertrophy; Renin-Angiotensin System | 1989 |
[The renin-angiotensin system: systemic and local function].
Topics: Angiotensin II; Cardiomegaly; Coronary Disease; Heart Failure; Humans; Hypertension; Peptidyl-Dipeptidase A; Renin-Angiotensin System | 1988 |
Relation of renin-angiotensin system activity to left ventricular hypertrophy and function in experimental and human hypertension.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Cardiomegaly; Humans; Hypertension; Rats; Rats, Inbred SHR; Renin-Angiotensin System | 1987 |
Clinical significance of hemodynamic findings in hypertension.
Topics: Angiotensin II; Blood Pressure; Blood Viscosity; Blood Volume; Cardiac Output; Cardiomegaly; Diuretics; Heart Rate; Hemodynamics; Humans; Hypertension; Hypertension, Renal; Propranolol; Receptors, Adrenergic; Renin | 1973 |
Trials
1 trial(s) available for angiotensin ii and Cardiomegaly
Article | Year |
---|---|
Statins exert the pleiotropic effects through small GTP-binding protein dissociation stimulator upregulation with a resultant Rac1 degradation.
Topics: Adaptor Proteins, Signal Transducing; Angiotensin II; Animals; Atorvastatin; Biomarkers; Cardiomegaly; Cells, Cultured; Cholesterol; Cholesterol, LDL; Coronary Vessels; Cross-Over Studies; Cytoskeletal Proteins; Disease Models, Animal; Dose-Response Relationship, Drug; Fibrosis; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Guanine Nucleotide Exchange Factors; Heptanoic Acids; Human Umbilical Vein Endothelial Cells; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Japan; Male; Mice; Mice, Knockout; Neuropeptides; Oxidative Stress; Phosphatidylinositol 3-Kinase; Pravastatin; Proto-Oncogene Proteins c-akt; Pyrroles; Quinolines; rac GTP-Binding Proteins; rac1 GTP-Binding Protein; RNA Interference; Signal Transduction; Transfection | 2013 |
Other Studies
1059 other study(ies) available for angiotensin ii and Cardiomegaly
Article | Year |
---|---|
Circ_nuclear factor I X (circNfix) attenuates pressure overload-induced cardiac hypertrophy via regulating miR-145-5p/ATF3 axis.
Topics: Activating Transcription Factor 3; Angiotensin II; Animals; Cardiomegaly; Humans; Mice; Mice, Inbred C57BL; MicroRNAs; Myocytes, Cardiac; RNA, Circular; Signal Transduction | 2021 |
Angiotensin-(3-7) alleviates isoprenaline-induced cardiac remodeling via attenuating cAMP-PKA and PI3K/Akt signaling pathways.
Topics: Angiotensin II; Animals; Cardiomegaly; Cardiovascular Agents; Cells, Cultured; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Disease Models, Animal; Fibrosis; Isoproterenol; Male; Mice, Inbred C57BL; Myocytes, Cardiac; Peptide Fragments; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Rats, Sprague-Dawley; Signal Transduction; Ventricular Remodeling | 2021 |
Capn4 aggravates angiotensin II-induced cardiac hypertrophy by activating the IGF-AKT signalling pathway.
Topics: Angiotensin II; Animals; Calpain; Cardiomegaly; Mice; Myocytes, Cardiac; Proto-Oncogene Proteins c-akt; Signal Transduction; Somatomedins | 2022 |
Clitoria ternatea (Linn.) flower extract attenuates vascular dysfunction and cardiac hypertrophy via modulation of Ang II/AT
Topics: Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Cardiomegaly; Clitoria; Flowers; Plant Extracts; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Signal Transduction; Transforming Growth Factor beta1 | 2022 |
Alarin moderated myocardial hypertrophy via inhibiting cyclic adenosine monophosphate/protein kinase A signaling pathway to attenuate autophagy.
Topics: Angiotensin II; Animals; Autophagy; Cardiomegaly; Cell Line; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Galanin-Like Peptide; Male; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; Rats; Rats, Sprague-Dawley; Receptors, Galanin; Signal Transduction | 2021 |
Aqueous extract of Solanum nigrum attenuates Angiotensin-II induced cardiac hypertrophy and improves cardiac function by repressing protein kinase C-ζ to restore HSF2 deSUMOlyation and Mel-18-IGF-IIR signaling suppression.
Topics: Angiotensin II; Animals; Cardiomegaly; Cardiotonic Agents; Cell Line; Disease Models, Animal; Dose-Response Relationship, Drug; Heat-Shock Proteins; Hypertension; Male; Myoblasts, Cardiac; Plant Extracts; Protein Kinase C; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, IGF Type 2; Solanum nigrum; Transcription Factors | 2022 |
Low-intensity pulsed ultrasound ameliorates angiotensin II-induced cardiac fibrosis by alleviating inflammation via a caveolin-1-dependent pathway.
Topics: Angiotensin II; Animals; Cardiomegaly; Caveolin 1; Cells, Cultured; Fibrosis; Inflammation; Male; Mice; Mice, Inbred C57BL; Myocardium; Rats; Rats, Sprague-Dawley; Signal Transduction; Ultrasonic Waves | 2021 |
Downregulation of miR-128 Ameliorates Ang II-Induced Cardiac Remodeling via SIRT1/PIK3R1 Multiple Targets.
Topics: Angiotensin II; Animals; Cardiomegaly; Mice, Inbred C57BL; MicroRNAs; Myocardium; Myocytes, Cardiac; Oxidative Stress; Sirtuin 1; Ventricular Remodeling | 2021 |
STING protects against cardiac dysfunction and remodelling by blocking autophagy.
Topics: Angiotensin II; Animals; Apoptosis; Autophagy; Autophagy-Related Protein-1 Homolog; Cardiomegaly; Disease Models, Animal; Gene Expression Regulation; Heart Failure; Humans; Membrane Proteins; Mice; Myocytes, Cardiac; Protective Agents; Signal Transduction; Sirolimus | 2021 |
Ventricular SK2 upregulation following angiotensin II challenge: Modulation by p21-activated kinase-1.
Topics: Angiotensin II; Animals; Apamin; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Cardiomegaly; Fingolimod Hydrochloride; Mice; Myocytes, Cardiac; p21-Activated Kinases; Protein Serine-Threonine Kinases; Rats; RNA, Small Interfering; Up-Regulation | 2022 |
NLRC5 enhances autophagy via inactivation of AKT/mTOR pathway and ameliorates cardiac hypertrophy.
Topics: Angiotensin II; Animals; Autophagy; Cardiomegaly; Myocytes, Cardiac; NLR Proteins; Proto-Oncogene Proteins c-akt; Rats; TOR Serine-Threonine Kinases | 2022 |
RNA binding Motif protein-38 regulates myocardial hypertrophy in LXR-α-dependent lipogenesis pathway.
Topics: Angiotensin II; Cardiomegaly; Humans; Lipogenesis; Liver X Receptors; Myocytes, Cardiac; RNA-Binding Proteins; Signal Transduction | 2021 |
S-nitrosylation of Hsp90 promotes cardiac hypertrophy in mice through GSK3β signaling.
Topics: Angiotensin II; Animals; Cardiomegaly; Glycogen Synthase Kinase 3 beta; Heart Failure; HSP90 Heat-Shock Proteins; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; Rats; Signal Transduction | 2022 |
Angiotensin Type 2 and Mas Receptor Activation Prevents Myocardial Fibrosis and Hypertrophy through the Reduction of Inflammatory Cell Infiltration and Local Sympathetic Activity in Angiotensin II-Dependent Hypertension.
Topics: Angiotensin I; Angiotensin II; Animals; Cardiomegaly; Disease Models, Animal; Fibrosis; Hypertension; Imidazoles; Injections, Intraperitoneal; Losartan; Male; Peptide Fragments; Proto-Oncogene Mas; Rats; Rats, Sprague-Dawley; Sulfonamides; Thiophenes; Tyrosine 3-Monooxygenase | 2021 |
MiR-410-3p facilitates Angiotensin II-induced cardiac hypertrophy by targeting Smad7.
Topics: 3' Untranslated Regions; Angiotensin II; Animals; Cardiomegaly; Cells, Cultured; Disease Models, Animal; HEK293 Cells; Humans; MicroRNAs; Myocytes, Cardiac; Primary Cell Culture; Rats; Smad7 Protein; Up-Regulation | 2022 |
Zyxin protects from hypertension-induced cardiac dysfunction.
Topics: Angiotensin II; Animals; Apoptosis; Blood Pressure; Cardiomegaly; Fibrosis; Hypertension; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocytes, Cardiac; Zyxin | 2022 |
[Effect and mechanism of leonurine on pressure overload-induced cardiac hypertrophy in rats].
Topics: Angiotensin II; Animals; Cardiomegaly; Gallic Acid; Hypertrophy, Left Ventricular; Myocardium; Rats | 2022 |
FTZ protects against cardiac hypertrophy and oxidative injury via microRNA-214 / SIRT3 signaling pathway.
Topics: Angiotensin II; Animals; Cardiomegaly; Drugs, Chinese Herbal; Mice; Mice, Inbred C57BL; MicroRNAs; Myocytes, Cardiac; Oxidative Stress; Signal Transduction; Sirtuin 3 | 2022 |
Osteocrin alleviates cardiac hypertrophy via attenuating oxidative stress.
Topics: Angiotensin II; Animals; Cardiomegaly; Fibrosis; Mice; Muscle Proteins; Myocytes, Cardiac; Oxidative Stress; Rats; Transcription Factors | 2022 |
Angiotensin II Induces Cardiac Edema and Hypertrophic Remodeling through Lymphatic-Dependent Mechanisms.
Topics: Angiotensin II; Animals; Cardiomegaly; Edema, Cardiac; Endothelial Cells; Lymphangiogenesis; Lymphatic Vessels; Mice; Mice, Knockout; Myocardium; Permeability; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Vascular Endothelial Growth Factor Receptor-3 | 2022 |
Inhibition of Src improves cardiac fibrosis in AngII-induced hypertrophy by regulating the expression of galectin-3.
Topics: Angiotensin II; Animals; Cardiomegaly; Fibrosis; Galectin 3; Mice; Mice, Knockout; Myocytes, Cardiac; src-Family Kinases | 2022 |
LongShengZhi alleviated cardiac remodeling via upregulation microRNA-150-5p with matrix metalloproteinase 14 as the target.
Topics: Angiotensin II; Animals; Cardiomegaly; Drugs, Chinese Herbal; Fibrosis; Matrix Metalloproteinase 14; MicroRNAs; Myocytes, Cardiac; Rats; Up-Regulation; Ventricular Remodeling | 2022 |
Circular RNA circ_0001006 aggravates cardiac hypertrophy via miR-214-3p/PAK6 axis.
Topics: 3' Untranslated Regions; Angiotensin II; Animals; Cardiomegaly; Cell Proliferation; Mice; MicroRNAs; Myocytes, Cardiac; RNA, Circular | 2022 |
Hydrogen Attenuates Thyroid Hormone-Induced Cardiac Hypertrophy in Rats by regulating angiotensin II type 1 receptor and NADPH oxidase 2 mediated oxidative stress.
Topics: Angiotensin II; Animals; Antioxidants; Cardiomegaly; Hydrogen; NADPH Oxidase 2; NADPH Oxidases; Oxidative Stress; Rats; Receptor, Angiotensin, Type 1; Thyroid Hormones; Thyroxine | 2022 |
MicroRNA miR-27a-3p accelerates cardiac hypertrophy by targeting neuro-oncological ventral antigen 1.
Topics: Angiotensin II; Animals; Cardiomegaly; Mice; MicroRNAs; Myocytes, Cardiac; Neuro-Oncological Ventral Antigen | 2022 |
Ginkgolide A alleviates cardiac remodeling in mice with myocardial infarction via binding to matrix metalloproteinase-9 to attenuate inflammation.
Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Cardiomegaly; Cardiotonic Agents; Fibronectins; Fibrosis; Ginkgolides; Heart Diseases; Inflammation; Lactones; Matrix Metalloproteinase 9; Mice; Myocardial Infarction; Myocytes, Cardiac; Rats; Ventricular Remodeling | 2022 |
The Prevention Role of Theaflavin-3,3'-digallate in Angiotensin II Induced Pathological Cardiac Hypertrophy via CaN-NFAT Signal Pathway.
Topics: Angiotensin II; Antioxidants; Biflavonoids; Calcineurin; Cardiomegaly; Catechin; Heart Failure; Humans; Myocytes, Cardiac; Signal Transduction | 2022 |
Sodium Ferulate Inhibits Rat Cardiomyocyte Hypertrophy Induced by Angiotensin II Through Enhancement of Endothelial Nitric Oxide Synthase/Nitric Oxide/Cyclic Guanosine Monophosphate Signaling Pathway.
Topics: Angiotensin II; Animals; Cardiomegaly; Coumaric Acids; Cyclic GMP; Esters; Guanosine Monophosphate; Myocytes, Cardiac; Nitric Oxide; Nitric Oxide Synthase Type III; Rats; Rats, Sprague-Dawley; Signal Transduction | 2022 |
Targeting of midkine alleviates cardiac hypertrophy via attenuation of oxidative stress and autophagy.
Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Autophagy; Cardiomegaly; Mice; Midkine; Myocytes, Cardiac; Natriuretic Peptide, Brain; Oxidative Stress | 2022 |
MicroRNA-384-5p protects against cardiac hypertrophy via the ALPK3 signaling pathway.
Topics: Angiotensin II; Animals; Cardiomegaly; Heart Failure; Humans; MicroRNAs; Muscle Proteins; Myocytes, Cardiac; Protein Kinases; Signal Transduction | 2022 |
Up-regulation of Nrf2/HO-1 and inhibition of TGF-β1/Smad2/3 signaling axis by daphnetin alleviates transverse aortic constriction-induced cardiac remodeling in mice.
Topics: Angiotensin II; Animals; Cardiomegaly; Collagen; Heme Oxygenase-1; Membrane Proteins; Mice; NF-E2-Related Factor 2; Reactive Oxygen Species; Signal Transduction; Smad2 Protein; Smad3 Protein; Transforming Growth Factor beta1; Umbelliferones; Up-Regulation; Ventricular Remodeling | 2022 |
Tumor Necrosis Factor-
Topics: Angiotensin II; Animals; Cardiomegaly; Disease Models, Animal; Inflammation; Intracellular Signaling Peptides and Proteins; Macrophages; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; Rats; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha | 2022 |
Sulfasalazine exacerbates angiotensin II-induced cardiac remodelling by activating Akt signal pathway.
Topics: Angiotensin II; Animals; Cardiomegaly; Fibrosis; Hypertrophy; Mice; Mice, Inbred C57BL; Myocardium; Myocytes, Cardiac; Proto-Oncogene Proteins c-akt; Signal Transduction; Sulfasalazine; Ventricular Remodeling | 2022 |
Circ-TLR4 promotes cardiac hypertrophy through recruiting FUS to stabilize TLR4 mRNA.
Topics: Angiotensin II; Atrial Natriuretic Factor; Cardiomegaly; Humans; Myocytes, Cardiac; Myosin Heavy Chains; Natriuretic Peptide, Brain; RNA-Binding Protein FUS; RNA, Circular; RNA, Messenger; Toll-Like Receptor 4 | 2022 |
Downregulation of lncRNA MALAT1 Inhibits Angiotensin II-induced Hypertrophic Effects of Cardiomyocytes by Regulating SIRT4 via miR-93-5p.
Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Cardiomegaly; Down-Regulation; Mice; Mice, Inbred C57BL; MicroRNAs; Mitochondrial Proteins; Myocytes, Cardiac; Neoplasms; RNA, Long Noncoding; Sirtuins | 2022 |
CCL17 acts as a novel therapeutic target in pathological cardiac hypertrophy and heart failure.
Topics: Angiotensin II; Animals; Cardiomegaly; Chemokine CCL17; Chemokines; Fibrosis; Heart Failure; Humans; Ligands; Mice; Mice, Inbred C57BL; Myocardium; Myocytes, Cardiac; Proteomics | 2022 |
Tabersonine attenuates Angiotensin II-induced cardiac remodeling and dysfunction through targeting TAK1 and inhibiting TAK1-mediated cardiac inflammation.
Topics: Angiotensin II; Animals; Cardiomegaly; Fibrosis; Heart Failure; Indole Alkaloids; Inflammation; MAP Kinase Kinase Kinases; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; Quinolines; Rats; Signal Transduction; Ventricular Remodeling | 2022 |
PKN2 deficiency leads both to prenatal 'congenital' cardiomyopathy and defective angiotensin II stress responses.
Topics: Angiotensin II; Animals; Cardiomegaly; Cardiomyopathies; Female; Hypertension; Mice; Mice, Knockout; Myocardium; Myocytes, Cardiac; Pregnancy; Protein Kinase C | 2022 |
Postnatal Deletion of Bmal1 in Cardiomyocyte Promotes Pressure Overload Induced Cardiac Remodeling in Mice.
Topics: Angiotensin II; Animals; ARNTL Transcription Factors; Cardiomegaly; Disease Models, Animal; Fibrosis; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocytes, Cardiac; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Ventricular Remodeling | 2022 |
Targeting miR-30d reverses pathological cardiac hypertrophy.
Topics: Angiotensin II; Animals; Cardiomegaly; China; Heart Failure; Humans; Intracellular Signaling Peptides and Proteins; Mice; MicroRNAs; Myocytes, Cardiac; Protein Serine-Threonine Kinases; Rats | 2022 |
Angiotensin II Mediates Cardiomyocyte Hypertrophy in Atrial Cardiomyopathy via Epigenetic Transcriptional Regulation.
Topics: Angiotensin II; Atrial Fibrillation; Cardiomegaly; Cardiomyopathies; Chromatin; Epigenesis, Genetic; Humans; Myocytes, Cardiac; Signal Transduction | 2022 |
METTL3 mediates Ang-II-induced cardiac hypertrophy through accelerating pri-miR-221/222 maturation in an m6A-dependent manner.
Topics: Angiotensin II; Animals; beta Catenin; Cardiomegaly; Methyltransferases; Mice; Mice, Inbred C57BL; MicroRNAs; Myocytes, Cardiac; Rats; RNA-Binding Proteins | 2022 |
ANGPTL8 is a negative regulator in pathological cardiac hypertrophy.
Topics: Angiopoietin-Like Protein 8; Angiopoietin-like Proteins; Angiotensin II; Animals; Antigens, CD; Cardiomegaly; Disease Models, Animal; Glycogen Synthase Kinase 3 beta; Heart Failure; Humans; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; Peptide Hormones; Proto-Oncogene Proteins c-akt; Rats; Receptors, Immunologic; Signal Transduction | 2022 |
Angiotensin II Receptor Blockers and Arrhythmias in Ventricular Hypertrophy.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Arrhythmias, Cardiac; Cardiomegaly; Humans; Receptor, Angiotensin, Type 1 | 2022 |
miR-21 upregulation exacerbates pressure overload-induced cardiac hypertrophy in aged hearts.
Topics: Angiotensin II; Animals; Cardiomegaly; Disease Models, Animal; Humans; Hypertension; Mice; Mice, Inbred C57BL; Mice, Knockout; MicroRNAs; Myocytes, Cardiac; Up-Regulation; Ventricular Remodeling | 2022 |
Genetic Deletion of Galectin-3 Exacerbates Age-Related Myocardial Hypertrophy and Fibrosis in Mice.
Topics: Angiotensin II; Animals; Cardiomegaly; Disease Models, Animal; Fibrosis; Galectin 3; Gene Deletion; Male; Matrix Metalloproteinase 9; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardium; Sirtuin 1; Transforming Growth Factor beta; Ventricular Remodeling | 2022 |
BMAL1 plays a critical role in the protection against cardiac hypertrophy through autophagy in vitro.
Topics: Angiotensin II; Animals; Apoptosis; Autophagy; Cardiomegaly; Humans; Myocytes, Cardiac; Rats | 2022 |
Downregulation of amphiregulin improves cardiac hypertrophy via attenuating oxidative stress and apoptosis.
Topics: Amphiregulin; Angiotensin II; Animals; Apoptosis; Cardiomegaly; Down-Regulation; Mice; Oxidative Stress; Rats | 2022 |
Diacerein alleviates Ang II-induced cardiac inflammation and remodeling by inhibiting the MAPKs/c-Myc pathway.
Topics: Angiotensin II; Animals; Anthraquinones; Cardiomegaly; Cardiomyopathies; Fibrosis; Heart Failure; Hypertension; Inflammation; Mice; Mice, Inbred C57BL; Myocardium; Myocytes, Cardiac; RNA; Ventricular Remodeling | 2022 |
Self-limiting bidirectional positive feedback between P53 and P21 is involved in cardiac hypertrophy.
Topics: Angiotensin II; Animals; Cardiomegaly; Feedback, Physiological; Myocytes, Cardiac; Proto-Oncogene Proteins p21(ras); Rats; Tumor Suppressor Protein p53 | 2022 |
miR-212 Promotes Cardiomyocyte Hypertrophy through Regulating Transcription Factor 7 Like 2.
Topics: Angiotensin II; Animals; Cardiomegaly; MicroRNAs; Myocytes, Cardiac; Rats; Transcription Factor 7-Like 2 Protein | 2022 |
GSDMD (Gasdermin D) Mediates Pathological Cardiac Hypertrophy and Generates a Feed-Forward Amplification Cascade via Mitochondria-STING (Stimulator of Interferon Genes) Axis.
Topics: Angiotensin II; Animals; Cardiomegaly; Humans; Interferons; Intracellular Signaling Peptides and Proteins; Mice; Mitochondria; Myocytes, Cardiac; Phosphate-Binding Proteins | 2022 |
Dock10 Regulates Cardiac Function under Neurohormonal Stress.
Topics: Angiotensin II; Animals; Cardiomegaly; Guanine Nucleotide Exchange Factors; JNK Mitogen-Activated Protein Kinases; Mice; Myocardium; Myocytes, Cardiac; p38 Mitogen-Activated Protein Kinases; Signal Transduction | 2022 |
G-protein coupled receptor 30 attenuates myocardial hypertrophy by reducing oxidative stress and apoptosis in Ang II-treated mice.
Topics: Angiotensin II; Animals; Apoptosis; Atrial Natriuretic Factor; Cardiomegaly; Female; Fibrosis; GTP-Binding Proteins; Mice; Myocytes, Cardiac; Myosin Heavy Chains; Natriuretic Peptide, Brain; Oxidative Stress; Peptide Hormones; Rats; Receptors, Estrogen; Receptors, G-Protein-Coupled | 2022 |
Secreted frizzled-related protein 3 alleviated cardiac remodeling induced by angiotensin II via inhibiting oxidative stress and apoptosis in mice.
Topics: Angiotensin II; Animals; Apoptosis; Cardiomegaly; Fibrosis; Hypertrophy; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; Oxidative Stress; Rats; Ventricular Remodeling | 2022 |
IRX2 activated by jumonji domain-containing protein 2A is crucial for cardiac hypertrophy and dysfunction in response to the hypertrophic stimuli.
Topics: Angiotensin II; Animals; beta Catenin; Cardiomegaly; Cardiomyopathy, Hypertrophic; Homeodomain Proteins; Jumonji Domain-Containing Histone Demethylases; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; Transcription Factors; Ventricular Dysfunction | 2023 |
Heart-targeting exosomes from human cardiosphere-derived cells improve the therapeutic effect on cardiac hypertrophy.
Topics: Angiotensin II; Animals; Cardiomegaly; Cytokine Receptor gp130; Exosomes; Humans; Lysosomal Membrane Proteins; Mice; MicroRNAs; Myocytes, Cardiac; Peptides; Proto-Oncogene Proteins c-akt; Rats | 2022 |
Cardiomyocyte p38 MAPKα suppresses a heart-adipose tissue-neutrophil crosstalk in heart failure development.
Topics: Adipose Tissue; Angiotensin II; Animals; Cardiomegaly; Fatty Acids; Heart Failure; Inflammation; Lipase; Lipids; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; Neutrophils; p38 Mitogen-Activated Protein Kinases; Tamoxifen | 2022 |
Development of non-bias phenotypic drug screening for cardiomyocyte hypertrophy by image segmentation using deep learning.
Topics: Angiotensin II; Animals; Cardiomegaly; Cells, Cultured; Cholesterol; Deep Learning; Drug Evaluation, Preclinical; Endothelin-1; Ezetimibe; Heart Failure; Mice; Myocytes, Cardiac; Rats | 2022 |
Inhibition of intermittent calcium-activated potassium channel (SK4) attenuates Ang II-induced hypertrophy of human-induced stem cell-derived cardiomyocytes via targeting Ras-Raf-MEK1/2-ERK1/2 and CN-NFAT signaling pathways.
Topics: Angiotensin II; Cardiomegaly; Humans; MAP Kinase Kinase 1; MAP Kinase Signaling System; Myocytes, Cardiac; NFATC Transcription Factors; RNA, Messenger; Signal Transduction; Stem Cells | 2023 |
Membrane Estrogen Receptor β Is Sufficient to Mitigate Cardiac Cell Pathology.
Topics: Angiotensin II; Animals; Cardiomegaly; Cricetinae; Estrogen Receptor alpha; Estrogen Receptor beta; Estrogens; Mice; Myocytes, Cardiac; Rats | 2022 |
A novel circ_0018553 protects against angiotensin-induced cardiac hypertrophy in cardiomyocytes by modulating the miR-4731/SIRT2 signaling pathway.
Topics: Angiotensin II; Cardiomegaly; Humans; MicroRNAs; Myocytes, Cardiac; RNA, Circular; Signal Transduction; Sirtuin 2 | 2023 |
MiR-423-5p Inhibition Exerts Protective Effects on Angiotensin II-Induced Cardiomyocyte Hypertrophy.
Topics: Angiotensin II; Cardiomegaly; Humans; MicroRNAs; Myocytes, Cardiac | 2023 |
Angiotensin II Type 1A Receptor Expressed in Smooth Muscle Cells is Required for Hypertensive Vascular Remodeling in Mice Infused With Angiotensin II.
Topics: Angiotensin II; Animals; Cardiomegaly; Fibrosis; Hypertension; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocytes, Smooth Muscle; Receptor, Angiotensin, Type 1; Vascular Remodeling | 2023 |
Increased angiotensin II coupled with decreased Adra1a expression enhances cardiac hypertrophy in pregnancy-associated hypertensive mice.
Topics: Angiotensin II; Animals; Cardiomegaly; Female; Humans; Hypertension, Pregnancy-Induced; Mice; Myocardium; Pregnancy; Receptors, Adrenergic, alpha-1; Renin-Angiotensin System | 2023 |
HypERlnc attenuates angiotensin II-induced cardiomyocyte hypertrophy via promoting SIRT1 SUMOylation-mediated activation of PGC-1α/PPARα pathway in AC16 cells.
Topics: Angiotensin II; Cardiomegaly; Heart Failure; Humans; Myocytes, Cardiac; Peptide Hormones; PPAR alpha; Sirtuin 1; Sumoylation | 2023 |
Circ_0001052 promotes cardiac hypertrophy via elevating Hipk3.
Topics: Angiotensin II; Aortic Valve Stenosis; Biological Assay; Cardiomegaly; Cell Proliferation; Humans; Intracellular Signaling Peptides and Proteins; MicroRNAs; Peptide Hormones; Protein Serine-Threonine Kinases; RNA, Circular; Serine-Arginine Splicing Factors | 2023 |
Herpud1 modulates hypertrophic signals independently of calmodulin nuclear translocation in rat myocardium-derived H9C2 cells.
Topics: Angiotensin II; Animals; Calmodulin; Cardiomegaly; Cell Line; Cells, Cultured; Myocytes, Cardiac; Rats; RNA, Small Interfering; Transcription Factors | 2023 |
Serum exosomes derived from spontaneously hypertensive rats induce cardiac hypertrophy in vitro and in vivo by increasing autocrine release of angiotensin II in cardiomyocytes.
Topics: Angiotensin II; Animals; Cardiomegaly; Exosomes; Hypertension; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; Rats; Rats, Inbred SHR; Renin; Renin-Angiotensin System | 2023 |
Silicate Ions Derived from Calcium Silicate Extract Decelerate Ang II-Induced Cardiac Remodeling.
Topics: Angiotensin II; Animals; Calcium; Cardiomegaly; Mice; Silicates; Ventricular Remodeling | 2023 |
Baicalin inhibits pressure overload-induced cardiac hypertrophy by regulating the SIRT3-dependent signaling pathway.
Topics: Angiotensin II; Animals; Cardiomegaly; Flavonoids; Mice; Myocytes, Cardiac; Proteasome Endopeptidase Complex; Rats; Signal Transduction; Sirtuin 3 | 2023 |
Discovery of 14-3-3 zeta as a potential biomarker for cardiac hypertrophy.
Topics: 14-3-3 Proteins; Angiotensin II; Biomarkers; Cardiomegaly; Humans; Myocardial Infarction; Myocytes, Cardiac; Proteomics | 2023 |
Gramine protects against pressure overload-induced pathological cardiac hypertrophy through Runx1-TGFBR1 signaling.
Topics: Angiotensin II; Animals; Cardiomegaly; Core Binding Factor Alpha 2 Subunit; Disease Models, Animal; Indole Alkaloids; Mice; Mice, Inbred C57BL; Molecular Docking Simulation; Myocytes, Cardiac; p38 Mitogen-Activated Protein Kinases; Rats; Receptor, Transforming Growth Factor-beta Type I; Signal Transduction; Transforming Growth Factor beta | 2023 |
SLC26A4-AS1 Aggravates AngII-induced Cardiac Hypertrophy by Enhancing SLC26A4 Expression.
Topics: Angiotensin II; Animals; Cardiomegaly; Mice; MicroRNAs; Myocytes, Cardiac; RNA, Antisense; Sulfate Transporters | 2023 |
Angiotensin II-induced calcium overload affects mitochondrial functions in cardiac hypertrophy by targeting the USP2/MFN2 axis.
Topics: Angiotensin II; Animals; Calcium; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Calcium, Dietary; Cardiomegaly; Mitochondria; Myocytes, Cardiac | 2023 |
TRIM-containing 44 aggravates cardiac hypertrophy via TLR4/NOX4-induced ferroptosis.
Topics: Angiotensin II; Animals; Cardiomegaly; Disease Models, Animal; Ferroptosis; Mice; Mice, Knockout; Myocytes, Cardiac; NADPH Oxidase 4; Toll-Like Receptor 4 | 2023 |
6-Formylindolo[3,2-b]carbazole Protects Against Angiotensin II-Induced Cellular Hypertrophy through the Induction of Cytochrome P450 1A1 and Its Associated 19(S)-HETE Metabolite In Vitro.
Topics: Angiotensin II; Arachidonic Acid; Carbazoles; Cardiomegaly; Cytochrome P-450 CYP1A1; Cytochrome P-450 Enzyme System; Humans; Hydroxyeicosatetraenoic Acids; Receptors, Aryl Hydrocarbon | 2023 |
CMTM3 deficiency induces cardiac hypertrophy by regulating MAPK/ERK signaling.
Topics: Angiotensin II; Animals; Cardiomegaly; Chemokines; Gene Knockout Techniques; Heart; MARVEL Domain-Containing Proteins; Mice; Myocytes, Cardiac; p38 Mitogen-Activated Protein Kinases; Phenylephrine; Phosphorylation; Rats; Up-Regulation | 2023 |
Long non-coding RNA KCND1 protects hearts from hypertrophy by targeting YBX1.
Topics: Angiotensin II; Animals; Cardiomegaly; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; RNA, Long Noncoding; Shal Potassium Channels; Transcription Factors | 2023 |
Pristimerin protects against pathological cardiac hypertrophy through improvement of PPARα pathway.
Topics: Angiotensin II; Animals; Cardiomegaly; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; PPAR alpha; Rats; Signal Transduction | 2023 |
Cardiac-specific BACH1 ablation attenuates pathological cardiac hypertrophy by inhibiting the Ang II type 1 receptor expression and the Ca2+/CaMKII pathway.
Topics: Angiotensin II; Animals; Calcium; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Cardiomegaly; Fibrosis; Losartan; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Myocytes, Cardiac | 2023 |
Sesamin suppresses angiotensin-II-enhanced oxidative stress and hypertrophic markers in H9c2 cells.
Topics: Angiotensin II; Cardiomegaly; Cardiovascular Diseases; Humans; Myocytes, Cardiac; Oxidative Stress; Reactive Oxygen Species | 2023 |
Integrin beta-like 1 mediates fibroblast-cardiomyocyte crosstalk to promote cardiac fibrosis and hypertrophy.
Topics: Angiotensin II; Animals; Cardiomegaly; Fibroblasts; Fibrosis; Heart Failure; Integrins; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; Rats; Ventricular Remodeling | 2023 |
Dapagliflozin attenuates myocardial hypertrophy via activating the SIRT1/HIF-1α signaling pathway.
Topics: Angiotensin II; Animals; Cardiomegaly; Fibrosis; Mice; Myocytes, Cardiac; Signal Transduction; Sirtuin 1; Stroke Volume; Ventricular Function, Left | 2023 |
Cardioprotective Effects of Sodium Glucose Cotransporter 2 Inhibition in Angiotensin II-Dependent Hypertension Are Mediated by the Local Reduction of Sympathetic Activity and Inflammation.
Topics: Angiotensin II; Animals; Blood Glucose; Blood Pressure; Cardiomegaly; Fibrosis; Hypertension; Inflammation; Rats; Rats, Sprague-Dawley; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Tyrosine 3-Monooxygenase | 2023 |
Transmembrane protein 117 knockdown protects against angiotensin-II-induced cardiac hypertrophy.
Topics: Angiotensin II; Animals; Cardiomegaly; Mice; Mitochondria; Myocytes, Cardiac; Oxidative Stress | 2023 |
Nuclear import of Mas-related G protein-coupled receptor member D induces pathological cardiac remodeling.
Topics: Active Transport, Cell Nucleus; Angiotensin II; Cardiomegaly; Humans; Ligands; Receptors, G-Protein-Coupled; Ventricular Remodeling | 2023 |
Effects of Angiotensin 1-7 and Mas Receptor Agonist on Renal System in a Rat Model of Heart Failure.
Topics: Angiotensin I; Angiotensin II; Animals; Cardiomegaly; Heart Failure; Kidney; Peptide Fragments; Rats; Renin-Angiotensin System | 2023 |
Resveratrol prevents Ang II-induced cardiac hypertrophy by inhibition of NF-κB signaling.
Topics: Angiotensin II; Animals; Cardiomegaly; Heart Failure; Mice; Myocytes, Cardiac; NF-kappa B; Rats; Resveratrol; Signal Transduction | 2023 |
Paeoniflorin alleviates AngII-induced cardiac hypertrophy in H9c2 cells by regulating oxidative stress and Nrf2 signaling pathway.
Topics: Angiotensin II; Animals; Apoptosis; Apoptosis Regulatory Proteins; bcl-2-Associated X Protein; Cardiomegaly; Myocytes, Cardiac; NF-E2-Related Factor 2; Oxidative Stress; Protein Kinases; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Signal Transduction; Superoxide Dismutase | 2023 |
The novel peptide athycaltide-1 attenuates Ang II-induced pathological myocardial hypertrophy by reducing ROS and inhibiting the activation of CaMKII and ERK1/2.
Topics: Angiotensin II; Animals; Calcium Signaling; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Cardiomegaly; Cells, Cultured; MAP Kinase Signaling System; Mice; Myocytes, Cardiac; Peptides; Reactive Oxygen Species | 2023 |
Inhibition of miR-25 Ameliorates Cardiac Dysfunction and Fibrosis by Restoring Krüppel-like Factor 4 Expression.
Topics: Angiotensin II; Animals; Calcium; Cardiomegaly; Cardiomyopathies; Fibrosis; Hypertension; Kruppel-Like Factor 4; Mice; Mice, Inbred C57BL; MicroRNAs; Myocytes, Cardiac | 2023 |
Effect of pharmacological heart failure drugs and gene therapy on Danon's cardiomyopathy.
Topics: Angiotensin II; Animals; Cardiomegaly; Fibrosis; Genetic Therapy; Glycogen Storage Disease Type IIb; Heart Failure; Humans; Mice; Ramipril; Reactive Oxygen Species; Spironolactone | 2023 |
Visfatin aggravates transverse aortic constriction-induced cardiac remodelling by enhancing macrophage-mediated oxidative stress in mice.
Topics: Angiotensin II; Animals; Aortic Valve Stenosis; Cardiomegaly; Constriction; Fibrosis; Macrophages; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; Nicotinamide Phosphoribosyltransferase; Oxidative Stress; Ventricular Remodeling | 2023 |
Pregnancy-induced physiological hypertrophic preconditioning attenuates pathological myocardial hypertrophy by activation of FoxO3a.
Topics: Angiotensin II; Animals; Aortic Valve Stenosis; Cardiomegaly; Female; Glycogen Synthase Kinase 3 beta; Heart; Heart Failure; Mice; Peptide Hormones; Pregnancy | 2023 |
Early-life exposure to lead changes cardiac development and compromises long-term cardiac function.
Topics: Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Female; Humans; Lead; Mice; Mice, Inbred ICR; Myocytes, Cardiac; Pregnancy | 2023 |
SOX4 as a potential therapeutic target for pathological cardiac hypertrophy.
Topics: Angiotensin II; Animals; Cardiomegaly; Heart Failure; Mice; Myocytes, Cardiac; Rats; Sirtuin 3; SOXC Transcription Factors | 2023 |
Exosomes derived from cardiac fibroblasts with angiotensin II stimulation provoke hypertrophy and autophagy inhibition in cardiomyocytes.
Topics: Angiotensin II; Animals; Autophagy; Cardiomegaly; Exosomes; Fibroblasts; Mice; Myocytes, Cardiac; Rats | 2023 |
PKD knockdown mitigates Ang II-induced cardiac hypertrophy and ferroptosis via the JNK/P53 signaling pathway.
Topics: Angiotensin II; Cardiomegaly; Ferroptosis; Humans; Myocytes, Cardiac; Signal Transduction; Tumor Suppressor Protein p53 | 2024 |
Repurposing an anti-cancer agent for the treatment of hypertrophic heart disease.
Topics: Angiotensin II; Animals; Cardiomegaly; Cardiovascular Agents; Case-Control Studies; Cells, Cultured; Disease Models, Animal; Drug Repositioning; Fibrosis; Gene Expression Regulation; Heart Failure; Humans; Integrin alphaVbeta3; Male; Mice; Myocytes, Cardiac; Neovascularization, Physiologic; Recovery of Function; Signal Transduction; Snake Venoms; Transcriptome | 2019 |
β-catenin/LEF1/IGF-IIR Signaling Axis Galvanizes the Angiotensin-II- induced Cardiac Hypertrophy.
Topics: Angiotensin II; Animals; beta Catenin; Biomarkers; Cardiomegaly; Cell Nucleus; GATA4 Transcription Factor; GTP-Binding Protein alpha Subunits, Gq-G11; Lymphoid Enhancer-Binding Factor 1; Myocytes, Cardiac; NFATC Transcription Factors; Promoter Regions, Genetic; Protein Kinase C-alpha; Rats, Inbred SHR; Receptor, IGF Type 2; Signal Transduction | 2019 |
Hexarelin protects cardiac H9C2 cells from angiotensin II-induced hypertrophy
Topics: Angiotensin II; Animals; Autophagosomes; Autophagy; Cardiomegaly; Cell Line; Cell Survival; Metabolic Networks and Pathways; Myocytes, Cardiac; Oligopeptides; Oxidative Stress; Protective Agents; Rats; Signal Transduction; TOR Serine-Threonine Kinases | 2019 |
A knock-in mutation at cysteine 144 of TRIM72 is cardioprotective and reduces myocardial TRIM72 release.
Topics: Angiotensin II; Animals; Cardiomegaly; Coronary Artery Disease; Cysteine; Disease Models, Animal; Gene Knock-In Techniques; Insulin Resistance; Membrane Proteins; Mice, Inbred C57BL; Mice, Mutant Strains; Mutation; Myocardial Reperfusion Injury; Myocardium | 2019 |
Interleukin enhancement binding factor 3 inhibits cardiac hypertrophy by targeting asymmetric dimethylarginine-nitric oxide.
Topics: Amidohydrolases; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Arginine; Cardiomegaly; Down-Regulation; Gene Knockdown Techniques; Losartan; Male; Myocytes, Cardiac; Nitric Oxide; Nuclear Factor 90 Proteins; Rats, Sprague-Dawley | 2019 |
MicroRNA-122 promotes cardiomyocyte hypertrophy via targeting FoxO3.
Topics: Angiotensin II; Animals; Animals, Newborn; Calcineurin; Cardiomegaly; Cell Size; Cells, Cultured; Forkhead Box Protein O3; Gene Expression Regulation; MicroRNAs; Myocytes, Cardiac; Rats, Sprague-Dawley; Signal Transduction; Vasoconstrictor Agents | 2019 |
Sodium butyrate attenuates angiotensin II-induced cardiac hypertrophy by inhibiting COX2/PGE2 pathway via a HDAC5/HDAC6-dependent mechanism.
Topics: Angiotensin II; Animals; Butyric Acid; Cardiomegaly; Cell Line; Cyclooxygenase 2; Dinoprostone; Gene Expression; Gene Knockdown Techniques; Histone Deacetylase 6; Histone Deacetylases; Hypertension; Myocytes, Cardiac; Rats, Sprague-Dawley; Signal Transduction | 2019 |
miR-154-5p Functions as an Important Regulator of Angiotensin II-Mediated Heart Remodeling.
Topics: Angiotensin II; Animals; Apoptosis; Cardiomegaly; Disease Models, Animal; Male; Mice; MicroRNAs; Myocytes, Cardiac | 2019 |
Deficiency of MicroRNA miR-1954 Promotes Cardiac Remodeling and Fibrosis.
Topics: Actins; Angiotensin II; Animals; bcl-2 Homologous Antagonist-Killer Protein; Cardiomegaly; Caspase 3; Collagen Type I; Collagen Type I, alpha 1 Chain; Collagen Type III; Collagen Type IV; Connective Tissue Growth Factor; Disease Models, Animal; Fibrosis; High-Throughput Nucleotide Sequencing; Interleukin-6; Mice, Transgenic; MicroRNAs; Myocardium; Organ Size; S100 Calcium-Binding Protein A4; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Thrombospondin 1; Transforming Growth Factor beta1; Up-Regulation; Ventricular Remodeling | 2019 |
BRD4 blockage alleviates pathological cardiac hypertrophy through the suppression of fibrosis and inflammation via reducing ROS generation.
Topics: Angiotensin II; Animals; Cardiomegaly; Cell Line; Fibrosis; Heart; Heme Oxygenase-1; Humans; Inflammation; Male; Mice; Mice, Inbred C57BL; Myocardium; Myocytes, Cardiac; NF-kappa B; Nuclear Proteins; Oxidative Stress; Protective Agents; Reactive Oxygen Species; Signal Transduction; Transcription Factors; Transforming Growth Factor beta1; Up-Regulation | 2020 |
MiR-21, MiR-29a, GATA4, and MEF2c Expression Changes in Endothelin-1 and Angiotensin II Cardiac Hypertrophy Stimulated Isl-1
Topics: Angiotensin II; Animals; Antigens, Surface; Biomarkers; Cardiomegaly; Cells, Cultured; Cellular Reprogramming; Connexin 43; Disease Susceptibility; Endothelin-1; GATA4 Transcription Factor; Genetic Predisposition to Disease; Immunophenotyping; MEF2 Transcription Factors; MicroRNAs; Myoblasts, Cardiac; Phenotype; Swine; Ventricular Remodeling | 2019 |
Effect of endostatin overexpression on angiotensin II-induced cardiac hypertrophy in rats.
Topics: Angiotensin II; Animals; Blotting, Western; Cardiomegaly; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Echocardiography; Endostatins; Fluorescent Antibody Technique; Male; Myocytes, Cardiac; Rats; Rats, Sprague-Dawley; Signal Transduction | 2019 |
Corosolic acid ameliorates cardiac hypertrophy via regulating autophagy.
Topics: AMP-Activated Protein Kinase Kinases; Angiotensin II; Animals; Autophagosomes; Autophagy; Cardiomegaly; Disease Models, Animal; Gene Expression Regulation; Humans; Mice; Microtubule-Associated Proteins; Myocytes, Cardiac; Protein Kinases; Rats; Signal Transduction; Triterpenes | 2019 |
Steroidogenic acute regulatory protein/aldosterone synthase mediates angiotensin II-induced cardiac fibrosis and hypertrophy.
Topics: Adrenal Glands; Angiotensin II; Animals; Biomarkers; Biopsy; Cardiomegaly; Cardiomyopathies; Collagen; Cytochrome P-450 CYP11B2; Disease Models, Animal; Disease Susceptibility; Fibrosis; Immunohistochemistry; Macrophages; Male; Models, Biological; Myocardium; Myofibroblasts; Phosphoproteins; Rats; Receptor, Angiotensin, Type 1; Signal Transduction; Smad2 Protein; Smad3 Protein | 2020 |
Long Noncoding RNA FTX Reduces Hypertrophy of Neonatal Mouse Cardiac Myocytes and Regulates the PTEN/PI3K/Akt Signaling Pathway by Sponging MicroRNA-22.
Topics: Actins; Angiotensin II; Animals; Animals, Newborn; Apoptosis; Cardiomegaly; Cells, Cultured; Heart Failure; Mice; Mice, Inbred C57BL; MicroRNAs; Myocardium; Myocytes, Cardiac; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; RNA, Long Noncoding; Signal Transduction | 2019 |
MicroRNA302-367-PI3K-PTEN-AKT-mTORC1 pathway promotes the development of cardiac hypertrophy through controlling autophagy.
Topics: Angiotensin II; Animals; Autophagosomes; Autophagy; Base Sequence; Cardiomegaly; Cell Line; Mechanistic Target of Rapamycin Complex 1; MicroRNAs; Myocytes, Cardiac; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Rats; Signal Transduction | 2020 |
Involvement of phosphatase and tensin homolog-induced putative kinase 1/Parkin-mediated autophagy in angiotensin II-induced cardiac hypertrophy in C57BL/6 mice.
Topics: Angiotensin II; Animals; Apoptosis; Autophagy; Cardiomegaly; Disease Models, Animal; Echocardiography; Heart Ventricles; Humans; Membrane Potential, Mitochondrial; Mice; Mice, Inbred C57BL; Mitochondria, Heart; Myocardium; Myocytes, Cardiac; Protein Kinases; Ubiquitin-Protein Ligases | 2020 |
NRF1-enhanced miR-4458 alleviates cardiac hypertrophy through releasing TTP-inhibited TFAM.
Topics: Angiotensin II; Animals; Base Sequence; Cardiomegaly; Cell Line; Male; Mice, Inbred C57BL; MicroRNAs; Nuclear Respiratory Factor 1; Phenotype; Protein Stability; Rats; Transcription Factors; Transcription, Genetic; Tristetraprolin | 2020 |
Complement component C3 and the TLR co-receptor CD14 are not involved in angiotensin II induced cardiac remodelling.
Topics: Angiotensin II; Animals; Biomarkers; Blood Pressure; Cardiomegaly; Complement C3; Fibrosis; Hypertrophy; Interleukin-6; Lipopolysaccharide Receptors; Mice; Myocardium; Myocytes, Cardiac; Organ Size; RNA, Messenger; Systole; Toll-Like Receptors; Ventricular Remodeling | 2020 |
MiR-326 targets MDK to regulate the progression of cardiac hypertrophy through blocking JAK/STAT and MAPK signaling pathways.
Topics: Angiotensin II; Animals; Cardiomegaly; Cell Line; Disease Models, Animal; Disease Progression; Down-Regulation; Humans; Janus Kinases; Male; MAP Kinase Signaling System; Mice; MicroRNAs; Midkine; Myocytes, Cardiac; Rats; STAT Transcription Factors | 2020 |
Neuron-derived orphan receptor-1 modulates cardiac gene expression and exacerbates angiotensin II-induced cardiac hypertrophy.
Topics: Angiotensin II; Animals; Biomarkers; Cardiomegaly; Collagen; Collagen Type I, alpha 1 Chain; Disease Models, Animal; Disease Progression; Electrocardiography; Fibroblasts; Fibrosis; Gene Expression Regulation; Humans; Inflammation; Mice, Inbred C57BL; Mice, Transgenic; Myocardium; Myocytes, Cardiac; Nuclear Receptor Subfamily 4, Group A, Member 3; Transcription, Genetic; Ventricular Remodeling | 2020 |
Aliskiren attenuates cardiac dysfunction by modulation of the mTOR and apoptosis pathways.
Topics: Amides; Angiotensin II; Animals; Apoptosis; Blotting, Western; Cardiomegaly; Disease Models, Animal; Fibrosis; Flow Cytometry; Fumarates; Isoproterenol; Male; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; TOR Serine-Threonine Kinases | 2020 |
Emodin and emodin-rich rhubarb inhibits histone deacetylase (HDAC) activity and cardiac myocyte hypertrophy.
Topics: Acetylation; Angiotensin II; Animals; Animals, Newborn; Cardiomegaly; Cardiotonic Agents; Disease Models, Animal; Emodin; Female; Gene Expression; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Hydroxamic Acids; Male; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; Rats; Rats, Sprague-Dawley; Rheum | 2020 |
High content screening identifies licoisoflavone A as a bioactive compound of Tongmaiyangxin Pills to restrain cardiomyocyte hypertrophy via activating Sirt3.
Topics: Acetylation; Angiotensin II; Animals; Cardiomegaly; Cells, Cultured; Disease Models, Animal; Drug Evaluation, Preclinical; Drugs, Chinese Herbal; Isoflavones; Isoproterenol; Male; Mice, Inbred C57BL; Mitochondria, Heart; Myocytes, Cardiac; Phenylephrine; Rats; Sirtuin 3 | 2020 |
Resveratrol suppresses interleukin-6 expression through activation of sirtuin 1 in hypertrophied H9c2 cardiomyoblasts.
Topics: Angiotensin II; Animals; Cardiomegaly; Cell Survival; Cells, Cultured; Gene Expression; Inflammation; Interleukin-6; Myocytes, Cardiac; Rats; Resveratrol; RNA, Messenger; Sirtuin 1; Transcription, Genetic | 2020 |
The association between microRNA-21 and hypertension-induced cardiac remodeling.
Topics: Aged; Angiotensin II; Animals; Animals, Newborn; Apoptosis Regulatory Proteins; Cardiomegaly; Disease Models, Animal; Female; Fibrosis; Humans; Hypertension; Male; Mice; Mice, Inbred C57BL; MicroRNAs; Middle Aged; Myocardium; Myocytes, Cardiac; Rats; Rats, Sprague-Dawley; RNA-Binding Proteins; Signal Transduction; Transcription Factor AP-1; Transforming Growth Factor beta1 | 2020 |
LncRNA AK045171 protects the heart from cardiac hypertrophy by regulating the SP1/MG53 signalling pathway.
Topics: Angiotensin II; Animals; Cardiomegaly; Disease Models, Animal; Down-Regulation; Membrane Proteins; Mice; Myocardium; Myocytes, Cardiac; RNA, Long Noncoding; Signal Transduction; Sp1 Transcription Factor | 2020 |
B38-CAP is a bacteria-derived ACE2-like enzyme that suppresses hypertension and cardiac dysfunction.
Topics: Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Carboxypeptidases; Cardiomegaly; Disease Models, Animal; Fibrosis; Heart Failure; Hypertension; Male; Mice; Mice, Inbred C57BL; Paenibacillus; Peptidyl-Dipeptidase A; Recombinant Proteins | 2020 |
STING is an essential regulator of heart inflammation and fibrosis in mice with pathological cardiac hypertrophy via endoplasmic reticulum (ER) stress.
Topics: Angiotensin II; Animals; Biomarkers; Cardiomegaly; Disease Models, Animal; Disease Susceptibility; Echocardiography; Endoplasmic Reticulum Stress; Fibrosis; Gene Expression; Gene Knockdown Techniques; Immunohistochemistry; Inflammation; Male; Membrane Proteins; Mice; Myocytes, Cardiac; Rats; Signal Transduction | 2020 |
Inhibition of histone demethylase JMJD1C attenuates cardiac hypertrophy and fibrosis induced by angiotensin II.
Topics: Aminopyridines; Angiotensin II; Animals; Cardiomegaly; Disease Models, Animal; Fibrosis; Gene Expression Regulation; Heart; Humans; Hydrazones; Jumonji Domain-Containing Histone Demethylases; Myocardium; Myocytes, Cardiac; Oxidoreductases, N-Demethylating; Rats; RNA, Small Interfering; Signal Transduction; Tissue Inhibitor of Metalloproteinase-1 | 2020 |
DPP (Dipeptidyl Peptidase)-4 Inhibitor Attenuates Ang II (Angiotensin II)-Induced Cardiac Hypertrophy via GLP (Glucagon-Like Peptide)-1-Dependent Suppression of Nox (Nicotinamide Adenine Dinucleotide Phosphate Oxidase) 4-HDAC (Histone Deacetylase) 4 Pathw
Topics: Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Dipeptidyl-Peptidase IV Inhibitors; Glucagon-Like Peptide 1; Heart Rate; Histone Deacetylases; Mice; Myocytes, Cardiac; NADPH Oxidase 4; Oxidative Stress; Pyrazoles; Rats; Signal Transduction; Thiazolidines | 2020 |
Delphinidin attenuates pathological cardiac hypertrophy via the AMPK/NOX/MAPK signaling pathway.
Topics: AMP-Activated Protein Kinases; Angiotensin II; Animals; Anthocyanins; Cardiomegaly; Fibrosis; Male; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; NADPH Oxidases; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Rats; Reactive Oxygen Species; Signal Transduction | 2020 |
TBC1D25 Regulates Cardiac Remodeling Through TAK1 Signaling Pathway.
Topics: Angiotensin II; Animals; Aorta; Cardiomegaly; Echocardiography; Gene Expression Regulation; GTPase-Activating Proteins; Heart Failure; Hypertrophy; Male; MAP Kinase Kinase Kinases; MAP Kinase Signaling System; Mice; Mice, Knockout; Myocytes, Cardiac; Phosphorylation; Protein Domains; Rats; Rats, Sprague-Dawley; Signal Transduction; Ventricular Remodeling | 2020 |
Fluconazole Represses Cytochrome P450 1B1 and Its Associated Arachidonic Acid Metabolites in the Heart and Protects Against Angiotensin II-Induced Cardiac Hypertrophy.
Topics: Angiotensin II; Animals; Arachidonic Acid; Cardiomegaly; Cytochrome P-450 Enzyme System; Fluconazole; Rats; Rats, Sprague-Dawley | 2020 |
Polyphyllin I attenuates pressure over-load induced cardiac hypertrophy via inhibition of Wnt/β-catenin signaling pathway.
Topics: Angiotensin II; Animals; Cardiomegaly; Diosgenin; Disease Models, Animal; Echocardiography; Male; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; Rats; Wnt Signaling Pathway | 2020 |
Wnt-C59 Attenuates Pressure Overload-Induced Cardiac Hypertrophy via Interruption of Wnt Pathway.
Topics: Angiotensin II; Animals; Aorta; Benzeneacetamides; Cardiomegaly; Cells, Cultured; Constriction; Male; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; Pyridines; Rats; Wnt Signaling Pathway | 2020 |
VSMC-Specific Deletion of FAM3A Attenuated Ang II-Promoted Hypertension and Cardiovascular Hypertrophy.
Topics: Adenosine Triphosphate; Angiotensin II; Animals; Arteries; Blood Pressure; Cardiomegaly; Cells, Cultured; Cytokines; Female; Gene Deletion; Heat Shock Transcription Factors; Humans; Hypertension; Male; Mice; Mice, Inbred C57BL; Middle Aged; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Rats; Receptors, Purinergic P2; Vasoconstriction; Vasoconstrictor Agents | 2020 |
Extracellular vesicular MicroRNA-27a* contributes to cardiac hypertrophy in chronic heart failure.
Topics: Adaptor Proteins, Signal Transducing; Angiotensin II; Animals; Biological Transport; Biomarkers; Cardiomegaly; Cells, Cultured; Coculture Techniques; Disease Susceptibility; Extracellular Vesicles; Fibroblasts; Gene Expression; Gene Expression Regulation; MicroRNAs; Myocytes, Cardiac; Organogenesis; Rats | 2020 |
DSCAM-AS1 mediates pro-hypertrophy role of GRK2 in cardiac hypertrophy aggravation via absorbing miR-188-5p.
Topics: Angiotensin II; Animals; Base Sequence; Cardiomegaly; Cell Line; G-Protein-Coupled Receptor Kinase 2; Gene Knockdown Techniques; Mice, Inbred C57BL; MicroRNAs; RNA, Long Noncoding; Up-Regulation | 2020 |
Quercetin Dihydrate inhibition of cardiac fibrosis induced by angiotensin II in vivo and in vitro.
Topics: Angiotensin II; Animals; Cardiomegaly; Cardiomyopathies; Collagen Type I; Collagen Type III; Disease Models, Animal; Disease Progression; Fibroblasts; Fibrosis; Male; Mice; Mice, Inbred C57BL; Myocardium; Quercetin; Rats | 2020 |
SP1-induced SNHG14 aggravates hypertrophic response in in vitro model of cardiac hypertrophy via up-regulation of PCDH17.
Topics: Angiotensin II; Animals; Base Sequence; Cadherins; Cardiomegaly; Gene Silencing; Male; Mice, Inbred C57BL; MicroRNAs; Models, Biological; Myocytes, Cardiac; Protocadherins; RNA, Long Noncoding; Sp1 Transcription Factor; Up-Regulation | 2020 |
Effects of Sirt3‑autophagy and resveratrol activation on myocardial hypertrophy and energy metabolism.
Topics: Acyl-CoA Dehydrogenase; Angiotensin II; Animals; Animals, Newborn; Atrial Natriuretic Factor; Autophagy; Beclin-1; Cardiomegaly; Cells, Cultured; Energy Metabolism; Female; Gene Silencing; Male; Microtubule-Associated Proteins; Myocytes, Cardiac; Natriuretic Peptide, Brain; Pyruvate Kinase; Rats, Sprague-Dawley; Resveratrol; Sirtuins | 2020 |
Activated FMS-like tyrosine kinase 3 ameliorates angiotensin II-induced cardiac remodelling.
Topics: Angiotensin II; Animals; Cardiomegaly; fms-Like Tyrosine Kinase 3; Male; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; Rats; Ventricular Remodeling | 2020 |
Puerarin ameliorated pressure overload-induced cardiac hypertrophy in ovariectomized rats through activation of the PPARα/PGC-1 pathway.
Topics: Angiotensin II; Animals; Aorta, Abdominal; Cardiomegaly; Cardiotonic Agents; Constriction, Pathologic; Energy Metabolism; Female; Isoflavones; Myocardium; Myocytes, Cardiac; Ovariectomy; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; PPAR alpha; Rats, Sprague-Dawley; Signal Transduction | 2021 |
Paired box 6 inhibits cardiac fibroblast differentiation.
Topics: Angiotensin II; Animals; Cardiomegaly; Cell Differentiation; Chemokine CXCL10; Disease Models, Animal; Extracellular Matrix Proteins; Fibroblasts; Fibrosis; Gene Expression Regulation; Gene Knockdown Techniques; Introns; Male; Mice; Mice, Inbred C57BL; Myocardium; PAX6 Transcription Factor; Promoter Regions, Genetic; Protein Binding; Receptors, Interleukin-1 Type II; RNA, Messenger; RNA, Small Interfering; Transforming Growth Factor beta1 | 2020 |
Resveratrol attenuates angiotensin II-induced cellular hypertrophy through the inhibition of CYP1B1 and the cardiotoxic mid-chain HETE metabolites.
Topics: Angiotensin II; Antioxidants; Atrial Natriuretic Factor; Cardiomegaly; Cardiotoxicity; Cell Line; Cytochrome P-450 CYP1B1; Humans; Hydroxyeicosatetraenoic Acids; Myosin Heavy Chains; Protective Agents; Resveratrol; Vasoconstrictor Agents | 2020 |
MiR-30e-5p is sponged by Kcnq1ot1 and represses Angiotensin II-induced hypertrophic phenotypes in cardiomyocytes by targeting ADAM9.
Topics: ADAM Proteins; Angiotensin II; Animals; Animals, Newborn; Base Sequence; Cardiomegaly; Cell Line; Down-Regulation; Membrane Proteins; Mice; MicroRNAs; Myocytes, Cardiac; Phenotype; Protein Binding; RNA, Long Noncoding; Up-Regulation | 2020 |
Sophocarpine ameliorates cardiac hypertrophy through activation of autophagic responses.
Topics: Alkaloids; Angiotensin II; Animals; Autophagy; Cardiomegaly; Gene Expression Regulation; Male; Mice; Mice, Inbred C57BL; Myocardium; Ventricular Remodeling | 2020 |
TRIF/EGFR signalling mediates angiotensin-II-induced cardiac remodelling in mice.
Topics: Adaptor Proteins, Vesicular Transport; Angiotensin II; Animals; Cardiomegaly; ErbB Receptors; Inflammation; Male; Mice, Inbred C57BL; Myocardium; Myocytes, Cardiac; RNA, Messenger; Signal Transduction; Ventricular Remodeling | 2020 |
GJA1-20k attenuates Ang II-induced pathological cardiac hypertrophy by regulating gap junction formation and mitochondrial function.
Topics: Angiotensin II; Animals; Cardiomegaly; Connexin 43; Down-Regulation; Gap Junctions; Janus Kinase 2; Male; Membrane Potential, Mitochondrial; Mitochondria; Myocardium; Organelle Biogenesis; Rats, Inbred WKY; Reactive Oxygen Species; Signal Transduction; Tyrphostins; Valsartan | 2021 |
Sulfated N-acetylglucosamino-glucuronopyranosyl-arabinopyranan from seafood Amphioctopus neglectus attenuates angiotensin-II prompted cardiac hypertrophy.
Topics: Acetylglucosamine; Angiotensin II; Animals; Antihypertensive Agents; Antioxidants; Cardiomegaly; Cephalopoda; Disease Susceptibility; Humans; Magnetic Resonance Spectroscopy; Molecular Docking Simulation; Molecular Dynamics Simulation; Monosaccharides; Peptidyl-Dipeptidase A; Polysaccharides; Seafood; Structure-Activity Relationship; Sulfates | 2020 |
Senolytic Agent Navitoclax Inhibits Angiotensin II-Induced Heart Failure in Mice.
Topics: Angiotensin II; Aniline Compounds; Animals; Apoptosis; Cardiac Pacing, Artificial; Cardiomegaly; Cells, Cultured; Cellular Senescence; Disease Models, Animal; Fibrosis; Heart Failure; Inflammation Mediators; Male; Mice, Inbred C57BL; Myocytes, Cardiac; Rats, Sprague-Dawley; Stroke Volume; Sulfonamides; Tachycardia, Ventricular; Ventricular Function, Left; Ventricular Remodeling | 2020 |
Ca
Topics: Acetylcysteine; Angiotensin II; Animals; Cardiomegaly; Free Radical Scavengers; Gene Expression Regulation; Humans; Isoenzymes; Mice; Mice, Transgenic; Mitogen-Activated Protein Kinase Kinases; Myocytes, Cardiac; NADPH Oxidase 5; Oxidative Stress; Phagocytes; Rats; Reactive Oxygen Species; Signal Transduction; Vasoconstrictor Agents; Ventricular Myosins | 2020 |
Bone marrow mesenchymal stem cell-derived exosomes attenuate cardiac hypertrophy and fibrosis in pressure overload induced remodeling.
Topics: Angiotensin II; Animals; Apoptosis; Cardiomegaly; Exosomes; Fibrosis; Male; Mesenchymal Stem Cells; Mice, Inbred C57BL; Myocytes, Cardiac; Myofibroblasts; Pressure; Ventricular Remodeling | 2020 |
Ubiquitin-specific protease 19 blunts pathological cardiac hypertrophy via inhibition of the TAK1-dependent pathway.
Topics: Angiotensin II; Animals; Animals, Newborn; Aortic Valve Stenosis; Cardiomegaly; CRISPR-Cas Systems; Disease Models, Animal; Endopeptidases; Fibrosis; Inflammation; Male; MAP Kinase Kinase Kinases; MAP Kinase Signaling System; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocytes, Cardiac; Phenylephrine; Pressure; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Ubiquitin-Protein Ligases; Ventricular Remodeling | 2020 |
MicroRNA-183 as a Novel Regulator Protects Against Cardiomyocytes Hypertrophy via Targeting TIAM1.
Topics: Angiotensin II; Animals; Cardiomegaly; Gene Expression Regulation; Heart Ventricles; MicroRNAs; Myocytes, Cardiac; Rats; T-Lymphoma Invasion and Metastasis-inducing Protein 1 | 2022 |
CSN6 aggravates Ang II-induced cardiomyocyte hypertrophy via inhibiting SIRT2.
Topics: Adaptor Proteins, Signal Transducing; Angiotensin II; Animals; Animals, Newborn; Cardiomegaly; Cell Size; COP9 Signalosome Complex; Gene Expression Regulation; Homeobox Protein Nkx-2.2; Homeodomain Proteins; Male; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; Proteasome Endopeptidase Complex; Protein Stability; Proteolysis; Rats; Rats, Sprague-Dawley; Signal Transduction; Sirtuin 2; Ubiquitin; Zebrafish Proteins | 2020 |
Mitochondrial pyruvate carrier abundance mediates pathological cardiac hypertrophy.
Topics: Angiotensin II; Animals; Anion Transport Proteins; Cardiomegaly; Cell Proliferation; Citric Acid Cycle; Constriction, Pathologic; Female; Heart Failure; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Mitochondria, Heart; Mitochondrial Membrane Transport Proteins; Monocarboxylic Acid Transporters; Myocardium; Myocytes, Cardiac; Pyruvic Acid | 2020 |
Inhibition of lncRNA Gm15834 Attenuates Autophagy-Mediated Myocardial Hypertrophy via the miR-30b-3p/ULK1 Axis in Mice.
Topics: Angiotensin II; Animals; Autophagy; Autophagy-Related Protein-1 Homolog; Cardiomegaly; Gene Expression Regulation; Male; Mice; Mice, Inbred C57BL; MicroRNAs; Myocytes, Cardiac; NF-kappa B; RNA, Long Noncoding; Signal Transduction; Vasoconstrictor Agents | 2021 |
Deubiquitinase Ubiquitin-Specific Protease 10 Deficiency Regulates Sirt6 signaling and Exacerbates Cardiac Hypertrophy.
Topics: Angiotensin II; Animals; Cardiomegaly; Cell Culture Techniques; Disease Models, Animal; Male; Mice; Mice, Transgenic; Myocytes, Cardiac; Signal Transduction; Sirtuins; Ubiquitin Thiolesterase | 2020 |
Transcribed ultraconserved region uc.242 is a novel regulator of cardiomyocyte hypertrophy induced by angiotensin II.
Topics: Angiotensin II; Cardiomegaly; Cells, Cultured; Humans; Myocytes, Cardiac; RNA, Long Noncoding; RNA, Messenger | 2021 |
MicroRNA-214 contributes to Ang II-induced cardiac hypertrophy by targeting SIRT3 to provoke mitochondrial malfunction.
Topics: Angiotensin II; Animals; Cardiomegaly; Cell Line; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; MicroRNAs; Mitochondria, Heart; Myocardium; Myocytes, Cardiac; Rats, Sprague-Dawley; Sirtuin 3 | 2021 |
Melatonin alleviates angiotensin-II-induced cardiac hypertrophy via activating MICU1 pathway.
Topics: Angiotensin II; Animals; Antioxidants; Calcium-Binding Proteins; Cardiomegaly; Disease Models, Animal; Gene Knockdown Techniques; Heart; In Vitro Techniques; Melatonin; Mice; Mitochondria; Mitochondrial Membrane Transport Proteins; Myocardium; Myocytes, Cardiac; Oxidative Stress; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Reactive Oxygen Species; Vasoconstrictor Agents | 2020 |
Mep1a contributes to Ang II-induced cardiac remodeling by promoting cardiac hypertrophy, fibrosis and inflammation.
Topics: Angiotensin II; Animals; Cardiomegaly; Cytokines; Fibrosis; Inflammation; Macrophages; Male; Metalloendopeptidases; Mice; Mice, Inbred C57BL; Mice, Knockout; Signal Transduction; Ventricular Remodeling | 2021 |
Tranilast prevents doxorubicin-induced myocardial hypertrophy and angiotensin II synthesis in rats.
Topics: Angiotensin II; Animals; Antioxidants; Cardiomegaly; Doxorubicin; Fibrosis; Heart Diseases; Male; Mast Cells; Myocardium; ortho-Aminobenzoates; Oxidative Stress; Rats; Rats, Wistar | 2021 |
Direct Actions of AT
Topics: Angiotensin II; Animals; Cardiomegaly; Hypertension; Mice; Mice, Knockout; Mice, Transgenic; Myocardium; Myocytes, Cardiac; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Vascular Resistance | 2021 |
Cardioprotective potential of amygdalin against angiotensin II induced cardiac hypertrophy, oxidative stress and inflammatory responses through modulation of Nrf2 and NF-κB activation.
Topics: Amygdalin; Angiotensin II; Animals; Cardiomegaly; Molecular Docking Simulation; Myocytes, Cardiac; NF-E2-Related Factor 2; NF-kappa B; Oxidative Stress | 2021 |
Angiotensin II Increases HMGB1 Expression in the Myocardium Through AT1 and AT2 Receptors When Under Pressure Overload.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Aorta; Cardiomegaly; Case-Control Studies; Constriction; HMGB1 Protein; Imidazoles; Losartan; Male; Mice; Mice, Inbred C57BL; Myocardium; Myocytes, Cardiac; Pyridines; Up-Regulation; Vasoconstrictor Agents | 2021 |
Angiotensin II-induced cardiomyocyte hypertrophy: A complex response dependent on intertwined pathways.
Topics: Angiotensin II; Cardiomegaly; Humans; Myocytes, Cardiac; Receptor, Angiotensin, Type 1 | 2021 |
Piperlongumine attenuates angiotensin-II-induced cardiac hypertrophy and fibrosis by inhibiting Akt-FoxO1 signalling.
Topics: Angiotensin II; Animals; Apoptosis; Cardiomegaly; Cardiomyopathies; Dioxolanes; Disease Models, Animal; Fibroblasts; Fibrosis; Heart Failure; Kruppel-Like Factor 4; Myocytes, Cardiac; Nerve Tissue Proteins; Phosphorylation; Proto-Oncogene Proteins c-akt; Rats; Signal Transduction | 2021 |
GRK5 is a regulator of fibroblast activation and cardiac fibrosis.
Topics: Angiotensin II; Animals; Animals, Newborn; Cardiomegaly; Cell Transdifferentiation; Fibroblasts; Fibrosis; G-Protein-Coupled Receptor Kinase 5; Mice, Knockout; Models, Biological; Myocardial Ischemia; Myocardium; Myofibroblasts; Rats | 2021 |
LRRC8A contributes to angiotensin II-induced cardiac hypertrophy by interacting with NADPH oxidases via the C-terminal leucine-rich repeat domain.
Topics: Angiotensin II; Animals; Cardiomegaly; Leucine; Membrane Proteins; Mice; NADPH Oxidases; Reactive Oxygen Species | 2021 |
Scoparone alleviates Ang II-induced pathological myocardial hypertrophy in mice by inhibiting oxidative stress.
Topics: Angiotensin II; Animals; Antioxidants; Biomarkers; Biopsy; Blood Pressure; Cardiomegaly; Collagen; Coumarins; Disease Management; Disease Models, Animal; Disease Susceptibility; Echocardiography; Fibroblasts; Immunohistochemistry; Male; Mice; Myocytes, Cardiac; Oxidative Stress; Rats | 2021 |
PHD Finger Protein 19 Promotes Cardiac Hypertrophy via Epigenetically Regulating SIRT2.
Topics: Angiotensin II; Animals; Cardiomegaly; Cells, Cultured; Disease Models, Animal; DNA Methylation; DNA-Binding Proteins; Epigenesis, Genetic; Gene Expression Regulation, Enzymologic; Humans; Male; Mice, Inbred C57BL; Myocytes, Cardiac; Rats, Sprague-Dawley; Sirtuin 2; Transcription Factors; Ventricular Remodeling | 2021 |
Exosomes Derived From Hypertrophic Cardiomyocytes Induce Inflammation in Macrophages
Topics: Angiotensin II; Animals; Animals, Newborn; Cardiomegaly; Cell Communication; Cellular Microenvironment; Exosomes; Humans; Inflammation; Inflammation Mediators; Interleukin-6; Interleukin-8; Macrophages; Mice; MicroRNAs; Mitogen-Activated Protein Kinases; Myocytes, Cardiac; Phosphorylation; Rats, Wistar; RAW 264.7 Cells; Signal Transduction | 2020 |
The Angiotensin II Type 1(AT1) Receptor and Cardiac Hypertrophy: Did We Have It Wrong All Along?
Topics: Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Hypertension; Mice; Receptor, Angiotensin, Type 1 | 2021 |
Ndufs1 Deficiency Aggravates the Mitochondrial Membrane Potential Dysfunction in Pressure Overload-Induced Myocardial Hypertrophy.
Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Biomarkers; Cardiomegaly; Constriction, Pathologic; Down-Regulation; Male; Membrane Potential, Mitochondrial; Mice, Inbred C57BL; Mitochondria, Heart; Myocardium; Myocytes, Cardiac; Myosin Heavy Chains; NADH Dehydrogenase; Natriuretic Peptide, Brain; Pressure; Rats; RNA-Seq; Single-Cell Analysis | 2021 |
Cardiac Oxidative Signaling and Physiological Hypertrophy in the Na/K-ATPase α1
Topics: Angiotensin II; Animals; Cardiac Glycosides; Cardiomegaly; Disease Models, Animal; Echocardiography; Heart; Male; Mice; Mutation; Myocardium; Ouabain; Protein Isoforms; Reactive Oxygen Species; RNA-Seq; Signal Transduction; Sodium-Potassium-Exchanging ATPase | 2021 |
Prevention of Fibrosis and Pathological Cardiac Remodeling by Salinomycin.
Topics: Angiotensin II; Animals; Antifibrotic Agents; Cardiomegaly; Cell Survival; Disease Models, Animal; Extracellular Matrix; Fibrosis; Gene Expression; Heart Failure; Humans; Male; Mice; Mice, Inbred C57BL; Myocardial Infarction; Myocardium; Myofibroblasts; NIH 3T3 Cells; p38 Mitogen-Activated Protein Kinases; Pyrans; rho-Associated Kinases; Ventricular Remodeling | 2021 |
Serum microRNA-30d is a sensitive biomarker for angiotensin II-induced cardiovascular complications in rats.
Topics: Angiotensin II; Animals; Biomarkers; Cardiomegaly; Hypertension; MicroRNAs; Myocytes, Cardiac; Natriuretic Peptide, Brain; Rats | 2021 |
miR-145-5p targets paxillin to attenuate angiotensin II-induced pathological cardiac hypertrophy via downregulation of Rac 1, pJNK, p-c-Jun, NFATc3, ANP and by Sirt-1 upregulation.
Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Cardiomegaly; Cells, Cultured; Gene Expression Regulation; MAP Kinase Kinase 4; MicroRNAs; Myoblasts, Cardiac; NFATC Transcription Factors; Paxillin; Proto-Oncogene Proteins c-jun; rac1 GTP-Binding Protein; Rats; Sirtuin 1; Vasoconstrictor Agents | 2021 |
Rap1GAP Mediates Angiotensin II-Induced Cardiomyocyte Hypertrophy by Inhibiting Autophagy and Increasing Oxidative Stress.
Topics: Angiotensin II; Animals; Autophagy; Cardiomegaly; GTPase-Activating Proteins; Oxidative Stress; Rats; Rats, Sprague-Dawley; Rats, Wistar | 2021 |
Neuregulin-1 compensates for endothelial nitric oxide synthase deficiency.
Topics: Angiotensin II; Animals; Cardiomegaly; Diastole; Endothelial Cells; Fibrosis; Gene Expression Regulation; Heart; Heart Rate; Kidney; Mice; Mice, Knockout; MicroRNAs; Myocardium; Neuregulin-1; Nitric Oxide; Nitric Oxide Synthase Type III; Random Allocation; Vasoconstrictor Agents | 2021 |
Lutein attenuates angiotensin II- induced cardiac remodeling by inhibiting AP-1/IL-11 signaling.
Topics: Angiotensin II; Animals; Cardiomegaly; Fibrosis; Interleukin-11; Lutein; Mice; Mice, Inbred C57BL; Myocardium; Rats; Transcription Factor AP-1; Ventricular Remodeling | 2021 |
MicroRNA-17-5p Promotes Cardiac Hypertrophy by Targeting Mfn2 to Inhibit Autophagy.
Topics: Angiotensin II; Animals; Autophagy; Cardiomegaly; Cells, Cultured; Disease Models, Animal; Gene Expression Regulation; GTP Phosphohydrolases; Male; MicroRNAs; Mitochondrial Proteins; Myocytes, Cardiac; Phosphatidylinositol 3-Kinase; Proto-Oncogene Proteins c-akt; Rats, Sprague-Dawley; Signal Transduction; TOR Serine-Threonine Kinases | 2021 |
Prostaglandin E1 attenuates AngII-induced cardiac hypertrophy via EP3 receptor activation and Netrin-1upregulation.
Topics: Alprostadil; Angiotensin II; Animals; Cardiomegaly; Male; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; Netrin-1; Rats; Rats, Sprague-Dawley; Receptors, Prostaglandin E, EP3 Subtype; Signal Transduction; Up-Regulation | 2021 |
Lp-PLA2 inhibition prevents Ang II-induced cardiac inflammation and fibrosis by blocking macrophage NLRP3 inflammasome activation.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Angiotensin II; Animals; Anti-Inflammatory Agents; Benzaldehydes; Cardiomegaly; Cardiotonic Agents; Enzyme Inhibitors; Fibrosis; Heart; Inflammasomes; Inflammation; Macrophages; Male; Mice, Inbred C57BL; NLR Family, Pyrin Domain-Containing 3 Protein; Oximes | 2021 |
Schisandra chinensis polysaccharides prevent cardiac hypertrophy by dissociating thioredoxin-interacting protein/thioredoxin-1 complex and inhibiting oxidative stress.
Topics: Angiotensin II; Animals; Antioxidants; Cardiomegaly; Cells, Cultured; Male; Mice; Mice, Inbred C57BL; Molecular Docking Simulation; Myocytes, Cardiac; Oxidative Stress; Polysaccharides; Rats; Schisandra; Thioredoxins | 2021 |
Ginkgolide B Protects Cardiomyocytes from Angiotensin II-Induced Hypertrophy via Regulation of Autophagy through SIRT1-FoxO1.
Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Autophagy; Cardiomegaly; Cell Line; Ginkgolides; Lactones; Myocytes, Cardiac; Nerve Tissue Proteins; Protective Agents; Rats; Signal Transduction; Sirtuin 1; Transcription, Genetic; Ventricular Myosins | 2021 |
SLC7A11/xCT Prevents Cardiac Hypertrophy by Inhibiting Ferroptosis.
Topics: Amino Acid Transport System y+; Amino Acid Transport Systems, Acidic; Angiotensin II; Animals; Cardiomegaly; Ferroptosis; Mice; Mice, Knockout; Myocytes, Cardiac; Rats | 2022 |
Fibroblast-specific IKK-β deficiency ameliorates angiotensin II-induced adverse cardiac remodeling in mice.
Topics: Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Cell Differentiation; Cell Movement; Cell Proliferation; Cells, Cultured; Collagen Type I; Fibroblasts; Fibrosis; Gene Knockdown Techniques; Heart Rate; Hypertension; I-kappa B Kinase; Inflammation; Macrophages; Male; Mice; Myocarditis; Myocardium; Organ Size; Protective Factors; Signal Transduction; Ventricular Remodeling | 2021 |
De-ubiquitination of p300 by USP12 Critically Enhances METTL3 Expression and Ang II-induced cardiac hypertrophy.
Topics: Adenosine; Angiotensin II; Animals; Animals, Newborn; Cardiomegaly; E1A-Associated p300 Protein; Gene Expression Regulation; Male; Methyltransferases; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocytes, Cardiac; Primary Cell Culture; Rats; Rats, Sprague-Dawley; Signal Transduction; Ubiquitin Thiolesterase; Ubiquitination | 2021 |
Azilsartan ameliorates ventricular hypertrophy in rats suffering from pressure overload-induced cardiac hypertrophy by activating the Keap1-Nrf2 signalling pathway.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antioxidants; Benzimidazoles; Cardiomegaly; Female; Heart Ventricles; Kelch-Like ECH-Associated Protein 1; Male; Myocardium; Myocytes, Cardiac; NF-E2-Related Factor 2; Oxadiazoles; Oxidative Stress; Rats, Sprague-Dawley; RNA, Messenger; Signal Transduction; Up-Regulation | 2021 |
Glucagon-like peptide-1 attenuates cardiac hypertrophy via the AngII/AT1R/ACE2 and AMPK/mTOR/p70S6K pathways.
Topics: Adenylate Kinase; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Blood Pressure; Cardiomegaly; Cardiotonic Agents; Cell Line; Disease Models, Animal; Glucagon-Like Peptide 1; Hypertension; Liraglutide; Male; Morpholines; Myocytes, Cardiac; Piperidines; Rats; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Ribosomal Protein S6 Kinases, 70-kDa; Signal Transduction; TOR Serine-Threonine Kinases; Triazines; Uracil | 2021 |
MicroRNA-27b-3p down-regulates FGF1 and aggravates pathological cardiac remodelling.
Topics: Angiotensin II; Animals; Cardiomegaly; Fibroblast Growth Factor 1; Fibrosis; Mice; Mice, Knockout; MicroRNAs; Myocytes, Cardiac; Ventricular Remodeling | 2022 |
MiR-26a-5p alleviates cardiac hypertrophy and dysfunction via targeting ADAM17.
Topics: ADAM17 Protein; Angiotensin II; Animals; Autophagy; Cardiomegaly; Cell Line; Disease Models, Animal; Male; Mice; Mice, Inbred C57BL; MicroRNAs; Myocytes, Cardiac; Signal Transduction | 2021 |
Resolvin-D1 attenuation of angiotensin II-induced cardiac inflammation in mice is associated with prevention of cardiac remodeling and hypertension.
Topics: Angiotensin II; Animals; Cardiomegaly; Chemokine CCL2; Disease Models, Animal; Docosahexaenoic Acids; Gene Expression Regulation; Humans; Hypertension; Inflammation; Intercellular Adhesion Molecule-1; Interleukin-1beta; Interleukin-6; Mice; Renin-Angiotensin System; Tumor Necrosis Factor-alpha; Vascular Cell Adhesion Molecule-1; Ventricular Remodeling | 2021 |
Roxadustat prevents Ang II hypertension by targeting angiotensin receptors and eNOS.
Topics: Angiotensin II; Animals; Aorta; Blood Pressure; Cardiomegaly; Cells, Cultured; Electrolytes; Endothelial Cells; Glycine; Hypertension; Hypoxia-Inducible Factor 1, alpha Subunit; Hypoxia-Inducible Factor-Proline Dioxygenases; Isoquinolines; Kidney Glomerulus; Male; Mice; Myocytes, Smooth Muscle; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase Type III; Oxidative Stress; Phosphorylation; Proteinuria; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; RNA, Messenger; Thiobarbituric Acid Reactive Substances; Urine; Vascular Remodeling | 2021 |
MiR-590-5p inhibits pathological hypertrophy mediated heart failure by targeting RTN4.
Topics: Angiotensin II; Animals; Apoptosis; Base Sequence; Biomarkers; Cardiomegaly; Cell Line; Disease Models, Animal; Down-Regulation; Heart Failure; Mice, Inbred C57BL; MicroRNAs; Nogo Proteins; Protein Binding | 2021 |
Comparative beneficial effects of nebivolol and nebivolol/valsartan combination against mitochondrial dysfunction in angiotensin II-induced pathology in H9c2 cardiomyoblasts.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Cardiomegaly; Cell Culture Techniques; Drug Combinations; Heart; Hypertension; Inflammation; Mechanistic Target of Rapamycin Complex 1; Mitochondria; Myoblasts, Cardiac; Myocardium; Nebivolol; Organelle Biogenesis; Oxidative Stress; Rats; Reactive Oxygen Species; Valsartan | 2021 |
Vinpocetine Attenuates Pathological Cardiac Remodeling by Inhibiting Cardiac Hypertrophy and Fibrosis.
Topics: Angiotensin II; Animals; Cardiomegaly; Cardiomyopathies; Cell Proliferation; Cells, Cultured; Cyclic Nucleotide Phosphodiesterases, Type 1; Cytoprotection; Disease Models, Animal; Dose-Response Relationship, Drug; Extracellular Matrix; Extracellular Matrix Proteins; Fibroblasts; Fibrosis; Male; Mice, Inbred C57BL; Myocytes, Cardiac; Phosphodiesterase Inhibitors; Signal Transduction; Ventricular Remodeling; Vinca Alkaloids | 2017 |
Critical Role of ADAMTS2 (A Disintegrin and Metalloproteinase With Thrombospondin Motifs 2) in Cardiac Hypertrophy Induced by Pressure Overload.
Topics: ADAMTS Proteins; Angiotensin II; Animals; Biopsy, Needle; Cardiomegaly; Disease Models, Animal; Disintegrins; Gene Expression Regulation; Humans; Metalloproteases; Mice; Mice, Transgenic; Myocytes, Cardiac; Phosphatidylinositol 3-Kinases; Phosphorylation; Proto-Oncogene Proteins c-akt; Random Allocation; Signal Transduction; Thrombospondins; Tissue Culture Techniques; Up-Regulation; Ventricular Dysfunction, Left; Ventricular Remodeling | 2017 |
Angiotensin-(1-7) attenuates angiotensin II-induced cardiac hypertrophy via a Sirt3-dependent mechanism.
Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Cardiomegaly; Cardiotonic Agents; Cell Size; Fibrosis; Male; Myocytes, Cardiac; Peptide Fragments; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Signal Transduction; Sirtuins; Superoxide Dismutase | 2017 |
(-)-Epicatechin Suppresses Angiotensin II-induced Cardiac Hypertrophy via the Activation of the SP1/SIRT1 Signaling Pathway.
Topics: Angiotensin II; Animals; Cardiomegaly; Catechin; Mice; Myocytes, Cardiac; Signal Transduction; Sirtuin 1; Sp1 Transcription Factor | 2017 |
Inhibition of Mid-chain HETEs Protects Against Angiotensin II-induced Cardiac Hypertrophy.
Topics: Angiotensin II; Animals; Cardiomegaly; Cardiotonic Agents; Cells, Cultured; Cytochrome P-450 CYP1B1; Humans; Hydroxyeicosatetraenoic Acids; Male; Myocytes, Cardiac; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Stilbenes | 2017 |
Crucial Role of ROCK2-Mediated Phosphorylation and Upregulation of FHOD3 in the Pathogenesis of Angiotensin II-Induced Cardiac Hypertrophy.
Topics: Amides; Analysis of Variance; Angiotensin II; Animals; Blotting, Western; Cardiomegaly; Cells, Cultured; Disease Models, Animal; Formins; Male; Microfilament Proteins; Myocytes, Cardiac; Phosphorylation; Pyridines; Random Allocation; Rats; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; rho-Associated Kinases; Signal Transduction; Up-Regulation | 2017 |
Role of microRNA-124 in cardiomyocyte hypertrophy inducedby angiotensin II.
Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Calreticulin; Cardiomegaly; Endoplasmic Reticulum Chaperone BiP; Endoplasmic Reticulum Stress; Gene Expression Regulation; Heat-Shock Proteins; Humans; MicroRNAs; Myocytes, Cardiac; Natriuretic Peptide, Brain; Rats; Ventricular Myosins | 2017 |
Stachydrine Protects Against Pressure Overload-Induced Cardiac Hypertrophy by Suppressing Autophagy.
Topics: Angiotensin II; Animals; Autophagy; Cardiomegaly; Cell Line; Heart; Male; Membrane Glycoproteins; Microtubule-Associated Proteins; Myocardium; NADH, NADPH Oxidoreductases; NADPH Oxidase 2; NADPH Oxidases; Phosphorylation; Pressure; Proline; Protective Agents; Rats, Wistar; Reactive Oxygen Species | 2017 |
Hydrogen sulfide pretreatment improves mitochondrial function in myocardial hypertrophy via a SIRT3-dependent manner.
Topics: Angiotensin II; Animals; Cardiomegaly; Hydrogen Sulfide; Male; Membrane Potential, Mitochondrial; Mice, Knockout; Mitochondria, Heart; Myocardium; Myocytes, Cardiac; Oxidative Stress; Rats, Sprague-Dawley; Sirtuin 3 | 2018 |
Exogenous cathepsin V protein protects human cardiomyocytes HCM from angiotensin Ⅱ-Induced hypertrophy.
Topics: Angiotensin II; Biomarkers; Cardiomegaly; Cardiotonic Agents; Cathepsins; Cell Line; Cysteine Endopeptidases; Gene Expression Regulation; Humans; Myocytes, Cardiac; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Signal Transduction; TOR Serine-Threonine Kinases | 2017 |
Lysyl oxidase overexpression accelerates cardiac remodeling and aggravates angiotensin II-induced hypertrophy.
Topics: Angiotensin II; Animals; Cardiomegaly; Fibroblasts; Gene Expression Regulation, Enzymologic; Humans; Inflammation; Mice; Mice, Transgenic; Myocardium; Protein-Lysine 6-Oxidase; Signal Transduction; Ventricular Remodeling | 2017 |
Plasminogen Activator Inhibitor Type I Controls Cardiomyocyte Transforming Growth Factor-β and Cardiac Fibrosis.
Topics: Angiotensin II; Animals; Bone Morphogenetic Protein 7; Cardiomegaly; Cells, Cultured; Female; Frameshift Mutation; Humans; Magnetic Resonance Imaging, Cine; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocytes, Cardiac; Plasminogen Activator Inhibitor 1; RNA; Sequence Analysis, RNA; Smad6 Protein; Transcription, Genetic; Transforming Growth Factor beta | 2017 |
Differential Effects of Myocardial Afadin on Pressure Overload-Induced Compensated Cardiac Hypertrophy.
Topics: Angiotensin II; Animals; Apoptosis; Cardiomegaly; Fibrosis; Humans; Mice; Mice, Knockout; Microfilament Proteins; Myocardium; Pressure; Stress, Mechanical | 2017 |
Melatonin protects against the pathological cardiac hypertrophy induced by transverse aortic constriction through activating PGC-1β: In vivo and in vitro studies.
Topics: Angiotensin II; Animals; Antioxidants; Cardiomegaly; Disease Models, Animal; Drug Evaluation, Preclinical; Fibrosis; Heart; Lung Diseases; Male; Melatonin; Mice, Inbred C57BL; Myocardium; Myocytes, Cardiac; Oxidative Stress; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Primary Cell Culture; Transcriptional Activation | 2017 |
The Inhibitory Effect of WenxinKeli on H9C2 Cardiomyocytes Hypertrophy Induced by Angiotensin II through Regulating Autophagy Activity.
Topics: Angiotensin II; Animals; Autophagy; Cardiomegaly; Heart Failure; Humans; Medicine, Chinese Traditional; Myocytes, Cardiac; Rats | 2017 |
Augmented sphingosine 1 phosphate receptor-1 signaling in cardiac fibroblasts induces cardiac hypertrophy and fibrosis through angiotensin II and interleukin-6.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Biphenyl Compounds; Cardiomegaly; Cells, Cultured; Fibroblasts; Heart Ventricles; Humans; Interleukin-6; Mice; Mice, Inbred C57BL; Mice, Transgenic; Myocardium; Myocytes, Cardiac; Peptidyl-Dipeptidase A; Phosphorylation; Plasmids; Receptors, Lysosphingolipid; Signal Transduction; Tetrazoles | 2017 |
The valosin-containing protein is a novel repressor of cardiomyocyte hypertrophy induced by pressure overload.
Topics: Angiotensin II; Animals; Aorta; Blood Pressure; Cardiomegaly; Cerebrovascular Disorders; Echocardiography; Gene Expression Regulation; Hypertension; Hypertrophy, Left Ventricular; Male; Mechanistic Target of Rapamycin Complex 1; Mice, Transgenic; Myocardium; Myocytes, Cardiac; Pressure; Primary Cell Culture; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Signal Transduction; Valosin Containing Protein; Ventricular Remodeling | 2017 |
Tanshinone-induced ERs suppresses IGFII activation to alleviate Ang II-mediated cardiac hypertrophy.
Topics: Abietanes; Angiotensin II; Animals; Cardiomegaly; Cell Line; Drugs, Chinese Herbal; Gene Expression; Heat Shock Transcription Factors; Humans; Insulin-Like Growth Factor II; Mitogen-Activated Protein Kinase Kinases; Myocytes, Cardiac; Rats; Receptor, IGF Type 2; Receptors, Estrogen; Signal Transduction; Sirtuin 1 | 2017 |
Lercanidipine attenuates angiotensin II-induced cardiomyocyte hypertrophy by blocking calcineurin-NFAT3 and CaMKII-HDAC4 signaling.
Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Calcineurin; Calcium Channel Blockers; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Cardiomegaly; Cells, Cultured; Dihydropyridines; Gene Expression Regulation; Histone Deacetylases; Myocytes, Cardiac; Natriuretic Peptide, Brain; NFATC Transcription Factors; Rats; Signal Transduction | 2017 |
A Systems Biology Approach to Investigating Sex Differences in Cardiac Hypertrophy.
Topics: Angiotensin II; Animals; Cardiomegaly; Disease Models, Animal; Female; Gene Expression Regulation; Gene Regulatory Networks; Male; Mice, Inbred C57BL; MicroRNAs; Myocardium; Oxazoles; PPAR alpha; Protein Interaction Maps; RNA, Messenger; Sex Characteristics; Sex Factors; Signal Transduction; Systems Biology; Time Factors; Tyrosine | 2017 |
Sirtuin 3 Deficiency Accelerates Hypertensive Cardiac Remodeling by Impairing Angiogenesis.
Topics: Acetylation; Angiotensin II; Animals; Cardiomegaly; Cells, Cultured; Collagen Type I; Collagen Type III; Disease Models, Animal; Disease Progression; Fibrosis; Genetic Predisposition to Disease; Hypertension; Mice, 129 Strain; Mice, Knockout; Mitochondria, Heart; Mitophagy; Myocardium; Neovascularization, Physiologic; Oxidative Stress; Phenotype; Protein Kinases; Signal Transduction; Sirtuin 3; Time Factors; Tissue Culture Techniques; Ubiquitin-Protein Ligases; Ventricular Remodeling | 2017 |
Dipeptidyl Peptidase-4 Inhibition With Saxagliptin Ameliorates Angiotensin II-Induced Cardiac Diastolic Dysfunction in Male Mice.
Topics: Adamantane; Adaptor Proteins, Signal Transducing; Angiotensin II; Animals; Aorta; Blood Pressure; Cardiomegaly; CD4-Positive T-Lymphocytes; CD8 Antigens; Diastole; Dipeptides; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Echocardiography; Fibrosis; Gene Expression; Heart; Inflammation; Interleukin-17; Interleukin-18; Lymphocytes; Macrophages; Male; Mice; Proto-Oncogene Proteins c-jun; Signal Transduction; Vascular Stiffness; Vasoconstrictor Agents | 2017 |
Zinc-finger protein 418 overexpression protects against cardiac hypertrophy and fibrosis.
Topics: Angiotensin II; Animals; Cardiomegaly; Cells, Cultured; Down-Regulation; Humans; Male; Mice; Mice, Knockout; Rats; Rats, Sprague-Dawley; Repressor Proteins; Transcription Factor AP-1 | 2017 |
Kaempferol Alleviates Angiotensin II-Induced Cardiac Dysfunction and Interstitial Fibrosis in Mice.
Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Cardiomegaly; Cell Survival; Cells, Cultured; Collagen Type I; Collagen Type II; Echocardiography; Fibroblasts; Fibrosis; Heart Ventricles; Human Umbilical Vein Endothelial Cells; Humans; Kaempferols; Male; Mice; Mice, Inbred C57BL; Microscopy, Fluorescence; Mitogen-Activated Protein Kinases; Myocardium; Myocytes, Cardiac; Natriuretic Peptide, Brain; Rats; Signal Transduction; Transforming Growth Factor beta1; Ventricular Remodeling | 2017 |
Nox4 genetic inhibition in experimental hypertension and metabolic syndrome.
Topics: Angiotensin II; Animals; Biomarkers; Blood Glucose; Blood Pressure; Cardiomegaly; Diet, High-Fat; Disease Models, Animal; Female; Fibrosis; Genetic Predisposition to Disease; Heart Rate; Hypertension; Male; Metabolic Syndrome; Mice, Inbred C57BL; Mice, Knockout; Myocardium; NADPH Oxidase 4; Phenotype; Reactive Oxygen Species; Time Factors; Triglycerides; Ventricular Remodeling | 2018 |
Estrogen receptor beta maintains expression of KLF15 to prevent cardiac myocyte hypertrophy in female rodents.
Topics: Angiotensin II; Animals; Animals, Newborn; Cardiomegaly; Estrogen Receptor beta; Female; Gene Expression Regulation; Kruppel-Like Transcription Factors; Male; MAP Kinase Kinase Kinases; Models, Biological; Myocytes, Cardiac; p38 Mitogen-Activated Protein Kinases; Rats; Signal Transduction; Transforming Growth Factor beta | 2018 |
Oleanonic acid ameliorates pressure overload-induced cardiac hypertrophy in rats: The role of PKCζ-NF-κB pathway.
Topics: Angiotensin II; Animals; Aorta; Cardiomegaly; Constriction, Pathologic; Gene Knockdown Techniques; Male; Myocytes, Cardiac; NF-kappa B; Phenylephrine; Phosphorylation; Pressure; Protein Kinase C; Rats, Sprague-Dawley; Signal Transduction; Transcription Factor RelA; Transcription, Genetic; Triterpenes | 2018 |
Gallic Acid Reduces Blood Pressure and Attenuates Oxidative Stress and Cardiac Hypertrophy in Spontaneously Hypertensive Rats.
Topics: Angiotensin II; Animals; Blood Pressure; Blood Pressure Determination; Cardiomegaly; Gallic Acid; GATA4 Transcription Factor; Gene Expression Regulation; Heart; Homeobox Protein Nkx-2.5; Humans; Hypertension; Male; NADPH Oxidase 2; Oxidative Stress; Rats; Rats, Inbred SHR | 2017 |
Inhibition of HSF2 SUMOylation via MEL18 upregulates IGF-IIR and leads to hypertension-induced cardiac hypertrophy.
Topics: Angiotensin II; Animals; Animals, Newborn; Cardiomegaly; Cells, Cultured; Dose-Response Relationship, Drug; Female; Heat-Shock Proteins; HEK293 Cells; Humans; Hypertension; Polycomb Repressive Complex 1; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Rats, Sprague-Dawley; Receptor, IGF Type 2; Sumoylation; Transcription Factors; Up-Regulation | 2018 |
DKK3 overexpression attenuates cardiac hypertrophy and fibrosis in an angiotensin-perfused animal model by regulating the ADAM17/ACE2 and GSK-3β/β-catenin pathways.
Topics: ADAM17 Protein; Adaptor Proteins, Signal Transducing; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Animals, Newborn; Apoptosis; beta Catenin; Cardiomegaly; Cell Proliferation; Disease Models, Animal; Fibroblasts; Fibrosis; Glycogen Synthase Kinase 3 beta; Inflammation; Intercellular Signaling Peptides and Proteins; Matrix Metalloproteinases; Mice, Inbred C57BL; Peptide Fragments; Peptidyl-Dipeptidase A; Perfusion; Phosphorylation; Signal Transduction; Smad3 Protein; Transforming Growth Factor beta1 | 2018 |
MiR-208a-3p aggravates autophagy through the PDCD4-ATG5 pathway in Ang II-induced H9c2 cardiomyoblasts.
Topics: Angiotensin II; Animals; Apoptosis Regulatory Proteins; Autophagy; Autophagy-Related Protein 5; Cardiomegaly; Cell Line; Down-Regulation; Humans; MicroRNAs; Myoblasts; Myocytes, Cardiac; Rats; RNA-Binding Proteins; Up-Regulation | 2018 |
MiR-181a mediates Ang II-induced myocardial hypertrophy by mediating autophagy.
Topics: Adenine; Angiotensin II; Animals; Autophagy; Autophagy-Related Protein 5; Cardiomegaly; Cells, Cultured; Disease Models, Animal; Down-Regulation; Male; MicroRNAs; Microtubule-Associated Proteins; Myocytes, Cardiac; Rats; Rats, Sprague-Dawley | 2017 |
Angiotensin II Facilitates Matrix Metalloproteinase-9-Mediated Myosin Light Chain Kinase Degradation in Pressure Overload-Induced Cardiac Hypertrophy.
Topics: Angiotensin II; Animals; Cardiomegaly; Cells, Cultured; Humans; Male; Matrix Metalloproteinase 9; Myocytes, Cardiac; Myosin-Light-Chain Kinase; Proteolysis; Rats, Sprague-Dawley | 2017 |
A new miRNA regulator, miR-672, reduces cardiac hypertrophy by inhibiting JUN expression.
Topics: 3' Untranslated Regions; Angiotensin II; Animals; Animals, Newborn; Cardiomegaly; Cells, Cultured; Gene Expression Profiling; Gene Expression Regulation; Gene Ontology; Mice, Inbred ICR; MicroRNAs; Myocytes, Cardiac; Proto-Oncogene Proteins c-jun; Rats, Sprague-Dawley | 2018 |
Anti-Interleukin-22-Neutralizing Antibody Attenuates Angiotensin II-Induced Cardiac Hypertrophy in Mice.
Topics: Angiotensin II; Animals; Antibodies, Neutralizing; Cardiomegaly; Cells, Cultured; Cytokines; Extracellular Signal-Regulated MAP Kinases; Fibrosis; Interleukin-22; Interleukins; Male; Mice; Mice, Inbred C57BL; Myocardium; RNA, Messenger; STAT3 Transcription Factor | 2017 |
Glycosylated CD147 reduces myocardial collagen cross-linking in cardiac hypertrophy.
Topics: Angiotensin II; Animals; Basigin; Cardiomegaly; Collagen; Echocardiography; Male; Myocardium; Rats; Rats, Sprague-Dawley | 2018 |
Osteoglycin attenuates cardiac fibrosis by suppressing cardiac myofibroblast proliferation and migration through antagonizing lysophosphatidic acid 3/matrix metalloproteinase 2/epidermal growth factor receptor signalling.
Topics: Angiotensin II; Animals; Cardiomegaly; Cell Movement; Cell Proliferation; Cells, Cultured; Disease Models, Animal; ErbB Receptors; Fibrosis; Hypertension; Intercellular Signaling Peptides and Proteins; Matrix Metalloproteinase 14; Matrix Metalloproteinase 2; Mice, Inbred C57BL; Mitogen-Activated Protein Kinases; Myocytes, Cardiac; Myofibroblasts; Receptor Cross-Talk; Receptors, Lysophosphatidic Acid; rho GTP-Binding Proteins; rho-Associated Kinases; rhoA GTP-Binding Protein; Signal Transduction; Ventricular Remodeling | 2018 |
Alamandine acts via MrgD to induce AMPK/NO activation against ANG II hypertrophy in cardiomyocytes.
Topics: AMP-Activated Protein Kinases; Angiotensin II; Animals; Cardiomegaly; Cells, Cultured; Enzyme Activation; Male; Mice, Inbred C57BL; Mice, Knockout; Myocytes, Cardiac; Nerve Tissue Proteins; Nitric Oxide; Oligopeptides; Phosphorylation; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats, Wistar; Receptors, G-Protein-Coupled; Signal Transduction | 2018 |
CXCL1-CXCR2 axis mediates angiotensin II-induced cardiac hypertrophy and remodelling through regulation of monocyte infiltration.
Topics: Adult; Aged; Aged, 80 and over; Angiotensin II; Animals; Cardiomegaly; Cell Movement; Chemokine CXCL1; Female; Fibrosis; Heart Failure; Humans; Male; Mice, Inbred C57BL; Mice, Knockout; Middle Aged; Monocytes; Myocardium; Receptors, Interleukin-8B; Signal Transduction; Up-Regulation | 2018 |
CXCL1-CXCR2 lead monocytes to the heart of the matter.
Topics: Angiotensin II; Cardiomegaly; Chemokine CXCL1; Humans; Monocytes; Receptors, Interleukin-8B | 2018 |
MicroRNA-19a/b-3p protect the heart from hypertension-induced pathological cardiac hypertrophy through PDE5A.
Topics: Angiotensin II; Animals; Cardiomegaly; Cells, Cultured; Cyclic Nucleotide Phosphodiesterases, Type 5; Gene Expression Regulation; Humans; Hypertension; Mice, Transgenic; MicroRNAs; Myocytes, Cardiac; Signal Transduction | 2018 |
C1QTNF1 attenuates angiotensin II-induced cardiac hypertrophy via activation of the AMPKa pathway.
Topics: Adipokines; AMP-Activated Protein Kinase Kinases; Angiotensin II; Animals; Cardiomegaly; Cells, Cultured; Disease Models, Animal; Fibrosis; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocytes, Cardiac; Phosphorylation; Protein Kinases; Rats; Rats, Sprague-Dawley; Signal Transduction; Vasoconstrictor Agents | 2018 |
Astragaloside IV protects against the pathological cardiac hypertrophy in mice.
Topics: Angiotensin II; Animals; Apoptosis; Cardiomegaly; Cardiotonic Agents; Enzyme Activation; Inflammation; Intracellular Signaling Peptides and Proteins; Male; Mice, Inbred C57BL; Myocardium; Myocytes, Cardiac; Phosphorylation; Pressure; Protein Serine-Threonine Kinases; Saponins; Signal Transduction; Triterpenes | 2018 |
sRAGE attenuates angiotensin II-induced cardiomyocyte hypertrophy by inhibiting RAGE-NFκB-NLRP3 activation.
Topics: Angiotensin II; Animals; Cardiomegaly; Cell Line; Extracellular Signal-Regulated MAP Kinases; HMGB1 Protein; Interleukin-1beta; Myocytes, Cardiac; NF-kappa B; NLR Family, Pyrin Domain-Containing 3 Protein; Protein Kinase C; Rats; Reactive Oxygen Species; Receptor for Advanced Glycation End Products; RNA, Small Interfering | 2018 |
Leflunomide counter
Topics: Angiotensin II; Aniline Compounds; Animals; Cardiomegaly; Crotonates; Fibrosis; Hydroxybutyrates; Leflunomide; Mice; Nitriles; Proto-Oncogene Proteins c-akt; Toluidines | 2018 |
Overexpression of SARAF Ameliorates Pressure Overload-Induced Cardiac Hypertrophy Through Suppressing STIM1-Orai1 in Mice.
Topics: Angiotensin II; Animals; Aorta, Abdominal; Atrial Natriuretic Factor; Cardiomegaly; Cell Line; Echocardiography; Male; Membrane Proteins; Mice; Mice, Inbred C57BL; Myocardium; Myocytes, Cardiac; Myosin Heavy Chains; Natriuretic Peptide, Brain; ORAI1 Protein; Pressure; Stromal Interaction Molecule 1; Up-Regulation; Ventricular Function, Left | 2018 |
N‑terminal truncated peroxisome proliferator‑activated receptor‑γ coactivator‑1α alleviates phenylephrine‑induced mitochondrial dysfunction and decreases lipid droplet accumulation in neonatal rat cardiomyocytes.
Topics: Adenosine Triphosphate; Angiotensin II; Animals; Cardiomegaly; Energy Metabolism; Lipid Droplets; Mitochondria, Heart; Myocytes, Cardiac; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Phenylephrine; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species | 2018 |
EndophilinA2 protects against angiotensin II-induced cardiac hypertrophy by inhibiting angiotensin II type 1 receptor trafficking in neonatal rat cardiomyocytes.
Topics: Acyltransferases; Adenoviridae; Angiotensin II; Animals; Animals, Newborn; Apoptosis; Cardiomegaly; Endoplasmic Reticulum Stress; Gene Expression Regulation; Genetic Vectors; Heat-Shock Proteins; Myocytes, Cardiac; Primary Cell Culture; Protein Transport; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; RNA, Small Interfering; Signal Transduction; Transfection | 2018 |
CD1d-dependent natural killer T cells attenuate angiotensin II-induced cardiac remodelling via IL-10 signalling in mice.
Topics: Adoptive Transfer; Angiotensin II; Animals; Antigens, CD1d; Cardiomegaly; Cells, Cultured; Coculture Techniques; Dendritic Cells; Disease Models, Animal; Fibrosis; Galactosylceramides; Hypertension; Inflammation Mediators; Interleukin-10; Male; Mice, Inbred C57BL; Mice, Knockout; Myocytes, Cardiac; Natural Killer T-Cells; NF-kappa B; Signal Transduction; STAT3 Transcription Factor; Transforming Growth Factor beta1; Ventricular Remodeling | 2019 |
Eriobotrya japonica ameliorates cardiac hypertrophy in H9c2 cardiomyoblast and in spontaneously hypertensive rats.
Topics: Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Cells, Cultured; Drugs, Chinese Herbal; Echocardiography; Eriobotrya; Heart; Hypertension; Male; Myocytes, Cardiac; Phytotherapy; Rats; Rats, Inbred SHR; Rats, Inbred WKY | 2018 |
Network-based predictions of in vivo cardiac hypertrophy.
Topics: Angiotensin II; Animals; Cardiomegaly; Computational Biology; Disease Models, Animal; Heart Failure; Humans; Mice; Mice, Transgenic; Myocardium; Myocytes, Cardiac; Signal Transduction | 2018 |
PARP1 interacts with HMGB1 and promotes its nuclear export in pathological myocardial hypertrophy.
Topics: Active Transport, Cell Nucleus; Angiotensin II; Animals; Cardiomegaly; Cell Nucleus; HMGB1 Protein; Isoproterenol; Male; Myocytes, Cardiac; Phenylephrine; Poly (ADP-Ribose) Polymerase-1; Rats, Sprague-Dawley | 2019 |
Irisin alleviates pressure overload-induced cardiac hypertrophy by inducing protective autophagy via mTOR-independent activation of the AMPK-ULK1 pathway.
Topics: AMP-Activated Protein Kinases; Angiotensin II; Animals; Autophagy; Autophagy-Related Protein-1 Homolog; Benzamides; Cardiomegaly; Fibronectins; Heart Failure; Humans; Mice; Mice, Transgenic; Myocytes, Cardiac; Phenylephrine; Pressure; Pyrimidines; Signal Transduction; TOR Serine-Threonine Kinases | 2018 |
Crosstalk between FGF23- and angiotensin II-mediated Ca
Topics: Angiotensin II; Animals; Animals, Newborn; Calcium; Calcium Signaling; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Cardiomegaly; Cells, Cultured; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Gene Expression; Histone Deacetylases; Myocytes, Cardiac; Rats; Receptor, Angiotensin, Type 1 | 2018 |
Testosterone plays a permissive role in angiotensin II-induced hypertension and cardiac hypertrophy in male rats.
Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Cardiomegaly; Hypertension; Male; Mesenteric Arteries; Orchiectomy; Rats; Rats, Wistar; Receptors, Androgen; Receptors, Angiotensin; Renin-Angiotensin System; Testosterone | 2019 |
Dioscin ameliorates cardiac hypertrophy through inhibition of the MAPK and Akt/GSK3β/mTOR pathways.
Topics: Angiotensin II; Animals; Cardiomegaly; Diosgenin; Glycogen Synthase Kinase 3 beta; Male; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinases; Proto-Oncogene Proteins c-akt; TOR Serine-Threonine Kinases; Vasoconstrictor Agents | 2018 |
Hydroxysafflor yellow A protects against angiotensin II‑induced hypertrophy.
Topics: Angiotensin II; Animals; Cardiomegaly; Cell Line; Chalcone; Disease Models, Animal; Heme Oxygenase-1; Male; Myocardial Infarction; NAD(P)H Dehydrogenase (Quinone); NF-E2-Related Factor 2; Protective Agents; Quinones; Rats; Rats, Sprague-Dawley; Signal Transduction | 2018 |
Effects of high- and low-dose aspirin on adaptive immunity and hypertension in the stroke-prone spontaneously hypertensive rat.
Topics: Adaptive Immunity; Angiotensin II; Animals; Aspirin; Biomarkers; Blood Pressure; Blood Vessels; Cardiomegaly; Cyclooxygenase 1; Cyclooxygenase 2; Cytokines; Disease Susceptibility; Dose-Response Relationship, Drug; Epoprostenol; Hypertension; Kidney; Mice; Rats; Rats, Inbred SHR; Real-Time Polymerase Chain Reaction; RNA, Messenger; Stroke; Systole; T-Lymphocytes; Thromboxanes | 2019 |
The Effects of Dracocephalum Heterophyllum Benth Flavonoid on Hypertrophic Cardiomyocytes Induced by Angiotensin II in Rats.
Topics: Angiotensin II; Animals; Animals, Newborn; Atrial Natriuretic Factor; Cardiomegaly; Cardiomyopathy, Hypertrophic; Cells, Cultured; China; Flavonoids; Heart Ventricles; Medicine, Tibetan Traditional; Myocardium; Myocytes, Cardiac; Natriuretic Peptide, Brain; Primary Cell Culture; Rats; Rats, Sprague-Dawley; Signal Transduction | 2018 |
Bakuchiol protects against pathological cardiac hypertrophy by blocking NF-κB signaling pathway.
Topics: Administration, Oral; Angiotensin II; Animals; Aorta; Atrial Natriuretic Factor; Cardiomegaly; Cardiotonic Agents; Collagen; Connective Tissue Growth Factor; Constriction, Pathologic; Gene Expression Regulation; Male; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; Natriuretic Peptide, Brain; NF-kappa B; Phenols; Plant Extracts; Primary Cell Culture; Psoralea; Signal Transduction | 2018 |
Effect of the Shensong Yangxin Capsule on Energy Metabolism in Angiotensin II-Induced Cardiac Hypertrophy.
Topics: Angiotensin II; Animals; Cardiomegaly; Energy Metabolism; Medicine, Chinese Traditional; Myocardium; Myocytes, Cardiac; Rats | 2018 |
Administration of ubiquitin-activating enzyme UBA1 inhibitor PYR-41 attenuates angiotensin II-induced cardiac remodeling in mice.
Topics: Angiotensin II; Animals; Benzoates; Blood Pressure; Cardiomegaly; Fibrosis; Furans; Gene Expression; Heart; Hypertension; Male; Mice; Myocardium; Pyrazoles; Signal Transduction; Ubiquitin-Activating Enzymes; Ventricular Remodeling | 2018 |
Angiotensin II requires an intact cardiac thyrotropin-releasing hormone (TRH) system to induce cardiac hypertrophy in mouse.
Topics: Angiotensin II; Animals; Blood Pressure; Body Weight; Cardiomegaly; Cells, Cultured; Disease Models, Animal; Disease Susceptibility; Drinking; Fibrosis; Gene Expression Profiling; Hypertrophy, Left Ventricular; Immunohistochemistry; Mice; Myocardium; NIH 3T3 Cells; Phenotype; Rats; RNA Interference; RNA, Small Interfering; Thyrotropin-Releasing Hormone | 2018 |
AdipoRon, an adiponectin receptor agonist, attenuates cardiac remodeling induced by pressure overload.
Topics: AMP-Activated Protein Kinases; Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Cell Differentiation; Fibroblasts; Humans; Male; Mice, Inbred C57BL; Mice, Knockout; Piperidines; Rats, Sprague-Dawley; Receptors, Adiponectin; Transforming Growth Factor beta1; Ventricular Remodeling | 2018 |
Nuclear translocation of calmodulin in pathological cardiac hypertrophy originates from ryanodine receptor bound calmodulin.
Topics: Angiotensin II; Animals; Biological Transport; Calmodulin; Cardiomegaly; Cell Nucleus; Cells, Cultured; Dantrolene; Histone Deacetylases; Mice; Nuclear Localization Signals; Phenylephrine; Receptors, G-Protein-Coupled; Ryanodine Receptor Calcium Release Channel; Suramin | 2018 |
Apoptosis in angiotensin II-stimulated hypertrophic cardiac cells -modulation by phenolics rich extract of Boerhavia diffusa L.
Topics: Angiotensin II; Animals; Apoptosis; bcl-2-Associated X Protein; Biomarkers; Cardiomegaly; Caspases; Cell Survival; Cytochromes c; Interleukin-10; Nyctaginaceae; p38 Mitogen-Activated Protein Kinases; Phenols; Plant Extracts; Rats; RNA, Messenger; Staining and Labeling; Tumor Necrosis Factor-alpha | 2018 |
Overexpression of miR-142-3p improves mitochondrial function in cardiac hypertrophy.
Topics: Angiotensin II; Animals; Apoptosis; Atrial Natriuretic Factor; Cardiomegaly; Carrier Proteins; Cells, Cultured; Heart Failure; Intracellular Signaling Peptides and Proteins; Male; MicroRNAs; Mitochondria, Heart; Myocardium; Natriuretic Peptide, Brain; Rats; Rats, Sprague-Dawley | 2018 |
The nuclear receptor RORα protects against angiotensin II-induced cardiac hypertrophy and heart failure.
Topics: Angiotensin II; Animals; Cardiomegaly; Cells, Cultured; Female; Fibroblasts; Heart Failure; Humans; Interleukin-6; Loss of Function Mutation; Mice; Mice, Inbred C57BL; Middle Aged; Mitochondria, Heart; Myocardial Contraction; Myocytes, Cardiac; Nuclear Receptor Subfamily 1, Group F, Member 1; Rats; Rats, Sprague-Dawley; STAT3 Transcription Factor | 2019 |
Hyperoside Protects Against Pressure Overload-Induced Cardiac Remodeling via the AKT Signaling Pathway.
Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Cardiomegaly; Cells, Cultured; Disease Models, Animal; Interleukin-1beta; Male; Mice; Mice, Inbred C57BL; Myocardium; Myocytes, Cardiac; Oxidative Stress; Protective Agents; Proto-Oncogene Proteins c-akt; Quercetin; Rats; Signal Transduction; Superoxide Dismutase; Ventricular Remodeling | 2018 |
Testin protects against cardiac hypertrophy by targeting a calcineurin-dependent signalling pathway.
Topics: Adult; Aged; Angiotensin II; Animals; Calcineurin; Cardiomegaly; Cardiomyopathy, Dilated; Case-Control Studies; Cytoskeletal Proteins; Disease Models, Animal; Female; Humans; Male; Mice, Inbred C57BL; Mice, Transgenic; Myocytes, Cardiac; NFATC Transcription Factors; RNA-Binding Proteins | 2019 |
Macrocyclic lactones from seafood Amphioctopus neglectus: Newly described natural leads to attenuate angiotensin-II induced cardiac hypertrophy.
Topics: Angiotensin II; Animals; Antioxidants; Biological Products; Cardiomegaly; Cell Line; Lactones; Molecular Docking Simulation; Myocytes, Cardiac; Octopodiformes; Structure-Activity Relationship | 2019 |
Effect of atorvastatin on cardiomyocyte hypertrophy through suppressing MURC induced by volume overload and cyclic stretch.
Topics: Angiotensin II; Animals; Anticholesteremic Agents; Arteriovenous Shunt, Surgical; Atorvastatin; Cardiomegaly; Extracellular Signal-Regulated MAP Kinases; Gene Expression Regulation; Male; Muscle Proteins; Myocytes, Cardiac; Rats; Rats, Wistar; Signal Transduction; Stress, Mechanical | 2019 |
Gallic Acid Suppresses Cardiac Hypertrophic Remodeling and Heart Failure.
Topics: Angiotensin II; Animals; Autophagy; Cardiomegaly; Cardiotonic Agents; Cell Enlargement; Cells, Cultured; Gallic Acid; Heart Failure; Male; Mice, Inbred C57BL; Myocarditis; Myocytes, Cardiac; Oxidative Stress; Rats, Sprague-Dawley; Signal Transduction | 2019 |
RORα nuclear receptors in protection against angiotensin II-induced cardiac hypertrophy.
Topics: Angiotensin II; Cardiomegaly; Heart Failure; Humans | 2019 |
Macrophage: beyond cardiac structural remodelling.
Topics: Angiotensin II; Cardiomegaly; Chemokine CXCL1; Heart; Humans; Macrophages; Monocytes | 2019 |
Cardiomyocyte calcineurin is required for the onset and progression of cardiac hypertrophy and fibrosis in adult mice.
Topics: Angiotensin II; Animals; Calcineurin; Cardiomegaly; Disease Progression; Fibrosis; Gene Expression Profiling; Mice; Mice, Knockout; Myocytes, Cardiac; Signal Transduction; Vasoconstrictor Agents | 2019 |
Angiotensin II Causes Biphasic STAT3 Activation Through TLR4 to Initiate Cardiac Remodeling.
Topics: Angiotensin II; Animals; Atrial Remodeling; Cardiomegaly; Cell Line; Interleukin-6; Mice; Mice, Knockout; Myocytes, Cardiac; Rats; Receptors, Interleukin-6; Signal Transduction; STAT3 Transcription Factor; Toll-Like Receptor 4 | 2018 |
Unc-51 like autophagy activating kinase 1 accelerates angiotensin II-induced cardiac hypertrophy through promoting oxidative stress regulated by Nrf-2/HO-1 pathway.
Topics: Angiotensin II; Animals; Autophagy; Autophagy-Related Protein-1 Homolog; Cardiomegaly; Cardiomyopathy, Dilated; Cells, Cultured; Heme Oxygenase-1; Humans; Male; Mice, Inbred C57BL; Myocardium; NF-E2-Related Factor 2; Oxidative Stress; Signal Transduction | 2019 |
Fibroblast growth factor-21 protects against fibrosis in hypertensive heart disease.
Topics: Angiotensin II; Animals; Biopsy; Blood Pressure; Cardiomegaly; Cells, Cultured; Disease Models, Animal; Fibroblast Growth Factors; Fibrosis; Gene Expression Regulation; Heart Rate; Heart Ventricles; Humans; Hypertension; Mice, Knockout; Myocardium; Rats, Sprague-Dawley; RNA, Messenger | 2019 |
Short-Chain Fatty Acid Propionate Protects From Hypertensive Cardiovascular Damage.
Topics: Angiotensin II; Animals; Anti-Inflammatory Agents; Aortic Diseases; Arrhythmias, Cardiac; Arterial Pressure; Atherosclerosis; Cardiomegaly; Disease Models, Animal; Hypertension; Male; Mice, Knockout, ApoE; Plaque, Atherosclerotic; Propionates; T-Lymphocytes, Regulatory; Th17 Cells | 2019 |
MiR-103 inhibiting cardiac hypertrophy through inactivation of myocardial cell autophagy via targeting TRPV3 channel in rat hearts.
Topics: Angiotensin II; Animals; Autophagy; Beclin-1; Cardiomegaly; Cells, Cultured; Down-Regulation; Heart; Heart Failure; Male; MicroRNAs; Myocytes, Cardiac; Rats; Rats, Wistar; Signal Transduction; TRPV Cation Channels; Up-Regulation | 2019 |
MicroRNA-375-3p inhibitor suppresses angiotensin II-induced cardiomyocyte hypertrophy by promoting lactate dehydrogenase B expression.
Topics: Angiotensin II; Animals; Aorta; Cardiomegaly; Disease Models, Animal; Gene Expression Regulation; Gene Knockdown Techniques; Heart Failure; Humans; Isoenzymes; L-Lactate Dehydrogenase; MicroRNAs; Myocardium; Myocytes, Cardiac; Myosin Heavy Chains; Natriuretic Peptide, Brain; Primary Cell Culture; Rats; Signal Transduction | 2019 |
Effect of muscarinic receptors agonist in the rat model of coronary heart disease: A potential therapeutic target in cardiovascular diseases.
Topics: Acetylcholine; Angiotensin II; Animals; Atrial Natriuretic Factor; Cardiomegaly; Cells, Cultured; Electrocardiography; Hemodynamics; Hypertrophy; Male; Muscarinic Agonists; Rats; Receptor, Muscarinic M3; Ventricular Function, Left; Ventricular Myosins | 2018 |
Loss of Apelin Augments Angiotensin II-Induced Cardiac Dysfunction and Pathological Remodeling.
Topics: Angiotensin II; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Animals; Apelin; Biopsy; Cardiomegaly; Disease Models, Animal; Echocardiography; Fibrosis; Heart Failure; Hypertension; Mice; Mice, Knockout; Myocardial Contraction; Myocytes, Cardiac; Peptidyl-Dipeptidase A; Ventricular Dysfunction; Ventricular Remodeling | 2019 |
SP1-SYNE1-AS1-miR-525-5p feedback loop regulates Ang-II-induced cardiac hypertrophy.
Topics: Angiotensin II; Animals; Cardiomegaly; Cell Proliferation; Cytoskeletal Proteins; Disease Models, Animal; Disease Progression; Gene Expression Regulation; Humans; Mice; MicroRNAs; Myocytes, Cardiac; Nerve Tissue Proteins; RNA, Long Noncoding; Sp1 Transcription Factor; Transcriptional Activation | 2019 |
Nrf2 deficiency aggravates Angiotensin II-induced cardiac injury by increasing hypertrophy and enhancing IL-6/STAT3-dependent inflammation.
Topics: Angiotensin II; Animals; Animals, Newborn; Cardiomegaly; Cells, Cultured; Inflammation; Interleukin-6; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Knockout; Myocytes, Cardiac; NF-E2-Related Factor 2; Rats, Sprague-Dawley; Signal Transduction; STAT3 Transcription Factor | 2019 |
Endothelial-specific deletion of Ets-1 attenuates Angiotensin II-induced cardiac fibrosis via suppression of endothelial-to-mesenchymal transition.
Topics: Angiotensin II; Animals; Cardiomegaly; Epithelial-Mesenchymal Transition; Fibrosis; Gene Expression Regulation; HEK293 Cells; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardium; Proto-Oncogene Protein c-ets-1; Signal Transduction; Transforming Growth Factor beta1; Twist Transcription Factors; Zinc Finger E-box-Binding Homeobox 1 | 2019 |
Fibroblast growth factor 21 protects the heart from angiotensin II-induced cardiac hypertrophy and dysfunction via SIRT1.
Topics: AMP-Activated Protein Kinases; Angiotensin II; Animals; Animals, Newborn; Apoptosis; Cardiomegaly; Cell Line; Cells, Cultured; Fibroblast Growth Factors; Gene Expression; Mice, Inbred C57BL; Mice, Knockout; Myocytes, Cardiac; Protein Binding; Protein Serine-Threonine Kinases; Rats; Reactive Oxygen Species; Sirtuin 1; Superoxide Dismutase | 2019 |
Down-regulation of miR-200c attenuates AngII-induced cardiac hypertrophy via targeting the MLCK-mediated pathway.
Topics: Angiotensin II; Animals; Antagomirs; Aorta; Apoptosis; Cardiomegaly; Constriction, Pathologic; Disease Models, Animal; Echocardiography; Gene Expression Regulation; Male; MicroRNAs; Myocytes, Cardiac; Myosin-Light-Chain Kinase; Oligoribonucleotides; Primary Cell Culture; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Signal Transduction | 2019 |
Novel role of mitochondrial GTPases 1 in pathological cardiac hypertrophy.
Topics: Angiotensin II; Animals; Cardiomegaly; Cardiomyopathy, Dilated; GTP Phosphohydrolases; Heart Failure; Humans; MAP Kinase Kinase Kinases; Mice; Mice, Knockout; Mitochondria; Myocytes, Cardiac; Oxidative Stress | 2019 |
CSN5 attenuates Ang II-induced cardiac hypertrophy through stabilizing LKB1.
Topics: AMP-Activated Protein Kinase Kinases; AMP-Activated Protein Kinases; Angiotensin II; Animals; Cardiomegaly; COP9 Signalosome Complex; Disease Models, Animal; Gene Expression Regulation; Humans; Mice; Myocytes, Cardiac; Peptide Hydrolases; Protein Binding; Protein Interaction Maps; Protein Kinases; Protein Serine-Threonine Kinases | 2019 |
GDF11 Attenuated ANG II-Induced Hypertrophic Cardiomyopathy and Expression of ANP, BNP and Beta-MHC Through Down- Regulating CCL11 in Mice.
Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Bone Morphogenetic Proteins; Cardiomegaly; Chemokine CCL11; Down-Regulation; Growth Differentiation Factors; Mice; Myocytes, Cardiac; Myosin Heavy Chains; Natriuretic Peptide, Brain | 2018 |
Irisin ameliorates angiotensin II-induced cardiomyocyte apoptosis through autophagy.
Topics: Angiotensin II; Animals; Apoptosis; Autophagy; Cardiomegaly; Cells, Cultured; Down-Regulation; Fibronectins; Humans; Mice; Mice, Inbred C57BL; Mice, Transgenic; Myocytes, Cardiac; Rats; Rats, Sprague-Dawley; Recombinant Proteins; RNA, Messenger; Signal Transduction | 2019 |
Angiotensin II-induced hypertension and cardiac hypertrophy are differentially mediated by TLR3- and TLR4-dependent pathways.
Topics: Adaptor Proteins, Vesicular Transport; Angiotensin II; Animals; Cardiomegaly; Disease Models, Animal; Hypertension; Immunity, Innate; Inflammation Mediators; Kidney; Male; Mice, Inbred C57BL; Mice, Knockout; Myocardium; Receptor, Angiotensin, Type 1; Signal Transduction; Toll-Like Receptor 3; Toll-Like Receptor 4 | 2019 |
DNA Damage Response Mediates Pressure Overload-Induced Cardiomyocyte Hypertrophy.
Topics: Angiotensin II; Animals; Cardiomegaly; Cell Cycle; Disease Models, Animal; DNA Damage; Mice; Myocytes, Cardiac | 2019 |
Monoamine oxidase inhibitors protect against coronary heart disease in rodent rat models: A pilot study.
Topics: Angiotensin II; Animals; Cardiomegaly; Disease Models, Animal; Hemodynamics; Male; Monoamine Oxidase Inhibitors; Myocardium; Oxazoles; Rats, Wistar | 2019 |
1.25 Dihydroxyvitamin D3 Attenuates Hypertrophy Markers in Cardiomyoblast H9c2 Cells: Evaluation of Sirtuin3 mRNA and Protein Level.
Topics: Angiotensin II; Animals; Calcitriol; Cardiomegaly; Myocytes, Cardiac; Rats; RNA, Messenger | 2019 |
Epigallocatechin-3-gallate inhibits angiotensin II-induced cardiomyocyte hypertrophy via regulating Hippo signaling pathway in H9c2 rat cardiomyocytes.
Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Cardiomegaly; Catechin; Cell Line; Gene Expression Regulation; Molecular Structure; Myocytes, Cardiac; Natriuretic Peptide, Brain; Protein Serine-Threonine Kinases; Rats; Reactive Oxygen Species; Signal Transduction | 2019 |
Epigenetic modulation of tenascin C in the heart: implications on myocardial ischemia, hypertrophy and metabolism.
Topics: Angiotensin II; Animals; Cardiomegaly; Coronary Artery Disease; DNA Methylation; Energy Metabolism; Epigenesis, Genetic; Extracellular Matrix; Extracellular Matrix Proteins; Fibrosis; Heart Diseases; Humans; Hypertrophy; Hypoxia; Male; Matrix Metalloproteinase 2; MicroRNAs; Myocardial Infarction; Myocardium; Nerve Tissue Proteins; Rats; Tenascin; Ventricular Remodeling | 2019 |
Rutaecarpine prevents hypertensive cardiac hypertrophy involving the inhibition of Nox4-ROS-ADAM17 pathway.
Topics: ADAM17 Protein; Angiotensin II; Animals; Aorta, Abdominal; Cardiomegaly; Constriction, Pathologic; Gene Expression Regulation; Humans; Hypertension; Indole Alkaloids; MAP Kinase Signaling System; Myocytes, Cardiac; NADPH Oxidase 4; Quinazolines; Rats; Rats, Inbred Dahl; Reactive Oxygen Species | 2019 |
Luteolin improves myocardial cell glucolipid metabolism by inhibiting hypoxia inducible factor-1α expression in angiotensin II/hypoxia-induced hypertrophic H9c2 cells.
Topics: Angiotensin II; Animals; Cardiomegaly; Carnitine O-Palmitoyltransferase; Fatty Acids, Nonesterified; Glucose; Glucose Transporter Type 4; Hypertrophy; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Luteolin; Myocardium; Myocytes, Cardiac; Plant Extracts; PPAR alpha; Protein Kinases; Rats | 2019 |
Inhibition of circHIPK3 prevents angiotensin II-induced cardiac fibrosis by sponging miR-29b-3p.
Topics: Angiotensin II; Animals; Cardiomegaly; Cells, Cultured; Fibrosis; Intracellular Signaling Peptides and Proteins; Mice; Mice, Inbred C57BL; MicroRNAs; Myocytes, Cardiac; Protein Serine-Threonine Kinases; RNA, Circular | 2019 |
Effects of ATRAP in Renal Proximal Tubules on Angiotensin-Dependent Hypertension.
Topics: Adaptor Proteins, Signal Transducing; Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Hypertension; Kidney Tubules, Proximal; Laser Capture Microdissection; Mice; Mice, Knockout; Nephrons; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Vasoconstrictor Agents | 2019 |
Allicin attenuates pathological cardiac hypertrophy by inhibiting autophagy via activation of PI3K/Akt/mTOR and MAPK/ERK/mTOR signaling pathways.
Topics: Angiotensin II; Animals; Autophagy; Cardiomegaly; Cardiotonic Agents; Disulfides; Male; MAP Kinase Signaling System; Myocytes, Cardiac; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Rats, Wistar; Signal Transduction; Sulfinic Acids; TOR Serine-Threonine Kinases | 2019 |
The TIR/BB-loop mimetic AS-1 prevents Ang II-induced hypertensive cardiac hypertrophy via NF-κB dependent downregulation of miRNA-143.
Topics: Angiotensin II; Animals; Animals, Newborn; Cardiomegaly; Down-Regulation; Gene Expression Regulation; Hypertension; Male; MAP Kinase Signaling System; Mice, Inbred C57BL; MicroRNAs; Myocytes, Cardiac; NF-kappa B; Phosphorylation; Pyrrolidines; Rats; Valine | 2019 |
Long non-coding RNA small nucleolar RNA host gene 7 facilitates cardiac hypertrophy via stabilization of SDA1 domain containing 1 mRNA.
Topics: Angiotensin II; Animals; Cardiomegaly; Cell Cycle Proteins; ELAV-Like Protein 1; Gene Silencing; Myocytes, Cardiac; Nuclear Proteins; Protein Binding; Rats, Sprague-Dawley; RNA Stability; RNA, Long Noncoding; RNA, Messenger; Up-Regulation | 2019 |
Cardiac hypertrophy in mice submitted to a swimming protocol: influence of training volume and intensity on myocardial renin-angiotensin system.
Topics: Angiotensin I; Angiotensin II; Animals; Cardiomegaly; Hypertrophy, Left Ventricular; Male; Mice, Inbred BALB C; Myocardium; Peptide Fragments; Physical Conditioning, Animal; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Swimming; Ventricular Remodeling | 2019 |
Alamandine attenuates long‑term hypertension‑induced cardiac fibrosis independent of blood pressure.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Cardiomegaly; Collagen Type I; Collagen Type I, alpha 1 Chain; Fibrosis; Heart Ventricles; Hypertension; Imidazoles; Male; Matrix Metalloproteinase 9; Oligopeptides; Proto-Oncogene Proteins c-akt; Pyridines; Rats; Rats, Inbred SHR; Renin-Angiotensin System | 2019 |
OBG-like ATPase 1 inhibition attenuates angiotensin II-induced hypertrophic response in human ventricular myocytes via GSK-3beta/beta-catenin signalling.
Topics: Adenosine Triphosphatases; Angiotensin II; Animals; beta Catenin; Cardiomegaly; Cell Line; Enzyme Inhibitors; Glycogen Synthase Kinase 3 beta; GTP-Binding Proteins; Heart Ventricles; Humans; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; Signal Transduction; Up-Regulation | 2019 |
Apigenin-induced HIF-1α inhibitory effect improves abnormal glucolipid metabolism in AngⅡ/hypoxia-stimulated or HIF-1α-overexpressed H9c2 cells.
Topics: Angiotensin II; Animals; Apigenin; Atrial Natriuretic Factor; Cardiomegaly; Cell Hypoxia; Cell Line; Down-Regulation; Glucose; Glucose Transporter Type 4; Hypoxia-Inducible Factor 1, alpha Subunit; Myocytes, Cardiac; PPAR alpha; PPAR gamma; Pyruvate Dehydrogenase Acetyl-Transferring Kinase; Rats; Up-Regulation | 2019 |
The immunoproteasome catalytic β5i subunit regulates cardiac hypertrophy by targeting the autophagy protein ATG5 for degradation.
Topics: Aged; Aged, 80 and over; Angiotensin II; Animals; Autophagy; Autophagy-Related Protein 5; Cardiomegaly; Case-Control Studies; Catalytic Domain; Female; Heart Failure; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Middle Aged; Myocardium; Natriuretic Peptide, Brain; Proteasome Endopeptidase Complex; Rats; RNA Interference; RNA, Small Interfering; Up-Regulation | 2019 |
[Aconitine ameliorates cardiomyocyte hypertrophy induced by angiotensin Ⅱ].
Topics: Aconitine; Actins; Angiotensin II; Atrial Natriuretic Factor; Cardiac Myosins; Cardiomegaly; Cells, Cultured; Humans; Hypertrophy; Myocytes, Cardiac; Myosin Heavy Chains; Natriuretic Peptide, Brain | 2019 |
The Role of Heme Oxygenase 1 in the Protective Effect of Caloric Restriction against Diabetic Cardiomyopathy.
Topics: Angiotensin II; Animals; Blood Glucose; Caloric Restriction; Carbazoles; Cardiomegaly; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Cardiomyopathies; Heme Oxygenase-1; Male; Malondialdehyde; Mesoporphyrins; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; Obesity; Oxidative Stress; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; PPAR gamma; Protoporphyrins; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Signal Transduction; Sirtuin 1 | 2019 |
Quantitative trait loci associated with angiotensin II and high-salt diet induced acute decompensated heart failure in Balb/CJ mice.
Topics: Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Chromosome Mapping; Diet; Disease Models, Animal; Echocardiography; Female; Genetic Linkage; Genetic Predisposition to Disease; Heart Failure; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred Strains; Oligonucleotide Array Sequence Analysis; Phenotype; Polymorphism, Single Nucleotide; Quantitative Trait Loci; Sodium Chloride, Dietary; Species Specificity; Thiobarbituric Acid Reactive Substances | 2019 |
Oridonin protects against cardiac hypertrophy by promoting P21-related autophagy.
Topics: Angiotensin II; Animals; Antineoplastic Agents, Phytogenic; Antioxidants; Autophagy; Cardiomegaly; Cyclin-Dependent Kinase Inhibitor p21; Disease Models, Animal; Diterpenes, Kaurane; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardium; Myocytes, Cardiac; Oxidative Stress; Phosphorylation; Proto-Oncogene Proteins c-akt; Rats; RNA, Small Interfering | 2019 |
LncRNA TUG1 contributes to cardiac hypertrophy via regulating miR-29b-3p.
Topics: Angiotensin II; Animals; Cardiomegaly; Cell Line; Gene Expression Regulation; HEK293 Cells; Humans; MicroRNAs; Myocytes, Cardiac; Rats; RNA, Long Noncoding; Transcriptional Activation; Up-Regulation | 2019 |
ERK1/2 communicates GPCR and EGFR signaling pathways to promote CTGF-mediated hypertrophic cardiomyopathy upon Ang-II stimulation.
Topics: Angiotensin II; Animals; Butadienes; Cardiomegaly; Cardiomyopathy, Hypertrophic; Cell Enlargement; Cell Line; Connective Tissue Growth Factor; Disease Models, Animal; ErbB Receptors; Heart Ventricles; MAP Kinase Signaling System; Myocytes, Cardiac; Nitriles; Phosphorylation; Rats; Receptors, G-Protein-Coupled; Signal Transduction | 2019 |
Soluble epoxide hydrolase inhibitor, TUPS, attenuates isoproterenol/angiotensin II-induced cardiac hypertrophy through mammalian target of rapamycin-mediated autophagy inhibition.
Topics: Angiotensin II; Animals; Autophagy; Beclin-1; Cardiomegaly; Cell Line; Cell Survival; Epoxide Hydrolases; Isoproterenol; Male; Microtubule-Associated Proteins; Myocytes, Cardiac; Pyrenes; Rats; Rats, Sprague-Dawley | 2019 |
Sodium (±)-5-bromo-2-(α-hydroxypentyl) benzoate ameliorates pressure overload-induced cardiac hypertrophy and dysfunction through inhibiting autophagy.
Topics: AMP-Activated Protein Kinases; Angiotensin II; Animals; Autophagy; Cardiomegaly; Cell Line; Heart Failure; Male; Metformin; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; Rats; Rats, Sprague-Dawley; Signal Transduction; TOR Serine-Threonine Kinases; Ventricular Remodeling | 2019 |
Cordycepin ameliorates cardiac hypertrophy via activating the AMPKα pathway.
Topics: AMP-Activated Protein Kinases; Angiotensin II; Animals; Cardiomegaly; Cardiotonic Agents; Deoxyadenosines; Fibrosis; Hemodynamics; Male; Mice, Inbred C57BL; Models, Biological; Myocytes, Cardiac; Oxidative Stress; Phosphorylation; Pressure; Signal Transduction | 2019 |
Prehypertension exercise training attenuates hypertension and cardiac hypertrophy accompanied by temporal changes in the levels of angiotensin II and angiotensin (1-7).
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Blood Pressure; Cardiomegaly; Diastole; Male; Myocardium; Peptide Fragments; Peptidyl-Dipeptidase A; Physical Conditioning, Animal; Prehypertension; Rats, Inbred SHR; Rats, Inbred WKY; Ventricular Remodeling | 2019 |
MicroRNA-92b-3p suppresses angiotensin II-induced cardiomyocyte hypertrophy via targeting HAND2.
Topics: 3' Untranslated Regions; Angiotensin II; Animals; Basic Helix-Loop-Helix Transcription Factors; Cardiomegaly; Cardiomyopathy, Hypertrophic; Disease Models, Animal; Heart Defects, Congenital; Heart Failure; Heart Ventricles; Mice; Mice, Inbred C57BL; MicroRNAs; Myocardium; Myocytes, Cardiac; RNA, Small Interfering; Signal Transduction; Up-Regulation | 2019 |
Klotho inhibits angiotensin II-induced cardiac hypertrophy, fibrosis, and dysfunction in mice through suppression of transforming growth factor-β1 signaling pathway.
Topics: Angiotensin II; Animals; Cardiomegaly; Down-Regulation; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Fibrosis; Glucuronidase; Klotho Proteins; Male; Mice; Mice, Inbred C57BL; MicroRNAs; Myocytes, Cardiac; Signal Transduction; Transforming Growth Factor beta1; Ventricular Remodeling | 2019 |
MiR-195-5p Promotes Cardiomyocyte Hypertrophy by Targeting MFN2 and FBXW7.
Topics: Angiotensin II; Animals; Cardiomegaly; F-Box-WD Repeat-Containing Protein 7; Gene Expression Regulation; GTP Phosphohydrolases; Male; Mice; MicroRNAs; Myocytes, Cardiac | 2019 |
Fenofibrate ameliorates cardiac hypertrophy by activation of peroxisome proliferator-activated receptor-α partly via preventing p65-NFκB binding to NFATc4.
Topics: Angiotensin II; Animals; Cardiomegaly; Cells, Cultured; Enzyme Activation; Fenofibrate; Hypolipidemic Agents; Male; Myocytes, Cardiac; Nerve Tissue Proteins; NFATC Transcription Factors; PPAR alpha; PPAR gamma; Protein Binding; Rats; Rats, Sprague-Dawley; Signal Transduction; Transcription Factor RelA | 2013 |
Angiotensin II-induced cardiac hypertrophy and fibrosis are promoted in mice lacking Fgf16.
Topics: Angiotensin II; Animals; Cardiomegaly; Cells, Cultured; Fibroblast Growth Factor 2; Fibroblast Growth Factors; Fibrosis; Mice; Mice, Inbred C57BL; Mice, Knockout | 2013 |
Angiotensin II regulates microRNA-132/-212 in hypertensive rats and humans.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Blood Pressure; Cardiomegaly; Disease Models, Animal; Endothelin-1; Female; Fibrosis; Gene Expression Regulation; Humans; Hypertension; Mice; Mice, Inbred C57BL; MicroRNAs; Oligonucleotide Array Sequence Analysis; Organ Specificity; Rats, Sprague-Dawley; Reproducibility of Results; Vasoconstrictor Agents | 2013 |
Deficiency of senescence marker protein 30 exacerbates angiotensin II-induced cardiac remodelling.
Topics: Aging; Angiotensin II; Animals; Apoptosis; Ascorbic Acid; bcl-2-Associated X Protein; Biomarkers; Calcium-Binding Proteins; Cardiomegaly; Caspase 3; Disease Models, Animal; Fibrosis; Heart Failure; Intracellular Signaling Peptides and Proteins; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardium; Oxidative Stress; Proto-Oncogene Proteins c-bcl-2; Signal Transduction; Ventricular Remodeling | 2013 |
Angiotensin II type 2 receptor (AT2R) is associated with increased tolerance of the hyperthyroid heart to ischemia-reperfusion.
Topics: AMP-Activated Protein Kinases; Angiotensin I; Angiotensin II; Angiotensin II Type 2 Receptor Blockers; Animals; Cardiomegaly; Hyperthyroidism; Imidazoles; Male; Myocardial Reperfusion Injury; Myocardium; Pyridines; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Thyroxine; Triiodothyronine; Ventricular Pressure | 2013 |
N-acetyl-seryl-aspartyl-lysyl-proline reduces cardiac collagen cross-linking and inflammation in angiotensin II-induced hypertensive rats.
Topics: Amino Acid Oxidoreductases; Angiotensin II; Animals; Body Weight; Cardiomegaly; CD4-Positive T-Lymphocytes; Collagen; Extracellular Matrix; Hypertension; Inflammation; Lung; Male; NF-kappa B; Oligopeptides; Organ Size; Protein-Lysine 6-Oxidase; Rats; Rats, Inbred Lew; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Ventricular Function, Left; Ventricular Remodeling | 2014 |
Fibulin-2 deficiency attenuates angiotensin II-induced cardiac hypertrophy by reducing transforming growth factor-β signalling.
Topics: Angiotensin II; Animals; Calcium-Binding Proteins; Cardiomegaly; Extracellular Matrix Proteins; Fibrosis; Hypertension; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardial Infarction; Myocardium; Signal Transduction; Transforming Growth Factor beta; Vasoconstrictor Agents | 2014 |
Upregulation of Nox4 promotes angiotensin II-induced epidermal growth factor receptor activation and subsequent cardiac hypertrophy by increasing ADAM17 expression.
Topics: ADAM Proteins; ADAM17 Protein; Angiotensin II; Animals; Cardiomegaly; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; ErbB Receptors; Male; Myocardium; NADPH Oxidase 4; NADPH Oxidases; Rats; Rats, Sprague-Dawley; RNA; Signal Transduction; Transcriptional Activation; Tumor Necrosis Factor-alpha; Up-Regulation | 2013 |
Effect of angiotensin II on rhythmic per2 expression in the suprachiasmatic nucleus and heart and daily rhythm of activity in Wistar rats.
Topics: Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; ARNTL Transcription Factors; Blood Pressure; Cardiomegaly; Circadian Rhythm; CLOCK Proteins; DNA-Binding Proteins; Gene Expression; Motor Activity; Myocardium; Nuclear Receptor Subfamily 1, Group D, Member 1; Peptidyl-Dipeptidase A; Period Circadian Proteins; Rats; Rats, Wistar; RNA, Messenger; Suprachiasmatic Nucleus; Transcription Factors | 2013 |
MicroRNA-22 downregulation by atorvastatin in a mouse model of cardiac hypertrophy: a new mechanism for antihypertrophic intervention.
Topics: Angiotensin II; Animals; Anticholesteremic Agents; Atorvastatin; Atrial Natriuretic Factor; Cardiomegaly; Cells, Cultured; Disease Models, Animal; Down-Regulation; Heptanoic Acids; Male; Mice; MicroRNAs; Myocardium; Myocytes, Cardiac; Myosin Heavy Chains; Natriuretic Peptide, Brain; Oligonucleotides, Antisense; Phosphoric Monoester Hydrolases; PTEN Phosphohydrolase; Pyrroles; Rats | 2013 |
The effect of intermedin on angiotensin II and endothelin-1 induced ventricular myocyte hypertrophy in neonatal rat.
Topics: Actins; Adrenomedullin; Analysis of Variance; Angiotensin II; Animals; Animals, Newborn; Cardiomegaly; Cell Size; Cells, Cultured; Drug Interactions; Endothelin-1; Gene Expression; Heart Ventricles; Membrane Glycoproteins; Myocytes, Cardiac; Myosin Heavy Chains; NADPH Oxidase 2; NADPH Oxidases; Neuropeptides; Protective Agents; Rats; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction | 2013 |
The β-arrestin-biased ligand TRV120023 inhibits angiotensin II-induced cardiac hypertrophy while preserving enhanced myofilament response to calcium.
Topics: Angiotensin II; Animals; Arrestins; beta-Arrestins; Calcium; Cardiomegaly; Cardiotonic Agents; Heart Ventricles; Male; Myocardial Contraction; Myofibrils; Oligopeptides; Organ Size; Rats; Rats, Sprague-Dawley; Treatment Outcome; Up-Regulation | 2013 |
Adult cardiac fibroblast proliferation is modulated by calcium/calmodulin-dependent protein kinase II in normal and hypertrophied hearts.
Topics: Angiotensin II; Animals; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Cardiomegaly; Cell Proliferation; Fibroblasts; Male; Mice; Mice, Inbred C57BL; Myocytes, Cardiac | 2014 |
Senescence marker protein 30 inhibits angiotensin II-induced cardiac hypertrophy and diastolic dysfunction.
Topics: Angiotensin II; Animals; Antioxidants; Ascorbic Acid; Blood Pressure; Calcium-Binding Proteins; Cardiomegaly; Cellular Senescence; Diastole; Echocardiography; Fibrosis; Hypertension; Intracellular Signaling Peptides and Proteins; Male; Mice; Mice, Transgenic; Oxidative Stress; Promoter Regions, Genetic; Superoxides | 2013 |
Diverse regulation of IP3 and ryanodine receptors by pentazocine through σ1-receptor in cardiomyocytes.
Topics: Adenosine Triphosphate; Angiotensin II; Animals; Anisoles; Calcium; Cardiomegaly; Cells, Cultured; Female; Heart; Hypertrophy, Left Ventricular; Inositol 1,4,5-Trisphosphate Receptors; Mitochondria; Myocardial Contraction; Myocytes, Cardiac; Narcotic Antagonists; Narcotics; Ovariectomy; Pentazocine; Propylamines; Rats; Rats, Wistar; Receptors, sigma; Ryanodine Receptor Calcium Release Channel; Sarcoplasmic Reticulum; Sigma-1 Receptor; Vasoconstrictor Agents | 2013 |
NADPH oxidases mediate a cellular "memory" of angiotensin II stress in hypertensive cardiac hypertrophy.
Topics: Angiotensin II; Animals; Apoptosis; Cardiomegaly; Cells, Cultured; Hypertension; Male; Mice, Inbred C57BL; Myocytes, Cardiac; NADPH Oxidases; Oxidative Stress; Rats, Sprague-Dawley; Reactive Oxygen Species; Signal Transduction | 2013 |
Stimulation of angiotensin type 1A receptors on catecholaminergic cells contributes to angiotensin-dependent hypertension.
Topics: Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Catecholamines; Hypertension; Mice; Mice, Knockout; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Subfornical Organ; Sympathetic Nervous System | 2013 |
Upregulation of M₃ muscarinic receptor inhibits cardiac hypertrophy induced by angiotensin II.
Topics: Angiotensin II; Animals; Blood Pressure; Body Weight; Cardiomegaly; Disease Models, Animal; Down-Regulation; Enzyme Activation; Heart Rate; MAP Kinase Signaling System; Mice; Mice, Transgenic; Myocardium; Organ Specificity; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptor, Muscarinic M3; Up-Regulation | 2013 |
Cardiac protective effects of irbesartan via the PPAR-gamma signaling pathway in angiotensin-converting enzyme 2-deficient mice.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Biphenyl Compounds; Cardiomegaly; Cardiotonic Agents; Collagen; Connective Tissue Growth Factor; Extracellular Signal-Regulated MAP Kinases; Fibrosis; Gene Expression Regulation; Irbesartan; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardium; Peptide Fragments; Peptidyl-Dipeptidase A; Phosphorylation; PPAR alpha; PPAR delta; PPAR gamma; Receptor, Angiotensin, Type 1; RNA, Messenger; Signal Transduction; Tetrazoles; Transforming Growth Factor beta | 2013 |
Inhalation of diesel exhaust does not exacerbate cardiac hypertrophy or heart failure in two mouse models of cardiac hypertrophy.
Topics: Air Pollutants; Angiotensin II; Animals; Cardiomegaly; Disease Models, Animal; Disease Progression; Echocardiography; Heart Failure; Heart Rate; Inhalation Exposure; Male; Mice; Mice, Inbred C57BL; Particle Size; Particulate Matter; Time Factors; Vehicle Emissions | 2013 |
Prevention of RhoA activation and cofilin-mediated actin polymerization mediates the antihypertrophic effect of adenosine receptor agonists in angiotensin II- and endothelin-1-treated cardiomyocytes.
Topics: Actin Depolymerizing Factors; Actins; Angiotensin II; Animals; Cardiomegaly; Cell Nucleus; Endothelin-1; Enzyme Activation; Models, Biological; Myocytes, Cardiac; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Polymerization; Protein Transport; Purinergic P1 Receptor Agonists; Rats; Rats, Sprague-Dawley; rhoA GTP-Binding Protein | 2014 |
Intrinsic-mediated caspase activation is essential for cardiomyocyte hypertrophy.
Topics: Angiotensin II; Animals; Animals, Newborn; Apoptosis; Bronchodilator Agents; Cardiomegaly; Caspase 3; Caspase 9; Cells, Cultured; Cysteine Proteinase Inhibitors; Endothelin-1; Enzyme Activation; Fluorescent Antibody Technique; Hypertrophy; In Vitro Techniques; Isoproterenol; Membrane Potential, Mitochondrial; Myocardium; Myocytes, Cardiac; Oligopeptides; Phenylephrine; Rats; Rats, Sprague-Dawley; Signal Transduction; Vasoconstrictor Agents | 2013 |
Comparison of extracts from cooked and raw lentil in antagonizing angiotensin II-induced hypertension and cardiac hypertrophy.
Topics: Angiotensin II; Animals; Cardiomegaly; Hypertension; Lens Plant; Male; Myocytes, Cardiac; Oxidative Stress; Phytotherapy; Plant Extracts; Rats; Rats, Sprague-Dawley; Ventricular Remodeling | 2013 |
Estrogen regulates histone deacetylases to prevent cardiac hypertrophy.
Topics: Angiotensin II; Animals; Cardiomegaly; Cells, Cultured; Estradiol; Estrogen Receptor beta; Estrogens; Female; GATA4 Transcription Factor; Heart; Histone Deacetylase 2; Histone Deacetylases; Isoquinolines; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; Phosphorylation; Protein Kinase C-delta; Rats; Repressor Proteins; RNA, Messenger; Transcriptional Activation | 2013 |
The C-terminus of the long AKAP13 isoform (AKAP-Lbc) is critical for development of compensatory cardiac hypertrophy.
Topics: A Kinase Anchor Proteins; Angiotensin II; Animals; Aorta; Apoptosis; Cardiomegaly; Collagen; Female; Gene Expression Regulation; Guanine Nucleotide Exchange Factors; Heart Failure; Histone Deacetylases; Male; Mice; Mice, Transgenic; Minor Histocompatibility Antigens; Myocardium; Phenylephrine; Protein Kinase C; Protein Structure, Tertiary; Signal Transduction | 2014 |
Solving the cardiac hypertrophy riddle: The angiotensin II-mechanical stress connection.
Topics: Angiotensin II; Animals; Cardiomegaly; Humans; Hyperplasia; Myocytes, Cardiac; Proto-Oncogene Proteins c-fos; Receptor, Angiotensin, Type 1; Signal Transduction; Stress, Mechanical | 2013 |
Autophagy-mediated degradation is necessary for regression of cardiac hypertrophy during ventricular unloading.
Topics: Angiotensin II; Animals; Autophagy; Autophagy-Related Protein 5; Cardiomegaly; Disease Models, Animal; Heart Ventricles; Mice; Mice, Mutant Strains; Microtubule-Associated Proteins | 2013 |
[Stimulation of adenosine A1 receptor attenuates angiotensin II induced myocardial hypertrophy in neonatal rats via the extracellular signal-regulated kinase signal pathways].
Topics: Adenosine A1 Receptor Agonists; Angiotensin II; Animals; Calcium; Cardiomegaly; Cells, Cultured; Female; Male; MAP Kinase Signaling System; Myocytes, Cardiac; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A1 | 2013 |
Reduced sarcolemmal expression and function of the NBCe1 isoform of the Na⁺-HCO₃⁻ cotransporter in hypertrophied cardiomyocytes of spontaneously hypertensive rats: role of the renin-angiotensin system.
Topics: Ammonium Compounds; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Bicarbonates; Cardiomegaly; Disease Models, Animal; Down-Regulation; Endosomes; Hydrogen-Ion Concentration; Hyperkalemia; Hypertension; Losartan; Male; Myocytes, Cardiac; Potassium; Protein Transport; Rats; Rats, Inbred SHR; Rats, Wistar; Renin-Angiotensin System; Sarcolemma; Sodium-Bicarbonate Symporters; Time Factors | 2014 |
Toll-interacting protein (Tollip) negatively regulates pressure overload-induced ventricular hypertrophy in mice.
Topics: Angiotensin II; Animals; Cardiomegaly; Down-Regulation; Humans; Intracellular Signaling Peptides and Proteins; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocytes, Cardiac; Proto-Oncogene Proteins c-akt; Signal Transduction; Ventricular Remodeling | 2014 |
Endogenous endothelin 1 mediates angiotensin II-induced hypertrophy in electrically paced cardiac myocytes through EGFR transactivation, reactive oxygen species and NHE-1.
Topics: Angiotensin II; Animals; Blotting, Western; Cardiomegaly; Cats; Disease Models, Animal; Electric Stimulation; Endothelin-1; ErbB Receptors; Hypertrophy; Myocytes, Cardiac; Reactive Oxygen Species; Real-Time Polymerase Chain Reaction; Signal Transduction; Sodium-Hydrogen Exchangers; Transcriptional Activation | 2014 |
Chronic infusion of enalaprilat into hypothalamic paraventricular nucleus attenuates angiotensin II-induced hypertension and cardiac hypertrophy by restoring neurotransmitters and cytokines.
Topics: Angiotensin II; Animals; Cardiomegaly; Chemokine CCL2; Enalaprilat; gamma-Aminobutyric Acid; Glutamic Acid; Heart; Hypertension; Interleukin-10; Interleukin-1beta; Interleukin-6; Kidney; Losartan; Male; Neurotransmitter Agents; Norepinephrine; Organ Size; Paraventricular Hypothalamic Nucleus; Peptidyl-Dipeptidase A; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Renin-Angiotensin System | 2014 |
Fluvoxamine rescues mitochondrial Ca2+ transport and ATP production through σ(1)-receptor in hypertrophic cardiomyocytes.
Topics: Adenosine Triphosphate; Angiotensin II; Animals; Calcium; Cardiomegaly; Cells, Cultured; Fluvoxamine; Immunohistochemistry; Male; Mice; Mitochondria; Myocytes, Cardiac; Rats; Receptors, sigma; Selective Serotonin Reuptake Inhibitors | 2014 |
Addition of ET(A) receptor blockade increases renoprotection provided by renin-angiotensin system blockade in 5/6 nephrectomized Ren-2 transgenic rats.
Topics: Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Endothelin Receptor Antagonists; Endothelin-1; Kidney; Kidney Diseases; Nephrectomy; Protective Agents; Rats, Sprague-Dawley; Rats, Transgenic; Receptor, Endothelin A; Renin; Renin-Angiotensin System; Systole | 2014 |
Cardiac-specific Traf2 overexpression enhances cardiac hypertrophy through activating AKT/GSK3β signaling.
Topics: Angiotensin II; Animals; Aorta; Cardiomegaly; Echocardiography; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Heart; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Myocytes, Cardiac; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Signal Transduction; TNF Receptor-Associated Factor 2; Up-Regulation; Ventricular Dysfunction, Left | 2014 |
Interferon regulatory factor 7 functions as a novel negative regulator of pathological cardiac hypertrophy.
Topics: Angiotensin II; Animals; Cardiomegaly; Cells, Cultured; Disease Models, Animal; Hypertrophy; I-kappa B Kinase; In Vitro Techniques; Interferon Regulatory Factor-7; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Myocytes, Cardiac; NF-kappa B; Signal Transduction | 2014 |
DPP4 deficiency preserved cardiac function in abdominal aortic banding rats.
Topics: Angiotensin II; Animals; Aorta, Abdominal; Cardiomegaly; Collagen; Dipeptidyl Peptidase 4; Glucagon-Like Peptide 1; Heart Function Tests; Hemodynamics; Male; Pressure; Rats; Rats, Inbred F344; Signal Transduction; Up-Regulation | 2014 |
Antagonist of C5aR prevents cardiac remodeling in angiotensin II-induced hypertension.
Topics: Angiotensin II; Animals; Cardiomegaly; Cardiovascular Agents; Collagen; Connective Tissue Growth Factor; Cytokines; Disease Models, Animal; Fibrosis; Hypertension; Mice, Inbred C57BL; Myocardium; Peptides, Cyclic; Receptor, Anaphylatoxin C5a; RNA, Messenger; Time Factors; Transforming Growth Factor beta1; Ventricular Remodeling | 2014 |
Crosstalk between AMPK activation and angiotensin II-induced hypertrophy in cardiomyocytes: the role of mitochondria.
Topics: AMP-Activated Protein Kinases; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Cardiomegaly; Gene Expression Regulation; Losartan; Metformin; Mitochondria; Myocytes, Cardiac; Nitric Oxide Synthase Type III; Rats; Receptor, Angiotensin, Type 1; Signal Transduction; Sirtuin 1; Tumor Suppressor Protein p53 | 2014 |
Deletion of soluble epoxide hydrolase attenuates cardiac hypertrophy via down-regulation of cardiac fibroblasts-derived fibroblast growth factor-2.
Topics: Angiotensin II; Animals; Cardiomegaly; Disease Models, Animal; Down-Regulation; Enzyme-Linked Immunosorbent Assay; Epoxide Hydrolases; Fibroblast Growth Factor 2; Fibroblasts; Gene Expression Regulation; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Microscopy, Confocal; Myocardium; Myocytes, Cardiac; Prospective Studies; Real-Time Polymerase Chain Reaction; Vasoconstrictor Agents | 2014 |
Phosphoinositide kinases play key roles in norepinephrine- and angiotensin II-induced increase in phosphatidylinositol 4,5-bisphosphate and modulation of cardiac function.
Topics: Angiotensin II; Animals; Cardiomegaly; Disease Models, Animal; Myocytes, Cardiac; Norepinephrine; Phosphatidylinositol 4,5-Diphosphate; Phosphatidylinositol-4-Phosphate 3-Kinase; Rats; Rats, Sprague-Dawley | 2014 |
Salvianolic acid B protects cardiomyocytes from angiotensin II-induced hypertrophy via inhibition of PARP-1.
Topics: Angiotensin II; Animals; Benzofurans; Cardiomegaly; Cells, Cultured; Myocytes, Cardiac; NAD; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Real-Time Polymerase Chain Reaction | 2014 |
Effect of adiponectin on cardiac β-catenin signaling pathway under angiotensin II infusion.
Topics: Adenoviridae; Adiponectin; Angiotensin II; Animals; beta Catenin; Cardiomegaly; Collagen Type I; Collagen Type III; Female; Gene Expression; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Immunoblotting; Infusion Pumps, Implantable; Mice; Mice, Knockout; Myocardium; Phosphorylation; Proto-Oncogene Proteins c-akt; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; TOR Serine-Threonine Kinases | 2014 |
Angiotensin II and the JNK pathway mediate urotensin II expression in response to hypoxia in rat cardiomyocytes.
Topics: Angiotensin II; Animals; Cardiomegaly; Cells, Cultured; Collagen; Humans; Hypoxia; MAP Kinase Signaling System; Myocytes, Cardiac; Rats; Rats, Wistar; Reactive Oxygen Species; Urotensins | 2014 |
Effects of a domain-selective ACE inhibitor in a mouse model of chronic angiotensin II-dependent hypertension.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Bradykinin; Cardiomegaly; Chronic Disease; Disease Models, Animal; Drug Evaluation, Preclinical; Hypertension; Hypertrophy; Kidney; Lisinopril; Mice; Mice, Transgenic | 2014 |
The long noncoding RNA CHRF regulates cardiac hypertrophy by targeting miR-489.
Topics: Angiotensin II; Animals; Apoptosis; Cardiomegaly; Cells, Cultured; Disease Models, Animal; Endothelial Cells; Fibroblasts; Gene Expression Regulation; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; MicroRNAs; Myeloid Differentiation Factor 88; Oligonucleotides; RNA Interference; RNA, Long Noncoding; Time Factors; Transfection | 2014 |
Mechanical stress triggers cardiomyocyte autophagy through angiotensin II type 1 receptor-mediated p38MAP kinase independently of angiotensin II.
Topics: Adaptor Proteins, Signal Transducing; Angiotensin II; Animals; Autophagy; Biomechanical Phenomena; Cardiomegaly; Cells, Cultured; Chlorocebus aethiops; COS Cells; Male; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; p38 Mitogen-Activated Protein Kinases; Rats; Stress, Physiological | 2014 |
Phenotypic screen quantifying differential regulation of cardiac myocyte hypertrophy identifies CITED4 regulation of myocyte elongation.
Topics: Angiotensin II; Animals; Animals, Newborn; bcl-2-Associated X Protein; Cardiomegaly; CCAAT-Enhancer-Binding Protein-beta; Cell Shape; Connective Tissue Growth Factor; Gene Expression Profiling; Gene Expression Regulation; Myocytes, Cardiac; Neuregulin-1; Rats; Rats, Sprague-Dawley; RNA, Messenger; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Signal Transduction; Tumor Necrosis Factor-alpha | 2014 |
Central blockade of TLR4 improves cardiac function and attenuates myocardial inflammation in angiotensin II-induced hypertension.
Topics: Angiotensin II; Animals; Blood Pressure; Brain; Cardiomegaly; Hypertension; Interleukin-1beta; Male; Myocarditis; NF-kappa B; Nitric Oxide Synthase; Paraventricular Hypothalamic Nucleus; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System; RNA, Messenger; Signal Transduction; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha | 2014 |
The ameliorating effects of long-term electroacupuncture on cardiovascular remodeling in spontaneously hypertensive rats.
Topics: Acupuncture Points; Angiotensin II; Animals; Aorta; Blood Pressure; Cardiomegaly; Collagen; Electroacupuncture; Endothelin-1; Enzyme-Linked Immunosorbent Assay; Hypertension; Male; Myocardium; Nitric Oxide; Nitric Oxide Synthase; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Rats, Wistar; Receptor, Angiotensin, Type 1; Vascular Remodeling | 2014 |
Differential role of TIMP2 and TIMP3 in cardiac hypertrophy, fibrosis, and diastolic dysfunction.
Topics: Angiotensin II; Animals; Cardiomegaly; Cardiomyopathies; Fibrosis; Heart Failure, Diastolic; Hypertrophy, Left Ventricular; Mice, Inbred C57BL; Mice, Knockout; Myocardium; Tissue Inhibitor of Metalloproteinase-2; Tissue Inhibitor of Metalloproteinase-3; Ventricular Remodeling | 2014 |
Relaxin does not improve Angiotensin II-induced target-organ damage.
Topics: Albuminuria; Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Humans; Hypertension; Male; Rats; Rats, Sprague-Dawley; Rats, Transgenic; Recombinant Proteins; Relaxin; Renin | 2014 |
Opposite effects of gene deficiency and pharmacological inhibition of soluble epoxide hydrolase on cardiac fibrosis.
Topics: Angiotensin II; Animals; Animals, Newborn; Arachidonic Acids; Biomarkers; Cardiomegaly; Chemokine CCL2; Disease Models, Animal; Epoxide Hydrolases; Fibrosis; Hypertension; Interleukin-6; Male; Metabolome; Mice; Mice, Inbred C57BL; Myocardium; Myofibroblasts; Ventricular Remodeling | 2014 |
Cardiac hypertrophy is negatively regulated by miR-541.
Topics: Angiotensin II; Animals; Cardiomegaly; Disease Models, Animal; Gene Expression Regulation; Male; Mice, Inbred C57BL; Mice, Transgenic; Microphthalmia-Associated Transcription Factor; MicroRNAs; Transcription, Genetic | 2014 |
miR-34a modulates angiotensin II-induced myocardial hypertrophy by direct inhibition of ATG9A expression and autophagic activity.
Topics: Angiotensin II; Animals; Autophagy; Base Sequence; Cardiomegaly; Disease Models, Animal; Gene Expression Regulation; Humans; Male; Membrane Proteins; MicroRNAs; Molecular Sequence Data; Myocardium; Myocytes, Cardiac; Rats, Sprague-Dawley; RNA, Small Interfering; Systole; Vacuoles | 2014 |
Protective effect of Boerhaavia diffusa L. against mitochondrial dysfunction in angiotensin II induced hypertrophy in H9c2 cardiomyoblast cells.
Topics: Angiotensin II; Animals; Calcium; Cardiomegaly; Cell Line; Cell Size; Heart; Membrane Potential, Mitochondrial; Mitochondria, Heart; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Mitochondrial Swelling; Myocardium; Nyctaginaceae; Oxidative Stress; Plant Extracts; Rats; Reactive Oxygen Species; Superoxides | 2014 |
Protection from hypertension in mice by the Mediterranean diet is mediated by nitro fatty acid inhibition of soluble epoxide hydrolase.
Topics: Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Cellulase; Diet, Mediterranean; Disease Models, Animal; Epoxide Hydrolases; Fatty Acids; Gene Knock-In Techniques; Hypertension; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Nitrates; Nitrites; Sulfhydryl Compounds; Vasoconstrictor Agents; Vasodilation | 2014 |
HDAC6 contributes to pathological responses of heart and skeletal muscle to chronic angiotensin-II signaling.
Topics: Angiotensin II; Animals; Cardiomegaly; Disease Models, Animal; Fibrosis; Heart Failure; Histone Deacetylase 6; Histone Deacetylase Inhibitors; Histone Deacetylases; Hydroxamic Acids; Indoles; Male; Mice; Mice, Knockout; Muscle, Skeletal; Muscular Atrophy; Myocardium; Signal Transduction; Stroke Volume; Systole; Time Factors; Ventricular Function, Left; Ventricular Remodeling | 2014 |
AG-690/11026014, a novel PARP-1 inhibitor, protects cardiomyocytes from AngII-induced hypertrophy.
Topics: Angiotensin II; Animals; Cardiomegaly; Cardiotonic Agents; Cytoprotection; Drug Evaluation, Preclinical; Enzyme Activation; Enzyme Inhibitors; Humans; Inhibitory Concentration 50; Membrane Glycoproteins; Molecular Docking Simulation; Myocytes, Cardiac; NAD; NADPH Oxidase 2; NADPH Oxidase 4; NADPH Oxidases; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Rats, Sprague-Dawley; Reactive Oxygen Species; Recombinant Proteins; Sirtuins; Thioglycolates; Up-Regulation; Xanthines | 2014 |
Fibrosis or hypertrophy: let TIMPs decide.
Topics: Angiotensin II; Animals; Cardiomegaly; Heart Failure, Diastolic; Hypertrophy, Left Ventricular; Tissue Inhibitor of Metalloproteinase-2; Tissue Inhibitor of Metalloproteinase-3 | 2014 |
Exogenous administration of thiosulfate, a donor of hydrogen sulfide, attenuates angiotensin II-induced hypertensive heart disease in rats.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Cardiomegaly; Disease Models, Animal; Hydrogen Sulfide; Hypertension; Male; Oxidative Stress; Rats; Rats, Sprague-Dawley; Sulfides; Thiosulfates | 2015 |
Mechanisms involving Ang II and MAPK/ERK1/2 signaling pathways underlie cardiac and renal alterations during chronic undernutrition.
Topics: Adenosine Triphosphatases; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Blood Pressure; Cardiomegaly; Cation Transport Proteins; Cyclic AMP-Dependent Protein Kinases; Heart; Heart Rate; Kidney Tubules, Proximal; Losartan; Male; Malnutrition; MAP Kinase Signaling System; Myocytes, Cardiac; Plasma Volume; Protein Kinase C; Rats; Rats, Wistar; Receptor, Angiotensin, Type 2; Sodium-Potassium-Exchanging ATPase | 2014 |
Inhibition of angiotensin II-induced cardiac hypertrophy and associated ventricular arrhythmias by a p21 activated kinase 1 bioactive peptide.
Topics: Angiotensin II; Animals; Arrhythmias, Cardiac; Cardiomegaly; Cells, Cultured; Male; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; p21-Activated Kinases; Peptides; Rats | 2014 |
Overexpression of PEP-19 suppresses angiotensin II-induced cardiomyocyte hypertrophy.
Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Calcineurin; Calcium; Calcium Signaling; Calcium-Binding Proteins; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Calmodulin; Calmodulin-Binding Proteins; Cardiomegaly; Cells, Cultured; Gene Expression; Hypertrophy; Male; Myocytes, Cardiac; Natriuretic Peptide, Brain; Nerve Tissue Proteins; Rats, Sprague-Dawley; Sarcoplasmic Reticulum | 2014 |
Identification of regulatory elements directing miR-23a-miR-27a-miR-24-2 transcriptional regulation in response to muscle hypertrophic stimuli.
Topics: 3T3 Cells; Angiotensin II; Animals; Cardiomegaly; Gene Expression Regulation; Genes, Regulator; Hypertrophy; Mice; MicroRNAs; Muscle, Skeletal; Myocytes, Cardiac; Norepinephrine; Promoter Regions, Genetic; Transcription, Genetic | 2014 |
Murine pressure overload models: a 30-MHz look brings a whole new "sound" into data interpretation.
Topics: Angiotensin II; Animals; Aorta, Thoracic; Cardiomegaly; Constriction, Pathologic; Data Interpretation, Statistical; Disease Models, Animal; Echocardiography; Echocardiography, Doppler; Mice; Mice, Inbred C57BL; Pressure; Vasoconstrictor Agents | 2014 |
Cytosolic CARP promotes angiotensin II- or pressure overload-induced cardiomyocyte hypertrophy through calcineurin accumulation.
Topics: Adenoviridae; Angiotensin II; Animals; Animals, Newborn; Aorta; Atrial Natriuretic Factor; Calcineurin; Calpain; Cardiomegaly; Constriction, Pathologic; Cyclosporine; Gene Expression Regulation; Genetic Vectors; Glycoproteins; Imidazoles; Mice; Muscle Proteins; Myocytes, Cardiac; Myosin Heavy Chains; Nuclear Proteins; Primary Cell Culture; Protein Transport; Rats; Repressor Proteins; RNA, Small Interfering; Signal Transduction; Tetrazoles | 2014 |
AdipoR1/APPL1 potentiates the protective effects of globular adiponectin on angiotensin II-induced cardiac hypertrophy and fibrosis in neonatal rat atrial myocytes and fibroblasts.
Topics: Adaptor Proteins, Signal Transducing; Adiponectin; AMP-Activated Protein Kinases; Angiotensin II; Animals; Cardiomegaly; Endomyocardial Fibrosis; Fibroblasts; Heart Atria; Myocytes, Cardiac; Nerve Tissue Proteins; NF-kappa B; Phosphatidylinositol 3-Kinases; Rats; Rats, Sprague-Dawley; Receptors, Adiponectin; Signal Transduction; Vasoconstrictor Agents | 2014 |
Kruppel-like factor 4 protein regulates isoproterenol-induced cardiac hypertrophy by modulating myocardin expression and activity.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Atrial Natriuretic Factor; Cardiomegaly; Cell Line; Gene Expression; Gene Expression Regulation; Histone Deacetylase Inhibitors; Hydroxamic Acids; Imidazoles; Isoproterenol; Kruppel-Like Factor 4; Kruppel-Like Transcription Factors; Mice, Inbred C57BL; Mice, Knockout; MicroRNAs; Myocytes, Cardiac; Natriuretic Peptide, C-Type; Nuclear Proteins; Protein Precursors; Tetrazoles; Trans-Activators | 2014 |
High-salt intake induces cardiomyocyte hypertrophy in rats in response to local angiotensin II type 1 receptor activation.
Topics: Acetylcysteine; Aldosterone; Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Body Weight; Cardiomegaly; Heart Rate; Hematocrit; Hydralazine; Losartan; Male; Myocytes, Cardiac; Potassium; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin-Angiotensin System; Sodium; Sodium Chloride, Dietary; Thiobarbituric Acid Reactive Substances | 2014 |
Roles of cGMP-dependent protein kinase I (cGKI) and PDE5 in the regulation of Ang II-induced cardiac hypertrophy and fibrosis.
Topics: Angiotensin II; Animals; Cardiomegaly; Cyclic GMP; Cyclic GMP-Dependent Protein Kinase Type I; Cyclic Nucleotide Phosphodiesterases, Type 5; Fibrosis; Genetic Markers; Hypertension; Mice; Muscle, Smooth; Myocardial Contraction; Myocytes, Cardiac; Nitric Oxide; Phosphodiesterase 5 Inhibitors; Piperazines; Purines; Sildenafil Citrate; Sulfones; Vasoconstrictor Agents | 2014 |
Tumor suppressor gene ING3 induces cardiomyocyte hypertrophy via inhibition of AMPK and activation of p38 MAPK signaling.
Topics: AMP-Activated Protein Kinases; Angiotensin II; Animals; Animals, Newborn; Aorta, Abdominal; Cardiomegaly; Cell Membrane; Imidazoles; Isoproterenol; Male; MAP Kinase Signaling System; Myocardium; Myocytes, Cardiac; p38 Mitogen-Activated Protein Kinases; Phenylephrine; Plasmids; Pyridines; Rats; Rats, Sprague-Dawley; RNA Interference; Tumor Suppressor Proteins | 2014 |
Critical role for lysine 685 in gene expression mediated by transcription factor unphosphorylated STAT3.
Topics: Acetylation; Angiotensin II; Cardiomegaly; Cell Line; Humans; Interleukin-6; Lysine; Mutation, Missense; Phosphorylation; Protein Processing, Post-Translational; STAT3 Transcription Factor; Transcriptional Activation | 2014 |
Actin dynamics is rapidly regulated by the PTEN and PIP2 signaling pathways leading to myocyte hypertrophy.
Topics: Actins; Angiotensin II; Animals; Cardiomegaly; Cell Size; Enzyme Activation; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; Phosphatidylinositol 4,5-Diphosphate; Phosphatidylinositol Phosphates; PTEN Phosphohydrolase; Rats; Rats, Sprague-Dawley; Signal Transduction; Subcellular Fractions | 2014 |
[Calreticulin-induced mitochondrial injury: a novel mechanism of cardiac hypertrophy].
Topics: Angiotensin II; Animals; Calreticulin; Cardiomegaly; Cells, Cultured; Membrane Potential, Mitochondrial; Mitochondria; Myocytes, Cardiac; Protein Biosynthesis; Rats; RNA, Small Interfering | 2014 |
Alpha-lipoic acid attenuates cardiac hypertrophy via downregulation of PARP-2 and subsequent activation of SIRT-1.
Topics: Angiotensin II; Animals; Cardiomegaly; Cells, Cultured; Down-Regulation; Heart; Male; Myocytes, Cardiac; Poly(ADP-ribose) Polymerases; Rats; Rats, Sprague-Dawley; Sirtuin 1; Thioctic Acid; Up-Regulation | 2014 |
Deletion of interleukin-6 prevents cardiac inflammation, fibrosis and dysfunction without affecting blood pressure in angiotensin II-high salt-induced hypertension.
Topics: Albumins; Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Echocardiography; Fibrosis; Heart; Heart Rate; Hypertension; Inflammation; Interleukin-6; Macrophages; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardium; Myocytes, Cardiac; Phenotype; Sodium Chloride, Dietary | 2015 |
Pressure overload-induced cardiac hypertrophy response requires janus kinase 2-histone deacetylase 2 signaling.
Topics: Active Transport, Cell Nucleus; Angiotensin II; Animals; Atrial Natriuretic Factor; Cardiomegaly; Cell Nucleus; Cells, Cultured; Histone Deacetylase 2; Hydroxamic Acids; Janus Kinase 2; Male; Mice, Inbred C57BL; Myocytes, Cardiac; Natriuretic Peptide, Brain; Peptide Fragments; Pressure; Rats; Signal Transduction; Tyrphostins | 2014 |
Endothelial MRTF-A mediates angiotensin II induced cardiac hypertrophy.
Topics: Angiotensin II; Animals; Cardiomegaly; Cell Line; Disease Models, Animal; Endothelial Cells; Endothelin-1; Endothelium, Vascular; Epigenesis, Genetic; Fibrosis; Gene Expression Regulation; Humans; Mice; Models, Biological; Promoter Regions, Genetic; Protein Binding; Proto-Oncogene Proteins c-fos; Proto-Oncogene Proteins c-jun; Trans-Activators; Transcriptional Activation | 2015 |
Polydatin prevents angiotensin II-induced cardiac hypertrophy and myocardial superoxide generation.
Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Body Weight; Cardiomegaly; Cells, Cultured; Glucosides; Male; Myocardium; Myocytes, Cardiac; NADPH Oxidases; Organ Size; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Resveratrol; RNA, Messenger; Signal Transduction; Stilbenes; Superoxides; Ventricular Myosins | 2015 |
Activation of the cardiac proteasome promotes angiotension II-induced hypertrophy by down-regulation of ATRAP.
Topics: Adaptor Proteins, Signal Transducing; Angiotensin II; Animals; Cardiomegaly; Down-Regulation; Enzyme Activation; Fibrosis; Inflammation; Male; Mice, Inbred C57BL; Models, Biological; Myocardium; p38 Mitogen-Activated Protein Kinases; Polyubiquitin; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Protein Subunits; Proteolysis; Receptor, Angiotensin, Type 1; Signal Transduction; STAT3 Transcription Factor; Ubiquitinated Proteins | 2015 |
SIRT1 functions as an important regulator of estrogen-mediated cardiomyocyte protection in angiotensin II-induced heart hypertrophy.
Topics: Angiotensin II; Animals; Cardiomegaly; Cells, Cultured; Disease Models, Animal; Estradiol; Female; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; Random Allocation; Rats; Rats, Sprague-Dawley; Signal Transduction; Sirtuin 1 | 2014 |
A crosstalk between chromatin remodeling and histone H3K4 methyltransferase complexes in endothelial cells regulates angiotensin II-induced cardiac hypertrophy.
Topics: Angiotensin II; Animals; Cardiomegaly; Cell Line, Transformed; Chromatin Assembly and Disassembly; Disease Models, Animal; DNA Helicases; Endothelial Cells; Endothelin-1; Histone Methyltransferases; Histone-Lysine N-Methyltransferase; Humans; Male; Mice; Nuclear Proteins; Promoter Regions, Genetic; Protein Binding; Signal Transduction; Trans-Activators; Transcription Factors | 2015 |
The role of mAKAPβ in the process of cardiomyocyte hypertrophy induced by angiotensin II.
Topics: A Kinase Anchor Proteins; Angiotensin II; Animals; Biomarkers; Cardiomegaly; Disease Models, Animal; Gene Expression; Hypertrophy; Male; Mitogen-Activated Protein Kinase 1; Myocytes, Cardiac; Rats; RNA Interference; RNA, Small Interfering | 2015 |
Angiotensin Ⅱ Activates MCP-1 and Induces Cardiac Hypertrophy and Dysfunction via Toll-like Receptor 4.
Topics: Adrenergic alpha-Agonists; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Biphenyl Compounds; Cardiomegaly; Chemokine CCL2; Hypertension; Irbesartan; Male; Mice; Mice, Inbred BALB C; Norepinephrine; Oxidative Stress; Tetrazoles; Toll-Like Receptor 4; Vasoconstrictor Agents | 2015 |
Chronic blockade of class I PI3-kinase attenuates Ang II-induced cardiac hypertrophy and autophagic alteration.
Topics: Angiotensin II; Animals; Autophagy; Cardiomegaly; Fibrosis; Male; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Signal Transduction | 2015 |
ANG II modulation of cardiac growth and remodeling in immature fetal sheep.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Biomarkers; Blood Pressure; Cardiomegaly; Cell Differentiation; Cell Enlargement; Cell Proliferation; Cell Size; Cyclin B1; Cyclin E; Cyclin-Dependent Kinase Inhibitor p21; Fetal Heart; Gestational Age; Hyperplasia; Hypertension; Mitogen-Activated Protein Kinases; Myocytes, Cardiac; Nitroprusside; Proliferating Cell Nuclear Antigen; Sheep; Signal Transduction; Time Factors; Vasodilator Agents | 2015 |
Histone Methyltransferase SET1 Mediates Angiotensin II-Induced Endothelin-1 Transcription and Cardiac Hypertrophy in Mice.
Topics: Angiotensin II; Animals; Cardiomegaly; Cells, Cultured; Disease Models, Animal; Endothelial Cells; Endothelin-1; Epigenomics; Histone Methyltransferases; Histone-Lysine N-Methyltransferase; Mice; Myocytes, Cardiac | 2015 |
3,3'-Diindolylmethane attenuates cardiac H9c2 cell hypertrophy through 5'-adenosine monophosphate-activated protein kinase-α.
Topics: AMP-Activated Protein Kinases; Angiotensin II; Animals; Atrial Natriuretic Factor; Cardiomegaly; Cardiotonic Agents; Cell Line; Gene Expression Regulation; Indoles; Models, Biological; Myocytes, Cardiac; Myosin Heavy Chains; Natriuretic Peptide, Brain; Phosphorylation; Rats; Signal Transduction; TOR Serine-Threonine Kinases; Vasoconstrictor Agents | 2015 |
Nuclear Translocation of Calpain-2 Mediates Apoptosis of Hypertrophied Cardiomyocytes in Transverse Aortic Constriction Rat.
Topics: Angiotensin II; Animals; Apoptosis; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Calpain; Cardiomegaly; Constriction, Pathologic; Gene Expression Regulation; Humans; Myocytes, Cardiac; Rats; Signal Transduction | 2015 |
Attenuation of renovascular hypertension by cyclooxygenase-2 inhibitor partly through ANP release.
Topics: Aldosterone; Angiotensin II; Animals; Atrial Natriuretic Factor; Blood Pressure; Cardiomegaly; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Gene Expression Regulation, Neoplastic; Humans; Hypertension, Renovascular; Natriuretic Peptide, Brain; Nitrobenzenes; Rats; Sulfonamides | 2015 |
6β-hydroxytestosterone, a cytochrome P450 1B1 metabolite of testosterone, contributes to angiotensin II-induced hypertension and its pathogenesis in male mice.
Topics: Angiotensin II; Animals; Cardiomegaly; Castration; Cytochrome P-450 CYP1B1; Disease Models, Animal; Gene Expression Regulation; Hydroxytestosterones; Hypertension; Male; Mice; Random Allocation; Reactive Oxygen Species; Reference Values | 2015 |
Novel role for retinol-binding protein 4 in the regulation of blood pressure.
Topics: Angiotensin II; Animals; Aorta; Blood Pressure; Cardiomegaly; Hypertension; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Nitric Oxide Synthase Type III; Obesity; Phosphorylation; Retinol-Binding Proteins, Plasma; Vasodilation | 2015 |
Targeting γ-secretases protect against angiotensin II-induced cardiac hypertrophy.
Topics: Amyloid Precursor Protein Secretases; Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Cells, Cultured; Dibenzazepines; Disease Models, Animal; Drug Evaluation, Preclinical; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Mice; Middle Aged; Muscle, Smooth, Vascular; Signal Transduction | 2015 |
Tumor necrosis factor receptor-associated factor 3 is a positive regulator of pathological cardiac hypertrophy.
Topics: Angiotensin II; Animals; Cardiomegaly; Disease Models, Animal; Female; Humans; Hypertrophy; Male; Mice; Mice, Knockout; Mice, Transgenic; Myocytes, Cardiac; Phenylephrine; Phosphorylation; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins c-akt; Signal Transduction; TNF Receptor-Associated Factor 3; Up-Regulation | 2015 |
The Ca(2+)-activated cation channel TRPM4 is a negative regulator of angiotensin II-induced cardiac hypertrophy.
Topics: Angiotensin II; Animals; Animals, Newborn; Calcium; Cardiomegaly; Male; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; Phosphoric Monoester Hydrolases; TRPM Cation Channels | 2015 |
A background Ca2+ entry pathway mediated by TRPC1/TRPC4 is critical for development of pathological cardiac remodelling.
Topics: Angiotensin II; Angiotensinogen; Animals; Calcium; Calcium Channels; Calcium Signaling; Cardiomegaly; Hemodynamics; Homeostasis; Mice, Knockout; Myocytes, Cardiac; TRPC Cation Channels; Ventricular Remodeling | 2015 |
The RNA-binding protein PCBP2 inhibits Ang II-induced hypertrophy of cardiomyocytes though promoting GPR56 mRNA degeneration.
Topics: Angiotensin II; Animals; Cardiomegaly; Cell Enlargement; Cell Line; Cells, Cultured; Down-Regulation; Gene Knockdown Techniques; Humans; Male; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; Rats; Receptors, G-Protein-Coupled; RNA Stability; RNA-Binding Proteins; RNA, Messenger | 2015 |
Angiotensin II increases secreted frizzled-related protein 5 (sFRP5) expression through AT1 receptor/Rho/ROCK1/JNK signaling in cardiomyocytes.
Topics: Adipokines; Amides; Angiotensin II; Animals; Animals, Newborn; Cardiomegaly; Cells, Cultured; Disease Models, Animal; Dose-Response Relationship, Drug; Eye Proteins; Myocytes, Cardiac; Pyridines; Rats; Tumor Necrosis Factor-alpha | 2015 |
Sildenafil Does Not Prevent Heart Hypertrophy and Fibrosis Induced by Cardiomyocyte Angiotensin II Type 1 Receptor Signaling.
Topics: Adaptor Proteins, Signal Transducing; Angiotensin II; Animals; Cardiomegaly; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Fibrosis; Mice; Mice, Inbred C57BL; Mice, Transgenic; Myocytes, Cardiac; Piperazines; Purines; Receptor, Angiotensin, Type 1; Signal Transduction; Sildenafil Citrate; Sulfonamides; Up-Regulation | 2015 |
Maternal High-Fat Diet Causes a Sex-Dependent Increase in AGTR2 Expression and Cardiac Dysfunction in Adult Male Rat Offspring.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Cardiomegaly; Diet, High-Fat; Female; Fetal Development; Genetic Predisposition to Disease; Heart Diseases; Imidazoles; Male; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Pregnancy; Prenatal Exposure Delayed Effects; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 2; Sex Characteristics | 2015 |
Puerarin Suppresses Angiotensin II-Induced Cardiac Hypertrophy by Inhibiting NADPH Oxidase Activation and Oxidative Stress-Triggered AP-1 Signaling Pathways.
Topics: Angiotensin II; Animals; Cardiomegaly; Dose-Response Relationship, Drug; Enzyme Activation; Isoflavones; Mice; Mice, Inbred C57BL; NADPH Oxidases; Oxidative Stress; Reactive Oxygen Species; Signal Transduction; Structure-Activity Relationship; Transcription Factor AP-1 | 2015 |
Caveolin-3 Overexpression Attenuates Cardiac Hypertrophy via Inhibition of T-type Ca2+ Current Modulated by Protein Kinase Cα in Cardiomyocytes.
Topics: Angiotensin II; Animals; Animals, Newborn; Blotting, Western; Calcium Channels, T-Type; Cardiomegaly; Caveolae; Caveolin 3; Cells, Cultured; Gene Expression; Male; Membrane Potentials; Mice, Inbred C57BL; Microscopy, Electron, Transmission; Myocytes, Cardiac; Patch-Clamp Techniques; Protein Kinase C-alpha; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference | 2015 |
Dual Activation of TRIF and MyD88 Adaptor Proteins by Angiotensin II Evokes Opposing Effects on Pressure, Cardiac Hypertrophy, and Inflammatory Gene Expression.
Topics: Adaptor Proteins, Vesicular Transport; Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Gene Expression; Inflammation; Mice; Mice, Knockout; Myeloid Differentiation Factor 88 | 2015 |
Oleanolic acid alleviated pressure overload-induced cardiac remodeling.
Topics: Angiotensin II; Animals; Anti-Inflammatory Agents; Antioxidants; Blood Glucose; Cardiomegaly; Diabetic Cardiomyopathies; Echocardiography; Fibrosis; Glucose; Hypertension; Male; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; Oleanolic Acid; Proto-Oncogene Proteins c-akt; RNA, Messenger; Signal Transduction; TOR Serine-Threonine Kinases; Ventricular Remodeling | 2015 |
TIEG1 Inhibits Angiotensin II-induced Cardiomyocyte Hypertrophy by Inhibiting Transcription Factor GATA4.
Topics: Angiotensin II; Animals; Animals, Newborn; Cardiomegaly; Cells, Cultured; DNA-Binding Proteins; GATA4 Transcription Factor; Myocytes, Cardiac; Rats; Rats, Sprague-Dawley; Transcription Factors | 2015 |
LC3B, a Protein That Serves as an Autophagic Marker, Modulates Angiotensin II-induced Myocardial Hypertrophy.
Topics: Angiotensin II; Animals; Animals, Newborn; Autophagy; Biomarkers; Cardiomegaly; Cells, Cultured; Microtubule-Associated Proteins; Myocytes, Cardiac; Rats; Rats, Sprague-Dawley | 2015 |
Pentoxifylline Ameliorates Cardiac Fibrosis, Pathological Hypertrophy, and Cardiac Dysfunction in Angiotensin II-induced Hypertensive Rats.
Topics: Angiotensin II; Animals; Cardiomegaly; Fibrosis; Hypertension; Inflammation Mediators; Male; Pentoxifylline; Phosphodiesterase Inhibitors; Rats; Rats, Sprague-Dawley | 2016 |
Tumor Necrosis Factor - Alpha Is Essential for Angiotensin II-Induced Ventricular Remodeling: Role for Oxidative Stress.
Topics: Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Collagen Type I; Collagen Type III; Connective Tissue Growth Factor; Fibrosis; Heart; Hypertension; Male; MAP Kinase Signaling System; Mice; Myocardium; NADPH Oxidases; NF-kappa B; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Receptor, Angiotensin, Type 1; RNA, Messenger; Signal Transduction; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha; Ventricular Remodeling | 2015 |
MITF interacts with the SWI/SNF subunit, BRG1, to promote GATA4 expression in cardiac hypertrophy.
Topics: Angiotensin II; Animals; Aorta; Base Sequence; Binding Sites; Cardiomegaly; Cell Line; Constriction, Pathologic; DNA Helicases; GATA4 Transcription Factor; Gene Expression Regulation; Isoproterenol; Male; Mice; Mice, Inbred C57BL; Microphthalmia-Associated Transcription Factor; Molecular Sequence Data; Myocytes, Cardiac; Nuclear Proteins; Primary Cell Culture; Protein Binding; Rats; Signal Transduction; Transcription Factors; Transcription, Genetic | 2015 |
Prolonged Subcutaneous Administration of Oxytocin Accelerates Angiotensin II-Induced Hypertension and Renal Damage in Male Rats.
Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Calcineurin; Cardiomegaly; Hypertension; Injections, Subcutaneous; Kidney; Male; Oxytocin; Rats; Rats, Sprague-Dawley; Renin | 2015 |
Adenosine A1 receptor activation attenuates cardiac hypertrophy and fibrosis in response to α1 -adrenoceptor stimulation in vivo.
Topics: Adenosine; Adenosine A1 Receptor Agonists; Adrenergic alpha-1 Receptor Agonists; Angiotensin II; Animals; Animals, Newborn; Cardiomegaly; Cell Culture Techniques; Dose-Response Relationship, Drug; Fibrosis; Insulin-Like Growth Factor I; Male; Matrix Metalloproteinase 2; Mice; Myocytes, Cardiac; Oxidative Stress; Phenylephrine; Rats; Receptor, Adenosine A1; Up-Regulation | 2016 |
Endothelial Bmx tyrosine kinase activity is essential for myocardial hypertrophy and remodeling.
Topics: Angiotensin II; Animals; Cardiomegaly; Cytokines; Endothelium, Vascular; Inflammation Mediators; Mice; Mice, Knockout; Mitochondria, Heart; Myocytes, Cardiac; Protein-Tyrosine Kinases; Signal Transduction | 2015 |
Consequences of postnatal vascular smooth muscle EGFR deletion on acute angiotensin II action.
Topics: Age Factors; Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Chemokine CCL2; Disease Models, Animal; Dose-Response Relationship, Drug; ErbB Receptors; Gene Deletion; Humans; Hypertension; Mice, Inbred C57BL; Mice, Knockout; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Phosphorylation; Plasminogen Activator Inhibitor 1; Signal Transduction; Time Factors; Vascular Remodeling; Vasoconstrictor Agents | 2016 |
19-Hydroxyeicosatetraenoic acid and isoniazid protect against angiotensin II-induced cardiac hypertrophy.
Topics: Angiotensin II; Animals; Arachidonic Acid; Cardiomegaly; Cells, Cultured; Cytochrome P-450 Enzyme System; Humans; Hydroxyeicosatetraenoic Acids; Isoniazid; Male; Myocytes, Cardiac; Protective Agents; Rats; Rats, Sprague-Dawley | 2015 |
A critical role of cardiac fibroblast-derived exosomes in activating renin angiotensin system in cardiomyocytes.
Topics: Amiloride; Angiotensin II; Aniline Compounds; Animals; Animals, Newborn; Benzylidene Compounds; Cardiomegaly; Exosomes; Fibroblasts; HEK293 Cells; Humans; Mice; Mitogen-Activated Protein Kinases; Models, Biological; Myocardium; Myocytes, Cardiac; Protein Array Analysis; Protein Kinase Inhibitors; Proteomics; Proto-Oncogene Proteins c-akt; Rats; Renin-Angiotensin System; Signal Transduction; Up-Regulation | 2015 |
Mas receptor mediates cardioprotection of angiotensin-(1-7) against Angiotensin II-induced cardiomyocyte autophagy and cardiac remodelling through inhibition of oxidative stress.
Topics: Angiotensin II; Animals; Autophagy; Cardiomegaly; Cardiotonic Agents; Cells, Cultured; Drug Evaluation, Preclinical; Male; Mice, Inbred C57BL; Myocytes, Cardiac; Oxidative Stress; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats, Sprague-Dawley; Receptors, G-Protein-Coupled | 2016 |
Interleukin-10 inhibits chronic angiotensin II-induced pathological autophagy.
Topics: Angiotensin II; Animals; Animals, Newborn; Apoptosis Regulatory Proteins; Autophagy; Beclin-1; Cardiomegaly; Down-Regulation; Enzyme Activation; Gene Deletion; Heart Failure; Heart Ventricles; Interleukin-10; Mechanistic Target of Rapamycin Complex 1; Mice, Inbred C57BL; Mice, Knockout; Models, Biological; Multiprotein Complexes; Myocytes, Cardiac; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; Rats, Sprague-Dawley; Signal Transduction; TOR Serine-Threonine Kinases | 2015 |
Meis1 promotes poly (rC)-binding protein 2 expression and inhibits angiotensin II-induced cardiomyocyte hypertrophy.
Topics: Angiotensin II; Animals; Cardiomegaly; Gene Expression; Homeodomain Proteins; Humans; Mice, Inbred C57BL; Myeloid Ecotropic Viral Integration Site 1 Protein; Myocytes, Cardiac; Neoplasm Proteins; Promoter Regions, Genetic; Proto-Oncogene Proteins c-akt; RNA-Binding Proteins; Signal Transduction; TOR Serine-Threonine Kinases; Transcriptional Activation | 2016 |
Thymosin β4 Prevents Angiotensin II-Induced Cardiomyocyte Growth by Regulating Wnt/WISP Signaling.
Topics: Active Transport, Cell Nucleus; Angiotensin II; Animals; Animals, Newborn; beta Catenin; Cardiomegaly; CCN Intercellular Signaling Proteins; Cell Size; Cells, Cultured; Gene Expression Regulation; Myocytes, Cardiac; Proto-Oncogene Proteins; Rats, Sprague-Dawley; Thymosin; Transfection; Wnt Signaling Pathway | 2016 |
Combination of angiotensin II and l-NG-nitroarginine methyl ester exacerbates mitochondrial dysfunction and oxidative stress to cause heart failure.
Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Cardiomegaly; DNA, Mitochondrial; Electron Transport Complex I; Electron Transport Complex II; Enzyme Inhibitors; Gene Expression; Heart; Heart Failure; Hydrogen Peroxide; Mice; Mitochondria, Heart; Myocardium; Natriuretic Peptide, Brain; Natriuretic Peptide, C-Type; NG-Nitroarginine Methyl Ester; Nitric Oxide; Oxidative Stress; Protein Precursors; Pyruvate Dehydrogenase Complex; Reverse Transcriptase Polymerase Chain Reaction; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Vasoconstrictor Agents | 2016 |
Novel EGFR inhibitors attenuate cardiac hypertrophy induced by angiotensin II.
Topics: Angiotensin II; Animals; Cardiomegaly; Cardiotonic Agents; Cell Line; Drug Evaluation, Preclinical; Epidermal Growth Factor; ErbB Receptors; Gene Knockdown Techniques; Mice, Inbred C57BL; Myocytes, Cardiac; Quinazolines; Rats; Tyrphostins | 2016 |
IL-10 for cardiac autophagy modulation: New direction in the pursuit of perfection.
Topics: Angiotensin II; Animals; Apoptosis Regulatory Proteins; Autophagy; Beclin-1; Cardiomegaly; Gene Expression Regulation; Heart Failure; Humans; Interleukin-10; Mice; Myocardium; Myocytes, Cardiac; Proto-Oncogene Proteins c-bcl-2; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Signal Transduction; Stroke Volume | 2016 |
Interleukin-10 deficiency aggravates angiotensin II-induced cardiac remodeling in mice.
Topics: Angiotensin II; Animals; Cardiomegaly; Collagen; Interleukin-10; Interleukin-6; Matrix Metalloproteinases; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardium; Natriuretic Peptide, Brain; Oncogene Protein v-akt; Ultrasonography; Ventricular Remodeling | 2016 |
Pleiotropic and puzzling effects of ATF3 in maladaptive cardiac remodeling.
Topics: Activating Transcription Factor 3; Angiotensin II; Animals; Cardiomegaly; Gene Expression Regulation; MAP Kinase Signaling System; Mice; Myocytes, Cardiac; Ventricular Remodeling | 2016 |
Adiponectin Upregulates MiR-133a in Cardiac Hypertrophy through AMPK Activation and Reduced ERK1/2 Phosphorylation.
Topics: Adiponectin; AMP-Activated Protein Kinases; Angiotensin II; Animals; Cardiomegaly; Connective Tissue Growth Factor; Disease Models, Animal; Echocardiography; Gene Expression; Gene Expression Regulation; Genetic Vectors; Lentivirus; Male; MicroRNAs; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Myocytes, Cardiac; Phosphorylation; Rats; Receptors, Adiponectin; Signal Transduction; Transduction, Genetic; Up-Regulation | 2016 |
BMP type I receptor ALK2 is required for angiotensin II-induced cardiac hypertrophy.
Topics: Activin Receptors, Type I; Activin Receptors, Type II; Angiotensin II; Animals; Bone Morphogenetic Protein 2; Bone Morphogenetic Protein 4; Bone Morphogenetic Protein Receptors, Type I; Cardiomegaly; Cells, Cultured; Disease Models, Animal; Dose-Response Relationship, Drug; Fibrosis; Inhibitor of Differentiation Protein 1; Mice, Inbred C57BL; Mice, Knockout; Myocytes, Cardiac; NFATC Transcription Factors; Phenylephrine; Phosphorylation; Pyrazoles; Pyrimidines; Rats, Sprague-Dawley; RNA Interference; Signal Transduction; Smad Proteins; Time Factors; Transfection | 2016 |
Tripartite motif 32 prevents pathological cardiac hypertrophy.
Topics: Angiotensin II; Animals; Cardiomegaly; Cell Differentiation; Cells, Cultured; Echocardiography; Heart Failure; Humans; Male; Mice, Knockout; Myocytes, Cardiac; Signal Transduction; Transcription Factors; Tripartite Motif Proteins; Ubiquitin-Protein Ligases | 2016 |
Dual-specificity phosphatase 14 protects the heart from aortic banding-induced cardiac hypertrophy and dysfunction through inactivation of TAK1-P38MAPK/-JNK1/2 signaling pathway.
Topics: Angiotensin II; Animals; Base Sequence; Cardiomegaly; Case-Control Studies; Cells, Cultured; Dual-Specificity Phosphatases; Heart Failure; HEK293 Cells; Humans; MAP Kinase Kinase Kinases; MAP Kinase Signaling System; Mice, Inbred C57BL; Mice, Transgenic; Mitogen-Activated Protein Kinase Phosphatases; Molecular Sequence Data; Myocytes, Cardiac; Rats | 2016 |
Overexpression of microRNA-99a Attenuates Cardiac Hypertrophy.
Topics: Angiotensin II; Animals; Cardiomegaly; Cell Enlargement; Cells, Cultured; Disease Models, Animal; Genetic Therapy; Heart Failure; Humans; Isoproterenol; Male; Mice; Mice, Inbred C57BL; MicroRNAs; Myocytes, Cardiac; Signal Transduction; TOR Serine-Threonine Kinases; Up-Regulation | 2016 |
Long Non-Coding RNA Malat-1 Is Dispensable during Pressure Overload-Induced Cardiac Remodeling and Failure in Mice.
Topics: Adaptor Proteins, Signal Transducing; Angiotensin II; Animals; Aorta, Thoracic; Cardiomegaly; Constriction, Pathologic; Crosses, Genetic; Fetal Proteins; Gene Expression Regulation; Heart Failure; Heterozygote; Ligation; Mice; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Pressure; Proteins; RNA Splicing; RNA, Long Noncoding; Ventricular Remodeling | 2016 |
Transient Receptor Potential Melastatin 7 Cation Channel Kinase: New Player in Angiotensin II-Induced Hypertension.
Topics: Analysis of Variance; Angiotensin II; Animals; Cardiomegaly; Disease Models, Animal; Disease Progression; Gene Expression Regulation; Hypertension; Male; Mice; Mice, Inbred C57BL; Muscle, Smooth, Vascular; Random Allocation; Reactive Oxygen Species; Risk Assessment; TRPM Cation Channels; Up-Regulation; Ventricular Dysfunction, Left | 2016 |
Effect of Atorvastatin on Expression of Peroxisome Proliferator-activated Receptor Beta/delta in Angiotensin II-induced Hypertrophic Myocardial Cells In Vitro.
Topics: Angiotensin II; Animals; Atorvastatin; Cardiomegaly; Cells, Cultured; Hydroxymethylglutaryl-CoA Reductase Inhibitors; PPAR delta; PPAR-beta; Rats; Rats, Wistar | 2015 |
Thrombospondin-4 knockout in hypertension protects small-artery endothelial function but induces aortic aneurysms.
Topics: Angiotensin II; Animals; Aorta; Aortic Aneurysm; Cardiomegaly; Collagen; Dilatation, Pathologic; Disease Models, Animal; Dose-Response Relationship, Drug; Endothelium, Vascular; Genetic Predisposition to Disease; Hypertension; Mesenteric Arteries; Mice, Knockout; Microscopy, Electron; Phenotype; Thrombospondins; Vascular Resistance; Vasodilation; Vasodilator Agents | 2016 |
Early administration of nifedipine protects against angiotensin II-induced cardiomyocyte hypertrophy through regulating CaMKII-SERCA2a pathway and apoptosis in rat cardiomyocytes.
Topics: Angiotensin II; Animals; Apoptosis; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Cardiomegaly; Myocytes, Cardiac; Nifedipine; Rats; Rats, Wistar | 2016 |
Klotho inhibits angiotensin II-induced cardiomyocyte hypertrophy through suppression of the AT1R/beta catenin pathway.
Topics: Angiotensin II; Animals; beta Catenin; Cardiomegaly; Cells, Cultured; Glucuronidase; Klotho Proteins; Myocytes, Cardiac; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Signal Transduction | 2016 |
Cardiac-Specific EPI64C Blunts Pressure Overload-Induced Cardiac Hypertrophy.
Topics: Angiotensin II; Animals; Blotting, Western; Calcineurin; Cardiac Output, High; Cardiomegaly; Disease Models, Animal; GTPase-Activating Proteins; Haplorhini; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Myocytes, Cardiac; Pressure; Random Allocation; Recovery of Function; Risk Assessment; Sensitivity and Specificity; Signal Transduction | 2016 |
SIRT4 accelerates Ang II-induced pathological cardiac hypertrophy by inhibiting manganese superoxide dismutase activity.
Topics: Angiotensin II; Animals; Cardiomegaly; Gene Knockdown Techniques; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mitochondria, Heart; Mitochondrial Proteins; Myocytes, Cardiac; Oxidative Stress; Reactive Oxygen Species; Sirtuins; Superoxide Dismutase; Vascular Remodeling; Vasoconstrictor Agents | 2017 |
Retinol-Binding Protein 4 Induces Cardiomyocyte Hypertrophy by Activating TLR4/MyD88 Pathway.
Topics: Adipocytes; Angiotensin II; Animals; Blotting, Western; Cardiomegaly; Cells, Cultured; Inflammation; Losartan; Male; Mice; Mice, Inbred C57BL; Myeloid Differentiation Factor 88; Myocytes, Cardiac; Oxidative Stress; Polymerase Chain Reaction; Reactive Oxygen Species; Retinol-Binding Proteins, Plasma; Signal Transduction; Toll-Like Receptor 4 | 2016 |
Fibulin-2 is essential for angiotensin II-induced myocardial fibrosis mediated by transforming growth factor (TGF)-β.
Topics: Angiotensin II; Animals; Calcium-Binding Proteins; Cardiomegaly; Disease Models, Animal; Extracellular Matrix Proteins; Fibrosis; Heart Failure; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Models, Cardiovascular; Myocardium; Signal Transduction; Transforming Growth Factor beta1; Ventricular Remodeling | 2016 |
The effects of different angiotensin II type 1 receptor blockers on the regulation of the ACE-AngII-AT1 and ACE2-Ang(1-7)-Mas axes in pressure overload-induced cardiac remodeling in male mice.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Blood Pressure; Cardiomegaly; Disease Models, Animal; Echocardiography; Hemodynamics; Hypertension; Male; Mice; Mice, Knockout; Myocardium; Myocytes, Cardiac; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptor, Angiotensin, Type 1; Receptors, G-Protein-Coupled; RNA, Small Interfering; Signal Transduction; Ventricular Remodeling | 2016 |
Estrogen receptor beta signals to inhibition of cardiac fibrosis.
Topics: AMP-Activated Protein Kinases; Angiotensin II; Animals; Cardiomegaly; Cells, Cultured; Collagen Type I; Collagen Type III; Disease Models, Animal; Estrogen Receptor beta; Fibrosis; Male; Mice; Myofibroblasts; Rats; Signal Transduction | 2016 |
The effect of resveratrol on angiotensin II levels and the rate of transcription of its receptors in the rat cardiac hypertrophy model.
Topics: Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Disease Models, Animal; Heart; Male; Myocardium; Rats; Rats, Wistar; Resveratrol; RNA, Messenger; Stilbenes; Transcription, Genetic | 2017 |
Suppressive Effects of Glucose-Dependent Insulinotropic Polypeptide on Cardiac Hypertrophy and Fibrosis in Angiotensin II-Infused Mouse Models.
Topics: Angiotensin II; Animals; Apolipoproteins E; Cardiomegaly; Cell Line; Fibrosis; Gastric Inhibitory Polypeptide; Gene Expression Regulation; Hypoxia-Inducible Factor 1, alpha Subunit; Mice; Mice, Knockout; Myocardium; Myocytes, Cardiac; Natriuretic Peptide, Brain; Transforming Growth Factor beta1 | 2016 |
Partial inhibition of activin receptor-like kinase 4 attenuates pressure overload-induced cardiac fibrosis and improves cardiac function.
Topics: Activin Receptors, Type I; Angiotensin II; Animals; Aorta; Apoptosis; Blood Pressure; Cardiomegaly; Cell Differentiation; Cell Proliferation; Cells, Cultured; Collagen; Disease Models, Animal; Fibroblasts; Fibrosis; Haploinsufficiency; Heterozygote; Male; Mice; Myocardium; Myocytes, Cardiac; Signal Transduction; Smad2 Protein; Smad3 Protein; Stroke Volume; Transforming Growth Factor beta; Up-Regulation; Ventricular Dysfunction, Left | 2016 |
NMNAT3 is involved in the protective effect of SIRT3 in Ang II-induced cardiac hypertrophy.
Topics: Acetylation; Angiotensin II; Animals; Animals, Newborn; Cardiomegaly; Cardiotonic Agents; Down-Regulation; Fluorescent Antibody Technique; Intracellular Space; Male; Mice, Knockout; Mitochondria; Models, Biological; Myocytes, Cardiac; Nicotinamide Phosphoribosyltransferase; Nicotinamide-Nucleotide Adenylyltransferase; Protein Binding; Rats; RNA, Messenger; Sirtuin 3 | 2016 |
Human Endomyocardial Biopsy Specimen-Derived Stromal Cells Modulate Angiotensin II-Induced Cardiac Remodeling.
Topics: Adult; Angiotensin II; Animals; Biopsy; Cardiomegaly; Cell Proliferation; Cell Transdifferentiation; Collagen; Female; Fibroblasts; Fibrosis; Humans; Immunomodulation; Male; Mice, Inbred C57BL; Myocardium; Myofibroblasts; Oxidative Stress; Stromal Cells; Vascular Remodeling; Ventricular Function, Left | 2016 |
Essential Role of Smooth Muscle STIM1 in Hypertension and Cardiovascular Dysfunction.
Topics: Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Cyclic GMP; Disease Models, Animal; Dose-Response Relationship, Drug; Endoplasmic Reticulum Stress; Fibrosis; Genetic Predisposition to Disease; Hypertension; Male; Mice, Knockout; Muscle, Smooth, Vascular; Myocardium; NADPH Oxidases; Nitric Oxide Synthase Type III; Nitrites; Phenotype; Phosphorylation; Reactive Oxygen Species; Signal Transduction; Stromal Interaction Molecule 1; Time Factors; Transcription Factor CHOP; Transforming Growth Factor beta; Vasodilation; Vasodilator Agents | 2016 |
Vascular ADAM17 as a Novel Therapeutic Target in Mediating Cardiovascular Hypertrophy and Perivascular Fibrosis Induced by Angiotensin II.
Topics: ADAM17 Protein; Angiotensin II; Animals; Cardiomegaly; Cells, Cultured; Disease Models, Animal; ErbB Receptors; Fibrosis; Humans; Hypertension; Male; Mice; Mice, Inbred C57BL; Molecular Targeted Therapy; Myocytes, Cardiac; Random Allocation; Renin-Angiotensin System; Sensitivity and Specificity; Signal Transduction; Vascular Remodeling; Ventricular Remodeling | 2016 |
p21(CIP1/WAF1)-dependent inhibition of cardiac hypertrophy in response to Angiotensin II involves Akt/Myc and pRb signaling.
Topics: Angiotensin II; Animals; Cardiomegaly; Cyclin-Dependent Kinase Inhibitor p21; Gene Expression Regulation; Heart; Heart Failure; Humans; Mice; Mice, Knockout; Oncogene Protein v-akt; Proto-Oncogene Proteins c-myc; Retinoblastoma Protein | 2016 |
Novel Protective Role for Ubiquitin-Specific Protease 18 in Pathological Cardiac Remodeling.
Topics: Analysis of Variance; Angiotensin II; Animals; Cardiomegaly; Cells, Cultured; Disease Models, Animal; Gene Expression Regulation; Heart Failure; Mice; Mice, Knockout; Myocytes, Cardiac; Random Allocation; Role; Sensitivity and Specificity; Signal Transduction; Ubiquitin Thiolesterase; Ventricular Remodeling | 2016 |
Human paraoxonase gene cluster overexpression alleviates angiotensin II-induced cardiac hypertrophy in mice.
Topics: Angiotensin II; Animals; Aryldialkylphosphatase; Blood Pressure; Blotting, Western; Cardiomegaly; Echocardiography; Fibrosis; Gene Expression Regulation, Enzymologic; Heart; Humans; Male; Matrix Metalloproteinases; Mice, Inbred C57BL; Mice, Transgenic; Multigene Family; Myocardium; Reverse Transcriptase Polymerase Chain Reaction; Tissue Inhibitor of Metalloproteinases; Ventricular Remodeling | 2016 |
Angiotensin II increases coronary fibrosis, cardiac hypertrophy and the incidence of myocardial infarctions in ApoE
Topics: Angiotensin II; Animals; Apolipoproteins E; Atherosclerosis; Cardiomegaly; Disease Models, Animal; Fibrillin-1; Mice; Myocardial Infarction; Myocardium; Organ Size; Peptide Fragments; Treatment Outcome | 2016 |
Pathological Ace2-to-Ace enzyme switch in the stressed heart is transcriptionally controlled by the endothelial Brg1-FoxM1 complex.
Topics: Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Cardiomegaly; Disease Models, Animal; DNA Helicases; Endothelial Cells; Forkhead Box Protein M1; Heart Failure; Humans; Mice; Multiprotein Complexes; Myocardium; Nuclear Proteins; Peptidyl-Dipeptidase A; Thiostrepton; Transcription Factors | 2016 |
Hydrogen Sulfide Regulates Krüppel-Like Factor 5 Transcription Activity via Specificity Protein 1 S-Sulfhydration at Cys664 to Prevent Myocardial Hypertrophy.
Topics: Angiotensin II; Animals; Animals, Newborn; Atrial Natriuretic Factor; Cardiomegaly; Case-Control Studies; Cystathionine gamma-Lyase; Gene Expression Regulation; Humans; Hydrogen Sulfide; Kruppel-Like Transcription Factors; Male; Morpholines; Myocardium; Myocytes, Cardiac; Organothiophosphorus Compounds; Platelet-Derived Growth Factor; Rats; Rats, Inbred SHR; Rats, Sprague-Dawley; RNA, Messenger; Sp1 Transcription Factor; Transcriptional Activation | 2016 |
LncRNA MIAT enhances cardiac hypertrophy partly through sponging miR-150.
Topics: Angiotensin II; Animals; Cardiomegaly; Mice; MicroRNAs; Myocardial Infarction; Myocytes, Cardiac; Rats; RNA, Long Noncoding | 2016 |
Zofenopril exerts a cardiovascular protective effect on rats infused with angiotensin II beyond angiotensin-converting enzyme inhibition.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Aorta, Thoracic; Blood Pressure; Captopril; Cardiomegaly; Collagen; Disease Models, Animal; Dose-Response Relationship, Drug; Fibrosis; Hydroxyproline; Hypertension; Male; Myocardium; Rats, Wistar; Superoxides; Time Factors; Vasodilation; Vasodilator Agents | 2016 |
Preservation of myocardial fatty acid oxidation prevents diastolic dysfunction in mice subjected to angiotensin II infusion.
Topics: Acetyl-CoA Carboxylase; Angiotensin II; Animals; Cardiomegaly; Diastole; Disease Models, Animal; Echocardiography; Energy Metabolism; Fatty Acids; Fibrosis; Gene Deletion; Magnetic Resonance Imaging; Male; Mice; Mice, Knockout; Myocardium; Organelle Biogenesis; Oxidation-Reduction; Oxidative Stress; Ventricular Dysfunction | 2016 |
Mnk1 (Mitogen-Activated Protein Kinase-Interacting Kinase 1) Deficiency Aggravates Cardiac Remodeling in Mice.
Topics: Analysis of Variance; Angiotensin II; Animals; Biomarkers; Cardiomegaly; Cells, Cultured; Disease Models, Animal; Mice; Mice, Knockout; Mitogen-Activated Protein Kinases; Myocytes, Cardiac; Protein Serine-Threonine Kinases; Random Allocation; Signal Transduction; Ventricular Remodeling | 2016 |
Myocyte-specific enhancer factor 2C: a novel target gene of miR-214-3p in suppressing angiotensin II-induced cardiomyocyte hypertrophy.
Topics: Angiotensin II; Animals; Antagomirs; Atrial Natriuretic Factor; Cardiomegaly; Cells, Cultured; Disease Models, Animal; Heart Ventricles; Male; MEF2 Transcription Factors; Mice; Mice, Inbred C57BL; MicroRNAs; Myocardium; Myocytes, Cardiac; Myosin Heavy Chains; NF-kappa B; RNA Interference; Signal Transduction; Up-Regulation | 2016 |
Glycine prevents pressure overload induced cardiac hypertrophy mediated by glycine receptor.
Topics: Angiotensin II; Animals; Cardiomegaly; Coculture Techniques; Glycine; Heart; Male; MAP Kinase Signaling System; Mice; Mice, Inbred C57BL; Rats; Rats, Sprague-Dawley; Receptors, Glycine | 2017 |
Mouse Sirt3 promotes autophagy in AngII-induced myocardial hypertrophy through the deacetylation of FoxO1.
Topics: Acetylation; Angiotensin II; Animals; Autophagy; Cardiomegaly; Cells, Cultured; Forkhead Box Protein O1; Mice; Rats; Sirtuin 3 | 2016 |
Protease-Activated Receptor 1 Contributes to Angiotensin II-Induced Cardiovascular Remodeling and Inflammation.
Topics: Angiotensin II; Animals; Aorta; Blood Pressure; Cardiomegaly; Coronary Vessels; Fibrosis; Hypertension; Inflammation; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardium; Receptor, PAR-1; Signal Transduction; Vascular Remodeling | 2017 |
Renal Denervation Attenuates Multi-Organ Fibrosis and Improves Vascular Remodeling in Rats with Transverse Aortic Constriction Induced Cardiomyopathy.
Topics: Alanine Transaminase; Angiotensin II; Animals; Aorta; Blood Pressure; Carbazoles; Cardiomegaly; Cardiomyopathies; Carvedilol; Constriction; Cystatin C; Denervation; Fibrosis; Heart Rate; Kidney; Malondialdehyde; Natriuretic Peptide, Brain; Organ Specificity; Oxidative Stress; Peptide Fragments; Procollagen; Propanolamines; Rats, Sprague-Dawley; Superoxide Dismutase; Transforming Growth Factor beta1; Vascular Remodeling | 2016 |
Syringin prevents cardiac hypertrophy induced by pressure overload through the attenuation of autophagy.
Topics: AMP-Activated Protein Kinases; Angiotensin II; Animals; Autophagy; Cardiomegaly; Cardiotonic Agents; Cell Line; Glucosides; Male; Mice, Inbred C57BL; Myocytes, Cardiac; Phenylpropionates; Pressure; Rats; Signal Transduction | 2017 |
Polyphenol rich ethanolic extract from Boerhavia diffusa L. mitigates angiotensin II induced cardiac hypertrophy and fibrosis in rats.
Topics: Angiotensin II; Animals; Antioxidants; Cardiomegaly; Ethanol; Fibrosis; Glutathione; Heart; Lipid Peroxidation; Male; Myocardium; Nyctaginaceae; Oxidative Stress; Plant Extracts; Plants, Medicinal; Polyphenols; Quercetin; Rats; Rats, Wistar; Reactive Oxygen Species | 2017 |
Pirfenidone controls the feedback loop of the AT1R/p38 MAPK/renin-angiotensin system axis by regulating liver X receptor-α in myocardial infarction-induced cardiac fibrosis.
Topics: Angiotensin II; Animals; Cardiomegaly; Collagen Type I; Collagen Type III; Feedback, Physiological; Fibrosis; Hemodynamics; Hydroxyproline; Liver X Receptors; Male; Myocardial Infarction; Myocardium; p38 Mitogen-Activated Protein Kinases; Peptidyl-Dipeptidase A; Phosphorylation; Proto-Oncogene Mas; Proto-Oncogene Proteins; Pyridones; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptors, G-Protein-Coupled; Renin-Angiotensin System; Signal Transduction; Systole; Ventricular Dysfunction | 2017 |
microRNA-10a Targets T-box 5 to Inhibit the Development of Cardiac Hypertrophy.
Topics: Angiotensin II; Animals; Cardiomegaly; Cells, Cultured; Disease Models, Animal; Gene Knockdown Techniques; Male; MicroRNAs; Random Allocation; Rats, Wistar; T-Box Domain Proteins | 2017 |
Let-7a Is an Antihypertrophic Regulator in the Heart via Targeting Calmodulin.
Topics: 3' Untranslated Regions; Angiotensin II; Animals; Atrial Natriuretic Factor; Calmodulin; Cardiomegaly; Cells, Cultured; MicroRNAs; Myocytes, Cardiac; Natriuretic Peptide, Brain; Rats; Real-Time Polymerase Chain Reaction; RNA, Messenger | 2017 |
Amplified pathogenic actions of angiotensin II in cysteine-rich LIM-only protein 4-negative mouse hearts.
Topics: alpha-Defensins; Angiotensin II; Animals; Cardiomegaly; Carrier Proteins; Cells, Cultured; Cyclic GMP; Heart; LIM Domain Proteins; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; Zebrafish | 2017 |
Novel Protective Role of Myeloid Differentiation 1 in Pathological Cardiac Remodelling.
Topics: Angiotensin II; Animals; Antigens, Surface; Cardiomegaly; Cells, Cultured; Humans; Male; MAP Kinase Signaling System; Membrane Glycoproteins; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Myocytes, Cardiac; NF-kappa B; Nitriles; Sulfones; Ventricular Remodeling | 2017 |
Isorhamnetin protects against cardiac hypertrophy through blocking PI3K-AKT pathway.
Topics: Angiotensin II; Animals; Cardiomegaly; Cardiotonic Agents; Echocardiography; Gene Expression Regulation; Male; Mice; Myocytes, Cardiac; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Quercetin; Rats; Signal Transduction | 2017 |
Synthesis of the novel PARP-1 inhibitor AG-690/11026014 and its protective effects on angiotensin II-induced mouse cardiac remodeling.
Topics: Angiotensin II; Animals; Cardiomegaly; Cardiotonic Agents; Fibrosis; Male; Mice, Inbred C57BL; Myocytes, Cardiac; Poly (ADP-Ribose) Polymerase-1; Sirtuin 1; Thioglycolates; Ventricular Remodeling; Xanthines | 2017 |
Overexpressed connective tissue growth factor in cardiomyocytes attenuates left ventricular remodeling induced by angiotensin II perfusion.
Topics: Actins; Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Collagen Type I; Connective Tissue Growth Factor; Echocardiography; Fibrosis; Heart; Heart Ventricles; Hypertension; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Myocardium; Myocytes, Cardiac; Reverse Transcriptase Polymerase Chain Reaction; Transforming Growth Factor beta; Vasoconstrictor Agents; Ventricular Remodeling | 2017 |
Emerin plays a crucial role in nuclear invagination and in the nuclear calcium transient.
Topics: Active Transport, Cell Nucleus; Angiotensin II; Aniline Compounds; Animals; Atrial Remodeling; Calcium; Cardiomegaly; Cytoplasm; Disease Models, Animal; Endothelin-1; Fluorescent Dyes; Gene Expression Regulation; Heterocyclic Compounds, 3-Ring; Humans; Membrane Proteins; Muscular Dystrophy, Emery-Dreifuss; Myocardium; Myocytes, Cardiac; Nuclear Envelope; Nuclear Proteins; Phenylephrine; Primary Cell Culture; Rats; Rats, Sprague-Dawley; RNA, Small Interfering; Ventricular Remodeling; Xanthenes | 2017 |
Differential roles of cardiomyocyte and macrophage peroxisome proliferator-activated receptor gamma in cardiac fibrosis.
Topics: Adiponectin; Angiotensin II; Animals; Cardiomegaly; Chemotaxis; Female; Fibrosis; Hypoglycemic Agents; Macrophages; Male; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Mice, Knockout; Myocardium; Myocytes, Cardiac; Pioglitazone; PPAR gamma; Thiazolidinediones; Vasoconstrictor Agents | 2008 |
Serotonin 5-HT(2B) receptor blockade prevents reactive oxygen species-induced cardiac hypertrophy in mice.
Topics: Angiotensin II; Animals; Cardiomegaly; Disease Models, Animal; Echocardiography, Doppler; Indoles; Isoproterenol; Mice; Mice, Inbred Strains; NADP; Probability; Quinolines; Random Allocation; Reactive Oxygen Species; Receptor, Serotonin, 5-HT2B; Reference Values; Sensitivity and Specificity; Serotonin Antagonists; Superoxides | 2008 |
[Changes of c-fos, c-jun mRNA expressions in cardiomyocyte hypertrophy induced by angiotensin II and effects of tanshinone II A].
Topics: Abietanes; Angiotensin II; Animals; Cardiomegaly; Gene Expression Regulation; Genes, fos; Genes, jun; Myocytes, Cardiac; Phenanthrenes; Proto-Oncogene Proteins c-fos; Proto-Oncogene Proteins c-jun; Rats; Rats, Wistar; RNA, Messenger; Tetrazoles; Valine; Valsartan | 2008 |
Cellular physiology of rat cardiac myocytes in cardiac fibrosis: in vitro simulation using the cardiac myocyte/cardiac non-myocyte co-culture system.
Topics: Angiotensin II; Angiotensinogen; Animals; Animals, Newborn; Atrial Natriuretic Factor; Cardiomegaly; Cell Separation; Cells, Cultured; Coculture Techniques; Diuretics, Osmotic; Endothelin-1; Fibrosis; Leucine; Mannitol; Myocardium; Myocytes, Cardiac; Natriuretic Peptide, Brain; Peptidyl-Dipeptidase A; Rats; Rats, Wistar; Receptors, Angiotensin; Renin; Thymidine; Transforming Growth Factor beta1; Tritium | 2008 |
[Inhibitory effect of tea polyphenols and EGCG on cultured hypertrophic myocyte induced by Ang II].
Topics: Angiotensin II; Animals; Animals, Newborn; Cardiomegaly; Catechin; Cells, Cultured; Female; Flavonoids; Male; Myocytes, Cardiac; Phenols; Polyphenols; Rats; Rats, Wistar; Tea | 2008 |
Cardiac metabolic compensation to hypertension requires lipoprotein lipase.
Topics: Adenosine Triphosphate; Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Desoxycorticosterone; Fatty Acids; Glucose; Glycogen; Hypertension; Lipid Metabolism; Lipids; Lipoprotein Lipase; Mice; Mice, Knockout; Myocardium; Oxidation-Reduction; Protein Serine-Threonine Kinases; Pyruvate Dehydrogenase Acetyl-Transferring Kinase; Triglycerides | 2008 |
Perinatal 2,3,7,8-tetrachlorodibenzo-p-dioxin exposure sensitizes offspring to angiotensin II-induced hypertension.
Topics: Angiotensin II; Animals; Blood Pressure; Carcinogens, Environmental; Cardiomegaly; Collagen; Disease Models, Animal; Female; Fibroblasts; Fibrosis; Gestational Age; Hypertension; Kidney; Male; Membrane Glycoproteins; Mice; Mice, Inbred C57BL; NADPH Oxidase 2; NADPH Oxidases; Polychlorinated Dibenzodioxins; Pregnancy; Prenatal Exposure Delayed Effects; Procollagen; Renin-Angiotensin System; RNA, Messenger; Telemetry; Time Factors; Ultrasonography | 2008 |
Cardiac hypertrophy is associated with altered thioredoxin and ASK-1 signaling in a mouse model of menopause.
Topics: Angiotensin II; Animals; Apoptosis; Blood Pressure; Blotting, Western; Cardiomegaly; Collagen; Disease Models, Animal; Female; Follicle Stimulating Hormone; Hypertension; MAP Kinase Kinase Kinase 5; Menopause; Mice; Mice, Knockout; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Myocardium; Oxidative Stress; Phosphorylation; Receptor, Angiotensin, Type 1; Signal Transduction; Superoxide Dismutase; Thioredoxins; Time Factors | 2008 |
Phosphorylation of pRb by cyclin D kinase is necessary for development of cardiac hypertrophy.
Topics: Angiotensin II; Animals; Animals, Newborn; Cardiomegaly; Cell Proliferation; Cells, Cultured; Cyclin D; Cyclin E; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase 6; Cyclins; DNA; DNA Replication; E2F Transcription Factors; Hexanones; Myocytes, Cardiac; Phosphorylation; Protein Biosynthesis; Purines; Rats; Rats, Wistar; Retinoblastoma Protein; Roscovitine; Up-Regulation | 2008 |
Angiotensin II type-1 receptor activation in the adult heart causes blood pressure-independent hypertrophy and cardiac dysfunction.
Topics: Age Factors; Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Fibrosis; Heart Rate; Humans; Hypertension; Infusion Pumps, Implantable; Male; Mice; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Transgenic; Mutation; Myocytes, Cardiac; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Stroke Volume; Time Factors; Ventricular Remodeling | 2009 |
Green tea attenuates angiotensin II-induced cardiac hypertrophy in rats by modulating reactive oxygen species production and the Src/epidermal growth factor receptor/Akt signaling pathway.
Topics: Angiotensin II; Animals; Cardiomegaly; Enzyme Activation; ErbB Receptors; Isoenzymes; Male; Mitogen-Activated Protein Kinases; NADPH Oxidases; Oncogene Protein v-akt; Protein Kinase C; Protein Subunits; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Signal Transduction; src-Family Kinases; Tea | 2008 |
Inhibition of ADP-ribosyl cyclase attenuates angiotensin II-induced cardiac hypertrophy.
Topics: ADP-ribosyl Cyclase; Angiotensin II; Animals; Azo Compounds; Calcium; Calcium Signaling; Cardiomegaly; Cell Size; Cyclic ADP-Ribose; Disease Models, Animal; Enzyme Inhibitors; Hypertension, Renovascular; Male; Myocytes, Cardiac; Nephrectomy; Phosphatidylinositol 3-Kinases; Phosphorylation; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Renal Artery; src-Family Kinases | 2009 |
Overexpression of vascular endothelial growth factor-B in mouse heart alters cardiac lipid metabolism and induces myocardial hypertrophy.
Topics: Angiotensin II; Animals; Blood Pressure; Capillaries; Cardiomegaly; Cardiomyopathies; Cell Size; Ceramides; Coronary Vessels; Disease Models, Animal; Heart Rate; Humans; Hypertension; Lipid Metabolism; Mice; Mice, Transgenic; Mitochondria, Heart; Myocardial Ischemia; Myocardium; Myocytes, Cardiac; Myosin Heavy Chains; Neovascularization, Physiologic; Oxidation-Reduction; Promoter Regions, Genetic; Skin; Time Factors; Triglycerides; Up-Regulation; Vascular Endothelial Growth Factor B; Ventricular Function, Left; Ventricular Myosins | 2008 |
Transgenic angiotensin-converting enzyme 2 overexpression in vessels of SHRSP rats reduces blood pressure and improves endothelial function.
Topics: Acetylcholine; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Animals, Genetically Modified; Blood Pressure; Cardiomegaly; Disease Models, Animal; Endothelium, Vascular; Gene Expression Regulation, Enzymologic; Humans; Hypertension; Muscle, Smooth, Vascular; Nitroprusside; Peptide Fragments; Peptidyl-Dipeptidase A; Rats; Rats, Inbred SHR; Vasodilator Agents | 2008 |
Insights into mechanisms linking cardiac hypertrophy and atrial fibrosis: evidence for a role of histone deacetylase in atrial fibrillation pathophysiology and therapy.
Topics: Angiotensin II; Animals; Atrial Fibrillation; Cardiomegaly; Connexins; Enzyme Inhibitors; Fibrosis; Gap Junction alpha-5 Protein; Histone Deacetylase Inhibitors; Histone Deacetylases; Homeodomain Proteins; Hydroxamic Acids; Mice; Mice, Transgenic; Time Factors | 2008 |
Changes in hemodynamic and neurohumoral control cause cardiac damage in one-kidney, one-clip hypertensive mice.
Topics: Adrenergic beta-Antagonists; Angiotensin II; Animals; Baroreflex; Blood Pressure; Cardiomegaly; Constriction; Disease Models, Animal; Fibrosis; Heart Rate; Hemodynamics; Hypertension, Renovascular; Kidney Cortex; Male; Mice; Muscarinic Antagonists; Renal Artery; Renin; Renin-Angiotensin System; Sympathetic Nervous System; Time Factors; Vagus Nerve | 2008 |
Angiotensin(1-7) blunts hypertensive cardiac remodeling by a direct effect on the heart.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Cardiomegaly; Crosses, Genetic; Heart; Hypertension; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Myocardium; Peptide Fragments; Peptidyl-Dipeptidase A; Renin-Angiotensin System; Ventricular Remodeling | 2008 |
Changes of c-fos and c-jun mRNA expression in angiotensin II-induced cardiomyocyte hypertrophy and effects of sodium tanshinone IIA sulfonate.
Topics: Angiotensin II; Animals; Animals, Newborn; Cardiomegaly; Cells, Cultured; Drugs, Chinese Herbal; Myocytes, Cardiac; Phenanthrenes; Proto-Oncogene Proteins c-fos; Proto-Oncogene Proteins c-jun; Rats; Rats, Wistar; RNA, Messenger | 2008 |
Histone-deacetylase inhibition reverses atrial arrhythmia inducibility and fibrosis in cardiac hypertrophy independent of angiotensin.
Topics: Angiotensin II; Animals; Arrhythmias, Cardiac; Cardiomegaly; Connexins; Enzyme Inhibitors; Fibrosis; Gap Junction alpha-5 Protein; Histone Deacetylase Inhibitors; Histone Deacetylases; Homeodomain Proteins; Hydroxamic Acids; Mice; Mice, Transgenic; Time Factors | 2008 |
Dopamine D2 receptor stimulation inhibits angiotensin II-induced hypertrophy in cultured neonatal rat ventricular myocytes.
Topics: Angiotensin II; Animals; Animals, Newborn; Bromocriptine; Calcium Signaling; Cardiomegaly; Cells, Cultured; Dopamine Agonists; Dopamine Antagonists; Endothelin-1; Haloperidol; Heart Ventricles; Mitogen-Activated Protein Kinases; Myocytes, Cardiac; Phosphorylation; Protein Kinase C; Rats; Rats, Wistar; Receptors, Dopamine D2 | 2009 |
Candesartan ameliorates cardiac dysfunction observed in angiotensin-converting enzyme 2-deficient mice.
Topics: Age Factors; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme 2; Animals; Benzimidazoles; Biphenyl Compounds; Cardiomegaly; Disease Models, Animal; Echocardiography; Female; Hypertension; Male; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Myocardium; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptor, Angiotensin, Type 1; Receptors, G-Protein-Coupled; Tetrazoles | 2008 |
The angiotensin converting enzyme 2/Ang-(1-7) axis in the heart: a role for MAS communication?
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Cardiomegaly; Female; Heart; Humans; Hypertension; Male; Mice; Mice, Knockout; Models, Animal; Myocardium; Peptide Fragments; Peptidyl-Dipeptidase A; Renin-Angiotensin System | 2008 |
Lysosomal cysteine peptidase cathepsin L protects against cardiac hypertrophy through blocking AKT/GSK3beta signaling.
Topics: Angiotensin II; Animals; Animals, Newborn; Apoptosis; Atrial Natriuretic Factor; Blotting, Western; Cardiomegaly; Caspases; Cathepsin L; Cathepsins; Cells, Cultured; Cysteine Endopeptidases; Echocardiography; Female; Gene Expression; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Myocardium; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction | 2009 |
EGCG inhibits proliferation of cardiac fibroblasts in rats with cardiac hypertrophy.
Topics: Angiotensin II; Animals; Antioxidants; Atrial Natriuretic Factor; Camellia sinensis; Cardiomegaly; Catechin; Cell Proliferation; Disease Models, Animal; DNA-Binding Proteins; Dose-Response Relationship, Drug; Endothelins; Enzyme Inhibitors; Fibroblasts; Fibrosis; Hydroxyproline; Male; Myocardium; Nitric Oxide Synthase Type II; Nitrites; Organ Size; Plant Extracts; Proliferating Cell Nuclear Antigen; Rats; Rats, Sprague-Dawley; Transcription Factors | 2009 |
Serotonin 5-HT2B receptor in cardiac fibroblast contributes to cardiac hypertrophy: a new therapeutic target for heart failure?
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Cardiomegaly; Cytokines; Drug Delivery Systems; ErbB Receptors; Fibroblasts; Heart Failure; Heparin-binding EGF-like Growth Factor; Humans; Intercellular Signaling Peptides and Proteins; Isoproterenol; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases; Mice; Mice, Transgenic; Myocardium; Rats; Receptor, Angiotensin, Type 1; Receptor, Serotonin, 5-HT2B; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Signal Transduction | 2009 |
The Ca(v)3.2 T-type Ca(2+) channel is required for pressure overload-induced cardiac hypertrophy in mice.
Topics: Angiotensin II; Animals; Animals, Newborn; Aorta; Blood Pressure; Calcineurin; Calcium Channel Blockers; Calcium Channels, T-Type; Calcium Signaling; Cardiomegaly; Cells, Cultured; Constriction; Disease Models, Animal; Ethosuximide; Genes, Reporter; Hypertension; Male; Membrane Potentials; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardium; NFATC Transcription Factors; Time Factors | 2009 |
Soluble epoxide hydrolase plays an essential role in angiotensin II-induced cardiac hypertrophy.
Topics: Angiotensin II; Animals; Animals, Newborn; Cardiomegaly; Epoxide Hydrolases; Mice; Mice, Knockout; Myocardium; Myocytes, Cardiac; Rats; Up-Regulation | 2009 |
Chronic NHE-1 blockade induces an antiapoptotic effect in the hypertrophied heart.
Topics: Angiotensin II; Animals; Anti-Arrhythmia Agents; Apoptosis; bcl-2-Associated X Protein; Blotting, Western; Cardiomegaly; Cell Nucleus; Guanidines; In Situ Nick-End Labeling; Male; Mitochondria, Heart; Myocardium; Myocytes, Cardiac; Rats; Rats, Inbred SHR; Sodium-Hydrogen Exchanger 1; Sodium-Hydrogen Exchangers; Sulfones; Superoxides | 2009 |
Calcium, calpains, and cardiac hypertrophy: a new link.
Topics: Angiotensin II; Animals; Calcium; Calpain; Cardiomegaly; Humans; Inositol 1,4,5-Trisphosphate Receptors; Myocardium; NF-kappa B; Signal Transduction | 2009 |
Targeted expression of receptor-associated late transducer inhibits maladaptive hypertrophy via blocking epidermal growth factor receptor signaling.
Topics: Adenoviridae; Angiotensin II; Animals; Cardiomegaly; Cells, Cultured; Collagen; Disease Models, Animal; Echocardiography; ErbB Receptors; Fibrosis; Intracellular Signaling Peptides and Proteins; Isoproterenol; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Myocardium; Myocytes, Cardiac; Rats; Rats, Sprague-Dawley; Signal Transduction | 2009 |
Air pollution and cardiac remodeling: a role for RhoA/Rho-kinase.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Angiotensin II; Animals; Atmosphere Exposure Chambers; Blood Pressure; Cardiomegaly; Collagen; Disease Models, Animal; Guanine Nucleotide Exchange Factors; Hypertension; Infusion Pumps; Inhalation Exposure; Injections, Intraperitoneal; Male; Matrix Metalloproteinases, Secreted; Mice; Mice, Inbred C57BL; Myocardium; Particulate Matter; Protein Kinase Inhibitors; rho GTP-Binding Proteins; Rho Guanine Nucleotide Exchange Factors; rho-Associated Kinases; rhoA GTP-Binding Protein; Signal Transduction; Vasoconstriction; Vasodilation; Ventricular Remodeling | 2009 |
Erythropoietin attenuates hypertrophy of neonatal rat cardiac myocytes induced by angiotensin-II in vitro.
Topics: Angiotensin II; Animals; Animals, Newborn; Atrial Natriuretic Factor; Base Sequence; Blotting, Western; Cardiomegaly; Cells, Cultured; DNA Primers; Erythropoietin; Heart; In Vitro Techniques; Myocardium; Nitric Oxide; Nitric Oxide Synthase Type III; Phosphatidylinositol 3-Kinases; Polymerase Chain Reaction; Proto-Oncogene Proteins c-akt; Rats; RNA, Messenger | 2009 |
Effect of sodium houttuyfonate on myocardial hypertrophy in mice and rats.
Topics: Alkanes; Angiotensin II; Animals; Captopril; Cardiomegaly; Cyclic AMP; Dose-Response Relationship, Drug; Endothelin-1; Hydroxyproline; Isoproterenol; Male; Mice; Myocardium; Myocytes, Cardiac; Organ Size; Rats; Rats, Sprague-Dawley; Sulfites; Thyroxine | 2009 |
Regulatory T cells ameliorate angiotensin II-induced cardiac damage.
Topics: Adoptive Transfer; Angiotensin II; Animals; Cardiomegaly; Fibrosis; Heart Diseases; Immunosuppression Therapy; Male; Mice; Mice, Inbred Strains; T-Lymphocytes, Regulatory; Treatment Outcome | 2009 |
Angiotensin II-mediated adaptive and maladaptive remodeling of cardiomyocyte excitation-contraction coupling.
Topics: Angiotensin II; Angiotensinogen; Animals; Calcium; Cardiomegaly; Electrophysiologic Techniques, Cardiac; Mice; Mice, Transgenic; Myocardial Contraction; Myocytes, Cardiac; Sodium-Calcium Exchanger | 2009 |
Liver X receptors are negative regulators of cardiac hypertrophy via suppressing NF-kappaB signalling.
Topics: Adenoviridae; Angiotensin II; Animals; Cardiomegaly; Cells, Cultured; DNA-Binding Proteins; Hydrocarbons, Fluorinated; Inflammation; Lipopolysaccharides; Liver X Receptors; Male; Mice; Mice, Inbred C57BL; NF-kappa B; Orphan Nuclear Receptors; Receptors, Cytoplasmic and Nuclear; Signal Transduction; Sulfonamides; Toll-Like Receptor 4 | 2009 |
Attenuation of angiotensin II-induced vascular dysfunction and hypertension by overexpression of Thioredoxin 2.
Topics: Analysis of Variance; Angiotensin II; Animals; Animals, Newborn; Blood Pressure Determination; Cardiomegaly; Disease Models, Animal; Endothelium, Vascular; Hypertension; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Oxygen Consumption; Random Allocation; Reactive Oxygen Species; Reference Values; Risk Factors; Thioredoxins; Vascular Resistance; Vasoconstriction; Vasodilation | 2009 |
Simvastatin inhibits angiotensin II-induced cardiac cell hypertrophy: role of Homer 1a.
Topics: Angiotensin II; Animals; Animals, Newborn; Anticholesteremic Agents; Cardiomegaly; Carrier Proteins; Cell Line; Drug Interactions; Drug Therapy, Combination; Extracellular Signal-Regulated MAP Kinases; Homer Scaffolding Proteins; Myocytes, Cardiac; Phosphorylation; Rats; Rats, Sprague-Dawley; RNA, Small Interfering; Simvastatin; Transfection; Up-Regulation | 2010 |
Effect of human umbilical cord blood cells on Ang-II-induced hypertrophy in mice.
Topics: Angiotensin II; Animals; Apoptosis; Biomarkers; Cardiomegaly; Cell Differentiation; Coculture Techniques; Fetal Blood; Histocompatibility Antigens Class I; Humans; Mice; Myocytes, Cardiac; Rats; Stem Cell Transplantation; Stem Cells | 2009 |
Inhibition of bilirubin metabolism induces moderate hyperbilirubinemia and attenuates ANG II-dependent hypertension in mice.
Topics: Angiotensin II; Animals; Bilirubin; Blood Pressure; Cardiomegaly; Disease Models, Animal; Glucuronosyltransferase; Hyperbilirubinemia; Hypertension; Indinavir; Male; Mice; Mice, Inbred C57BL; Nitrates; Nitrites; Organic Cation Transport Proteins; Oxidative Stress | 2009 |
Tumor necrosis factor-alpha--converting enzyme roles in hypertension-induced hypertrophy: look both ways when crossing the street.
Topics: ADAM Proteins; ADAM12 Protein; ADAM17 Protein; Angiotensin II; Animals; Cardiomegaly; Fibrosis; Matrix Metalloproteinase 2; Mice; Models, Biological; Myocardium; Rats; RNA Interference; Signal Transduction | 2009 |
Tumor necrosis factor-alpha-converting enzyme is a key regulator of agonist-induced cardiac hypertrophy and fibrosis.
Topics: ADAM Proteins; ADAM12 Protein; ADAM17 Protein; Angiotensin II; Animals; Blood Pressure; Blotting, Western; Cardiomegaly; Echocardiography; Fibrosis; Male; Matrix Metalloproteinase 2; Mice; Mice, Inbred C57BL; Myocardium; Rats; Rats, Inbred SHR; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; Signal Transduction | 2009 |
Impairment of the angiotensin-converting enzyme 2-angiotensin-(1-7)-Mas axis contributes to the acceleration of two-kidney, one-clip Goldblatt hypertension.
Topics: Angiotensin I; Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Disease Models, Animal; Disease Progression; Hypertension, Renovascular; Infusion Pumps, Implantable; Peptide Fragments; Rats; Rats, Transgenic; Surgical Instruments; Telemetry; Vasodilator Agents | 2009 |
Aliskiren enhances the protective effects of valsartan against cardiovascular and renal injury in endothelial nitric oxide synthase-deficient mice.
Topics: Amides; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Blood Pressure; Cardiomegaly; Cardiovascular Diseases; Cardiovascular System; Drug Synergism; Drug Therapy, Combination; Fumarates; Gene Expression; Kidney; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; NADPH Oxidases; Nitric Oxide Synthase Type III; Receptor, Angiotensin, Type 1; Renin; RNA, Messenger; Superoxides; Tetrazoles; Tunica Intima; Valine; Valsartan | 2009 |
NF-kappaB activation is required for adaptive cardiac hypertrophy.
Topics: Angiotensin II; Animals; Apoptosis; Cardiomegaly; Disease Models, Animal; Female; Fibrosis; I-kappa B Proteins; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mutation; Myocardium; Myocytes, Cardiac; Myosin Heavy Chains; NF-kappa B; NF-KappaB Inhibitor alpha; Receptor, Angiotensin, Type 1; Sex Characteristics; Signal Transduction; Ventricular Remodeling | 2009 |
Three-dimensional alignment of the aggregated myocytes in the normal and hypertrophic murine heart.
Topics: Angiotensin II; Animals; Cardiomegaly; Cell Aggregation; Diffusion Magnetic Resonance Imaging; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; Ultrasonography; Vasoconstrictor Agents | 2009 |
Connective tissue growth factor overexpression in cardiomyocytes promotes cardiac hypertrophy and protection against pressure overload.
Topics: Angiotensin II; Animals; Base Sequence; Calcium; Cardiomegaly; Connective Tissue Growth Factor; DNA Primers; Enzyme Activation; Humans; Isoproterenol; MAP Kinase Kinase 4; Mice; Mice, Transgenic; Myocardial Ischemia; Myocardium; Polymerase Chain Reaction; Pressure; Proto-Oncogene Proteins c-akt; Rats | 2009 |
Inhibition of farnesylpyrophosphate synthase prevents angiotensin II-induced hypertrophic responses in rat neonatal cardiomyocytes: involvement of the RhoA/Rho kinase pathway.
Topics: Alendronate; Angiotensin II; Animals; Animals, Newborn; Cardiomegaly; Dimethylallyltranstransferase; Hypertrophy; Myocytes, Cardiac; Prenylation; Rats; rho-Associated Kinases; rhoA GTP-Binding Protein; Signal Transduction | 2009 |
Interaction between renin-angiotensin and sympathetic nervous systems in a rat model of pressure overload cardiac hypertrophy.
Topics: Angiotensin II; Animals; Aortic Valve Stenosis; Blood Pressure; Cardiomegaly; Electrocardiography; Male; Methoxamine; Norepinephrine; Phenylephrine; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System; Sympathetic Nervous System | 2009 |
Attenuation of angiotensin II-induced hypertension and cardiac hypertrophy in transgenic mice overexpressing a type 1 receptor mutant.
Topics: Angiotensin II; Animals; Aorta; Blood Pressure; Cardiomegaly; Cells, Cultured; Endothelium, Vascular; Enzyme Activation; Hypertension; Mice; Mice, Transgenic; Protein Kinases; Proto-Oncogene Proteins c-akt; Receptor, Angiotensin, Type 1; rhoA GTP-Binding Protein | 2009 |
Globular adiponectin inhibits angiotensin II-induced nuclear factor kappaB activation through AMP-activated protein kinase in cardiac hypertrophy.
Topics: Adiponectin; AMP-Activated Protein Kinases; Angiotensin II; Animals; Atrial Natriuretic Factor; Cardiomegaly; Enzyme Activation; Heart Ventricles; Humans; I-kappa B Proteins; Myocytes, Cardiac; NF-kappa B; Phosphorylation; Rats | 2010 |
Long-term blockade of L/N-type Ca(2+) channels by cilnidipine ameliorates repolarization abnormality of the canine hypertrophied heart.
Topics: Action Potentials; Amlodipine; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Atrioventricular Block; Benzimidazoles; Biphenyl Compounds; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, N-Type; Cardiomegaly; Chronic Disease; Dihydropyridines; Dogs; Electrocardiography; Epinephrine; Female; Male; Neurotransmitter Agents; Norepinephrine; Tetrazoles; Time Factors | 2009 |
3,3',4',5,7-Pentamethylquercetin reduces angiotensin II-induced cardiac hypertrophy and apoptosis in rats.
Topics: Angiotensin II; Animals; Apoptosis; Cardiomegaly; Cardiotonic Agents; Down-Regulation; Gene Expression; Male; Molecular Structure; NADPH Oxidases; Quercetin; Rats; Rats, Sprague-Dawley | 2009 |
Role of Ca2+/calmodulin-stimulated cyclic nucleotide phosphodiesterase 1 in mediating cardiomyocyte hypertrophy.
Topics: Angiotensin II; Animals; Calcium; Calcium Signaling; Calmodulin; Cardiomegaly; Cardiotonic Agents; Cells, Cultured; Cyclic GMP; Cyclic Nucleotide Phosphodiesterases, Type 1; Enzyme Inhibitors; Gene Expression Regulation, Enzymologic; Heart Ventricles; Humans; Isoproterenol; Male; Mice; Myocytes, Cardiac; Rats; Rats, Sprague-Dawley; Second Messenger Systems | 2009 |
Blood pressure and renal blow flow responses in heme oxygenase-2 knockout mice.
Topics: Administration, Oral; Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Disease Models, Animal; Female; Heme Oxygenase (Decyclizing); Hypertension; Infusion Pumps, Implantable; Infusions, Subcutaneous; Kidney; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Renal Circulation; Vascular Resistance; Vasoconstriction | 2009 |
Protection of angiotensin II-induced vascular hypertrophy in vascular smooth muscle-targeted receptor activity-modifying protein 2 transgenic mice.
Topics: Adrenomedullin; Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Cells, Cultured; Disease Models, Animal; Female; Hypertension; Hypertrophy; Hypotension; Intracellular Signaling Peptides and Proteins; Lipopolysaccharides; Male; Membrane Proteins; Mice; Mice, Inbred C57BL; Mice, Transgenic; Muscle, Smooth, Vascular; Receptor Activity-Modifying Proteins; Receptors, Adrenomedullin; Receptors, Peptide; Vasculitis | 2009 |
Controlling myocyte cGMP: phosphodiesterase 1 joins the fray.
Topics: Angiotensin II; Animals; Calcium; Calcium Signaling; Calmodulin; Cardiomegaly; Cardiotonic Agents; Cells, Cultured; Cyclic GMP; Cyclic Nucleotide Phosphodiesterases, Type 1; Enzyme Inhibitors; Gene Expression Regulation, Enzymologic; Heart Ventricles; Humans; Isoproterenol; Male; Mice; Myocytes, Cardiac; Rats; Rats, Sprague-Dawley; Second Messenger Systems | 2009 |
Lack of glutathione peroxidase 1 accelerates cardiac-specific hypertrophy and dysfunction in angiotensin II hypertension.
Topics: Angiotensin II; Animals; Aorta, Thoracic; Blood Pressure; Blotting, Western; Body Weight; Cardiomegaly; Echocardiography; Glutathione Peroxidase; Glutathione Peroxidase GPX1; Heart; Hypertension; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardium; Ventricular Dysfunction, Left | 2010 |
Evidence for the importance of adiponectin in the cardioprotective effects of pioglitazone.
Topics: Adiponectin; AMP-Activated Protein Kinases; Angiotensin II; Animals; Blotting, Western; Cardiomegaly; Cardiotonic Agents; Collagen Type I; Collagen Type II; Extracellular Signal-Regulated MAP Kinases; Fibrosis; Hypoglycemic Agents; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardium; Phosphorylation; Pioglitazone; Reverse Transcriptase Polymerase Chain Reaction; Thiazolidinediones | 2010 |
Angiotensin-(1-7) prevents cardiomyocyte pathological remodeling through a nitric oxide/guanosine 3',5'-cyclic monophosphate-dependent pathway.
Topics: Angiotensin I; Angiotensin II; Animals; Animals, Newborn; Blood Pressure; Calcium; Cardiomegaly; Cell Size; Cells, Cultured; Cyclic GMP; Hypertension; Microscopy, Confocal; Myocytes, Cardiac; NFATC Transcription Factors; Nitric Oxide; Peptide Fragments; Protein Transport; Rats; Rats, Sprague-Dawley; Rats, Transgenic; Signal Transduction | 2010 |
The inhibitory effects of rosiglitazone on cardiac hypertrophy through modulating the renin-angiotensin system in diet-induced hypercholesterolemic rats.
Topics: Angiotensin II; Animals; Biphenyl Compounds; Cardiomegaly; Cholesterol, Dietary; Hypercholesterolemia; Irbesartan; Male; Myocardium; PPAR gamma; Rats; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin-Angiotensin System; Rosiglitazone; Tetrazoles; Thiazolidinediones | 2010 |
Sympathetic nervous system modulation of inflammation and remodeling in the hypertensive heart.
Topics: Analysis of Variance; Angiotensin II; Animals; Cardiomegaly; Cells, Cultured; Cytokines; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Hypertension; Inflammation Mediators; Male; Myocytes, Cardiac; Probability; Random Allocation; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Substance P; Sympathectomy; Sympathetic Nervous System; Ventricular Remodeling | 2010 |
Metabolomics in angiotensin II-induced cardiac hypertrophy.
Topics: Angiotensin II; Animals; Animals, Genetically Modified; Biomarkers; Cardiomegaly; Disease Models, Animal; Fatty Acids; Female; Humans; Hypoxanthine; Linoleic Acids; Male; Metabolomics; Mitochondria, Heart; Oxidative Stress; Probability; Random Allocation; Rats; Rats, Sprague-Dawley; Reference Values; Sirtuin 1; Survival Rate; Tetrazoles; Valine; Valsartan | 2010 |
Modulation of angiotensin II-mediated cardiac remodeling by the MEF2A target gene Xirp2.
Topics: Angiotensin II; Animals; Apoptosis; Binding Sites; Cardiomegaly; Cytoskeletal Proteins; Disease Models, Animal; DNA-Binding Proteins; Fibrosis; Gene Expression Regulation; Infusion Pumps, Implantable; Infusions, Subcutaneous; LIM Domain Proteins; MEF2 Transcription Factors; Mice; Mice, Transgenic; Myocardium; Myogenic Regulatory Factors; Myosin Heavy Chains; Nuclear Proteins; Promoter Regions, Genetic; Signal Transduction; Transcriptional Activation; Ventricular Myosins; Ventricular Remodeling | 2010 |
Caveolin-1 ablation reduces the adverse cardiovascular effects of N-omega-nitro-L-arginine methyl ester and angiotensin II.
Topics: Aldosterone; Amino Acid Sequence; Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Caveolin 1; Endothelial Cells; Male; Mice; Mice, Knockout; Molecular Sequence Data; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase Type III; Receptor, Angiotensin, Type 1; Receptors, Mineralocorticoid; Signal Transduction | 2010 |
Lymphocyte responses exacerbate angiotensin II-dependent hypertension.
Topics: Angiotensin II; Animals; Body Weight; Cardiomegaly; Crosses, Genetic; Disease Progression; Heart; Hemodynamics; Hypertension; Kidney; Lymphocytes; Mice; Mice, Inbred C3H; Mice, SCID; Organ Size; RNA, Messenger | 2010 |
Endothelial nitric oxide synthase-independent protective action of statin against angiotensin II-induced atrial remodeling via reduced oxidant injury.
Topics: Analysis of Variance; Angiotensin II; Animals; Antioxidants; Atrial Fibrillation; Blood Pressure; Blotting, Western; Cardiomegaly; Cyclic N-Oxides; Echocardiography; Fibrosis; Heart Atria; Heart Rate; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Mice; Mice, Knockout; Myocytes, Cardiac; Nitric Oxide Synthase Type III; Oxidative Stress; Quinolines; Renin-Angiotensin System; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Smad2 Protein; Smad3 Protein; Spin Labels; Transforming Growth Factor beta1 | 2010 |
Cardiac-specific activation of angiotensin II type 1 receptor-associated protein completely suppresses cardiac hypertrophy in chronic angiotensin II-infused mice.
Topics: Adaptor Proteins, Signal Transducing; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Blood Pressure; Body Weight; Cardiomegaly; Genotype; Heart Rate; Imidazoles; Male; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Mitogen-Activated Protein Kinase Kinases; Reverse Transcriptase Polymerase Chain Reaction; RNA; Tetrazoles | 2010 |
Growth differentiation factor 15 acts anti-apoptotic and pro-hypertrophic in adult cardiomyocytes.
Topics: Age Factors; Angiotensin II; Animals; Apoptosis; Cardiomegaly; Cells, Cultured; Extracellular Signal-Regulated MAP Kinases; Growth Differentiation Factor 15; Male; Myocytes, Cardiac; Nitric Oxide Donors; Oligonucleotides; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Protein Kinase Inhibitors; Rats; Rats, Wistar; Signal Transduction; Smad1 Protein; Time Factors; Transforming Growth Factor beta1; Ventricular Remodeling | 2010 |
Inhibition of angiotensin-converting enzyme 2 exacerbates cardiac hypertrophy and fibrosis in Ren-2 hypertensive rats.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Cardiomegaly; Fibrosis; Heart Ventricles; Imidazoles; Leucine; Male; Peptide Fragments; Peptidyl-Dipeptidase A; Rats; Rats, Transgenic | 2010 |
Effect of intermedin1-53 on angiotensin II-induced hypertrophy in neonatal rat ventricular myocytes.
Topics: Adrenomedullin; Angiotensin II; Animals; Animals, Newborn; Cardiomegaly; Cells, Cultured; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Heart Ventricles; Myocytes, Cardiac; Natriuretic Peptide, Brain; Neuropeptides; Rats; Rats, Wistar; RNA, Messenger | 2010 |
Novel insights into the mechanisms mediating the local antihypertrophic effects of cardiac atrial natriuretic peptide: role of cGMP-dependent protein kinase and RGS2.
Topics: Adrenergic beta-Agonists; Angiotensin II; Animals; Atrial Natriuretic Factor; Calcium; Cardiomegaly; Cell Line; Cyclic GMP-Dependent Protein Kinases; Humans; Isoproterenol; Kidney; Membrane Potentials; Mice; Mice, Knockout; Myocytes, Cardiac; Patch-Clamp Techniques; Receptors, Atrial Natriuretic Factor; RGS Proteins; TRPC Cation Channels; TRPC6 Cation Channel; Vasoconstrictor Agents | 2010 |
[Inhibitory effect on activated renin-angiotensin system by astragaloside IV in rats with pressure-overload induced cardiac hypertrophy].
Topics: Aldosterone; Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Enzyme-Linked Immunosorbent Assay; Hypertrophy, Left Ventricular; Male; Peptidyl-Dipeptidase A; Polymerase Chain Reaction; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin-Angiotensin System; Saponins; Triterpenes | 2009 |
Angiotensin-(1-9) regulates cardiac hypertrophy in vivo and in vitro.
Topics: Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Biphenyl Compounds; Bradykinin; Cardiomegaly; Cell Enlargement; Cells, Cultured; Enalapril; Humans; Hypertrophy, Left Ventricular; In Vitro Techniques; Insulin-Like Growth Factor I; Male; Myocardial Infarction; Myocytes, Cardiac; Norepinephrine; Peptide Fragments; Peptidyl-Dipeptidase A; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System; Tetrazoles; Ventricular Function, Left | 2010 |
Resveratrol induces mitochondrial biogenesis and ameliorates Ang II-induced cardiac remodeling in transgenic rats harboring human renin and angiotensinogen genes.
Topics: Angiotensin II; Angiotensinogen; Animals; Blood Pressure; Cardiomegaly; Genes; Heart; Humans; Hypertension; Male; Mitochondria; Rats; Rats, Sprague-Dawley; Rats, Transgenic; Renin; Renin-Angiotensin System; Resveratrol; Stilbenes | 2010 |
Antihypertensive effects of Ocimum basilicum L. (OBL) on blood pressure in renovascular hypertensive rats.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Aspartic Acid Endopeptidases; Blood Pressure; Captopril; Cardiomegaly; Disease Models, Animal; Endothelin-1; Endothelin-Converting Enzymes; Hypertension, Renovascular; Kidney; Male; Metalloendopeptidases; Ocimum basilicum; Plant Extracts; Rats; Rats, Wistar | 2010 |
Increased dietary NaCl potentiates the effects of elevated prorenin levels on blood pressure and organ disease.
Topics: Angiotensin II; Angiotensins; Animals; Blood Pressure; Cardiomegaly; Chymosin; Enzyme Precursors; Fibrosis; Hypertension; Kidney Diseases; Male; Random Allocation; Rats; Rats, Transgenic; Renin; Retrospective Studies; Sodium Chloride, Dietary | 2010 |
Monocytic fibroblast precursors mediate fibrosis in angiotensin-II-induced cardiac hypertrophy.
Topics: Angiotensin II; Animals; Cardiomegaly; Chemokine CCL2; Collagen; Fibroblasts; Fibrosis; Hypertension; Lung Diseases, Interstitial; Mice; Mice, Inbred C57BL; Mice, Knockout; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Vasoconstrictor Agents | 2010 |
Celecoxib, but not rofecoxib or naproxen, attenuates cardiac hypertrophy and fibrosis induced in vitro by angiotensin and aldosterone.
Topics: Aldosterone; Angiotensin II; Animals; Animals, Newborn; Anti-Inflammatory Agents, Non-Steroidal; Cardiomegaly; Celecoxib; Collagen; Cyclooxygenase 2 Inhibitors; Female; Fibroblasts; Fibrosis; Heart; Hep G2 Cells; Hepatocytes; Humans; Lactones; Male; Myocardium; Myocytes, Cardiac; Naproxen; Pyrazoles; Rats; Renin-Angiotensin System; Sulfonamides; Sulfones; Vasoconstrictor Agents | 2010 |
A distinct AMP-activated protein kinase phosphorylation site characterizes cardiac hypertrophy induced by L-thyroxine and angiotensin II.
Topics: AMP-Activated Protein Kinases; Angiotensin II; Animals; Cardiomegaly; Cells, Cultured; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocytes, Cardiac; Phosphorylation; Polymerase Chain Reaction; RNA; Thyroxine; Vasoconstrictor Agents | 2010 |
Cross-talk between MAPKs and PI-3K pathways alters the functional density of I(K) channels in hypertrophied hearts.
Topics: Angiotensin II; Animals; Cardiomegaly; Homeostasis; Insulin-Like Growth Factor I; Male; Mitogen-Activated Protein Kinases; p38 Mitogen-Activated Protein Kinases; Patch-Clamp Techniques; Phosphatidylinositol 3-Kinases; Potassium Channels; Rats; Rats, Sprague-Dawley; Receptor Cross-Talk; Signal Transduction | 2010 |
Trimetazidine inhibits pressure overload-induced cardiac fibrosis through NADPH oxidase-ROS-CTGF pathway.
Topics: Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Cell Proliferation; Cells, Cultured; Collagen; Connective Tissue Growth Factor; Disease Models, Animal; Dose-Response Relationship, Drug; Down-Regulation; Fibroblasts; Fibrosis; Hypertension; Male; Malondialdehyde; Myocardium; NADPH Oxidases; rac1 GTP-Binding Protein; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Signal Transduction; Time Factors; Trimetazidine; Vasodilator Agents | 2010 |
Intracellular or extracellular heat shock protein 70 differentially regulates cardiac remodelling in pressure overload mice.
Topics: Angiotensin II; Animals; Antibodies; Benzhydryl Compounds; Blood Pressure; Cardiomegaly; Chemokine CCL2; Disease Models, Animal; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Fibrosis; HSP70 Heat-Shock Proteins; Hypertension; Male; Mice; Mice, Inbred ICR; Myocardium; p38 Mitogen-Activated Protein Kinases; Protein Transport; Pyrrolidinones; Signal Transduction; Time Factors; Toll-Like Receptor 4; Transcription, Genetic; Transforming Growth Factor beta1; Ventricular Remodeling | 2010 |
Silibinin attenuates cardiac hypertrophy and fibrosis through blocking EGFR-dependent signaling.
Topics: Angiotensin II; Animals; Animals, Newborn; Blotting, Western; Cardiomegaly; Cell Shape; Cells, Cultured; Dose-Response Relationship, Drug; ErbB Receptors; Fibrosis; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Male; Mice; Mice, Inbred C57BL; Myocardium; Myocytes, Cardiac; Phosphatidylinositol 3-Kinases; Phosphorylation; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Signal Transduction; Silybin; Silymarin | 2010 |
Mechanical stress-evoked but angiotensin II-independent activation of angiotensin II type 1 receptor induces cardiac hypertrophy through calcineurin pathway.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Calcineurin; Calcineurin Inhibitors; Cardiomegaly; Chlorocebus aethiops; COS Cells; Losartan; Mice; Mice, Mutant Strains; Receptor, Angiotensin, Type 1; Stress, Mechanical; Tacrolimus | 2010 |
The IP3 receptor regulates cardiac hypertrophy in response to select stimuli.
Topics: Age Factors; Angiotensin II; Animals; Arrhythmias, Cardiac; Calcineurin; Calcium Signaling; Cardiomegaly; Disease Models, Animal; Endothelin-1; GTP-Binding Protein alpha Subunits, Gq-G11; Inositol 1,4,5-Trisphosphate; Inositol 1,4,5-Trisphosphate Receptors; Isoproterenol; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Myocytes, Cardiac; Phenotype; Physical Exertion | 2010 |
Apocynin attenuates pressure overload-induced cardiac hypertrophy in rats by reducing levels of reactive oxygen species.
Topics: Acetophenones; Angiotensin II; Animals; Antioxidants; Atrial Natriuretic Factor; Base Sequence; Captopril; Cardiomegaly; DNA Primers; Enzyme Inhibitors; Male; NADPH Oxidases; Phosphoproteins; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; RNA, Messenger | 2010 |
Heparin cofactor II protects against angiotensin II-induced cardiac remodeling via attenuation of oxidative stress in mice.
Topics: Analysis of Variance; Angiotensin II; Animals; Atrial Natriuretic Factor; Cardiomegaly; Echocardiography; Fibrosis; Heart Atria; Heparin Cofactor II; Mice; Mice, Transgenic; Myocardium; Natriuretic Peptide, Brain; Oxidative Stress; Transforming Growth Factor beta1; Ventricular Remodeling | 2010 |
Persistent antihypertensive effect of aliskiren is accompanied by reduced proteinuria and normalization of glomerular area in Ren-2 transgenic rats.
Topics: Amides; Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Cardiomegaly; Disease Models, Animal; Fumarates; Heart Rate; Hypertension; Kidney Glomerulus; Losartan; Male; Proteinuria; Rats; Rats, Transgenic; Renin; Time Factors | 2010 |
The nonpeptide AVE0991 attenuates myocardial hypertrophy as induced by angiotensin II through downregulation of transforming growth factor-beta1/Smad2 expression.
Topics: Angiotensin II; Animals; Animals, Newborn; Cardiomegaly; Cardiovascular Agents; Cell Size; Cells, Cultured; Dose-Response Relationship, Drug; Down-Regulation; Imidazoles; Myocytes, Cardiac; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Sprague-Dawley; Receptors, G-Protein-Coupled; RNA, Messenger; Signal Transduction; Smad2 Protein; Transforming Growth Factor beta1 | 2010 |
Angiotensin-converting enzyme 2 suppresses pathological hypertrophy, myocardial fibrosis, and cardiac dysfunction.
Topics: Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Cardiomegaly; Cells, Cultured; CHO Cells; Collagen Type I, alpha 1 Chain; Cricetinae; Cricetulus; Down-Regulation; Fibrosis; Humans; Hypertrophy, Left Ventricular; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardium; Peptidyl-Dipeptidase A; Recombinant Proteins | 2010 |
Furanocoumarins-imperatorin inhibits myocardial hypertrophy both in vitro and in vivo.
Topics: Angiotensin II; Animals; Cardiomegaly; Cardiovascular Agents; Cells, Cultured; Furocoumarins; Heart Failure; Molecular Structure; Myocardium; Myocytes, Cardiac; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Rats, Sprague-Dawley | 2010 |
Preferential accumulation and export of high molecular weight FGF-2 by rat cardiac non-myocytes.
Topics: Angiotensin II; Animals; Biological Transport, Active; Cardiomegaly; Caspase 1; Cell Enlargement; Cells, Cultured; Culture Media, Conditioned; Fibroblast Growth Factor 2; Fibroblasts; Immunity, Innate; Molecular Weight; Myocardium; Myocytes, Cardiac; Myofibroblasts; Rats; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2 | 2011 |
Salt-induced cardiac hypertrophy and interstitial fibrosis are due to a blood pressure-independent mechanism in Wistar rats.
Topics: Aldosterone; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Blood Pressure; Cardiomegaly; Collagen Type I; Collagen Type III; Disease Models, Animal; Drinking; Eating; Echocardiography; Fibrosis; Gene Expression; Heart Ventricles; Hydralazine; Hypertension; Losartan; Male; Myocardium; Potassium; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin; Renin-Angiotensin System; Sodium; Sodium Chloride, Dietary; Transforming Growth Factor beta; Urine | 2010 |
Gene silencing of myofibrillogenesis regulator-1 by adenovirus-delivered small interfering RNA suppresses cardiac hypertrophy induced by angiotensin II in mice.
Topics: Adenoviridae; Angiotensin II; Animals; Cardiomegaly; Disease Models, Animal; Extracellular Matrix; Gene Silencing; Gene Transfer Techniques; Male; Matrix Metalloproteinase 2; Mice; Mice, Inbred C57BL; Muscle Proteins; RNA, Small Interfering; Signal Transduction; Tissue Inhibitor of Metalloproteinase-2 | 2010 |
Cytochrome P450 1B1 contributes to angiotensin II-induced hypertension and associated pathophysiology.
Topics: Angiotensin II; Animals; Aorta; Aryl Hydrocarbon Hydroxylases; Blood Pressure; Blotting, Western; Cardiomegaly; Cytochrome P-450 CYP1B1; Endothelium, Vascular; Hypertension; Infusions, Intravenous; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mitogen-Activated Protein Kinases; Myocardium; NADPH Oxidases; Organ Size; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Stilbenes; Vasoconstrictor Agents | 2010 |
Evidence that apoptotic signalling in hypertrophic cardiomyocytes is determined by mitochondrial pathways involving protein kinase Cδ.
Topics: Acetophenones; Angiotensin II; Animals; Apoptosis; Benzopyrans; Cardiomegaly; Caspase 3; Caspase 9; Cells, Cultured; Endothelin-1; Imidazoles; Insulin-Like Growth Factor I; Mitochondria; Myocytes, Cardiac; Peptides, Cyclic; Protein Kinase C-delta; Protein Transport; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Endothelin; Signal Transduction; Triiodothyronine | 2010 |
Similar renoprotection after renin-angiotensin-dependent and -independent antihypertensive therapy in 5/6-nephrectomized Ren-2 transgenic rats: are there blood pressure-independent effects?
Topics: Aldosterone; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Cardiomegaly; Creatinine; Diabetic Nephropathies; Diuretics; Drug Therapy, Combination; Furosemide; Hydrochlorothiazide; Hypertension; Indoles; Kidney Failure, Chronic; Labetalol; Losartan; Proteinuria; Rats; Rats, Sprague-Dawley; Rats, Transgenic; Renin; Renin-Angiotensin System | 2010 |
Knockdown of farnesylpyrophosphate synthase prevents angiotensin II-mediated cardiac hypertrophy.
Topics: Angiotensin II; Animals; Cardiomegaly; Dimethylallyltranstransferase; Gene Knockdown Techniques; Humans; Male; MAP Kinase Kinase 4; Mitogen-Activated Protein Kinases; Myocytes, Cardiac; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Rats; Rats, Inbred SHR; Rats, Inbred WKY; rhoA GTP-Binding Protein; RNA, Small Interfering; Signal Transduction; Transfection | 2010 |
Cellular FLICE-inhibitory protein protects against cardiac remodeling induced by angiotensin II in mice.
Topics: Angiotensin II; Animals; Cardiomegaly; CASP8 and FADD-Like Apoptosis Regulating Protein; Extracellular Signal-Regulated MAP Kinases; Fibrosis; Humans; Male; Mice; Mice, Transgenic; Myocardium; Vasoconstrictor Agents; Ventricular Remodeling | 2010 |
Modulation of human embryonic stem cell-derived cardiomyocyte growth: a testbed for studying human cardiac hypertrophy?
Topics: Angiotensin II; Cardiomegaly; Cell Cycle; Cell Differentiation; Cell Line; Cell Proliferation; Cell Size; Cells, Cultured; Embryonic Stem Cells; Gene Expression Regulation; Humans; MAP Kinase Kinase 3; Myocytes, Cardiac; p38 Mitogen-Activated Protein Kinases; Phenylephrine; Protein Kinase Inhibitors; Signal Transduction; Vasoconstrictor Agents | 2011 |
MMP-2 mediates angiotensin II-induced hypertension under the transcriptional control of MMP-7 and TACE.
Topics: ADAM Proteins; ADAM17 Protein; Angiotensin II; Animals; Cardiomegaly; Fibrosis; Gene Expression Regulation, Enzymologic; Hypertension; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 7; Mice; Mice, Inbred C57BL; Myocardium; Rats; Rats, Sprague-Dawley; RNA Interference; Transcription, Genetic; Up-Regulation | 2011 |
The H9C2 cell line and primary neonatal cardiomyocyte cells show similar hypertrophic responses in vitro.
Topics: Angiotensin II; Animals; Cardiomegaly; Cell Culture Techniques; Cell Line; Disease Models, Animal; Endothelin-1; Humans; Myoblasts, Cardiac; Myocytes, Cardiac; Rats | 2011 |
High density lipoprotein downregulates angiotensin II type 1 receptor and inhibits angiotensin II-induced cardiac hypertrophy.
Topics: Angiotensin II; Animals; Cardiomegaly; Cells, Cultured; Disease Models, Animal; Down-Regulation; Lipoproteins, HDL; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; Rats; Receptor, Angiotensin, Type 1 | 2011 |
Mitofusin 2 inhibits angiotensin II-induced myocardial hypertrophy.
Topics: Angiotensin II; Animals; Animals, Newborn; Atrial Natriuretic Factor; Cardiomegaly; Gene Expression Regulation; GTP Phosphohydrolases; Membrane Proteins; Mitochondrial Proteins; Myocytes, Cardiac; Phosphorylation; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Up-Regulation | 2011 |
Concerted regulation of cGMP and cAMP phosphodiesterases in early cardiac hypertrophy induced by angiotensin II.
Topics: Angiotensin II; Animals; Cardiomegaly; Cyclic AMP; Cyclic GMP; Cyclic Nucleotide Phosphodiesterases, Type 4; Gene Expression Regulation, Enzymologic; Heart Ventricles; Hydrolysis; Isoenzymes; Male; Membrane Glycoproteins; Models, Biological; NADPH Oxidase 2; NADPH Oxidases; Rats; Rats, Wistar | 2010 |
[Effect of NOS and PTEN on cardiomyocyte hypertrophy induced by angiotensin II].
Topics: Angiotensin II; Animals; Animals, Newborn; Cardiomegaly; Cells, Cultured; Myocytes, Cardiac; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; PTEN Phosphohydrolase; Rats; Rats, Sprague-Dawley; RNA, Messenger | 2005 |
Impairment of cardiac function and remodeling induced by myocardial infarction in rats are attenuated by the nonpeptide angiotensin-(1-7) analog AVE 0991.
Topics: Angiotensin II; Animals; Cardiomegaly; Cardiotonic Agents; Collagen; Disease Models, Animal; Hemodynamics; Imidazoles; Male; Myocardial Contraction; Myocardial Infarction; Myocardium; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Sprague-Dawley; Receptors, G-Protein-Coupled; Signal Transduction; Stroke Volume; Transforming Growth Factor beta1; Tumor Necrosis Factor-alpha; Ventricular Function, Left; Ventricular Remodeling | 2012 |
Thioredoxin 1 negatively regulates angiotensin II-induced cardiac hypertrophy through upregulation of miR-98/let-7.
Topics: Adenoviridae; Angiotensin II; Animals; Cardiomegaly; Cells, Cultured; Cyclin D2; Disease Models, Animal; Mice; Mice, Transgenic; MicroRNAs; Myocytes, Cardiac; Rats; Rats, Wistar; Signal Transduction; Thioredoxins; Up-Regulation | 2011 |
Lack of microsomal prostaglandin E synthase-1 reduces cardiac function following angiotensin II infusion.
Topics: Angiotensin II; Animals; Blood Pressure; Cardiac Output; Cardiomegaly; Echocardiography; Hypertension; Intramolecular Oxidoreductases; Mice; Mice, Inbred C57BL; Mice, Knockout; Microsomes; Myocytes, Cardiac; Prostaglandin-E Synthases; Ventricular Function | 2011 |
Up-regulation of p27(kip1) contributes to Nrf2-mediated protection against angiotensin II-induced cardiac hypertrophy.
Topics: Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Cells, Cultured; Cyclin-Dependent Kinase Inhibitor p27; Feedback, Physiological; Male; Mice; Myocytes, Cardiac; NF-E2-Related Factor 2; Oxidative Stress; Phenols; Plant Extracts; Rats; RNA Processing, Post-Transcriptional; RNA, Small Interfering; Up-Regulation; Vasoconstrictor Agents | 2011 |
Blood pressures in newborns with twin-twin transfusion syndrome.
Topics: Angiotensin II; Apgar Score; Birth Weight; Blood Pressure; Cardiomegaly; Critical Care; Female; Fetofetal Transfusion; Gestational Age; Heart Ventricles; Hemoglobinometry; Humans; Infant, Newborn; Male; Pregnancy; Survival Rate | 2011 |
IRF3 regulates cardiac fibrosis but not hypertrophy in mice during angiotensin II-induced hypertension.
Topics: Angiotensin II; Animals; Apoptosis; Blotting, Western; Bone Marrow Transplantation; Cardiomegaly; Cell Proliferation; Cells, Cultured; DNA, Complementary; Echocardiography; Fibrosis; Gene Expression Profiling; Hypertension; Immunity, Innate; Interferon Regulatory Factor-3; Leukocyte Common Antigens; Mice; Mice, Inbred ICR; Mice, Knockout; Proto-Oncogene Proteins c-bcl-2; Ventricular Remodeling | 2011 |
Activation of peroxisome proliferator-activated receptor-γ downregulates soluble epoxide hydrolase in cardiomyocytes.
Topics: Angiotensin II; Animals; Cardiomegaly; Cell Line; Epoxide Hydrolases; Gene Expression Regulation, Enzymologic; Humans; Ligands; Male; Mice; Mice, Knockout; Myocytes, Cardiac; PPAR gamma; Promoter Regions, Genetic; Rats; Rats, Sprague-Dawley; Rosiglitazone; Thiazolidinediones; Vasodilator Agents | 2011 |
Restriction of big hearts by a small RNA.
Topics: Angiotensin II; Animals; Cardiomegaly; Cyclin D2; Disease Models, Animal; Mice; MicroRNAs; Oxidation-Reduction; Signal Transduction; Thioredoxins | 2011 |
Mitochondrial oxidative stress mediates angiotensin II-induced cardiac hypertrophy and Galphaq overexpression-induced heart failure.
Topics: Angiotensin II; Animals; Cardiomegaly; Catalase; DNA Damage; DNA, Mitochondrial; Gene Expression Regulation; GTP-Binding Protein alpha Subunits, Gq-G11; Heart Failure; Mice; Mice, Transgenic; Mitochondria, Heart; Models, Animal; Myocytes, Cardiac; Oxidative Stress; Reactive Oxygen Species; Reverse Transcriptase Inhibitors; Zidovudine | 2011 |
Cyclophilin A promotes cardiac hypertrophy in apolipoprotein E-deficient mice.
Topics: Angiotensin II; Animals; Animals, Newborn; Apolipoproteins E; Bone Marrow Cells; Bone Marrow Transplantation; Cardiomegaly; Cell Communication; Cell Movement; Cell Proliferation; Cells, Cultured; Cyclophilin A; Disease Models, Animal; Fibroblasts; Inflammation; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardium; Myocytes, Cardiac; Oxidative Stress; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Recombinant Proteins; Time Factors | 2011 |
Histone acetylation is essential for ANG-II-induced IGF-IIR gene expression in H9c2 cardiomyoblast cells and pathologically hypertensive rat heart.
Topics: Acetylation; Angiotensin II; Animals; Blotting, Western; Cardiomegaly; Chromatin Immunoprecipitation; CpG Islands; DNA Methylation; Gene Expression; Histones; Hypertension; Myoblasts; Myocardium; Myocytes, Cardiac; Rats; Rats, Inbred SHR; Receptor, IGF Type 2; Reverse Transcriptase Polymerase Chain Reaction; Up-Regulation; Ventricular Remodeling | 2012 |
Regulation of L-type inward calcium channel activity by captopril and angiotensin II via the phosphatidyl inositol 3-kinase pathway in cardiomyocytes from volume-overload hypertrophied rat hearts.
Topics: Angiotensin II; Animals; Calcium Channels, L-Type; Captopril; Cardiomegaly; Male; Myocytes, Cardiac; Phosphatidylinositol 3-Kinase; Phosphoinositide-3 Kinase Inhibitors; Rats; Rats, Sprague-Dawley; Signal Transduction | 2011 |
New take on the role of angiotensin II in cardiac hypertrophy and fibrosis.
Topics: Aldosterone; Angiotensin II; Animals; Cardiomegaly; Fibrosis; Humans; Hypertension; Inflammation; Mice; Myocardium; Oxidative Stress; Receptor, Angiotensin, Type 1; Sodium; Ventricular Remodeling | 2011 |
Mitochondrial oxidative stress mediates induction of autophagy and hypertrophy in angiotensin-II treated mouse hearts.
Topics: Angiotensin II; Animals; Autophagy; Cardiomegaly; Catalase; Heart Failure; Mice; Mitochondria, Heart; Oxidative Stress; Peroxisomes; Reactive Oxygen Species | 2011 |
CCR2 mediates the uptake of bone marrow-derived fibroblast precursors in angiotensin II-induced cardiac fibrosis.
Topics: Analysis of Variance; Angiotensin II; Animals; Biomarkers; Blood Pressure; Bone Marrow Cells; Cardiomegaly; Cell Movement; Disease Models, Animal; Fibroblasts; Fibrosis; Heart Diseases; Heart Rate; Hypertension; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardium; Receptors, CCR2; Stem Cells; Stroke Volume; Time Factors; Ultrasonography; Ventricular Dysfunction, Left; Ventricular Function, Left; Ventricular Remodeling | 2011 |
Attenuation of microRNA-22 derepressed PTEN to effectively protect rat cardiomyocytes from hypertrophy.
Topics: Angiotensin II; Animals; Base Sequence; Cardiomegaly; Cell Enlargement; Cells, Cultured; DNA Primers; MicroRNAs; Models, Cardiovascular; Myocytes, Cardiac; Phenylephrine; PTEN Phosphohydrolase; Rats; Up-Regulation | 2012 |
Targeting mitochondrial oxidative stress in heart failure throttling the afterburner.
Topics: Angiotensin II; Cardiomegaly; Heart; Humans; Membrane Potentials; Mitochondria; NADPH Oxidases; Oligopeptides; Oxidative Stress; Reactive Oxygen Species | 2011 |
Adiponectin mediates cardioprotection in oxidative stress-induced cardiac myocyte remodeling.
Topics: Adiponectin; AMP-Activated Protein Kinases; Analysis of Variance; Angiotensin II; Animals; Atrial Natriuretic Factor; Cardiomegaly; Cells, Cultured; Disease Models, Animal; Extracellular Signal-Regulated MAP Kinases; Fibrosis; Genes, Reporter; Hydrogen Peroxide; Hypertrophy, Left Ventricular; Male; Matrix Metalloproteinases; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocytes, Cardiac; NADPH Oxidases; Natriuretic Peptide, Brain; NF-kappa B; Oxidants; Oxidative Stress; Phosphorylation; Rats; Reactive Oxygen Species; Recombinant Proteins; RNA, Messenger; Signal Transduction; Time Factors; Transfection; Ventricular Remodeling | 2011 |
Regulation of the instantaneous inward rectifier and the delayed outward rectifier potassium channels by Captopril and Angiotensin II via the Phosphoinositide-3 kinase pathway in volume-overload-induced hypertrophied cardiac myocytes.
Topics: Angiotensin II; Animals; Blotting, Western; Captopril; Cardiomegaly; Delayed Rectifier Potassium Channels; Male; Myocytes, Cardiac; Patch-Clamp Techniques; Phosphatidylinositol 3-Kinases; Potassium Channels, Inwardly Rectifying; Rats | 2011 |
The role of E2F1 in the development of hypertrophic cardiomyopathy.
Topics: Angiotensin II; Animals; Apoptosis; Atrial Natriuretic Factor; Cardiomegaly; Cardiomyopathy, Hypertrophic; Cardiotonic Agents; Cell Cycle; E2F1 Transcription Factor; Gene Expression Regulation; Humans; Isoproterenol; Male; Mice; Mice, Knockout; Mice, Transgenic; Myocytes, Cardiac; RNA, Messenger; Signal Transduction; Vasoconstrictor Agents | 2011 |
Analysis of p53 and NF-κB signaling in modulating the cardiomyocyte fate during hypertrophy.
Topics: Age Factors; Angiotensin II; Animals; Animals, Newborn; Apoptosis; Cardiomegaly; Cells, Cultured; Male; Myocytes, Cardiac; NF-kappa B; Rats; Rats, Wistar; Signal Transduction; Tumor Suppressor Protein p53; Vasoconstrictor Agents | 2011 |
Role of AT₁ receptor-mediated salt retention in angiotensin II-dependent hypertension.
Topics: Albuminuria; Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Diet, Sodium-Restricted; Disease Progression; Hypertension, Renal; Kidney; Kidney Transplantation; Male; Mice; Mice, 129 Strain; Mice, Inbred C57BL; Mineralocorticoid Receptor Antagonists; Receptor, Angiotensin, Type 1; Salts | 2011 |
The antifibrotic agent pirfenidone inhibits angiotensin II-induced cardiac hypertrophy in mice.
Topics: Angiotensin II; Animals; Blood Pressure; Body Weight; Cardiomegaly; Fibrosis; Heart; Heart Rate; Hypertension; Male; Mice; Mice, Inbred BALB C; Myocardium; Pyridones | 2012 |
Angiotensin-converting enzyme and Angiotensin-converting enzyme 2 are involved in sinoaortic denervation-induced cardiovascular hypertrophy in rats.
Topics: Angiotensin II; Animals; Baroreflex; Base Sequence; Blotting, Western; Cardiomegaly; Denervation; DNA Primers; Isoenzymes; Male; Peptidyl-Dipeptidase A; Rats; Real-Time Polymerase Chain Reaction; Sinoatrial Node | 2011 |
Effects of ethanolic extract from Radix Scrophulariae on ventricular remodeling in rats.
Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Blood Chemical Analysis; Captopril; Cardiomegaly; Collagen; Coronary Vessels; Endothelin-1; Ethanol; Gene Expression Regulation; Hemodynamics; Hydroxyproline; Male; Matrix Metalloproteinase 2; Myocardial Infarction; Myocardium; Myocytes, Cardiac; Organ Size; Plant Extracts; Plant Roots; Random Allocation; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System; RNA, Messenger; Scrophularia; Tumor Necrosis Factor-alpha; Ventricular Remodeling | 2012 |
Changes in cardiac structure and function in rats immunized by angiotensin type 1 receptor peptides.
Topics: Angiotensin II; Animals; Autoantibodies; Blood Pressure; Cardiomegaly; Cell Enlargement; Heart; Heart Rate; Male; Myocytes, Cardiac; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1 | 2011 |
Caloric restriction ameliorates angiotensin II-induced mitochondrial remodeling and cardiac hypertrophy.
Topics: Angiotensin II; Angiotensinogen; Animals; Apoptosis; Autophagy; Blood Pressure; Body Temperature; Caloric Restriction; Cardiomegaly; Endoplasmic Reticulum Stress; Energy Metabolism; Heart Rate; Humans; Mitochondria; Mitochondrial Diseases; Myocytes, Cardiac; Oxidative Stress; Proteome; Rats; Rats, Sprague-Dawley; Rats, Transgenic; Renin; Survival Rate; Vasoconstrictor Agents | 2012 |
Angiotensin II-induced cardiomyocyte hypertrophy in vitro is TAK1-dependent and Smad2/3-independent.
Topics: Angiotensin II; Animals; Animals, Newborn; Cardiomegaly; Cells, Cultured; MAP Kinase Kinase Kinases; Myocytes, Cardiac; Rats; Rats, Sprague-Dawley; Signal Transduction; Smad2 Protein; Smad3 Protein; Transforming Growth Factor beta1 | 2012 |
Pak1 as a novel therapeutic target for antihypertrophic treatment in the heart.
Topics: Angiotensin II; Animals; Cardiomegaly; Disease Models, Animal; Female; Fingolimod Hydrochloride; Male; MAP Kinase Kinase 4; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocytes, Cardiac; NFATC Transcription Factors; p21-Activated Kinases; Propylene Glycols; Rats; Signal Transduction; Sphingosine; Stress, Physiological | 2011 |
Loss of receptor activity-modifying protein 3 exacerbates cardiac hypertrophy and transition to heart failure in a sex-dependent manner.
Topics: Angiotensin II; Animals; Cardiomegaly; Cardiovascular Diseases; Disease Models, Animal; Female; Gene Expression; Gene Expression Profiling; Gene Knockout Techniques; Genetic Association Studies; Heart Failure; Hypertension; Hypertrophy, Right Ventricular; Kidney Diseases; Male; Mice; Mice, Knockout; Phenotype; Proto-Oncogene Proteins c-akt; Receptor Activity-Modifying Protein 3; Renin; Sex Factors | 2012 |
Angiotensin-(1-7) attenuates angiotensin II-induced cardiac remodeling associated with upregulation of dual-specificity phosphatase 1.
Topics: Angiotensin I; Angiotensin II; Animals; Antihypertensive Agents; Cardiomegaly; Drug Interactions; Dual Specificity Phosphatase 1; Fibrosis; Hypertension; Male; MAP Kinase Signaling System; Myocardium; Peptide Fragments; Rats; Rats, Sprague-Dawley; Up-Regulation; Vasoconstrictor Agents; Ventricular Remodeling | 2012 |
Hydrogen sulfide attenuates cardiac hypertrophy and fibrosis induced by abdominal aortic coarctation in rats.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Aortic Coarctation; Cardiomegaly; Connexin 43; Enalapril; Fibrosis; Hydrogen Sulfide; Male; Myocytes, Cardiac; Rats; Rats, Sprague-Dawley | 2012 |
Involvement of autophagy in cardiac remodeling in transgenic mice with cardiac specific over-expression of human programmed cell death 5.
Topics: Angiotensin II; Animals; Apoptosis; Apoptosis Regulatory Proteins; Autophagy; Cardiomegaly; Cardiomyopathy, Dilated; Heart Failure; Humans; Mice; Mice, Transgenic; Myocardium; Myosin Heavy Chains; Neoplasm Proteins; Organ Specificity; Survival Analysis; Ultrasonography; Up-Regulation; Ventricular Remodeling | 2012 |
Cardiac lineage protein-1 (CLP-1) regulates cardiac remodeling via transcriptional modulation of diverse hypertrophic and fibrotic responses and angiotensin II-transforming growth factor β (TGF-β1) signaling axis.
Topics: Angiotensin II; Angiotensinogen; Animals; Cardiomegaly; Extracellular Matrix; Fibroblasts; Fibrosis; Heterozygote; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Myosin Heavy Chains; RNA-Binding Proteins; Signal Transduction; Smad3 Protein; STAT3 Transcription Factor; Transcription Factors; Transcription, Genetic; Transforming Growth Factor beta1; Ventricular Remodeling | 2012 |
Reduction of NADPH-oxidase activity ameliorates the cardiovascular phenotype in a mouse model of Williams-Beuren Syndrome.
Topics: Acetophenones; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Arteries; Blood Pressure; Cardiomegaly; Constriction, Pathologic; Disease Models, Animal; Elastin; Enzyme Activation; Enzyme Inhibitors; Humans; Hypertension; Losartan; Mice; NADPH Oxidases; Oxidative Stress; Sequence Deletion; Williams Syndrome | 2012 |
Sirtuin 6 protects cardiomyocytes from hypertrophy in vitro via inhibition of NF-κB-dependent transcriptional activity.
Topics: Angiotensin II; Animals; Aorta, Abdominal; Cardiomegaly; Cells, Cultured; Constriction, Pathologic; Male; Myocytes, Cardiac; NAD; NF-kappa B; Rats; Rats, Sprague-Dawley; RNA Interference; RNA, Messenger; Sirtuins; Transcription, Genetic; Ultrasonography; Up-Regulation | 2013 |
ET-1 from endothelial cells is required for complete angiotensin II-induced cardiac fibrosis and hypertrophy.
Topics: Angiotensin II; Animals; Blood Pressure; Blotting, Northern; Blotting, Western; Cardiomegaly; Disease Models, Animal; Endothelial Cells; Endothelin-1; Fibrosis; Gene Expression Regulation; Male; Mice; Mice, Knockout; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Myocardium; Polymerase Chain Reaction; Protein Kinase C-delta; Protein Kinase C-epsilon | 2012 |
Effects of proangiotensin-12 infused continuously over 14 days in conscious rats.
Topics: Aldosterone; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Animals; Antihypertensive Agents; Cardiomegaly; Heart; Hypertension; Infusions, Subcutaneous; Male; Myocardium; Organ Size; Peptide Fragments; Random Allocation; Rats; Rats, Wistar; Time Factors; Vasoconstrictor Agents; Weight Gain | 2012 |
Cardiac remodeling is not modulated by overexpression of muscle LIM protein (MLP).
Topics: Angiotensin II; Animals; Animals, Newborn; Aorta; Blood Pressure; Cardiomegaly; Cells, Cultured; Disease Models, Animal; Gene Expression Regulation; Genotype; Ligation; LIM Domain Proteins; Mice; Mice, 129 Strain; Mice, Transgenic; Muscle Proteins; Myocardial Contraction; Myocardium; Phenotype; Rats; Rats, Wistar; Ultrasonography; Ventricular Function, Left; Ventricular Remodeling | 2012 |
Nmnat2 protects cardiomyocytes from hypertrophy via activation of SIRT6.
Topics: Amide Synthases; Angiotensin II; Animals; Cardiomegaly; Gene Knockdown Techniques; Isoenzymes; Male; Myocytes, Cardiac; NAD; Nicotinamide-Nucleotide Adenylyltransferase; Proteasome Endopeptidase Complex; Rats; Rats, Sprague-Dawley; Sirtuins; Tissue Distribution | 2012 |
Nitroxyl (HNO) stimulates soluble guanylyl cyclase to suppress cardiomyocyte hypertrophy and superoxide generation.
Topics: Angiotensin II; Animals; Cardiomegaly; Cell Adhesion Molecules; Cyclic GMP; Endothelin-1; Guanylate Cyclase; Microfilament Proteins; Myocytes, Cardiac; NADPH Oxidases; Natriuretic Peptide, Brain; Nitrites; Nitrogen Oxides; p38 Mitogen-Activated Protein Kinases; Phosphoproteins; Phosphorylation; Rats; Reactive Oxygen Species; Receptors, Cytoplasmic and Nuclear; Signal Transduction; Soluble Guanylyl Cyclase; Superoxides | 2012 |
Promyelocytic leukemia zinc finger protein activates GATA4 transcription and mediates cardiac hypertrophic signaling from angiotensin II receptor 2.
Topics: Angiotensin II; Angiotensin II Type 2 Receptor Blockers; Animals; Binding Sites; Blood Pressure; Cardiomegaly; Fibrosis; GATA4 Transcription Factor; Gene Expression Regulation; Heart; Kruppel-Like Transcription Factors; Male; Mice; Mice, Knockout; Myocytes, Cardiac; Promyelocytic Leukemia Zinc Finger Protein; Protein Binding; Receptor, Angiotensin, Type 2; Signal Transduction; Transcription, Genetic | 2012 |
Choline inhibits angiotensin II-induced cardiac hypertrophy by intracellular calcium signal and p38 MAPK pathway.
Topics: Angiotensin II; Animals; Animals, Newborn; Blotting, Western; Calcineurin; Calcium Signaling; Cardiomegaly; Cells, Cultured; Choline; Electrocardiography; Heart; Hemodynamics; In Vitro Techniques; Male; Mice; Myocytes, Cardiac; Organ Size; p38 Mitogen-Activated Protein Kinases; Rats; Rats, Wistar; Reactive Oxygen Species; Real-Time Polymerase Chain Reaction; Receptor, Muscarinic M3; Signal Transduction | 2012 |
CIKS (Act1 or TRAF3IP2) mediates Angiotensin-II-induced Interleukin-18 expression, and Nox2-dependent cardiomyocyte hypertrophy.
Topics: Adaptor Proteins, Signal Transducing; Angiotensin II; Animals; Cardiomegaly; Cells, Cultured; Collagen; Endomyocardial Fibrosis; Gene Expression; Interleukin-18; Male; Matrix Metalloproteinase 9; Membrane Glycoproteins; Mice; Myocytes, Cardiac; NADPH Oxidase 2; NADPH Oxidases; NF-kappa B; rac1 GTP-Binding Protein; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Transcription Factor AP-1 | 2012 |
Repression of cardiac hypertrophy by KLF15: underlying mechanisms and therapeutic implications.
Topics: Angiotensin II; Animals; Binding Sites; Cardiomegaly; Cell Differentiation; COS Cells; Disease Models, Animal; DNA-Binding Proteins; Gene Expression Regulation; Genetic Therapy; Humans; Kruppel-Like Transcription Factors; Mice; Mutant Proteins; Nuclear Proteins; Oncogene Proteins, Fusion; Promoter Regions, Genetic; Trans-Activators; Transcription Factors | 2012 |
[Hypertension-induced fibrosis: a balance story].
Topics: Aldosterone; Angiotensin II; Animals; Bone Morphogenetic Proteins; Cardiomegaly; Disease Models, Animal; Fibrosis; Gene Expression Regulation; Heart Failure; Hypertension; Male; Mice; Mice, Transgenic; Myocytes, Cardiac; Natriuretic Peptide, Brain; Renin; Renin-Angiotensin System | 2012 |
Agonist-induced hypertrophy and diastolic dysfunction are associated with selective reduction in glucose oxidation: a metabolic contribution to heart failure with normal ejection fraction.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Cardiomegaly; Cyclin-Dependent Kinases; E2F Transcription Factors; Energy Metabolism; Glucose; Heart Failure; Male; Mice; Mice, Inbred C57BL; Myocardium; Oxidation-Reduction; Phenylephrine; Protein Serine-Threonine Kinases; Pyruvate Dehydrogenase Acetyl-Transferring Kinase; Receptor, Angiotensin, Type 1; Receptors, Adrenergic, alpha; Retinoblastoma Protein; Signal Transduction; Stroke Volume; Time Factors; Ultrasonography; Ventricular Function | 2012 |
Cardiomyocyte-specific transgenic expression of lysyl oxidase-like protein-1 induces cardiac hypertrophy in mice.
Topics: Amino Acid Oxidoreductases; Aminopropionitrile; Angiotensin II; Animals; Animals, Newborn; Cardiomegaly; Cells, Cultured; Disease Models, Animal; Echocardiography; Endothelin-1; In Vitro Techniques; Leucine; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Myocytes, Cardiac; Rats; Rats, Wistar | 2012 |
DIOL triterpenes block profibrotic effects of angiotensin II and protect from cardiac hypertrophy.
Topics: Angiotensin II; Animals; Apoptosis; Cardiomegaly; Cell Proliferation; Collagen; Dose-Response Relationship, Drug; Fibrosis; Male; Mice; Myofibroblasts; Oleanolic Acid; Rats; Triterpenes | 2012 |
Interferon-γ signaling inhibition ameliorates angiotensin II-induced cardiac damage.
Topics: Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Fibrosis; Heart; Inflammation; Interferon-gamma; Interleukin-17; Interleukin-23; Kidney; Membrane Proteins; Mice; Mice, Knockout; Microfilament Proteins; Myocardium; Podocytes; Signal Transduction | 2012 |
Angiotensin-converting enzyme 2 over-expression in the central nervous system reduces angiotensin-II-mediated cardiac hypertrophy.
Topics: Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Blood Pressure; Brain; Cardiomegaly; Heart; Hemodynamics; Mice; Neurons; Norepinephrine; Peptidyl-Dipeptidase A; Renin-Angiotensin System | 2012 |
The orphan receptor TR3 participates in angiotensin II-induced cardiac hypertrophy by controlling mTOR signalling.
Topics: Angiotensin II; Animals; Cardiomegaly; Gene Knockdown Techniques; Humans; Male; Mechanistic Target of Rapamycin Complex 1; Mice; Mice, Inbred C57BL; Mice, Knockout; Multiprotein Complexes; Nuclear Receptor Subfamily 4, Group A, Member 1; Proteins; Rats; Signal Transduction; TOR Serine-Threonine Kinases; Tuberous Sclerosis Complex 1 Protein; Tuberous Sclerosis Complex 2 Protein; Tumor Suppressor Proteins; Ubiquitination | 2013 |
Bone morphogenetic protein-4 mediates cardiac hypertrophy, apoptosis, and fibrosis in experimentally pathological cardiac hypertrophy.
Topics: Angiotensin II; Animals; Apoptosis; Bone Morphogenetic Protein 4; Cardiomegaly; Fibrosis; Heart Failure; Humans; Mice; Myocardium; Myocytes, Cardiac; Physical Conditioning, Animal; Reactive Oxygen Species | 2013 |
PARP-2 knockdown protects cardiomyocytes from hypertrophy via activation of SIRT1.
Topics: Angiotensin II; Animals; Cardiomegaly; Cells, Cultured; Male; Myocytes, Cardiac; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Rats; Rats, Sprague-Dawley; RNA, Small Interfering; Sirtuin 1; Transfection | 2013 |
FHL2 prevents cardiac hypertrophy in mice with cardiac-specific deletion of ROCK2.
Topics: Angiotensin II; Animals; Cardiomegaly; Fibrosis; Heart; LIM-Homeodomain Proteins; Male; Mice; Mice, Knockout; Mitogen-Activated Protein Kinases; Muscle Proteins; Myocytes, Cardiac; rho-Associated Kinases; Transcription Factors; Up-Regulation | 2013 |
Inhibition of farnesyl pyrophosphate synthase attenuates angiotensin II-induced cardiac hypertrophy and fibrosis in vivo.
Topics: Alendronate; Angiotensin II; Animals; Atrial Natriuretic Factor; Cardiomegaly; Contraindications; Fibrosis; Gene Expression Regulation; Geranyltranstransferase; Humans; Male; Mice; Myocytes, Cardiac; Natriuretic Peptide, Brain; p38 Mitogen-Activated Protein Kinases; rho GTP-Binding Proteins; rhoA GTP-Binding Protein; Signal Transduction; Terpenes; Transforming Growth Factor beta1 | 2013 |
Atrial natriuretic peptide exerts protective action against angiotensin II-induced cardiac remodeling by attenuating inflammation via endothelin-1/endothelin receptor A cascade.
Topics: Angiotensin II; Animals; Anti-Inflammatory Agents; Atrial Natriuretic Factor; Cardiomegaly; Cells, Cultured; Disease Models, Animal; Endothelin-1; Fibrillar Collagens; Fibroblasts; Fibrosis; Heart Diseases; Inflammation; Inflammation Mediators; Infusions, Intravenous; Macrophages; Male; Mitral Valve; Myocardial Contraction; Myocardium; Rats; Rats, Inbred WKY; Receptor, Endothelin A; Signal Transduction; Stroke Volume; Time Factors; Ventricular Function, Left; Ventricular Remodeling | 2013 |
Apocynin attenuates oxidative stress and cardiac fibrosis in angiotensin II-induced cardiac diastolic dysfunction in mice.
Topics: Acetophenones; Angiotensin II; Animals; Blood Pressure; Blotting, Western; Cardiomegaly; Cardiotonic Agents; Cell Culture Techniques; Cells, Cultured; Diastole; Fibroblasts; Heart Rate; Immunohistochemistry; Male; Mice; Mice, Inbred C57BL; Myocardium; Oxidative Stress | 2013 |
TNF receptor 1 signaling is critically involved in mediating angiotensin-II-induced cardiac fibrosis.
Topics: Angiotensin II; Animals; Cardiomegaly; Cell Differentiation; Cell Size; Cells, Cultured; Coculture Techniques; Collagen; Cytokines; Fibrosis; Gene Expression; Humans; Inflammation Mediators; Mice; Mice, 129 Strain; Mice, Inbred C57BL; Myocardium; Myocytes, Cardiac; Myofibroblasts; Receptors, Tumor Necrosis Factor, Type I; Signal Transduction; Transendothelial and Transepithelial Migration; Transforming Growth Factor beta1; Tumor Necrosis Factor-alpha | 2013 |
Angiotensin II reduces cardiac AdipoR1 expression through AT1 receptor/ROS/ERK1/2/c-Myc pathway.
Topics: Acetyl-CoA Carboxylase; Adenylate Kinase; Adiponectin; Adipose Tissue; Angiotensin II; Animals; Animals, Newborn; Blood Vessels; Cardiomegaly; Enzyme Activation; Gene Expression Regulation; Male; MAP Kinase Signaling System; Membrane Glycoproteins; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Muscle, Skeletal; Myocytes, Cardiac; NADPH Oxidase 2; NADPH Oxidases; Phosphorylation; Proto-Oncogene Proteins c-myc; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Receptors, Adiponectin | 2013 |
Role of STAT3 in angiotensin II-induced hypertension and cardiac remodeling revealed by mice lacking STAT3 serine 727 phosphorylation.
Topics: Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Collagen; Cytokines; Electrocardiography; Fibrosis; Heart; Hemodynamics; Hypertension; Ischemic Preconditioning, Myocardial; Mice; Mice, Inbred C57BL; Mice, Transgenic; Myocardium; Myocytes, Cardiac; Phosphorylation; Serine; STAT3 Transcription Factor; Vasoconstrictor Agents | 2013 |
ANG II causes insulin resistance and induces cardiac metabolic switch and inefficiency: a critical role of PDK4.
Topics: Angiotensin II; Animals; Cardiomegaly; Disease Models, Animal; Echocardiography; Energy Metabolism; Fatty Acids; Glucose; Glucose Tolerance Test; Heart; Heart Failure, Diastolic; Insulin Resistance; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardium; Oxidation-Reduction; Phosphorylation; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins c-akt; Pyruvate Dehydrogenase Acetyl-Transferring Kinase; Pyruvate Dehydrogenase Complex; Renin-Angiotensin System; Sirtuin 3 | 2013 |
Increased preload directly induces the activation of heat shock transcription factor 1 in the left ventricular overloaded heart.
Topics: Angiotensin II; Animals; Cardiomegaly; DNA-Binding Proteins; Epinephrine; Gene Expression Regulation; Heat Shock Transcription Factors; Heat-Shock Proteins; Hemodynamics; Male; Norepinephrine; Organ Culture Techniques; Rats; Rats, Sprague-Dawley; Stress, Mechanical; Transcription Factors; Vasopressins; Ventricular Dysfunction, Left | 2002 |
AT1 receptor blockade reduces cardiac calcineurin activity in hypertensive rats.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Calcineurin; Cardiomegaly; Echocardiography; Fibrosis; Gene Expression Regulation; Hypertension; Male; Myocardium; Peptidyl-Dipeptidase A; Rats; Rats, Inbred SHR; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; RNA, Messenger; Stress, Mechanical; Tacrolimus; Tetrazoles; Time Factors; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2002 |
Sodium tanshinone IIA sulfonate derived from Danshen (Salvia miltiorrhiza) attenuates hypertrophy induced by angiotensin II in cultured neonatal rat cardiac cells.
Topics: Angiotensin II; Animals; Cardiomegaly; Cell Division; Cell Survival; Cells, Cultured; Drug Interactions; Heart; Myocardium; Phenanthrenes; Rats; Rats, Wistar; Salvia miltiorrhiza | 2002 |
Guanylyl cyclase-A inhibits angiotensin II type 1A receptor-mediated cardiac remodeling, an endogenous protective mechanism in the heart.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensinogen; Animals; Atrial Natriuretic Factor; Blood Pressure; Body Weight; Cardiomegaly; Collagen; Fibrosis; Gene Targeting; Guanylate Cyclase; Heart Rate; Heart Ventricles; Hypertension; Imidazoles; Mice; Mice, Knockout; Myocardium; Natriuretic Peptide, Brain; Olmesartan Medoxomil; Organ Size; Peptidyl-Dipeptidase A; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Receptors, Atrial Natriuretic Factor; RNA, Messenger; Tetrazoles; Transforming Growth Factor beta; Transforming Growth Factor beta1; Transforming Growth Factor beta2; Ventricular Remodeling | 2002 |
Tissue angiotensin II during progression or ventricular hypertrophy to heart failure in hypertensive rats; differential effects on PKC epsilon and PKC beta.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Cardiomegaly; Disease Progression; Echocardiography; Enzyme Activation; Heart Failure; Hypertension; Male; Myocardium; Organ Size; Protein Kinase C; Protein Kinase C beta; Protein Kinase C-epsilon; Protein Transport; Rats; Rats, Inbred Dahl; Stress, Mechanical; Tetrazoles; Valine; Valsartan; Ventricular Function, Left | 2002 |
Gq-coupled receptor agonists mediate cardiac hypertrophy via the vasculature.
Topics: Angiotensin II; Animals; Cardiomegaly; Catecholamines; Cells, Cultured; Enzyme Activation; GTP-Binding Protein alpha Subunits, Gq-G11; Heart; Hemodynamics; Heterotrimeric GTP-Binding Proteins; Infusion Pumps, Implantable; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microfilament Proteins; Mitogen-Activated Protein Kinases; Muscle Proteins; Muscle, Smooth, Vascular; Peptide Fragments; Phenylephrine; Receptors, Cell Surface; Serotonin; Signal Transduction; Time; Vasoconstrictor Agents | 2002 |
Time-dependent expression of chymase and angiotensin converting enzyme in the hamster heart under pressure overload.
Topics: Angiotensin II; Animals; Cardiomegaly; Chymases; Cricetinae; Disease Models, Animal; Gene Expression Regulation, Enzymologic; Hypertension, Renal; Male; Myocardium; Myocytes, Cardiac; Peptidyl-Dipeptidase A; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Serine Endopeptidases; Time Factors; Transcription, Genetic; Ventricular Pressure | 2002 |
[Clinico-genetic aspects of the hypotensive response and regression of left ventricular hypertrophy in arterial hypertension patients].
Topics: Angiotensin II; Antihypertensive Agents; Cardiomegaly; Female; Humans; Hypertension; Male; Middle Aged; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Polymorphism, Genetic; Receptors, Angiotensin; Renin-Angiotensin System | 2002 |
Melusin, a muscle-specific integrin beta1-interacting protein, is required to prevent cardiac failure in response to chronic pressure overload.
Topics: Angiotensin II; Animals; Aortic Coarctation; Biomechanical Phenomena; Cardiac Output, Low; Cardiomegaly; Carrier Proteins; Cytoskeletal Proteins; Echocardiography; Female; Gene Silencing; Heart Ventricles; Hemodynamics; Integrin beta1; Male; Mice; Mice, Knockout; Muscle Proteins; Muscle, Skeletal; Myocardium; Phenylephrine; Signal Transduction; Stress, Mechanical; Vasoconstrictor Agents; Ventricular Function | 2003 |
Tonin in rat heart with experimental hypertrophy.
Topics: Adrenergic beta-Agonists; Angiotensin II; Animals; Atrial Natriuretic Factor; Cardiomegaly; Disease Progression; Gene Expression Regulation; Isoproterenol; Male; Myocardium; Organ Size; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; RNA Probes; Tissue Kallikreins | 2003 |
Antihypertrophic actions of the natriuretic peptides in adult rat cardiomyocytes: importance of cyclic GMP.
Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Cardiomegaly; Cyclic GMP; Drug Interactions; Guanylate Cyclase; Male; Muscle Cells; Natriuretic Peptide, Brain; Natriuretic Peptide, C-Type; Rats; Rats, Sprague-Dawley; Receptors, Atrial Natriuretic Factor | 2003 |
[Effects of amiloride on calcium current in thyroxine-induced hypertrophied rat heart].
Topics: Amiloride; Angiotensin II; Animals; Calcium Channels, L-Type; Cardiomegaly; Cell Separation; Female; Male; Myocytes, Cardiac; Random Allocation; Rats; Rats, Wistar; Thyroxine | 2000 |
Cardiovascular and renal effects of cyclooxygenase inhibition in transgenic rats harboring mouse renin-2 gene (TGR[mREN2]27).
Topics: Albuminuria; Angiotensin II; Animals; Animals, Genetically Modified; Antihypertensive Agents; Blood Pressure; Body Weight; Cardiomegaly; Cardiovascular System; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Eating; Furans; Gene Expression Regulation, Enzymologic; Isoenzymes; Kidney; Losartan; Male; Membrane Proteins; Mice; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Sprague-Dawley; Renin; RNA, Messenger; Sulindac; Urination | 2003 |
Sodium restriction prevents cardiac hypertrophy and oxidative stress in angiotensin II hypertension.
Topics: Albuminuria; Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Hypertension, Renal; Myocardium; Oxidative Stress; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Renal Circulation; Sodium, Dietary; Vasoconstrictor Agents | 2003 |
Down-regulation of bradykinin B2-receptor mRNA in the heart in pressure-overload cardiac hypertrophy in the rat.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Aorta; Benzimidazoles; Biphenyl Compounds; Cardiomegaly; Cell Membrane; Down-Regulation; Gene Expression; Heart; Humans; Kallikreins; Kininogens; Male; Myocardium; Rats; Rats, Wistar; Receptor, Bradykinin B2; Receptors, Bradykinin; RNA, Messenger; Tetrazoles; Vasoconstriction | 2003 |
Endothelin ETA receptor antagonism does not attenuate angiotensin II-induced cardiac hypertrophy in vivo in rats.
Topics: Aldosterone; Angiotensin II; Animals; Arginine Vasopressin; Blood Pressure; Cardiomegaly; Endothelin A Receptor Antagonists; Endothelin-1; Heart Ventricles; Infusions, Intravenous; Male; Oxazoles; Rats; Rats, Sprague-Dawley; Renin; Sulfonamides | 2003 |
Expression of the translational repressor NAT1 in experimental models of cardiac hypertrophy.
Topics: Acetyltransferases; Angiotensin II; Animals; Arylamine N-Acetyltransferase; Body Weight; Cardiomegaly; Carrier Proteins; Disease Models, Animal; Gene Expression Regulation; Heart Ventricles; Hypertension; Isoenzymes; Male; Molecular Weight; Organ Size; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Rats, Wistar; RNA Processing, Post-Transcriptional | 2003 |
NADPH oxidase-derived superoxide anion mediates angiotensin II-induced cardiac hypertrophy.
Topics: Angiotensin II; Animals; Antioxidants; Atrial Natriuretic Factor; Cardiomegaly; Myocytes, Cardiac; NADPH Oxidases; Promoter Regions, Genetic; rac1 GTP-Binding Protein; Rats; Reactive Oxygen Species; Superoxides; Vasoconstrictor Agents | 2003 |
Lipoic acid supplementation prevents angiotensin II-induced renal injury.
Topics: Albuminuria; Angiotensin II; Animals; Animals, Genetically Modified; Antioxidants; Blood Pressure; Cardiomegaly; Cell Division; Glutathione; Homeostasis; Kidney; Leukocytes; Male; Myocardium; Nephritis; NF-kappa B; Oxidative Stress; Rats; Rats, Sprague-Dawley; Thioctic Acid; Transcription Factor AP-1; Vasoconstrictor Agents | 2003 |
Activation and functional significance of the renin-angiotensin system in mice with cardiac restricted overexpression of tumor necrosis factor.
Topics: Age Factors; Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensinogen; Animals; Body Weight; Cardiomegaly; Collagen; Hemodynamics; Losartan; Mice; Mice, Transgenic; Myocardium; Organ Size; Organ Specificity; Peptidyl-Dipeptidase A; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Renin; Renin-Angiotensin System; RNA, Messenger; Tumor Necrosis Factor-alpha; Ventricular Remodeling | 2003 |
Cardiology patient page. What is an angiotensin converting enzyme inhibitor?
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Cardiomegaly; Cardiovascular Diseases; Contraindications; Drug Interactions; Humans; Hypertension; Patient Selection; Vasoconstriction | 2003 |
Role of calcineurin in angiotensin II-induced cardiac myocyte hypertrophy of rats.
Topics: Angiotensin II; Animals; Animals, Newborn; Atrial Natriuretic Factor; Calcineurin; Cardiomegaly; Cells, Cultured; Cyclosporine; Myocytes, Cardiac; Rats; Rats, Wistar; RNA, Messenger | 2001 |
Long-term inhibition of Rho-kinase suppresses angiotensin II-induced cardiovascular hypertrophy in rats in vivo: effect on endothelial NAD(P)H oxidase system.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Angiotensin II; Animals; Aorta, Thoracic; Cardiomegaly; Cell Movement; Coronary Vessels; Endothelium, Vascular; Enzyme Inhibitors; Hypertension; Intracellular Signaling Peptides and Proteins; Macrophages; Male; NADPH Oxidases; Organ Culture Techniques; Protein Serine-Threonine Kinases; Rats; Rats, Inbred WKY; rho-Associated Kinases; Superoxides; Vasoconstrictor Agents; Vasodilation | 2003 |
Protective effects of the angiotensin II type 1 (AT1) receptor blockade in low-renin deoxycorticosterone acetate (DOCA)-treated spontaneously hypertensive rats.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Cardiomegaly; Desoxycorticosterone; Endothelins; Hypertension; Isoprostanes; Kidney; Losartan; Male; Malondialdehyde; Proteinuria; Rats; Rats, Inbred SHR; Renin | 2004 |
Contrasting roles of NADPH oxidase isoforms in pressure-overload versus angiotensin II-induced cardiac hypertrophy.
Topics: Angiotensin II; Animals; Aorta; Bacterial Proteins; Blood Pressure; Cardiomegaly; Constriction, Pathologic; Disease Models, Animal; Disease Progression; Hypertension; Isoenzymes; Male; Membrane Glycoproteins; Mice; Mice, Knockout; Myocardium; NADH, NADPH Oxidoreductases; NADPH Oxidase 2; NADPH Oxidase 4; NADPH Oxidases; Reactive Oxygen Species | 2003 |
Apoptosis signal-regulating kinase 1 plays a pivotal role in angiotensin II-induced cardiac hypertrophy and remodeling.
Topics: Angiotensin II; Animals; Apoptosis; Blood Pressure; Body Weight; Cardiomegaly; Coronary Vessels; Disease Models, Animal; Disease Progression; Fibrosis; Gene Expression; Heart Rate; Infusion Pumps, Implantable; MAP Kinase Kinase Kinase 5; MAP Kinase Kinase Kinases; Mice; Mice, Knockout; Mitogen-Activated Protein Kinases; Myocardium; Receptor, Angiotensin, Type 1; Superoxides; Ventricular Remodeling | 2003 |
Cardiomyocyte-specific endothelin A receptor knockout mice have normal cardiac function and an unaltered hypertrophic response to angiotensin II and isoproterenol.
Topics: Angiotensin II; Animals; Base Sequence; Cardiomegaly; DNA; Female; Heart; Isoproterenol; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardial Contraction; Myocytes, Cardiac; Receptor, Endothelin A; Receptor, Endothelin B; RNA, Messenger | 2003 |
Elevated intracardiac angiotensin II leads to cardiac hypertrophy and mechanical dysfunction in normotensive mice.
Topics: Angiotensin II; Angiotensinogen; Animals; Blood Pressure; Cardiomegaly; Heart Rate; Mice; Mice, Transgenic; Myocardial Contraction; Myocardium; Rats; Tachycardia, Ventricular; Ventricular Remodeling | 2003 |
Angiotensin II signaling pathways mediate expression of cardiac T-type calcium channels.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Animals, Newborn; Bosentan; Butadienes; Calcium Channels, T-Type; Calcium-Calmodulin-Dependent Protein Kinases; Cardiomegaly; Constriction, Pathologic; Dose-Response Relationship, Drug; Endothelin Receptor Antagonists; Endothelin-1; Enzyme Inhibitors; Flavonoids; Gene Expression; Losartan; Male; Membrane Potentials; Mitogen-Activated Protein Kinase Kinases; Myocytes, Cardiac; Nickel; Nitriles; Oligopeptides; Peptides, Cyclic; Piperidines; Rats; Rats, Wistar; Receptors, Angiotensin; Receptors, Endothelin; RNA, Messenger; Signal Transduction; Sulfonamides | 2003 |
Accelerated cardiac hypertrophy and renal damage induced by angiotensin II in adrenomedullin knockout mice.
Topics: Adrenomedullin; Angiotensin II; Animals; Cardiomegaly; Male; Mice; Mice, Knockout; Peptides; Renal Insufficiency; Time Factors; Vasoconstrictor Agents; Vasodilator Agents | 2003 |
Entacapone protects from angiotensin II-induced inflammation and renal injury.
Topics: Angiotensin II; Animals; Animals, Genetically Modified; Biomarkers; Blood Pressure; Cardiomegaly; Catechol O-Methyltransferase; Catechols; Creatinine; Dinoprost; Disease Models, Animal; Dopamine; Enzyme Inhibitors; Hypertension; Inflammation; Intercellular Adhesion Molecule-1; Kidney; Kidney Diseases; Leukocytes; Male; Models, Cardiovascular; Nitriles; Norepinephrine; Rats; Rats, Sprague-Dawley; RNA, Messenger | 2003 |
Inhibitory effect of antisense oligodeoxynucleotide to p44/p42 MAPK on angiotensin II-induced hypertrophic response in cultured neonatal rat cardiac myocyte.
Topics: Angiotensin II; Animals; Animals, Newborn; Cardiomegaly; Cells, Cultured; Gene Expression; Genes, fos; Genes, myc; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Myocytes, Cardiac; Oligodeoxyribonucleotides, Antisense; Rats; Rats, Wistar; RNA, Messenger | 2004 |
Inhibitory effect of epigallocatechin 3-O-gallate on vascular smooth muscle cell hypertrophy induced by angiotensin II.
Topics: Angiotensin II; Animals; Cardiomegaly; Catechin; Cells, Cultured; Male; Mitogen-Activated Protein Kinase Kinases; Muscle, Smooth, Vascular; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction | 2004 |
Role for thromboxane receptors in angiotensin-II-induced hypertension.
Topics: Albuminuria; Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Cyclooxygenase 1; Heart; Heart Rate; Hypertension; Isoenzymes; Male; Membrane Proteins; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Knockout; Myocardium; Prostaglandin-Endoperoxide Synthases; Receptors, Thromboxane A2, Prostaglandin H2; Survival Analysis | 2004 |
Inhibitory effect of trilinolein on angiotensin II-induced cardiomyocyte hypertrophy.
Topics: Angiotensin II; Animals; Cardiomegaly; Cells, Cultured; Dose-Response Relationship, Drug; Myocytes, Cardiac; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Triglycerides | 2004 |
Angiotensin II induced upregulation of G alpha q/11, phospholipase C beta 3 and extracellular signal-regulated kinase 1/2 via angiotensin II type 1 receptor.
Topics: Angiotensin II; Animals; Cardiomegaly; Cells, Cultured; GTP-Binding Protein alpha Subunits, Gq-G11; Hypertension; Isoenzymes; Male; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Myocytes, Cardiac; Phospholipase C beta; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Signal Transduction; Type C Phospholipases; Up-Regulation | 2004 |
Tissue angiotensin II in the regulation of inflammatory and fibrogenic components of repair in the rat heart.
Topics: Aldosterone; Angiotensin II; Animals; Cardiomegaly; Collagen Type I; Disease Models, Animal; Drug Therapy, Combination; Fibrosis; Heart; In Situ Hybridization; Infusions, Parenteral; Male; Myocardium; Nephrectomy; NF-kappa B; Rats; Rats, Sprague-Dawley; Sodium Chloride, Dietary; Tetrazoles; Valine; Valsartan | 2004 |
Direct evidence for increased hydroxyl radicals in angiotensin II-induced cardiac hypertrophy through angiotensin II type 1a receptor.
Topics: Angiotensin II; Animals; Blood Pressure Determination; Cardiomegaly; Cyclic N-Oxides; Electron Spin Resonance Spectroscopy; Hydroxyl Radical; Mice; Mice, Knockout; Myocardium; Nitrogen Oxides; Reactive Oxygen Species; Receptor, Angiotensin, Type 1 | 2003 |
Protective effects of endogenous adrenomedullin on cardiac hypertrophy, fibrosis, and renal damage.
Topics: Adrenomedullin; Angiotensin II; Angiotensinogen; Animals; Aorta, Abdominal; Cardiomegaly; Collagen Type I; Constriction; Enzyme Activation; Enzyme Inhibitors; Fibroblasts; Fibrosis; Gene Expression Regulation; Genes, fos; Genes, Lethal; Glomerulosclerosis, Focal Segmental; Heterozygote; Male; MAP Kinase Signaling System; Mice; Mice, Knockout; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Myocytes, Cardiac; Natriuretic Peptide, Brain; Peptides; Peptidyl-Dipeptidase A; Protein Kinase C; Proto-Oncogene Proteins c-fos; Transforming Growth Factor beta; Ventricular Remodeling | 2004 |
Influence of cytokines and growth factors in ANG II-mediated collagen upregulation by fibroblasts in rats: role of myocytes.
Topics: Angiotensin II; Animals; Cardiomegaly; Cells, Cultured; Coculture Techniques; Collagen; Cytokines; Fibroblasts; Interleukin-6; Myocardium; Myocytes, Cardiac; Paracrine Communication; Rats; Rats, Inbred WKY; RNA, Messenger; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha; Up-Regulation | 2004 |
Activation of IP prostanoid receptors prevents cardiomyocyte hypertrophy via cAMP-dependent signaling.
Topics: Angiotensin II; Animals; Biomarkers; Cardiomegaly; Cyclic AMP; Endothelin-1; Epoprostenol; Iloprost; Male; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Myocytes, Cardiac; Rats; Rats, Sprague-Dawley; Receptors, Epoprostenol; Receptors, Prostaglandin; Signal Transduction | 2004 |
High-level apoptosis is persistent in myocardiocytes of sinoaortic-denervated rats.
Topics: Angiotensin II; Animals; Apoptosis; Baroreflex; bcl-2-Associated X Protein; Body Weight; Cardiomegaly; Denervation; Fas Ligand Protein; fas Receptor; Male; Membrane Glycoproteins; Myocytes, Cardiac; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Sprague-Dawley | 2004 |
Aldosterone antagonist facilitates the cardioprotective effects of angiotensin receptor blockers in hypertensive rats.
Topics: Aldosterone; Angiotensin II; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Body Weight; Cardiomegaly; Cardiotonic Agents; Collagen Type I; Collagen Type III; Drug Synergism; Fibrosis; Hypertension; Male; Mineralocorticoid Receptor Antagonists; Myocardium; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; RNA, Messenger; Spironolactone; Tetrazoles | 2004 |
Osteopontin modulates angiotensin II-induced fibrosis in the intact murine heart.
Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Blood Pressure; Blotting, Northern; Cardiomegaly; Cell Adhesion; Cell Division; Disease Models, Animal; Dose-Response Relationship, Drug; Extracellular Matrix; Fibroblasts; Fibrosis; Mice; Mice, Knockout; Models, Cardiovascular; Muscle Proteins; Myocardium; Nuclear Proteins; Osteopontin; Repressor Proteins; Sialoglycoproteins; Up-Regulation; Vasoconstrictor Agents | 2004 |
Thioredoxin-interacting protein controls cardiac hypertrophy through regulation of thioredoxin activity.
Topics: Angiotensin II; Animals; Aortic Diseases; Cardiomegaly; Carrier Proteins; Cell Cycle Proteins; Cell Size; Cells, Cultured; Constriction, Pathologic; Disease Models, Animal; Genetic Vectors; Heart; Ligation; Male; Myocardium; Myocytes, Cardiac; Oxidation-Reduction; Phenylephrine; Random Allocation; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Signal Transduction; Single-Blind Method; Stress, Mechanical; Thioredoxins; Transcriptional Activation | 2004 |
Role of osteopontin in cardiac fibrosis and remodeling in angiotensin II-induced cardiac hypertrophy.
Topics: Aldosterone; Angiotensin II; Animals; Apoptosis; Blood Pressure; Cardiomegaly; Cell Size; Eplerenone; Fibrosis; Heart Rate; Hypertrophy, Left Ventricular; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardium; Myocytes, Cardiac; Osteopontin; Reverse Transcriptase Polymerase Chain Reaction; Sialoglycoproteins; Spironolactone; Ultrasonography; Ventricular Remodeling | 2004 |
Vascular synthesis of aldosterone: role in hypertension.
Topics: Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Vessels; Cardiomegaly; Cytochrome P-450 CYP11B2; Hypertension; Male; Rats; Rats, Inbred SHR; Rats, Wistar; Receptor, Angiotensin, Type 1; RNA, Messenger; Sodium Chloride; Species Specificity | 2004 |
Mechanical stress activates angiotensin II type 1 receptor without the involvement of angiotensin II.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Cardiomegaly; COS Cells; Cytosol; GTP-Binding Proteins; Humans; Janus Kinase 2; Mice; Mice, Knockout; Mitogen-Activated Protein Kinases; Muscle Contraction; Myocytes, Cardiac; Phosphatidylinositols; Protein Transport; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Stress, Mechanical; Tetrazoles; Up-Regulation | 2004 |
Hypertension caused by angiotensin II infusion involves increased superoxide production in the central nervous system.
Topics: Adenoviridae; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Brain Chemistry; Cardiomegaly; Genetic Therapy; Genetic Vectors; Humans; Hypertension; Infusion Pumps, Implantable; Infusions, Parenteral; Injections, Intraventricular; Isoenzymes; Losartan; Mice; Mice, Inbred C57BL; Myocardium; Organ Size; Oxidation-Reduction; Oxidative Stress; Recombinant Fusion Proteins; Subfornical Organ; Superoxide Dismutase; Superoxides | 2004 |
Heme oxygenase-1 inhibits angiotensin II-induced cardiac hypertrophy in vitro and in vivo.
Topics: Angiotensin II; Animals; Bilirubin; Cardiomegaly; Heme Oxygenase (Decyclizing); Heme Oxygenase-1; Male; Myocytes, Cardiac; Rats; Rats, Wistar; Reactive Oxygen Species | 2004 |
A ternary complex of transcription factors, Nishéd and NFATc4, and co-activator p300 bound to an intronic sequence, intronic regulatory element, is pivotal for the up-regulation of myosin light chain-2v gene in cardiac hypertrophy.
Topics: Amino Acid Sequence; Angiotensin II; Animals; Base Sequence; Binding, Competitive; Blotting, Northern; Blotting, Western; Cardiac Myosins; Cardiomegaly; Cell Nucleus; Cells, Cultured; Chick Embryo; DNA; DNA-Binding Proteins; DNA, Complementary; Gene Library; Genes, Reporter; Introns; Luciferases; Models, Genetic; Molecular Sequence Data; Muscle, Skeletal; Myosin Light Chains; NFATC Transcription Factors; Nuclear Proteins; Oligonucleotides; Precipitin Tests; Protein Binding; Repressor Proteins; RNA; RNA, Messenger; T-Lymphocytes; Trans-Activators; Transcription Factors; Transcription, Genetic; Transfection; Up-Regulation | 2004 |
Prolonged endoplasmic reticulum stress in hypertrophic and failing heart after aortic constriction: possible contribution of endoplasmic reticulum stress to cardiac myocyte apoptosis.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Aortic Valve Stenosis; Apoptosis; Cardiomegaly; Cells, Cultured; Disease Models, Animal; Disease Progression; Endoplasmic Reticulum; Gene Expression Regulation; Heart Failure; Humans; Imidazoles; Ligation; Male; Mice; Mice, Inbred C57BL; Molecular Chaperones; Myocytes, Cardiac; Natriuretic Peptide, Brain; Olmesartan Medoxomil; Rats; Rats, Inbred WKY; RNA, Messenger; Signal Transduction; Stress, Physiological; Tetrazoles; Thapsigargin; Tunicamycin | 2004 |
Angiotensin AT2 receptor contributes to cardiovascular remodelling of aged rats during chronic AT1 receptor blockade.
Topics: Aging; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Animals; Aorta; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Cardiomegaly; Fibrosis; Heart Rate; Hypertrophy; Imidazoles; Myocardium; Pyridines; Rats; Rats, Inbred WKY; Receptor, Angiotensin, Type 2; Telemetry; Tetrazoles; Ventricular Remodeling | 2004 |
Isorhapontigenin, a new resveratrol analog, attenuates cardiac hypertrophy via blocking signaling transduction pathways.
Topics: Angiotensin II; Animals; Antioxidants; Aorta; Blood Pressure; Blotting, Western; Cardiomegaly; Dose-Response Relationship, Drug; Echocardiography; Enzyme Activation; Free Radicals; Glutathione Peroxidase; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Heart; Heart Ventricles; Hydrogen Peroxide; L-Lactate Dehydrogenase; Leucine; Lipid Peroxidation; Malondialdehyde; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Models, Chemical; Myocytes, Cardiac; NF-kappa B; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Protein Kinase C; Proto-Oncogene Proteins c-fos; Proto-Oncogene Proteins c-jun; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Resveratrol; Ribosomal Protein S6 Kinases, 70-kDa; Signal Transduction; Stilbenes; Superoxide Dismutase; Time Factors; Transcription Factor AP-1 | 2005 |
Development of a substrate of atrial fibrillation during chronic atrioventricular block in the goat.
Topics: Aldosterone; Angiotensin II; Animals; Atrial Fibrillation; Atrial Natriuretic Factor; Cardiac Pacing, Artificial; Cardiomegaly; Cell Size; Chronic Disease; Connexin 43; Connexins; Female; Gap Junction alpha-5 Protein; Goats; Heart Block; Heart Conduction System; Hemodynamics; Hypertrophy; Myocytes, Cardiac; Neural Conduction; Norepinephrine; Refractory Period, Electrophysiological | 2005 |
PKCepsilon-PKD1 signaling complex at Z-discs plays a pivotal role in the cardiac hypertrophy induced by G-protein coupling receptor agonists.
Topics: Adrenergic alpha-Agonists; Angiotensin II; Animals; Cardiomegaly; Cells, Cultured; Endothelin-1; Heart; Mutation; Myocardium; Norepinephrine; Phorbol Esters; Protein Kinase C; Protein Kinase C-epsilon; Rats; Rats, Wistar; Receptors, G-Protein-Coupled; Signal Transduction | 2005 |
Magnesium supplementation prevents angiotensin II-induced myocardial damage and CTGF overexpression.
Topics: Angiotensin II; Angiotensinogen; Animals; Animals, Genetically Modified; Blood Pressure; Cardiomegaly; Connective Tissue Growth Factor; Dietary Supplements; Fibrosis; Humans; Immediate-Early Proteins; Immunosuppressive Agents; Intercellular Signaling Peptides and Proteins; Magnesium; Male; Myocardium; Rats; Rats, Sprague-Dawley; Renin; RNA, Messenger; Tacrolimus | 2005 |
Letter regarding article by Hu et al, "heme oxygenase-1 inhibits angiotensin II-induced cardiac hypertrophy in vitro and in vivo".
Topics: Angiotensin II; Carbon Monoxide; Cardiomegaly; Cell Proliferation; Heme Oxygenase (Decyclizing); Heme Oxygenase-1; Humans; Membrane Proteins; Organometallic Compounds; Proto-Oncogene Proteins p21(ras); Reactive Oxygen Species | 2005 |
Angiotensin II-dependent chronic hypertension and cardiac hypertrophy are unaffected by gp91phox-containing NADPH oxidase.
Topics: Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Chronic Disease; Collagen; Humans; Hypertension; Kidney; Membrane Glycoproteins; Mice; Mice, Transgenic; Myocardium; NADH, NADPH Oxidoreductases; NADPH Oxidase 1; NADPH Oxidase 2; NADPH Oxidase 4; NADPH Oxidases; Reactive Oxygen Species; Renin; Tyrosine | 2005 |
The FOXO3a transcription factor regulates cardiac myocyte size downstream of AKT signaling.
Topics: Angiotensin II; Animals; Animals, Newborn; Cardiomegaly; Cell Size; Cells, Cultured; DNA-Binding Proteins; Enzyme Activation; Forkhead Box Protein O3; Forkhead Transcription Factors; Gene Expression; Gene Expression Regulation; Growth Hormone; Heart Ventricles; Insulin; Insulin-Like Growth Factor I; Mechanoreceptors; Mice; Mice, Knockout; Microarray Analysis; Muscle Proteins; Mutagenesis; Myocytes, Cardiac; Nerve Tissue Proteins; Phosphorylation; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Rats; Receptor, Insulin; RNA, Messenger; Signal Transduction; SKP Cullin F-Box Protein Ligases; Transcription Factors; Transfection | 2005 |
Elevated dietary sodium intake exacerbates myocardial hypertrophy associated with cardiac-specific overproduction of angiotensin II.
Topics: Angiotensin II; Angiotensinogen; Animals; Cardiomegaly; Dose-Response Relationship, Drug; Mice; Mice, Transgenic; Myocardium; Organ Size; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Sodium, Dietary | 2004 |
A potential role for angiotensin II in obesity induced cardiac hypertrophy and ischaemic/reperfusion injury.
Topics: Angiotensin II; Animals; Blood Glucose; Cardiac Output; Cardiomegaly; Male; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Obesity; Rats; Rats, Wistar; Tumor Necrosis Factor-alpha; Ventricular Remodeling | 2005 |
Inhibition of Rho-kinase by fasudil attenuated angiotensin II-induced cardiac hypertrophy in apolipoprotein E deficient mice.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Angiotensin II; Animals; Apolipoproteins E; Atrial Natriuretic Factor; Blood Pressure; Cardiomegaly; Collagen Type III; Coronary Vessels; Dose-Response Relationship, Drug; Fibrosis; Gene Expression; Heart Rate; Intracellular Signaling Peptides and Proteins; Male; Mice; Mice, Knockout; Myocardium; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Reverse Transcriptase Polymerase Chain Reaction; rho-Associated Kinases; RNA, Messenger; Up-Regulation | 2005 |
Cyclooxygenase-2 inhibitors attenuate angiotensin II-induced oxidative stress, hypertension, and cardiac hypertrophy in rats.
Topics: Angiotensin II; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cardiomegaly; Cells, Cultured; Cyclooxygenase Inhibitors; Hypertension; Lactones; Male; Myocardium; NF-kappa B; Oxidative Stress; Rats; Rats, Sprague-Dawley; Sulfonamides; Sulfones | 2005 |
Requirement of nuclear factor-kappaB in angiotensin II- and isoproterenol-induced cardiac hypertrophy in vivo.
Topics: Angiotensin II; Animals; Apoptosis; Cardiomegaly; I-kappa B Proteins; Interleukin-6; Isoproterenol; Mice; Myocytes, Cardiac; NF-kappa B; NF-KappaB Inhibitor alpha; Receptors, Interleukin-6 | 2005 |
[Effect of danshensu and ligustrazine on related genes of myocardial hypertrophy induced by angiotensin II].
Topics: Angiotensin II; Animals; Animals, Newborn; Atrial Natriuretic Factor; Cardiomegaly; Cells, Cultured; Drugs, Chinese Herbal; Female; Lactates; Male; Myocytes, Cardiac; Pyrazines; Rats; Rats, Wistar; RNA, Messenger | 2005 |
Correction of endothelial dysfunction by tetrahydrobiopterin: new hope for the treatment of arterial hypertension?
Topics: Angiotensin II; Animals; Antioxidants; Biopterins; Cardiomegaly; Endothelium, Vascular; Hypertension; Immunohistochemistry; Male; Myocardium; NADPH Oxidases; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Rats; Rats, Sprague-Dawley; RNA, Messenger; Superoxides; Tyrosine; Up-Regulation | 2005 |
Supplementation with tetrahydrobiopterin prevents the cardiovascular effects of angiotensin II-induced oxidative and nitrosative stress.
Topics: Acetophenones; Angiotensin II; Animals; Antioxidants; Aorta, Thoracic; Biopterins; Cardiomegaly; Disease Models, Animal; Enzyme Inhibitors; Hypertension; Immunohistochemistry; Male; NADPH Oxidases; Nitrates; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Nitrites; Oxidative Stress; Rats; Rats, Sprague-Dawley; RNA, Messenger; Superoxides; Time Factors; Tyrosine; Up-Regulation | 2005 |
Androgen receptor gene knockout male mice exhibit impaired cardiac growth and exacerbation of angiotensin II-induced cardiac fibrosis.
Topics: Angiotensin II; Animals; Blood Pressure; Cardiomegaly; DNA-Binding Proteins; Fibrosis; Heart Rate; Male; Mice; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinase 7; Myocardium; Receptors, Androgen; RNA, Messenger; Smad2 Protein; Trans-Activators; Transforming Growth Factor beta; Transforming Growth Factor beta1; Ventricular Remodeling | 2005 |
Continuous inhibition of the renin-angiotensin system and protection from hypertensive end-organ damage by brief treatment with angiotensin II type 1 receptor blocker in stroke-prone spontaneously hypertensive rats.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Blood Pressure; Cardiomegaly; Cerebral Cortex; Histocytochemistry; Hypertension; Intercellular Adhesion Molecule-1; Kidney; Male; Myocardium; Nephrosclerosis; Rats; Rats, Inbred SHR; Renin; Renin-Angiotensin System; Stroke | 2005 |
Different effects on inhibition of cardiac hypertrophy in spontaneously hypertensive rats by monotherapy and combination therapy of adrenergic receptor antagonists and/or the angiotensin II type 1 receptor blocker under comparable blood pressure reduction
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Atenolol; Blood Pressure; Cardiomegaly; Doxazosin; Drug Therapy, Combination; Echocardiography; Heart Rate; Hypertension; Losartan; Male; Natriuretic Peptide, Brain; Rats; Rats, Inbred SHR; RNA, Messenger | 2005 |
Growing old, angiotensin II, cardiac hypertrophy, and death: making the connection with p66Shc.
Topics: Adaptor Proteins, Signal Transducing; Aging; Angiotensin II; Animals; Cardiomegaly; Humans; Hypertension; Shc Signaling Adaptor Proteins; Src Homology 2 Domain-Containing, Transforming Protein 1 | 2005 |
Angiotensin II-mediated phenotypic cardiomyocyte remodeling leads to age-dependent cardiac dysfunction and failure.
Topics: Aging; Angiotensin II; Angiotensinogen; Animals; Calcium; Calcium-Transporting ATPases; Cardiac Output, Low; Cardiomegaly; Cardiomyopathy, Dilated; Male; Mice; Mice, Transgenic; Myocardial Contraction; Myocardium; Myocytes, Cardiac; Myosin Heavy Chains; Phenotype; Promoter Regions, Genetic; Rats; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Ventricular Remodeling | 2005 |
Role of blood pressure reduction in prevention of cardiac and vascular hypertrophy.
Topics: Adrenergic beta-Antagonists; Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Atenolol; Blood Pressure; Cardiomegaly; Collagen; Disease Progression; Endothelium, Vascular; Heart Rate; Hypertension; Imidazoles; Male; Mesenteric Arteries; Myocardium; Rats; Rats, Inbred SHR; Tetrazoles; Vascular Diseases; Vascular Resistance | 2005 |
Characterizing the role of endothelin-1 in the progression of cardiac hypertrophy in aryl hydrocarbon receptor (AhR) null mice.
Topics: Angiotensin II; Animals; Blood Pressure; Body Weight; Cardiomegaly; Disease Progression; Echocardiography; Endothelin A Receptor Antagonists; Endothelin-1; Fibrosis; Hypertrophy, Left Ventricular; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocytes, Cardiac; Organ Size; Peptides, Cyclic; Receptor, Endothelin A; Receptors, Aryl Hydrocarbon; RNA, Messenger | 2006 |
Role of myofibrillogenesis regulator-1 in myocardial hypertrophy.
Topics: Amino Acid Sequence; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Animals, Newborn; Aortic Valve Stenosis; Cardiomegaly; Cell Size; Losartan; Male; Molecular Sequence Data; Muscle Proteins; Myocytes, Cardiac; Rats; Rats, Sprague-Dawley; RNA Interference | 2006 |
Pitavastatin inhibits cardiac hypertrophy in a rat model of progressive renal injury.
Topics: Angiotensin II; Animals; Animals, Newborn; Atrial Natriuretic Factor; Blood Pressure; Cardiomegaly; Cells, Cultured; Disease Models, Animal; Disease Progression; Enzyme Activation; Enzyme Inhibitors; Extracellular Signal-Regulated MAP Kinases; Kidney; Male; Myocytes, Cardiac; Nephrectomy; Phosphorylation; Quinolines; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Vasoconstrictor Agents | 2005 |
Mechanical stretch-induced hypertrophy of neonatal rat ventricular myocytes is mediated by beta(1)-integrin-microtubule signaling pathways.
Topics: Angiotensin II; Animals; Animals, Newborn; Antibodies; Cardiomegaly; Cells, Cultured; Colchicine; Disease Models, Animal; In Vitro Techniques; Integrin beta1; Microscopy, Confocal; Microtubules; Myocytes, Cardiac; Rats; Rats, Sprague-Dawley; Signal Transduction; Stress, Mechanical | 2006 |
Angiotensin-converting enzyme inhibitors: a new mechanism of action.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Cardiomegaly; Cell Division; Collagen; Heart; Kidney; Leukocyte Count; Male; Myocardium; Rats; Rats, Sprague-Dawley; Ventricular Function, Left | 2005 |
[Relationship between apoptosis and alteration of the energetic metabolism pathways of hypertrophic cardiomyocytes induced by hypoxia-reoxygenation].
Topics: Angiotensin II; Animals; Animals, Newborn; Apoptosis; Cardiomegaly; Cell Enlargement; Cell Hypoxia; Energy Metabolism; Myocardial Reperfusion Injury; Myocytes, Cardiac; Norepinephrine; Oxygen; Rats | 2005 |
Dominant-negative c-Jun inhibits rat cardiac hypertrophy induced by angiotensin II and hypertension.
Topics: Adenoviridae; Angiotensin II; Animals; Blotting, Western; Cardiomegaly; Chemokine CCL2; Collagen Type I; Collagen Type III; Collagen Type IV; Gene Deletion; Genes, Dominant; Genetic Therapy; Genetic Vectors; Hypertension; Injections; Male; Models, Animal; Natriuretic Peptide, Brain; Phosphorylation; Plasminogen Activator Inhibitor 1; Rats; Rats, Sprague-Dawley; Ribosomal Protein S6 Kinases, 70-kDa; Transcription Factor AP-1 | 2006 |
Decreased perivascular fibrosis but not cardiac hypertrophy in ROCK1+/- haploinsufficient mice.
Topics: Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Fibrosis; Intracellular Signaling Peptides and Proteins; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardial Infarction; NG-Nitroarginine Methyl Ester; Protein Serine-Threonine Kinases; Quaternary Ammonium Compounds; rho-Associated Kinases; Vascular Diseases | 2005 |
Activation of AMP-activated protein kinase enhances angiotensin ii-induced proliferation in cardiac fibroblasts.
Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Angiotensin II; Animals; Cardiomegaly; Cell Proliferation; Cells, Cultured; Drug Synergism; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Fibroblasts; Multienzyme Complexes; Myocardium; Organ Size; Proline; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins c-fos; Rats; Rats, Wistar; Ribonucleotides; RNA, Messenger; RNA, Small Interfering; Signal Transduction; Thymidine | 2006 |
Cardiac-specific overexpression of diacylglycerol kinase zeta prevents Gq protein-coupled receptor agonist-induced cardiac hypertrophy in transgenic mice.
Topics: Angiotensin II; Animals; Cardiomegaly; Diacylglycerol Kinase; Diglycerides; GTP-Binding Protein alpha Subunits, Gq-G11; Heterotrimeric GTP-Binding Proteins; Mice; Mice, Transgenic; Myocardium; Myocytes, Cardiac; Phenylephrine; Promoter Regions, Genetic; Protein Kinase C; Rats; RNA, Messenger; Signal Transduction; Ventricular Myosins | 2006 |
Inhibition of histone deacetylation blocks cardiac hypertrophy induced by angiotensin II infusion and aortic banding.
Topics: Angiotensin II; Animals; Aortic Valve Stenosis; Biomarkers; Cardiomegaly; Disease Models, Animal; Drug Evaluation, Preclinical; Enzyme Inhibitors; Histone Deacetylase Inhibitors; Male; Mice; Mice, Inbred Strains; Rats; Rats, Sprague-Dawley; Treatment Outcome | 2006 |
Role of adiponectin receptors in endothelin-induced cellular hypertrophy in cultured cardiomyocytes and their expression in infarcted heart.
Topics: Adiponectin; Angiotensin II; Animals; Cardiomegaly; Cells, Cultured; Endothelin-1; Endothelins; Image Processing, Computer-Assisted; Immunohistochemistry; Myocardial Infarction; Myocytes, Cardiac; Neurotransmitter Agents; Norepinephrine; Rats; Rats, Sprague-Dawley; Receptors, Adiponectin; Receptors, Cell Surface; RNA, Messenger; RNA, Small Interfering; Transfection; Tumor Necrosis Factor-alpha | 2006 |
Effects of trans-resveratrol on hypertension-induced cardiac hypertrophy using the partially nephrectomized rat model.
Topics: Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Cardiovascular Agents; Endothelin-1; Hypertension, Renal; Male; Myocardium; Nephrectomy; Nitric Oxide; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes | 2005 |
Effects of cyclosporine A on angiotensin II-induced cardiomyocyte hypertrophy in neonatal rats.
Topics: Angiotensin II; Animals; Animals, Newborn; Calcium; Cardiomegaly; Cells, Cultured; Cyclosporine; Myocytes, Cardiac; Proto-Oncogene Proteins c-fos; Rats | 2005 |
Deletion of angiotensin-converting enzyme 2 accelerates pressure overload-induced cardiac dysfunction by increasing local angiotensin II.
Topics: Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Aorta; Carboxypeptidases; Cardiac Output, Low; Cardiomegaly; Cells, Cultured; Constriction, Pathologic; Enzyme Activation; Gene Deletion; Gene Expression; Heart; Hypertension; Male; Mice; Mice, Knockout; Mitogen-Activated Protein Kinases; Myocardium; Myocytes, Cardiac; Osmolar Concentration; Peptidyl-Dipeptidase A; RNA, Messenger | 2006 |
Glycogen synthase kinase 3beta together with 14-3-3 protein regulates diabetic cardiomyopathy: effect of losartan and tempol.
Topics: 14-3-3 Proteins; Angiotensin II; Animals; Apoptosis; Blood Glucose; Body Weight; Cardiomegaly; Cardiomyopathies; Cyclic N-Oxides; Diabetes Complications; Endomyocardial Fibrosis; Glycogen Synthase Kinase 3; Losartan; Mice; Mice, Transgenic; Mitogen-Activated Protein Kinases; Myocardium; NFATC Transcription Factors; Organ Size; Oxidative Stress; Phosphorylation; Protein Transport; Signal Transduction; Spin Labels; Streptozocin | 2006 |
[Preventive effect of trans-resveratrol on hypertension-induced cardiac hypertrophy in partially nephrectomized rats].
Topics: Angiotensin II; Animals; Cardiomegaly; Cardiovascular Agents; Endothelin-1; Hypertension; Male; Myocardium; Nephrectomy; Nitric Oxide; Random Allocation; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes | 2005 |
[Atorvastatin upregulates the expression of PPAR alpha/gamma and inhibits the hypertrophy of cardiac myocytes in vitro].
Topics: Angiotensin II; Animals; Atorvastatin; Cardiomegaly; Cells, Cultured; Gene Expression Regulation; Heptanoic Acids; Myocytes, Cardiac; PPAR alpha; PPAR-beta; Pyrroles; Rats; Rats, Wistar; Up-Regulation | 2005 |
Poly(ADP-ribose) polymerase-1-deficient mice are protected from angiotensin II-induced cardiac hypertrophy.
Topics: Angiotensin II; Animals; Cardiomegaly; Cells, Cultured; Endomyocardial Fibrosis; Gene Expression Regulation, Enzymologic; Mice; Mice, Knockout; Muscle Cells; Myocardium; NAD; Oxidative Stress; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerases; Signal Transduction; Sirtuin 1; Sirtuins | 2006 |
Requirement of Rac1 in the development of cardiac hypertrophy.
Topics: Angiotensin II; Animals; Cardiomegaly; Cells, Cultured; Gene Deletion; MAP Kinase Kinase Kinase 5; Mice; Mice, Inbred C57BL; Mice, Knockout; NADPH Oxidases; NF-kappa B; rac1 GTP-Binding Protein; Superoxides | 2006 |
Association of RhoGDIalpha with Rac1 GTPase mediates free radical production during myocardial hypertrophy.
Topics: Angiotensin II; Animals; Blotting, Western; Cardiomegaly; Cells, Cultured; Fluorobenzenes; Free Radicals; Guanine Nucleotide Dissociation Inhibitors; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunoprecipitation; Leucine; Lipid Peroxidation; Mice; Mice, Inbred C57BL; Myocardium; NADPH Oxidases; Protein Binding; Pyrimidines; rac1 GTP-Binding Protein; rho Guanine Nucleotide Dissociation Inhibitor alpha; rho-Specific Guanine Nucleotide Dissociation Inhibitors; RNA Interference; Rosuvastatin Calcium; Sulfonamides; Superoxides | 2006 |
HMG-CoA reductase inhibitor fluvastatin prevents angiotensin II-induced cardiac hypertrophy via Rho kinase and inhibition of cyclin D1.
Topics: Adenoviridae Infections; Amides; Angiotensin II; Animals; Animals, Newborn; Cardiomegaly; Cells, Cultured; Cyclin D1; Electrophoresis, Polyacrylamide Gel; Enzyme Inhibitors; Fatty Acids, Monounsaturated; Fluvastatin; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunoblotting; Indoles; Intracellular Signaling Peptides and Proteins; Leucine; Male; Mevalonic Acid; Myocardium; Myocytes, Cardiac; Protein Serine-Threonine Kinases; Pyridines; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; rho-Associated Kinases; RNA, Messenger | 2006 |
Contribution of PI 3-kinase isoforms to angiotensin II- and alpha-adrenoceptor-mediated signalling pathways in cardiomyocytes.
Topics: Angiotensin II; Animals; Cardiomegaly; Cells, Cultured; Chromones; Electrophoresis, Polyacrylamide Gel; Enzyme Inhibitors; Isoenzymes; Male; Microscopy, Fluorescence; Morpholines; Myocytes, Cardiac; p38 Mitogen-Activated Protein Kinases; Phenylalanine; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Rats; Rats, Wistar; Reactive Oxygen Species; Receptors, Adrenergic, alpha; Reverse Transcriptase Polymerase Chain Reaction; Ribosomal Protein S6 Kinases; Signal Transduction; Transforming Growth Factor beta | 2006 |
Epigallocathechin-3 gallate inhibits cardiac hypertrophy through blocking reactive oxidative species-dependent and -independent signal pathways.
Topics: Angiotensin II; Animals; Animals, Newborn; Antioxidants; Blotting, Northern; Blotting, Western; Cardiomegaly; Catechin; Electrophoretic Mobility Shift Assay; Enzyme Activation; ErbB Receptors; Hypertension; Male; MAP Kinase Kinase 4; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Signal Transduction; Transcription Factor AP-1 | 2006 |
[Protein kinase Cdelta is possibly involved in the transition from hypertrophy to apoptosis of myocardiocytes].
Topics: Angiotensin II; Animals; Animals, Newborn; Apoptosis; Cardiomegaly; Cell Enlargement; Endothelin-1; Heart Failure; Myocytes, Cardiac; Primary Cell Culture; Protein Kinase C-delta; Rats; Rats, Sprague-Dawley | 2006 |
An autocrine role for leptin in mediating the cardiomyocyte hypertrophic effects of angiotensin II and endothelin-1.
Topics: Adipocytes; Angiotensin II; Animals; Animals, Newborn; Autocrine Communication; Cardiomegaly; Cells, Cultured; Endothelin-1; Gene Expression Regulation; Heart Ventricles; Leptin; MAP Kinase Signaling System; Myocytes, Cardiac; Obesity; Rats; Rats, Sprague-Dawley; Vasoconstrictor Agents | 2006 |
Estrogen and salt sensitivity in the female mRen(2). Lewis rat.
Topics: Aldosterone; Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Estrogens; Female; Gene Expression Regulation; Heart Rate; Hypertension; Kidney Diseases; Ovariectomy; Peptidyl-Dipeptidase A; Rats; Rats, Inbred Lew; Renin; Renin-Angiotensin System; Sodium Chloride, Dietary | 2006 |
[Angiotensin II induced cardiac hypertrophy is blocked by PTEN via suppressing Ca2+/Calcineurin pathway].
Topics: Adenoviridae; Angiotensin II; Animals; Calcineurin; Calcium; Cardiomegaly; Cells, Cultured; DNA, Complementary; Myocytes, Cardiac; PTEN Phosphohydrolase; Rats; Rats, Wistar; RNA, Messenger; Signal Transduction | 2006 |
An angiotensin II type 1 receptor mutant lacking epidermal growth factor receptor transactivation does not induce angiotensin II-mediated cardiac hypertrophy.
Topics: Angiotensin II; Animals; Apoptosis; Cardiomegaly; Diastole; Echocardiography; ErbB Receptors; Fibrosis; Genes, Dominant; Heart; Mice; Mice, Transgenic; Mutation; Myocardium; Phenylalanine; Receptor, Angiotensin, Type 1; Transcriptional Activation; Tyrosine; Ventricular Function, Left | 2006 |
Down-regulation of cardiac apelin system in hypertrophied and failing hearts: Possible role of angiotensin II-angiotensin type 1 receptor system.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Apelin; Cardiomegaly; Carrier Proteins; Down-Regulation; Heart Failure; Intercellular Signaling Peptides and Proteins; Male; Rats; Rats, Inbred Dahl; Receptor, Angiotensin, Type 1; RNA, Messenger; Signal Transduction | 2006 |
Small gene effect and exercise training-induced cardiac hypertrophy in mice: an Ace gene dosage study.
Topics: Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Gene Dosage; Genetic Variation; Heart Rate; Male; Mice; Mice, Inbred C57BL; Muscle, Skeletal; Myocardium; Myocytes, Cardiac; Peptidyl-Dipeptidase A; Physical Conditioning, Animal; Renin; Renin-Angiotensin System; Swimming | 2006 |
Foxo transcription factors blunt cardiac hypertrophy by inhibiting calcineurin signaling.
Topics: Angiotensin II; Animals; Calcineurin; Calcium-Binding Proteins; Cardiomegaly; Cells, Cultured; Forkhead Box Protein O1; Forkhead Box Protein O3; Forkhead Transcription Factors; Gene Expression Regulation; Intracellular Signaling Peptides and Proteins; Male; Mice; Mice, Inbred C57BL; Muscle Proteins; Myocytes, Cardiac; Nerve Tissue Proteins; NFATC Transcription Factors; Phosphatidylinositol 3-Kinases; Phosphoric Monoester Hydrolases; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Signal Transduction; Transcription Factors | 2006 |
Soluble guanylate cyclase stimulation on cardiovascular remodeling in angiotensin II-induced hypertensive rats.
Topics: Angiotensin II; Animals; Cardiomegaly; Cardiovascular System; Cells, Cultured; Guanylate Cyclase; Hypertension; Male; Pyrazoles; Pyridines; Rats; Rats, Wistar; Solubility | 2006 |
Chronic angiotensin II stimulation in the heart produces an acquired long QT syndrome associated with IK1 potassium current downregulation.
Topics: Action Potentials; Angiotensin II; Animals; Base Sequence; Cardiomegaly; Disease Models, Animal; DNA Primers; Down-Regulation; Electrocardiography; Humans; In Vitro Techniques; Intermediate-Conductance Calcium-Activated Potassium Channels; Long QT Syndrome; Male; Mice; Mice, Transgenic; Myocytes, Cardiac; Patch-Clamp Techniques; Potassium Channels, Inwardly Rectifying; RNA, Messenger | 2007 |
TRPC3 and TRPC6 are essential for angiotensin II-induced cardiac hypertrophy.
Topics: Angiotensin II; Animals; Animals, Newborn; Calcium Channels, L-Type; Calcium Signaling; Cardiomegaly; Cells, Cultured; Diglycerides; Inositol 1,4,5-Trisphosphate; Ion Channel Gating; Membrane Potentials; Myocytes, Cardiac; NFATC Transcription Factors; Rats; Signal Transduction; TRPC Cation Channels; Type C Phospholipases; Vasoconstrictor Agents | 2006 |
Integrin-linked kinase expression is elevated in human cardiac hypertrophy and induces hypertrophy in transgenic mice.
Topics: Alanine; Angiotensin II; Animals; Arginine; Cardiomegaly; cdc42 GTP-Binding Protein; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Fetus; Heart Ventricles; Humans; Infant; Mice; Mice, Transgenic; Mutation; Myocardium; Myocytes, Cardiac; Phosphorylation; Protein Serine-Threonine Kinases; rac1 GTP-Binding Protein; Ribosomal Protein S6 Kinases, 70-kDa; Ventricular Outflow Obstruction | 2006 |
Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney.
Topics: Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Gene Expression Regulation; Heart; Homeostasis; Humans; Hypertension; Kidney; Kidney Transplantation; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardium; Receptor, Angiotensin, Type 1; Sodium | 2006 |
Prevention of angiotensin II-induced cardiac remodeling by angiotensin-(1-7).
Topics: Analysis of Variance; Angiotensin I; Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Disease Models, Animal; Fibrosis; Heart; Hypertension; Male; Myocardium; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, G-Protein-Coupled; Time Factors; Transforming Growth Factor beta; Ventricular Remodeling | 2007 |
Carbonic anhydrase inhibition prevents and reverts cardiomyocyte hypertrophy.
Topics: Age Factors; Angiotensin II; Animals; Atrial Natriuretic Factor; Calcium; Carbonic Anhydrase II; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Cardiomegaly; Cardiotonic Agents; Cation Transport Proteins; Cells, Cultured; Chloride-Bicarbonate Antiporters; Ethoxzolamide; Gene Expression; Humans; Kidney; Membrane Potentials; Membrane Transport Proteins; Mice; Myocytes, Cardiac; Phenylephrine; Rats; Sodium-Hydrogen Exchanger 1; Sodium-Hydrogen Exchangers; Sulfate Transporters; Transfection; Vasoconstrictor Agents | 2007 |
Urotensin II accelerates cardiac fibrosis and hypertrophy of rats induced by isoproterenol.
Topics: Angiotensin II; Animals; Cardiomegaly; Cell Proliferation; Collagen; Fibroblasts; Fibrosis; Hydroxyproline; Isoproterenol; Lactate Dehydrogenases; Male; Malondialdehyde; Myocardium; Random Allocation; Rats; Rats, Wistar; Receptors, G-Protein-Coupled; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Urotensins | 2007 |
Effect of pioglitazone on the expression of inflammatory cytokines in attenuating rat cardiomyocyte hypertrophy.
Topics: Angiotensin II; Animals; Anti-Inflammatory Agents; Atrial Natriuretic Factor; Cardiomegaly; Cells, Cultured; Interleukin-1beta; Interleukin-6; Leucine; Myocytes, Cardiac; Natriuretic Peptide, Brain; Pioglitazone; PPAR gamma; Rats; Rats, Wistar; RNA, Messenger; Thiazolidinediones | 2006 |
Adapter molecule DOC-2 is differentially expressed in pressure and volume overload hypertrophy and inhibits collagen synthesis in cardiac fibroblasts.
Topics: Adaptor Proteins, Signal Transducing; Adaptor Proteins, Vesicular Transport; Angiotensin II; Animals; Aorta, Abdominal; Arteriovenous Shunt, Surgical; Cardiomegaly; Cells, Cultured; Collagen; Disease Models, Animal; Extracellular Signal-Regulated MAP Kinases; Fibroblasts; Flavonoids; Gene Expression; Ligation; Myocytes, Cardiac; Phorbol Esters; Phosphorylation; Protein Kinase C; Protein Kinase Inhibitors; Rats; Rats, Sprague-Dawley; RNA, Messenger; Signal Transduction; Transfection; Ventricular Remodeling | 2007 |
Effects of dietary salt load and salt depletion on the course of hypertension and angiotensin II levels in male and female heterozygous Ren-2 transgenic rats.
Topics: Angiotensin II; Animals; Animals, Genetically Modified; Blood Pressure; Cardiomegaly; Female; Heterozygote; Hypertension, Renal; Kidney; Male; Rats; Rats, Sprague-Dawley; Renin; Renin-Angiotensin System; Sex Characteristics; Sodium Chloride, Dietary | 2007 |
Primary role of angiotensin-converting enzyme-2 in cardiac production of angiotensin-(1-7) in transgenic Ren-2 hypertensive rats.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Animals; Animals, Genetically Modified; Cardiomegaly; Disease Models, Animal; Half-Life; Hypertension; Imidazoles; Kinetics; Leucine; Male; Mice; Myocardium; Peptide Fragments; Peptidyl-Dipeptidase A; Rats; Rats, Sprague-Dawley; Renin | 2007 |
Re-expression of proteins involved in cytokinesis during cardiac hypertrophy.
Topics: Actomyosin; Amides; Angiotensin II; Animals; Antihypertensive Agents; Biomarkers; Calpain; Cardiomegaly; Cell Nucleus Division; Cullin Proteins; Cytokinesis; Heart; Hypertension; Intracellular Signaling Peptides and Proteins; Mice; Myocytes, Cardiac; Myofibrils; Protein Serine-Threonine Kinases; Pyridines; Rats; Rats, Inbred Dahl; rho GTP-Binding Proteins; rho-Associated Kinases; Up-Regulation | 2007 |
Contribution of different Nox homologues to cardiac remodeling in two-kidney two-clip renovascular hypertensive rats: effect of valsartan.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Aorta; Blood Pressure; Cardiomegaly; Disease Models, Animal; Fibrosis; Heart Ventricles; Hypertension, Renovascular; Ligation; Male; Malondialdehyde; Membrane Glycoproteins; NADH, NADPH Oxidoreductases; NADPH Oxidase 1; NADPH Oxidase 2; NADPH Oxidase 4; NADPH Oxidases; Rats; Rats, Sprague-Dawley; Renal Artery; Superoxides; Tetrazoles; Valine; Valsartan; Ventricular Function, Left; Ventricular Remodeling | 2007 |
Sodium tanshinone IIA sulfonate depresses angiotensin II-induced cardiomyocyte hypertrophy through MEK/ERK pathway.
Topics: Angiotensin II; Animals; Cardiomegaly; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase Kinases; Molecular Structure; Myocytes, Cardiac; Phenanthrenes; Rats; Rats, Wistar | 2007 |
Beta-catenin downregulation is required for adaptive cardiac remodeling.
Topics: Angiotensin II; Animals; beta Catenin; Cardiomegaly; Gene Expression Regulation; Insulin-Like Growth Factor Binding Protein 5; Mice; Mice, Inbred C57BL; T-Box Domain Proteins; Ventricular Remodeling | 2007 |
Angiotensin II-induced sudden arrhythmic death and electrical remodeling.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensinogen; Animals; Animals, Genetically Modified; Blood Pressure; Cardiac Pacing, Artificial; Cardiomegaly; Connexin 43; Death, Sudden, Cardiac; Disease Models, Animal; Electrocardiography; Heart Conduction System; Hypertension; Losartan; Male; Myocardium; Rats; Rats, Sprague-Dawley; Renin; RNA, Messenger; Shal Potassium Channels; Tachycardia, Ventricular; Telemetry; Time Factors; Ventricular Remodeling | 2007 |
Overexpression of myofibrillogenesis regulator-1 aggravates cardiac hypertrophy induced by angiotensin II in mice.
Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Cardiomegaly; Endomyocardial Fibrosis; Female; Gene Expression Regulation; Humans; Mice; Mice, Transgenic; Muscle Proteins; Myocardium; Natriuretic Peptide, Brain; NF-kappa B; RNA, Messenger; Signal Transduction; Vasoconstrictor Agents; Ventricular Remodeling | 2007 |
CD59 or C3 are not requred for angiotensin II-dependent hypertension or hypertrophy in mice.
Topics: Angiotensin II; Animals; Aorta, Thoracic; Body Weight; Cardiomegaly; CD59 Antigens; Complement Activation; Complement C3; Cyclic GMP; Dose-Response Relationship, Drug; Hypertension; Male; Mice; Mice, Inbred C57BL; Nitric Oxide; Platelet Endothelial Cell Adhesion Molecule-1; Receptor, Angiotensin, Type 1; Tissue Culture Techniques | 2007 |
MicroRNAs are aberrantly expressed in hypertrophic heart: do they play a role in cardiac hypertrophy?
Topics: Angiotensin II; Animals; Cardiomegaly; Cells, Cultured; Gene Expression Profiling; Heart; Mice; Mice, Inbred C57BL; MicroRNAs; Myocytes, Cardiac; Oligonucleotide Array Sequence Analysis; Oligonucleotides, Antisense; Rats; Rats, Sprague-Dawley | 2007 |
Genetic disruption of guanylyl cyclase/natriuretic peptide receptor-A upregulates ACE and AT1 receptor gene expression and signaling: role in cardiac hypertrophy.
Topics: Angiotensin II; Animals; Captopril; Cardiomegaly; Cyclic GMP; Fibrosis; Gene Expression Regulation; Guanylate Cyclase; Heart Ventricles; Hydralazine; Hypertension; Interleukin-6; Mice; Mice, Inbred C57BL; Mice, Knockout; NF-kappa B; Peptidyl-Dipeptidase A; Receptor, Angiotensin, Type 1; Receptors, Atrial Natriuretic Factor; Renin-Angiotensin System; Signal Transduction; Thiobarbituric Acid Reactive Substances; Tumor Necrosis Factor-alpha | 2007 |
Classic interleukin-6 receptor signaling and interleukin-6 trans-signaling differentially control angiotensin II-dependent hypertension, cardiac signal transducer and activator of transcription-3 activation, and vascular hypertrophy in vivo.
Topics: Angiotensin II; Animals; Aorta; Blood Pressure; Cardiomegaly; Hypertension; Hypertrophy; Interleukin-6; Mice; Myocardium; Receptors, Interleukin-6; Recombinant Fusion Proteins; Signal Transduction; STAT3 Transcription Factor; Transcriptional Activation | 2007 |
Simvastatin reverses target organ damage and oxidative stress in Angiotensin II hypertension: comparison with apocynin, tempol, and hydralazine.
Topics: Acetophenones; Albuminuria; Angiotensin II; Animals; Antihypertensive Agents; Antioxidants; Cardiomegaly; Carotid Arteries; Cyclic N-Oxides; Hydralazine; Hypertension; Hypolipidemic Agents; Male; Oxidative Stress; Rats; Rats, Sprague-Dawley; Simvastatin; Spin Labels; Superoxides; Tunica Media | 2007 |
Angiotensin II receptors subtypes mediate diverse gene expression profile in adult hypertrophic cardiomyocytes.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Animals; Aorta, Abdominal; Cardiomegaly; Cells, Cultured; Disease Models, Animal; Gene Expression Profiling; Gene Expression Regulation; Imidazoles; Interleukin-1beta; Interleukin-6; Ligation; Losartan; Male; Myocytes, Cardiac; Oligonucleotide Array Sequence Analysis; Pyridines; Radioimmunoassay; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Time Factors; Tumor Necrosis Factor-alpha | 2007 |
Imbalance between CaM kinase II and calcineurin activities impairs caffeine-induced calcium release in hypertrophic cardiomyocytes.
Topics: Angiotensin II; Animals; Calcineurin; Calcium; Calcium-Binding Proteins; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Cardiomegaly; Cells, Cultured; Endothelin-1; Immunohistochemistry; Indazoles; Phenylephrine; Phosphorylation; Rats; Rats, Wistar | 2007 |
Anabolic steroids induce cardiac renin-angiotensin system and impair the beneficial effects of aerobic training in rats.
Topics: Anabolic Agents; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Blood Pressure; Cardiomegaly; Collagen; Gene Expression Regulation; Heart Rate; Hydroxyproline; Losartan; Male; Myocardial Contraction; Myocardium; Nandrolone; Nandrolone Decanoate; Peptidyl-Dipeptidase A; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Swimming; Testosterone; Time Factors; Ventricular Function, Left; Ventricular Remodeling | 2007 |
Absence of peroxisome proliferator-activated receptor-alpha abolishes hypertension and attenuates atherosclerosis in the Tsukuba hypertensive mouse.
Topics: Aldosterone; Angiotensin II; Animals; Atherosclerosis; Blood Pressure; Cardiomegaly; Diet, Atherogenic; Disease Models, Animal; Fenofibrate; Genotype; Humans; Hypertension; Hypolipidemic Agents; Mice; Mice, Knockout; Mice, Transgenic; PPAR alpha; Renin; Renin-Angiotensin System | 2007 |
Synergetic antioxidant and vasodilatory action of carbon monoxide in angiotensin II - induced cardiac hypertrophy.
Topics: Angiotensin II; Animals; Antioxidants; Aorta; Blood Pressure; Carbon Monoxide; Carboxyhemoglobin; Cardiomegaly; Hydralazine; Hypercholesterolemia; Lipid Peroxides; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; NADPH Oxidases; Phosphorylation; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; Receptors, LDL; Vasodilator Agents | 2007 |
Calsarcin-1 protects against angiotensin-II induced cardiac hypertrophy.
Topics: Angiotensin II; Animals; Animals, Newborn; Atrial Natriuretic Factor; Calcineurin; Calcium-Binding Proteins; Cardiomegaly; Carrier Proteins; Genetic Therapy; Intracellular Signaling Peptides and Proteins; Mice; Mice, Transgenic; Muscle Proteins; RNA, Messenger; Signal Transduction | 2007 |
Mice expressing ACE only in the heart show that increased cardiac angiotensin II is not associated with cardiac hypertrophy.
Topics: Alleles; Angiotensin I; Angiotensin II; Angiotensinogen; Animals; Aorta, Abdominal; Blood Pressure; Blotting, Western; Cardiac Catheterization; Cardiomegaly; Connexin 43; DNA; Electrocardiography; Heart; Kidney; Mice; Mice, Knockout; Mice, Transgenic; Myocardium; Osmolar Concentration; Peptidyl-Dipeptidase A; Reverse Transcriptase Polymerase Chain Reaction; Tissue Distribution; Ventricular Function, Left | 2008 |
Novel anti-inflammatory mechanisms of N-Acetyl-Ser-Asp-Lys-Pro in hypertension-induced target organ damage.
Topics: Angiotensin II; Animals; Anti-Inflammatory Agents; Azo Compounds; Blotting, Western; Cardiomegaly; Cell Separation; Collagen; Fibrosis; Galectin 3; Heart Rate; Hypertension; In Vitro Techniques; Inflammation; Kidney; Male; Mice; Mice, Inbred C57BL; Myocardium; Neutrophil Infiltration; Oligopeptides; Stem Cells; Tumor Necrosis Factor-alpha | 2008 |
Propofol depresses angiotensin II-induced cardiomyocyte hypertrophy in vitro.
Topics: Angiotensin II; Animals; Cardiomegaly; Cell Survival; Cells, Cultured; Cytoprotection; Extracellular Signal-Regulated MAP Kinases; Mitogen-Activated Protein Kinase Kinases; Myocytes, Cardiac; NF-kappa B; Phosphorylation; Propofol; Rats; Rats, Wistar; Reactive Oxygen Species | 2008 |
Peroxisome proliferator-activated receptor beta/delta activation improves angiotensin II-induced cardiac hypertrophy in vitro.
Topics: Angiotensin II; Animals; Cardiomegaly; Cell Membrane; Cells, Cultured; Cytokines; Down-Regulation; Fluorescent Antibody Technique; In Vitro Techniques; Leucine; Myocytes, Cardiac; PPAR delta; PPAR-beta; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Staining and Labeling; Thiazoles | 2008 |
Involvement of calcium-sensing receptor in cardiac hypertrophy-induced by angiotensinII through calcineurin pathway in cultured neonatal rat cardiomyocytes.
Topics: Angiotensin II; Animals; Animals, Newborn; Calcineurin; Calcium; Cardiomegaly; Cells, Cultured; Myocytes, Cardiac; Rats; Rats, Wistar; Receptors, Calcium-Sensing; Signal Transduction | 2008 |
Protein kinase CK2 links extracellular growth factor signaling with the control of p27(Kip1) stability in the heart.
Topics: Aging; Angiotensin II; Animals; Cardiomegaly; Casein Kinase II; Cell Proliferation; Cells, Cultured; Cyclin-Dependent Kinase Inhibitor p27; Humans; Intercellular Signaling Peptides and Proteins; Mice; Mice, Knockout; Myocardium; Myocytes, Cardiac; Protein Binding; Rats; Signal Transduction | 2008 |
Angiotensin II regulates cardiac hypertrophy via oxidative stress but not antioxidant enzyme activities in experimental renovascular hypertension.
Topics: Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Catalase; Glutathione; Hypertension, Renovascular; Losartan; Male; NADPH Oxidases; Oxidative Stress; Rats; Rats, Wistar; Superoxide Dismutase | 2008 |
Angiotensin II activates myostatin expression in cultured rat neonatal cardiomyocytes via p38 MAP kinase and myocyte enhance factor 2 pathway.
Topics: Angiotensin II; Animals; Animals, Newborn; Cardiomegaly; MADS Domain Proteins; MAP Kinase Signaling System; MEF2 Transcription Factors; Myocytes, Cardiac; Myogenic Regulatory Factors; Myostatin; p38 Mitogen-Activated Protein Kinases; Promoter Regions, Genetic; Protein Biosynthesis; Rats; Rats, Wistar; Signal Transduction | 2008 |
Estrogen inhibits cardiac hypertrophy: role of estrogen receptor-beta to inhibit calcineurin.
Topics: Angiotensin II; Animals; Calcineurin; Calcium-Binding Proteins; Cardiomegaly; Collagen; Estradiol; Estrogen Receptor beta; Estrogens; Female; Fibrosis; Intracellular Signaling Peptides and Proteins; Mice; Mice, Inbred C57BL; Mice, Knockout; Models, Biological; Muscle Proteins; Myocardium; Myosin Heavy Chains; Ovariectomy | 2008 |
Involvement of tumor necrosis factor-alpha in angiotensin II-mediated effects on salt appetite, hypertension, and cardiac hypertrophy.
Topics: Angiotensin II; Animals; Appetite; Blood Pressure; Cardiomegaly; Heart; Hypertension; Male; Mice; Mice, Knockout; NF-kappa B; Receptor, Angiotensin, Type 1; Sodium Chloride; Thirst; Tumor Necrosis Factor-alpha | 2008 |
Prevention of salt-induced hypertension and fibrosis by AT1-receptor blockers in Dahl S rats.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Aorta; Benzimidazoles; Benzoates; Blood Pressure; Cardiomegaly; Dose-Response Relationship, Drug; Fibrosis; Heart Rate; Hypertension; Hypertrophy; Kidney; Losartan; Male; Myocardium; Organ Specificity; Rats; Rats, Inbred Dahl; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Sodium, Dietary; Telmisartan | 2008 |
Chromogranin B regulates calcium signaling, nuclear factor kappaB activity, and brain natriuretic peptide production in cardiomyocytes.
Topics: Age Factors; Angiotensin II; Animals; Calcium; Calcium Signaling; Cardiomegaly; Cells, Cultured; Chromogranin B; Inositol 1,4,5-Trisphosphate Receptors; Myocytes, Cardiac; Natriuretic Peptide, Brain; NF-kappa B; NFATC Transcription Factors; Promoter Regions, Genetic; Rats; Transcription, Genetic; Vasoconstrictor Agents | 2008 |
Alpha2-antiplasmin is a critical regulator of angiotensin II-mediated vascular remodeling.
Topics: Angiotensin II; Animals; Apoptosis; Cardiomegaly; Cell Proliferation; Collagen Type I; Cyclin-Dependent Kinase Inhibitor p21; Disease Models, Animal; Eye Proteins; Fibrosis; Gelatinases; Hypertension; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardium; Nerve Growth Factors; NG-Nitroarginine Methyl Ester; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Proto-Oncogene Proteins c-myc; Serpins; Thoracic Arteries; Tumor Suppressor Protein p53 | 2008 |
Stimulation of lymphocyte responses by angiotensin II promotes kidney injury in hypertension.
Topics: Albuminuria; Angiotensin II; Animals; Cardiomegaly; Cell Proliferation; Cytoskeleton; Disease Models, Animal; Hypertension; Immunosuppressive Agents; Interferon-gamma; Kidney Diseases; Male; Mice; Mice, Knockout; Mycophenolic Acid; Sodium Chloride, Dietary; T-Lymphocytes; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha; Vasoconstrictor Agents | 2008 |
Renal hypertension in the Brattleboro diabetes insipidus rat.
Topics: Angiotensin II; Animals; Body Weight; Cardiomegaly; Constriction; Deamino Arginine Vasopressin; Diabetes Insipidus; Diuresis; Drinking; Hematocrit; Hypertension, Renal; Rats; Rats, Brattleboro; Rats, Mutant Strains; Renal Artery; Renin | 1982 |
Left ventricular mass in middle-aged men. Relationship to blood pressure, sympathetic nervous activity, hormonal and metabolic factors.
Topics: Angiotensin II; Blood Glucose; Blood Pressure; Cardiomegaly; Echocardiography; Humans; Hypertension; Insulin; Isometric Contraction; Male; Middle Aged; Norepinephrine; Renin-Angiotensin System; Sympathetic Nervous System | 1983 |
Pulmonary vascular changes in young and aging rats exposed to 5,486 m altitude.
Topics: Aging; Altitude; Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Dose-Response Relationship, Drug; Hematocrit; Hypoxia; Male; Muscle, Smooth, Vascular; Polycythemia; Pulmonary Circulation; Rats; Rats, Inbred Strains; Vasoconstriction | 1984 |
The role of pulmonary vascular responses to chronic hypoxia in the development of chronic mountain sickness in rats.
Topics: Altitude Sickness; Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Hypertension, Pulmonary; Hypoxia; Lung; Polycythemia; Rats; Rats, Inbred Strains; Vascular Resistance; Vasoconstriction | 1984 |
[Prevention of the development of genetic hypertension by MK 421 in the SHR].
Topics: Angiotensin II; Animals; Antihypertensive Agents; Cardiomegaly; Dipeptides; Enalapril; Hypertension; Male; Norepinephrine; Rats; Rats, Inbred Strains | 1982 |
Effects of losartan, an angiotensin II antagonist, on the development of cardiac hypertrophy due to volume overload.
Topics: Angiotensin II; Animals; Biphenyl Compounds; Blood Pressure; Cardiac Volume; Cardiomegaly; Imidazoles; Losartan; Male; Organ Size; Peptidyl-Dipeptidase A; Rats; Rats, Wistar; Renin; Tetrazoles | 1995 |
Angiotensin AT1 receptor-mediated attenuation of cardiac hypertrophy due to volume overload: involvement of endothelin.
Topics: Amino Acid Sequence; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Azepines; Biphenyl Compounds; Cardiac Volume; Cardiomegaly; Endothelin Receptor Antagonists; Endothelins; Heart; Heart Ventricles; Hypertrophy, Left Ventricular; Imidazoles; Indoles; Losartan; Male; Molecular Sequence Data; Myocardium; Organ Size; Rats; Rats, Wistar; Receptors, Angiotensin; Tetrazoles; Time Factors | 1995 |
Basal and angiotensin II-induced cytosolic free calcium in adult rat cardiomyocytes and fibroblasts after volume overload.
Topics: Analysis of Variance; Angiotensin II; Animals; Atrial Natriuretic Factor; Calcium; Cardiac Volume; Cardiomegaly; Cells, Cultured; Culture Media; Cytosol; Fibroblasts; Male; Myocardium; Radioimmunoassay; Rats; Rats, Sprague-Dawley; Stimulation, Chemical; Vasoconstrictor Agents | 1995 |
Comparable effects of angiotensin II and converting enzyme blockade on hemodynamics and cardiac hypertrophy in spontaneously hypertensive rats.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Biphenyl Compounds; Cardiac Output; Cardiomegaly; Heart; Hemodynamics; Hypertension; Kidney; Lisinopril; Male; Organ Size; Rats; Rats, Inbred SHR; Rats, Wistar; Renal Circulation; Tetrazoles | 1995 |
Induction of immediate-early genes by angiotensin II and endothelin-1 in adult rat cardiomyocytes.
Topics: Angiotensin II; Animals; Cardiomegaly; Cells, Cultured; DNA-Binding Proteins; Early Growth Response Protein 1; Endothelins; Gene Expression Regulation; Genes, fos; Genes, Immediate-Early; Immediate-Early Proteins; Male; Myocardium; Rats; Rats, Inbred WKY; RNA; Transcription Factors | 1993 |
Effect of indapamide on cyclic adenosine 3',5'-monophosphate signal transduction system in isolated adult rat cardiomyocytes from normal myocardium and cardiac hypertrophy.
Topics: 1-Methyl-3-isobutylxanthine; Angiotensin II; Animals; Binding, Competitive; Carbachol; Cardiomegaly; Colforsin; Cyclic AMP; Heart; In Vitro Techniques; Indapamide; Isoproterenol; Male; Myocardium; Rats; Rats, Wistar; Signal Transduction | 1993 |
Angiotensin II maintains, but does not mediate, isoproterenol-induced cardiac hypertrophy in rats.
Topics: Actins; Angiotensin II; Animals; Base Sequence; Biphenyl Compounds; Blood Pressure; Captopril; Cardiomegaly; DNA; DNA Primers; Dose-Response Relationship, Drug; Gene Expression; Genes, fos; Heart; Hydralazine; Hydroxyproline; Imidazoles; Isoproterenol; Labetalol; Losartan; Male; Methyldopa; Molecular Sequence Data; Myocardium; Myosins; Polymerase Chain Reaction; Rats; Rats, Sprague-Dawley; RNA; RNA, Messenger; Tetrazoles; Transcription, Genetic | 1994 |
Angiotensin II induced alteration of cyclic adenosine 3',5'-monophosphate generation in the hypertrophic myocardium of Dahl salt-sensitive rat on a high-salt diet.
Topics: 1-Methyl-3-isobutylxanthine; Adenylate Cyclase Toxin; Angiotensin II; Animals; Cardiomegaly; Cell Size; Colforsin; Cyclic AMP; Diet; Flow Cytometry; In Vitro Techniques; Isoproterenol; Male; Muscle Proteins; Pertussis Toxin; Rats; Rats, Inbred Strains; Sodium Chloride; Virulence Factors, Bordetella | 1994 |
Trophic effects of angiotensin II on neonatal rat cardiac myocytes are mediated by cardiac fibroblasts.
Topics: Angiotensin II; Animals; Animals, Newborn; Cardiomegaly; Fibroblasts; Heart; Myocardium; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Tissue Distribution; Transforming Growth Factor beta | 1995 |
Ca(2+)-growth coupling in angiotensin II-induced hypertrophy in cultured rat cardiac cells.
Topics: Angiotensin II; Animals; Calcium; Cardiomegaly; Cell Size; Cells, Cultured; Gene Expression Regulation; Image Processing, Computer-Assisted; Microscopy, Fluorescence; Myocardium; Proto-Oncogene Proteins c-fos; Rats; Rats, Wistar; Tetradecanoylphorbol Acetate; Vasoconstrictor Agents | 1995 |
Rapamycin selectively inhibits angiotensin II-induced increase in protein synthesis in cardiac myocytes in vitro. Potential role of 70-kD S6 kinase in angiotensin II-induced cardiac hypertrophy.
Topics: Analysis of Variance; Angiotensin II; Animals; Anti-Bacterial Agents; Cardiomegaly; Cells, Cultured; Enzyme Activation; Genes, fos; Immunoblotting; Muscle Proteins; Myocardium; Phenotype; Phosphorylation; Polyenes; Precipitin Tests; Protein Biosynthesis; Protein Serine-Threonine Kinases; Radioimmunoassay; Rats; Sirolimus; Staining and Labeling | 1995 |
Cardiac renin-angiotensin system in the hypertrophied heart.
Topics: Angiotensin II; Animals; Base Sequence; Cardiomegaly; Male; Molecular Sequence Data; Rats; Rats, Sprague-Dawley; Renin; Renin-Angiotensin System; RNA, Messenger | 1995 |
Angiotensin II partly mediates mechanical stress-induced cardiac hypertrophy.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Biphenyl Compounds; Cardiomegaly; Cells, Cultured; Electrophoresis, Polyacrylamide Gel; Enzyme Activation; Mitogen-Activated Protein Kinase Kinases; Myocardium; Phenylalanine; Protein Kinases; Rats; Rats, Wistar; Receptors, Angiotensin; Saralasin; Signal Transduction; Stress, Mechanical; Tetrazoles | 1995 |
Mechanical stress activates protein kinase cascade of phosphorylation in neonatal rat cardiac myocytes.
Topics: Amino Acid Sequence; Angiotensin II; Animals; Animals, Newborn; Calcium-Calmodulin-Dependent Protein Kinases; Cardiomegaly; Cells, Cultured; Enzyme Activation; MAP Kinase Kinase Kinases; Molecular Sequence Data; Myocardium; Phosphorylation; Protein Kinase C; Protein Kinases; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-raf; Rats; Rats, Wistar; Ribosomal Protein S6 Kinases; Signal Transduction; Stress, Mechanical | 1995 |
[Effect of angiotensin and taurine on arrhythmia in cultured neonatal rat hypertrophic heart myocytes].
Topics: Action Potentials; Angiotensin II; Animals; Animals, Newborn; Cardiomegaly; Cells, Cultured; Myocardial Contraction; Myocardium; Rats; Rats, Sprague-Dawley; Taurine | 1995 |
Cardiac renin-angiotensin system: role in development of pressure-overload hypertrophy.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Aortic Valve Stenosis; Blood Pressure; Cardiomegaly; Disease Models, Animal; Heart Failure; Humans; Myocardial Contraction; Rats; Renin-Angiotensin System; Ventricular Function, Left | 1995 |
Increased vulnerability of hypertrophied myocardium to ischemia and reperfusion injury. Relation to cardiac renin-angiotensin system.
Topics: Angiotensin II; Animals; Cardiomegaly; Male; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Rats; Rats, Wistar; Renin; Renin-Angiotensin System | 1995 |
Angiotensin II type I receptor antagonist inhibits the gene expression of transforming growth factor-beta 1 and extracellular matrix in cardiac and vascular tissues of hypertensive rats.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Aorta; Benzimidazoles; Biphenyl Compounds; Cardiomegaly; Enalapril; Extracellular Matrix Proteins; Gene Expression Regulation; Hypertension; Male; Mesenteric Arteries; Myocardium; Rats; Rats, Inbred SHR; Rats, Inbred WKY; RNA, Messenger; Tetrazoles; Transforming Growth Factor beta | 1995 |
Effect of chronic treatment of adult spontaneously hypertensive rats with an endothelin receptor antagonist.
Topics: Administration, Oral; Angiotensin II; Animals; Blood Pressure; Body Weight; Bosentan; Cardiomegaly; Endothelin Receptor Antagonists; Endothelins; Muscle, Smooth, Vascular; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Sulfonamides | 1995 |
Effect of angiotensin II on calcium release phenomena in normal and hypertrophied single cardiac myocytes.
Topics: Angiotensin II; Animals; Blood Pressure; Calcium; Cardiomegaly; Electric Stimulation; Heart Ventricles; Hypertension; In Vitro Techniques; Male; Rats; Rats, Sprague-Dawley; Reference Values | 1994 |
Intracellular signaling and genetic reprogramming during agonist-induced hypertrophy of cardiomyocytes.
Topics: Adrenergic alpha-Agonists; Angiotensin II; Animals; Cardiomegaly; Cell Division; Cells, Cultured; Endothelins; Heart; Phosphatidylinositols; Receptors, Adrenergic, alpha-1; Signal Transduction; Thrombin | 1995 |
[Cardiac function in isolated working rat heart with pressure overload hypertrophy: correlation with myocardial angiotensin II].
Topics: Angiotensin II; Animals; Blood Flow Velocity; Cardiomegaly; Coronary Circulation; Heart Rate; In Vitro Techniques; Male; Rats; Rats, Wistar; Renin-Angiotensin System; Ventricular Function, Left | 1995 |
Angiotensin II induces cardiac phenotypic modulation and remodeling in vivo in rats.
Topics: Actins; Angiotensin II; Animals; Atrial Natriuretic Factor; Base Sequence; Body Weight; Cardiomegaly; Collagen; Gene Expression; Heart; Male; Molecular Sequence Data; Phenotype; Rats; Rats, Wistar; RNA, Messenger; Transforming Growth Factor beta | 1995 |
Cardiovascular hypertrophy in one-kidney, one clip renal hypertensive rats: a role for angiotensin II?
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta, Thoracic; Biphenyl Compounds; Blood Pressure; Body Weight; Cardiomegaly; Hypertension, Renovascular; Hypertrophy; Imidazoles; Indoles; Losartan; Male; Muscle, Smooth, Vascular; Perindopril; Rats; Rats, Inbred WKY; Tetrazoles | 1994 |
[Role of cardiac renin-angiotensin system in swimming induced physiological myocardial hypertrophy].
Topics: Angiotensin II; Animals; Cardiomegaly; Female; Peptidyl-Dipeptidase A; Physical Exertion; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System | 1994 |
Effect of chronic treatment with prazosin and L-arginine on the elevation of blood pressure during cold exposure.
Topics: Adrenal Glands; Angiotensin II; Animals; Arginine; Blood Pressure; Cardiomegaly; Cold Temperature; Epinephrine; Hypertension; Levodopa; Male; Prazosin; Rats; Rats, Sprague-Dawley; RNA, Messenger; Stress, Physiological; Thyroid Hormones; Tyrosine 3-Monooxygenase | 1994 |
Effect of an AT1 receptor antagonist (CV-11974) on angiotensin II-induced cardiomyocyte hypertrophy in vitro.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Biphenyl Compounds; Blotting, Northern; Cardiomegaly; Cells, Cultured; DNA, Complementary; Endothelin-1; Endothelins; Heart; Imidazoles; Muscle, Smooth, Vascular; Myocardium; Protein Precursors; Pyridines; Rats; Rats, Wistar; Receptors, Angiotensin; Receptors, Endothelin; RNA, Messenger; Tetrazoles | 1994 |
Angiotensin II receptor antagonist, TCV-116, prevents myocardial hypertrophy in spontaneously hypertensive rats.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Cardiomegaly; Endomyocardial Fibrosis; Hypertension; Iodine Radioisotopes; Kinetics; Myocardium; Prodrugs; Rats; Rats, Inbred SHR; Receptors, Angiotensin; Tetrazoles | 1994 |
Role of polyamines in hypertension induced by angiotensin II.
Topics: Angiotensin II; Animals; Aorta; Cardiomegaly; Disease Models, Animal; Heart Ventricles; Hypertension; Liver; Male; Mesenteric Arteries; Myocardium; Polyamines; Putrescine; Rats; Rats, Inbred WKY; Spermidine; Spermine | 1995 |
Hypertrophic growth of cultured neonatal rat heart cells mediated by type 1 angiotensin II receptor.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Animals, Newborn; Biphenyl Compounds; Calcium; Cardiomegaly; Cells, Cultured; Imidazoles; Intracellular Membranes; Losartan; Myocardium; Osmolar Concentration; Protein Biosynthesis; Protein Kinase C; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; RNA, Messenger; Tetrazoles | 1994 |
Distribution and function of cardiac angiotensin AT1- and AT2-receptor subtypes in hypertrophied rat hearts.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Binding Sites; Biphenyl Compounds; Cardiomegaly; Hemodynamics; Imidazoles; Losartan; Male; Myocardium; Pyridines; Rats; Rats, Wistar; Receptors, Angiotensin; Reference Values; Tetrazoles; Tissue Distribution | 1994 |
[Effect of angiotensin II on collagen metabolism in cultured rat cardiac fibroblasts: its relation to cardiac hypertrophy].
Topics: Angiotensin II; Animals; Cardiomegaly; Cells, Cultured; Collagen; Fibroblasts; Heart; Myocardium; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Rats, Wistar | 1994 |
Angiotensin II induces fibronectin expression associated with cardiac fibrosis in the rat.
Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Cardiomegaly; Fibronectins; Gene Expression; Male; Rats; Rats, Wistar; RNA, Messenger; Transforming Growth Factor beta | 1994 |
Angiotensin receptor regulates cardiac hypertrophy and transforming growth factor-beta 1 expression.
Topics: Angiotensin II; Animals; Aortic Coarctation; Atrial Natriuretic Factor; Biphenyl Compounds; Cardiomegaly; Gene Expression Regulation; Imidazoles; Losartan; Male; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Tetrazoles; Transforming Growth Factor beta | 1994 |
Renin-angiotensin system and minoxidil-induced cardiac hypertrophy in rats.
Topics: Angiotensin II; Animals; Biphenyl Compounds; Blood Pressure; Cardiomegaly; Enalapril; Heart; Hemodynamics; Imidazoles; Losartan; Male; Minoxidil; Rats; Rats, Wistar; Renin; Renin-Angiotensin System; Tetrazoles; Ventricular Function, Left | 1993 |
Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro.
Topics: Actins; Angiotensin I; Angiotensin II; Angiotensinogen; Animals; Animals, Newborn; Atrial Natriuretic Factor; Cardiomegaly; Cells, Cultured; Cytoplasmic Granules; Endothelins; Gene Expression Regulation; Genes, fos; Hypertrophy; In Vitro Techniques; Mechanoreceptors; Myocardium; Peptidyl-Dipeptidase A; Rats; Renin; RNA, Messenger; Stress, Mechanical | 1993 |
Identification of functional angiotensin II receptors on rat cardiac fibroblasts.
Topics: Angiotensin II; Animals; Cardiomegaly; Cells, Cultured; Collagen; Endomyocardial Fibrosis; Extracellular Matrix; Fibroblasts; Fibronectins; Gene Expression Regulation; Kinetics; Myocardium; Rats; Receptors, Angiotensin; RNA, Messenger | 1993 |
Contractile function of right ventricular papillary muscle after left ventricular infarction in rats: effects of early and late inhibition of angiotensin converting enzyme.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiomegaly; Male; Myocardial Contraction; Myocardial Infarction; Papillary Muscles; Rats; Rats, Wistar; Ventricular Function, Right | 1993 |
Endothelin-1 is an autocrine/paracrine factor in the mechanism of angiotensin II-induced hypertrophy in cultured rat cardiomyocytes.
Topics: Angiotensin II; Animals; Base Sequence; Biphenyl Compounds; Cardiomegaly; Cells, Cultured; Endothelin Receptor Antagonists; Endothelins; Gene Expression; Imidazoles; In Vitro Techniques; Losartan; Molecular Sequence Data; Muscle Proteins; Myocardium; Oligodeoxyribonucleotides; Oligonucleotides, Antisense; Peptides, Cyclic; Rats; Rats, Wistar; RNA, Messenger; Tetrazoles | 1993 |
Molecular characterization of angiotensin II--induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts. Critical role of the AT1 receptor subtype.
Topics: Angiotensin II; Angiotensinogen; Animals; Cardiomegaly; Cells, Cultured; Fibroblasts; Gene Expression Regulation; Genes, fos; Hyperplasia; Myocardium; Rats; Receptors, Angiotensin; Transforming Growth Factor beta | 1993 |
Rat angiotensin II (type 1A) receptor mRNA regulation and subtype expression in myocardial growth and hypertrophy.
Topics: Angiotensin II; Animals; Base Sequence; Cardiomegaly; Heart; Hypertension; Male; Molecular Sequence Data; Myocardium; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Angiotensin; RNA, Messenger | 1993 |
[Tissue factors contributing to cardiac hypertrophy in cardiomyopathic hamsters (BIO14.6): involvement of transforming growth factor-beta 1 and tissue renin-angiotensin system in the progression of cardiac hypertrophy].
Topics: Angiotensin II; Animals; Cardiomegaly; Cardiomyopathy, Hypertrophic; Cells, Cultured; Cricetinae; Guinea Pigs; Male; Mesocricetus; Myocardium; Peptidyl-Dipeptidase A; Phosphatidylinositols; Renin-Angiotensin System; RNA, Messenger; Transforming Growth Factor beta | 1993 |
Angiotensin II, sodium, and cardiovascular hypertrophy in spontaneously hypertensive rats.
Topics: Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Hypertension; Indoles; Male; Perindopril; Rats; Rats, Inbred SHR; Sodium | 1993 |
The renin-angiotensin system and volume overload-induced cardiac hypertrophy in rats. Effects of angiotensin converting enzyme inhibitor versus angiotensin II receptor blocker.
Topics: Angiotensin II; Animals; Aorta; Arteriovenous Shunt, Surgical; Biphenyl Compounds; Body Weight; Cardiac Volume; Cardiomegaly; Enalapril; Hemodynamics; Imidazoles; Losartan; Male; Myocardium; Organ Size; Rats; Rats, Wistar; Renin; Renin-Angiotensin System; Tetrazoles; Venae Cavae | 1993 |
Endothelin-1 and angiotensin II receptors in cells from rat hypertrophied heart. Receptor regulation and intracellular Ca2+ modulation.
Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Calcium; Cardiomegaly; Cells, Cultured; Endothelins; Male; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptor, Endothelin A; Receptors, Angiotensin; Receptors, Endothelin | 1996 |
Angiotensin II stimulates the autocrine production of transforming growth factor-beta 1 in adult rat cardiac fibroblasts.
Topics: Angiotensin II; Animals; Cardiomegaly; Culture Media, Conditioned; Endomyocardial Fibrosis; Fibroblasts; Gene Expression Regulation; Male; Myocardium; Rats; Rats, Sprague-Dawley; RNA, Messenger; Stimulation, Chemical; Transforming Growth Factor beta | 1995 |
Activation of p70 S6 protein kinase is necessary for angiotensin II-induced hypertrophy in neonatal rat cardiac myocytes.
Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Cardiomegaly; Cells, Cultured; Enzyme Activation; Gene Expression; Genes, fos; Immunosuppressive Agents; Myocardium; Phosphorylation; Polyenes; Protein Serine-Threonine Kinases; Rats; Rats, Wistar; Receptors, Angiotensin; Ribosomal Protein S6 Kinases; Sirolimus | 1996 |
Vascular smooth muscle polyploidy and cardiac hypertrophy in genetic hypertension.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Biphenyl Compounds; Cardiomegaly; Female; Hypertension; Imidazoles; Indoles; Losartan; Male; Muscle, Smooth, Vascular; Perindopril; Polyploidy; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Tetrazoles | 1996 |
Heparin and heparan sulfate block angiotensin II-induced hypertrophy in cultured neonatal rat cardiomyocytes. A possible role of intrinsic heparin-like molecules in regulation of cardiomyocyte hypertrophy.
Topics: Angiotensin II; Animals; Cardiomegaly; Cells, Cultured; Heart; Heparin; Heparin Lyase; Heparitin Sulfate; Humans; Hypertrophy; Leucine; Myocardium; Polysaccharide-Lyases; Rats; Recombinant Proteins | 1996 |
Inhibition of 5-lipoxygenase-activating protein (FLAP) reduces pulmonary vascular reactivity and pulmonary hypertension in hypoxic rats.
Topics: 5-Lipoxygenase-Activating Proteins; Altitude; Angiotensin II; Animals; Arachidonate 5-Lipoxygenase; Cardiomegaly; Carrier Proteins; Endothelium, Vascular; Gene Expression; Hypertension, Pulmonary; Hypoxia; Immunohistochemistry; In Situ Hybridization; Indoles; Inflammation; Lipoxygenase Inhibitors; Male; Membrane Proteins; Mice; Mice, Knockout; Pulmonary Artery; Rats; Rats, Sprague-Dawley; Vasoconstriction | 1996 |
Cardiac hypertrophy in the Dahl rat is associated with increased tyrosine phosphorylation of several cytosolic proteins, including a 120 kDa protein.
Topics: Angiotensin II; Animals; Blotting, Western; Cardiomegaly; Cytosol; Heart Ventricles; Hypertension; Molecular Weight; Muscle Proteins; Muscle, Skeletal; Myocardium; Phosphorylation; Phosphotyrosine; Precipitin Tests; Rats; Rats, Mutant Strains; Sodium Chloride, Dietary; Tyrosine | 1996 |
[Heart hypertrophy. Determinant factors and molecular mechanisms].
Topics: Adult; Age Factors; Aged; Angiotensin II; Cardiomegaly; Female; Hemodynamics; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Obesity; Racial Groups; Risk Factors; Sex Factors; Thyroid Hormones | 1995 |
[Effect of cilazapril, a converting enzyme inhibitor, on cardiovascular hypertrophy in the hypertensive patient].
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Cardiomegaly; Cilazapril; Endothelium, Vascular; Humans; Hypertension; Rats; Renin-Angiotensin System; Vasodilation | 1996 |
Autocrine secretion of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro.
Topics: Angiotensin II; Animals; Cardiomegaly; Cells, Cultured; Genes, fos; Rabbits; Rats | 1996 |
The effect of afterload and angiotensin II on proto-oncogene mRNA levels in the isolated working rat heart.
Topics: Angiotensin II; Animals; Blotting, Northern; Cardiomegaly; Female; Gene Expression; Hypertension; Perfusion; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-fos; Proto-Oncogene Proteins c-myc; ras Proteins; Rats; Rats, Wistar; RNA, Messenger | 1996 |
Effect of acute and chronic losartan treatment on glucose tolerance and insulin sensitivity in fructose-fed rats.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Biphenyl Compounds; Body Weight; Cardiomegaly; Diet; Fructose; Glucose Tolerance Test; Hyperinsulinism; Imidazoles; Insulin; Insulin Resistance; Losartan; Male; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System; Tetrazoles | 1996 |
Renin-angiotensin system in stretch-induced hypertrophy of cultured neonatal rat heart cells.
Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Angiotensins; Animals; Antihypertensive Agents; Biphenyl Compounds; Captopril; Cardiomegaly; Cells, Cultured; Heart; Imidazoles; Losartan; Muscle Proteins; Muscle Spindles; Myocardium; Rats; Rats, Sprague-Dawley; Renin; Tetrazoles | 1996 |
Role of type 1 and type 2 angiotensin receptors in angiotensin II-induced cardiomyocyte hypertrophy.
Topics: Angiotensin II; Animals; Cardiomegaly; Cells, Cultured; Imidazoles; Proteins; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin | 1996 |
Local stress, not systemic factors, regulate gene expression of the cardiac renin-angiotensin system in vivo: a comprehensive study of all its components in the dog.
Topics: Angiotensin II; Animals; Cardiomegaly; Chymases; Dogs; Gene Expression; Heart Failure; Myocardium; Peptidyl-Dipeptidase A; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Renin; RNA, Messenger; Serine Endopeptidases | 1996 |
Hypertension induced in pregnant mice by placental renin and maternal angiotensinogen.
Topics: Angiotensin II; Angiotensinogen; Animals; Blood Pressure; Cardiomegaly; Crosses, Genetic; Disease Models, Animal; Female; Humans; Hypertension; Kidney Glomerulus; Male; Mice; Mice, Transgenic; Placenta; Pregnancy; Pregnancy Complications, Cardiovascular; Renin | 1996 |
Desmin gene expression in cardiac myocytes is responsive to contractile activity and stretch.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Animals, Newborn; Base Sequence; Cardiomegaly; Dactinomycin; Desmin; Gene Expression; Molecular Sequence Data; Myocardial Contraction; Myocardium; Oligonucleotide Probes; Physical Stimulation; Rats; Receptors, Angiotensin; RNA Polymerase II; RNA, Messenger; Stress, Mechanical | 1996 |
Altered signal transduction system in hypertrophied myocardium: angiotensin II stimulates collagen synthesis in hypertrophied hearts.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Biphenyl Compounds; Cardiomegaly; Cells, Cultured; Collagen; Fibroblasts; Imidazoles; Losartan; Male; Myocardium; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Renin-Angiotensin System; RNA, Messenger; Saralasin; Signal Transduction; Tetrazoles | 1996 |
Angiotensin II mediates mechanical stress-induced cardiac hypertrophy.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Calcium-Calmodulin-Dependent Protein Kinases; Cardiomegaly; Cells, Cultured; Culture Media, Conditioned; Enzyme Activation; Heart; Hypertrophy, Left Ventricular; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinase Kinases; Mitogen-Activated Protein Kinases; Myocardial Contraction; Myocardium; Protein Kinases; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-raf; Rats; Rats, Wistar; Stress, Mechanical | 1996 |
Cardiac angiotensin converting enzyme and endothelin receptor in rats with chronic myocardial infarction.
Topics: Angiotensin II; Animals; Autoradiography; Cardiomegaly; Chronic Disease; Endothelin-1; Female; Heart Failure; Image Processing, Computer-Assisted; Iodine Radioisotopes; Ligation; Myocardial Infarction; Myocardium; Peptidyl-Dipeptidase A; Rats; Rats, Wistar; Receptors, Endothelin; Renin; Ventricular Function, Left | 1996 |
Endothelin and angiotensin II stimulation of Na+-H+ exchange is impaired in cardiac hypertrophy.
Topics: Amiloride; Ammonium Chloride; Angiotensin II; Animals; Body Weight; Calcium; Cardiomegaly; Cell Size; Cells, Cultured; Endothelin-1; Hydrogen-Ion Concentration; Male; Myocardium; Phorbol Esters; Protein Kinase C; Rats; Rats, Wistar; Sodium-Hydrogen Exchangers | 1997 |
Differences in cultured cardiac fibroblast populations isolated from SHR and WKY rats.
Topics: Actins; Angiotensin II; Angiotensinogen; Animals; Cardiomegaly; Cells, Cultured; Fibroblasts; Heart Ventricles; Immunohistochemistry; Myocardium; Plasmids; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Angiotensin; RNA, Messenger | 1995 |
Down-regulation of aortic and cardiac AT1 receptor gene expression in transgenic (mRen-2) 27 rats.
Topics: Analysis of Variance; Angiotensin II; Animals; Animals, Genetically Modified; Aorta; Base Sequence; Blood Pressure; Cardiomegaly; Down-Regulation; Heart; Hypertension; Mice; Molecular Sequence Data; Muscle Contraction; Muscle, Smooth, Vascular; Myocardium; Polymerase Chain Reaction; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Renin-Angiotensin System; RNA, Messenger; Vasoconstrictor Agents | 1997 |
Cardiac hypertrophy in diabetic spontaneously hypertensive rats: role of angiotensin II?
Topics: Angiotensin II; Animals; Blood Pressure; Body Weight; Cardiac Volume; Cardiomegaly; Diabetes Mellitus, Experimental; Heart Septum; Hypertension; Hypertrophy, Left Ventricular; Male; Organ Size; Rats; Rats, Inbred SHR | 1997 |
Pressure-independent effects of AT1-receptor antagonism on cardiovascular remodeling in aortic-banded rats.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Aorta; Biphenyl Compounds; Blood Pressure; Cardiomegaly; Constriction; Coronary Circulation; Coronary Vessels; Heart; Imidazoles; Losartan; Male; Organ Size; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Tetrazoles; Vascular Resistance | 1997 |
Humoral factor(s) produced by pressure overload enhance cardiac hypertrophy and natriuretic peptide expression.
Topics: Angiotensin II; Animals; Aortic Coarctation; Atrial Natriuretic Factor; Atrophy; Blood Pressure; Body Weight; Cardiomegaly; Endothelin-1; Heart Rate; Heart Transplantation; Hypertension; Male; Myosins; Natriuretic Peptide, Brain; Nerve Tissue Proteins; Rats; Rats, Inbred Lew; RNA, Messenger; Transcription, Genetic; Transplantation, Heterotopic; Transplantation, Isogeneic | 1997 |
Volume-overload cardiac hypertrophy is unaffected by ACE inhibitor treatment in dogs.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiomegaly; Cell Separation; Chymases; Collagen; Dogs; Heart Ventricles; Hemodynamics; Hyperemia; Myocardium; Peptidyl-Dipeptidase A; Receptors, Angiotensin; RNA, Messenger; Serine Endopeptidases | 1997 |
Cross-talk between receptor-mediated phospholipase C-beta and D via protein kinase C as intracellular signal possibly leading to hypertrophy in serum-free cultured cardiomyocytes.
Topics: Angiotensin II; Animals; Cardiomegaly; Cells, Cultured; Culture Media, Serum-Free; Down-Regulation; Endothelin-1; Histones; Immunoblotting; Isoenzymes; Myocardium; Phenylephrine; Phospholipase C beta; Phospholipase D; Protein Biosynthesis; Protein Kinase C; Proteins; Rats; Rats, Wistar; Signal Transduction; Tetradecanoylphorbol Acetate; Type C Phospholipases | 1997 |
Contractile systolic and diastolic dysfunction in renin-induced hypertensive cardiomyopathy.
Topics: Angiotensin II; Animals; Animals, Genetically Modified; Calcium-Binding Proteins; Calcium-Transporting ATPases; Cardiomegaly; Collagen; Diastole; Heart; Hydroxyproline; Hypertension; Mice; Myocardial Contraction; Myocardium; Myosin Heavy Chains; Rats; Renin; RNA, Messenger; Sarcoplasmic Reticulum; Systole | 1997 |
Role of angiotensin II in early cardiovascular growth and vascular amplifier development in spontaneously hypertensive rats.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Animals, Newborn; Antihypertensive Agents; Body Weight; Cardiomegaly; Cardiovascular System; Hypertension; Hypertrophy; Indoles; Kidney; Losartan; Male; Mesenteric Arteries; Organ Size; Papaverine; Perindopril; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Time Factors; Vascular Resistance | 1997 |
Trophic effect of human pericardial fluid on adult cardiac myocytes. Differential role of fibroblast growth factor-2 and factors related to ventricular hypertrophy.
Topics: Adult; Aged; Aged, 80 and over; Angiotensin II; Animals; Atrial Natriuretic Factor; Body Fluids; Cardiomegaly; Female; Fibroblast Growth Factor 2; Heart; Heart Ventricles; Humans; Male; Middle Aged; Myocardium; Pericardium; Rats; Rats, Wistar; Transforming Growth Factor beta | 1997 |
Significance of ventricular myocytes and nonmyocytes interaction during cardiocyte hypertrophy: evidence for endothelin-1 as a paracrine hypertrophic factor from cardiac nonmyocytes.
Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Cardiomegaly; Cattle; Coculture Techniques; Culture Media, Conditioned; Endothelin Receptor Antagonists; Endothelin-1; Hypertrophy; Lipoproteins, LDL; Myocardium; Natriuretic Peptide, Brain; Nerve Tissue Proteins; Paracrine Communication; Rats; Rats, Wistar; Receptors, Angiotensin; Receptors, Endothelin; RNA, Messenger; Transforming Growth Factor beta; Ventricular Function | 1997 |
The effects of angiotensin II and specific angiotensin receptor blockers on embryonic cardiac development and looping patterns.
Topics: Actins; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Cardiomegaly; Fetal Heart; Fibroblasts; Heart Ventricles; Hypertrophy; Imidazoles; Losartan; Morphogenesis; Myocardium; Myosin Heavy Chains; Organ Culture Techniques; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin | 1997 |
Reduction of angiotensin II-induced activation of mitogen-activated protein kinase in cardiac hypertrophy.
Topics: Angiotensin II; Animals; Calcium-Calmodulin-Dependent Protein Kinases; Cardiomegaly; Cell Compartmentation; Enzyme Activation; Muscle, Skeletal; Protein Kinase C; Rats; Rats, Mutant Strains; Signal Transduction; Sodium Chloride, Dietary | 1997 |
Biphasic activation of the JAK/STAT pathway by angiotensin II in rat cardiomyocytes.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Biphenyl Compounds; Cardiomegaly; Cells, Cultured; Interferon-gamma; Interferons; Janus Kinase 2; Myocardium; Phosphorylation; Phosphotransferases; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Rats; Rats, Wistar; Signal Transduction; Stereoisomerism; Tetrazoles; Trans-Activators; Tyrosine | 1998 |
Effect of ecadotril, a neutral endopeptidase inhibitor, on myocardial hypertrophy in the rat aortic insufficiency model.
Topics: Angiotensin II; Animals; Aortic Diseases; Blood Pressure; Cardiomegaly; Disease Models, Animal; Guanosine Monophosphate; Male; Protease Inhibitors; Rats; Rats, Wistar; Thiorphan | 1998 |
Role of ion channels and exchangers in mechanical stretch-induced cardiomyocyte hypertrophy.
Topics: Angiotensin II; Animals; Benzimidazoles; Biphenyl Compounds; Calcium-Calmodulin-Dependent Protein Kinases; Cardiomegaly; Cytoplasm; Endothelin-1; Enzyme Activation; Enzyme Inhibitors; Flavonoids; Guanidines; Hydrogen-Ion Concentration; Ion Channels; MAP Kinase Kinase 1; Mechanoreceptors; Mitogen-Activated Protein Kinase Kinases; Muscle Proteins; Peptides, Cyclic; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-raf; Rats; Rats, Wistar; Signal Transduction; Sodium-Hydrogen Exchangers; Sulfones; Tetrazoles | 1998 |
Pressure-overload hypertrophy is unabated in mice devoid of AT1A receptors.
Topics: Angiotensin II; Animals; Blood Pressure; Body Weight; Cardiomegaly; Heterozygote; Mice; Mice, Knockout; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Renin | 1998 |
Increased mRNA expression of cardiac renin-angiotensin system and collagen synthesis in spontaneously hypertensive rats.
Topics: Angiotensin II; Angiotensinogen; Animals; Blood Pressure; Cardiomegaly; Collagen; Hypertension; Myocardium; Organ Size; Peptidyl-Dipeptidase A; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Renin-Angiotensin System; RNA, Messenger | 1998 |
Acute pressure overload could induce hypertrophic responses in the heart of angiotensin II type 1a knockout mice.
Topics: Angiotensin II; Animals; Aorta; Calcium-Calmodulin-Dependent Protein Kinases; Cardiomegaly; Gene Expression; Genes, fos; Genes, jun; Hemodynamics; Infusions, Intravenous; Mice; Mice, Knockout; Natriuretic Peptide, Brain; Nerve Tissue Proteins; Polymerase Chain Reaction; Transcription, Genetic; Ventricular Pressure | 1998 |
A calcineurin-dependent transcriptional pathway for cardiac hypertrophy.
Topics: Angiotensin II; Animals; Animals, Newborn; Atrial Natriuretic Factor; Calcineurin; Cardiomegaly; Cell Nucleus; DNA-Binding Proteins; GATA4 Transcription Factor; Immunosuppressive Agents; Mice; Mice, Transgenic; Myocardium; Natriuretic Peptide, Brain; NFATC Transcription Factors; Nuclear Proteins; Phenylephrine; Promoter Regions, Genetic; Rats; Recombinant Fusion Proteins; Signal Transduction; Transcription Factors; Transcription, Genetic; Transcriptional Activation; Zinc Fingers | 1998 |
Signal transduction and activator of transcription (STAT) protein-dependent activation of angiotensinogen promoter: a cellular signal for hypertrophy in cardiac muscle.
Topics: Angiotensin II; Angiotensinogen; Animals; Cardiomegaly; Cells, Cultured; DNA-Binding Proteins; Gene Expression Regulation; Heart; Male; Milk Proteins; Promoter Regions, Genetic; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Rats, Wistar; Signal Transduction; STAT3 Transcription Factor; STAT5 Transcription Factor; STAT6 Transcription Factor; Trans-Activators; Transcriptional Activation | 1998 |
Endothelin-1 expression in hearts of transgenic hypertensive mice overexpressing angiotensin II.
Topics: Angiotensin II; Animals; Cardiomegaly; Disease Progression; Endothelin Receptor Antagonists; Endothelin-1; Hemodynamics; Humans; Hypertension; Indans; Male; Mice; Mice, Transgenic; Myocardium; Polymerase Chain Reaction; Receptor, Endothelin A; Receptor, Endothelin B; RNA, Messenger | 1998 |
Pressure overload induces cardiac hypertrophy in angiotensin II type 1A receptor knockout mice.
Topics: Angiotensin II; Animals; Aorta, Abdominal; Blood Pressure; Cardiomegaly; Echocardiography; Hypertension; Mice; Mice, Knockout; Polymerase Chain Reaction; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; RNA, Messenger; Signal Transduction; Transcription, Genetic | 1998 |
Blood pressure-independent cardiac hypertrophy induced by locally activated renin-angiotensin system.
Topics: Angiotensin II; Angiotensinogen; Animals; Blood Pressure; Blotting, Northern; Blotting, Southern; Blotting, Western; Cardiomegaly; DNA; Heart Rate; Immunohistochemistry; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Transgenic; Myocardium; Polymerase Chain Reaction; Rabbits; Rats; Renin; Renin-Angiotensin System; RNA; Transgenes | 1998 |
Angiotensin II stimulation in vitro induces hypertrophy of normal and postinfarcted ventricular myocytes.
Topics: Angiotensin II; Animals; Cardiomegaly; Cell Size; Cells, Cultured; Male; Microscopy, Confocal; Muscle Fibers, Skeletal; Myocardial Infarction; Myocardium; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Up-Regulation; Vasoconstrictor Agents; Ventricular Function, Left; Ventricular Function, Right | 1998 |
Taurine improves angiotensin II-induced hypertrophy of cultured neonatal rat heart cells.
Topics: Angiotensin II; Animals; Animals, Newborn; Cardiomegaly; Cells, Cultured; Heart; Myocardium; Rats; Rats, Wistar; Taurine | 1998 |
Effects of taurine on signal transduction steps induced during hypertrophy of rat heart myocytes.
Topics: Angiotensin II; Animals; Calcium; Cardiomegaly; Cells, Cultured; Heart; Myocardium; Nifedipine; Ouabain; Rats; Ryanodine; Signal Transduction; Taurine | 1998 |
Angiotensin II receptor subtype AT1 and AT2 expression after heart transplantation.
Topics: Adult; Analysis of Variance; Angiotensin II; Cardiomegaly; Female; Gene Expression Regulation; Heart Transplantation; Humans; Male; Middle Aged; Polymerase Chain Reaction; Postoperative Period; Receptors, Angiotensin; RNA, Messenger; Time Factors | 1998 |
Inhibitory effects of antioxidants on neonatal rat cardiac myocyte hypertrophy induced by tumor necrosis factor-alpha and angiotensin II.
Topics: Angiotensin II; Animals; Animals, Newborn; Antioxidants; Butylated Hydroxyanisole; Cardiomegaly; Catalase; Cells, Cultured; Leucine; Rats; Rats, Wistar; Reactive Oxygen Species; Recombinant Proteins; Tritium; Tumor Necrosis Factor-alpha; Vitamin E | 1998 |
Effects of angiotensin II on expression of the gap junction channel protein connexin43 in neonatal rat ventricular myocytes.
Topics: Angiotensin II; Animals; Animals, Newborn; Cardiomegaly; Connexin 43; Culture Techniques; Gap Junctions; Heart Ventricles; Microscopy, Confocal; Microscopy, Electron; Microscopy, Fluorescence; Rats; Signal Transduction; Up-Regulation | 1998 |
Angiotensin II-induced hypertrophy of adult rat cardiomyocytes is blocked by nitric oxide.
Topics: 1-Methyl-3-isobutylxanthine; 8-Bromo Cyclic Adenosine Monophosphate; Angiotensin II; Animals; Bradykinin; Cardiomegaly; Cells, Cultured; Coculture Techniques; Cyclic GMP; Endothelium, Vascular; Heart; Iloprost; Indomethacin; Male; Molsidomine; Myocardium; Nitric Oxide; Nitric Oxide Donors; Nitroprusside; omega-N-Methylarginine; Phenylalanine; Protein Biosynthesis; Rats; Rats, Sprague-Dawley | 1998 |
Differential activation of cardiac c-jun amino-terminal kinase and extracellular signal-regulated kinase in angiotensin II-mediated hypertension.
Topics: Analysis of Variance; Angiotensin II; Animals; Aorta; Blood Pressure; Calcium-Calmodulin-Dependent Protein Kinases; Cardiomegaly; Dose-Response Relationship, Drug; Enzyme Activation; Heart Ventricles; Hypertension; Infusions, Intra-Arterial; Infusions, Intravenous; JNK Mitogen-Activated Protein Kinases; Male; Mitogen-Activated Protein Kinases; Rats; Rats, Sprague-Dawley | 1998 |
Angiotensin and endothelin: messengers that couple ventricular stretch to the Na+/H+ exchanger and cardiac hypertrophy.
Topics: Angiotensin II; Cardiomegaly; Endothelin-1; Humans; Myocardium; Signal Transduction; Sodium-Hydrogen Exchangers | 1998 |
Perindopril effects on angiotensin I elimination in lung after experimental myocardial injury induced by intracoronary microembolization in rats.
Topics: Angiotensin I; Angiotensin II; Animals; Antihypertensive Agents; Cardiomegaly; Chromatography, High Pressure Liquid; Hemodynamics; Indoles; Infusions, Intravenous; Lung; Male; Microspheres; Perindopril; Rats; Rats, Wistar | 1998 |
Local renin-angiotensin system contributes to hyperthyroidism-induced cardiac hypertrophy.
Topics: Analysis of Variance; Angiotensin II; Animals; Cardiomegaly; Hyperthyroidism; Male; Myocardium; Rats; Rats, Sprague-Dawley; Renin; Renin-Angiotensin System; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Thyroxine | 1999 |
Tissue-localized angiotensin II enhances cardiac and renal disorders in Tsukuba hypertensive mice.
Topics: Angiotensin II; Angiotensinogen; Animals; Antihypertensive Agents; Blood Pressure; Cardiomegaly; Catecholamines; Humans; Hydralazine; Hypertension; Kidney Diseases; Lisinopril; Mice; Mice, Inbred C57BL; Mice, Transgenic; Renin | 1998 |
Angiotensin II stimulates cardiac myocyte hypertrophy via paracrine release of TGF-beta 1 and endothelin-1 from fibroblasts.
Topics: Angiotensin II; Animals; Animals, Newborn; Blotting, Northern; Blotting, Western; Cardiomegaly; Cells, Cultured; Coculture Techniques; Culture Media, Conditioned; Endothelin-1; Fibroblasts; Microscopy, Fluorescence; Myocardium; Paracrine Communication; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; RNA, Messenger; Transforming Growth Factor beta; Vasoconstrictor Agents | 1998 |
Role of NO and angiotensin II in the early development of endothelial functions impairment and cardiac hypertrophy in deoxycorticosterone acetate-salt hypertension.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Cardiomegaly; Desoxycorticosterone; Endothelium, Vascular; Hypertension; In Vitro Techniques; Losartan; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Organ Size; Rats; Rats, Sprague-Dawley; Sodium Chloride; Splanchnic Circulation | 1998 |
Effects of angiotensin II on inotropy and intracellular Ca2+ handling in normal and hypertrophied rat myocardium.
Topics: Angiotensin II; Animals; Calcium; Cardiomegaly; Heart; Male; Myocardial Contraction; Myocardium; Rats; Rats, Inbred Lew | 1998 |
Rho family small G proteins play critical roles in mechanical stress-induced hypertrophic responses in cardiac myocytes.
Topics: Angiotensin II; Animals; Calcium-Calmodulin-Dependent Protein Kinases; Cardiomegaly; Cells, Cultured; Enzyme Activation; GTP-Binding Proteins; Guanine Nucleotide Dissociation Inhibitors; Mutation; Myocardium; Phenylalanine; ras Proteins; Rats; Rats, Wistar; rho-Specific Guanine Nucleotide Dissociation Inhibitors; rhoA GTP-Binding Protein; src-Family Kinases; Stress, Mechanical | 1999 |
Comparison of irbesartan with captopril effects on cardiac hypertrophy and gene expression in heart failure-prone male SHHF/Mcc-fa(cp) rats.
Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Atrial Natriuretic Factor; Biphenyl Compounds; Blood Pressure; Body Weight; Captopril; Cardiomegaly; Dose-Response Relationship, Drug; Echocardiography; Gene Expression; Heart Failure; Irbesartan; Isoenzymes; Male; Myosin Heavy Chains; Organ Size; Rats; Rats, Inbred Strains; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin; RNA, Messenger; Systole; Tetrazoles | 1999 |
Renin-angiotensin system stimulates cardiac and renal disorders in Tsukuba hypertensive mice.
Topics: Angiotensin II; Angiotensinogen; Animals; Blood Pressure; Cardiomegaly; Humans; Hydralazine; Hypertension; Kidney Diseases; Lisinopril; Mice; Mice, Inbred C57BL; Renin; Renin-Angiotensin System; Survival Rate | 1999 |
Interaction between neutral endopeptidase and angiotensin converting enzyme inhibition in rats with myocardial infarction: effects on cardiac hypertrophy and angiotensin and bradykinin peptide levels.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Body Weight; Bradykinin; Cardiomegaly; Cyclic GMP; Drug Synergism; Indoles; Male; Myocardial Infarction; Neprilysin; Peptidyl-Dipeptidase A; Perindopril; Potassium; Protease Inhibitors; Radioimmunoassay; Rats; Rats, Sprague-Dawley; Renin; Sodium; Thiorphan | 1999 |
[Modelling of myocardial hypertrophy in vitro for solving problems of medicinal correction].
Topics: Adrenergic alpha-Agonists; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Animals, Newborn; Blood Physiological Phenomena; Cardiomegaly; Cells, Cultured; Disease Models, Animal; Fibroblasts; Models, Biological; Norepinephrine; Protein Biosynthesis; Rats; Stimulation, Chemical; Surface Properties | 1998 |
Evidence for angiotensin-converting enzyme- and chymase-mediated angiotensin II formation in the interstitial fluid space of the dog heart in vivo.
Topics: Angiotensin II; Animals; Cardiomegaly; Chymases; Dogs; Extracellular Space; Myocardium; Peptidyl-Dipeptidase A; Serine Endopeptidases | 1999 |
Activation of cardiac aldosterone production in rat myocardial infarction: effect of angiotensin II receptor blockade and role in cardiac fibrosis.
Topics: Aldosterone; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Atrial Natriuretic Factor; Cardiomegaly; Fibrosis; Gene Expression; Heart; Heart Ventricles; Male; Myocardial Infarction; Myocardium; Norepinephrine; Rats; Rats, Wistar; Steroids | 1999 |
Mechanical stretch activates the JAK/STAT pathway in rat cardiomyocytes.
Topics: Angiotensin II; Animals; Antigens, CD; Autocrine Communication; Calcium; Carcinogens; Cardiomegaly; Cells, Cultured; Cytokine Receptor gp130; DNA-Binding Proteins; Endothelin-1; Gene Expression Regulation, Enzymologic; Interleukin-6; Janus Kinase 1; Janus Kinase 2; Membrane Glycoproteins; Mice; Mice, Inbred ICR; Muscle Fibers, Skeletal; Myocardial Contraction; Myocardium; Paracrine Communication; Phosphorylation; Protein Kinase C; Protein-Tyrosine Kinases; Proteins; Proto-Oncogene Proteins; Rats; Rats, Wistar; Signal Transduction; Sodium-Potassium-Exchanging ATPase; STAT1 Transcription Factor; STAT3 Transcription Factor; Stress, Mechanical; Tetradecanoylphorbol Acetate; Trans-Activators; TYK2 Kinase | 1999 |
[Myocardial hypertrophy in rabbits with vasorenal arterial hypertension during pharmacological blockade of formation of angiotensin II and its interaction with specific receptors].
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Cardiomegaly; Hypertension, Renovascular; Hypertrophy, Left Ventricular; Male; Myocardium; Rabbits; Receptors, Angiotensin; Tetrazoles; Valine; Valsartan | 1999 |
Interaction between endothelin and angiotensin II.
Topics: Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Endothelin Receptor Antagonists; Endothelins; Heart Atria; Heart Ventricles; Male; Rats; Rats, Sprague-Dawley; Receptor, Endothelin A; Receptors, Endothelin | 1999 |
Hyperglycaemia abolishes the antihypertrophic efficacy of bradykinin in rat ventricular myocytes.
Topics: Angiotensin II; Animals; Aorta; Bradykinin; Cardiomegaly; Cattle; Coculture Techniques; Endothelium, Vascular; Glucose; Heart Ventricles; Hyperglycemia; Male; Myocardium; Phenylalanine; Rats; Rats, Sprague-Dawley | 1999 |
Lovastatin prevents angiotensin II-induced cardiac hypertrophy in cultured neonatal rat heart cells.
Topics: Angiotensin II; Animals; Animals, Newborn; Calcium-Calmodulin-Dependent Protein Kinases; Cardiomegaly; Cell Division; Cell Membrane; Cells, Cultured; DNA; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Myocardium; Naphthalenes; Pravastatin; Proto-Oncogene Proteins p21(ras); Rats; Rats, Sprague-Dawley; RNA; Simvastatin | 1999 |
Downregulation of cardiac AT1-receptor expression and angiotensin II concentrations after long-term blockade of the renin-angiotensin system in cardiomyopathic hamsters.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Binding, Competitive; Cardiomegaly; Cricetinae; Down-Regulation; Heart Ventricles; Losartan; Male; Mesocricetus; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Renin-Angiotensin System | 1999 |
Angiotensin II enhances integrin and alpha-actinin expression in adult rat cardiac fibroblasts.
Topics: Actinin; Age Factors; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antigens, CD; Antihypertensive Agents; Biphenyl Compounds; Cardiomegaly; Cell Adhesion; Cell Adhesion Molecules; Cells, Cultured; Collagen; Fibroblasts; Fibronectins; Focal Adhesion Kinase 1; Focal Adhesion Protein-Tyrosine Kinases; Gene Expression; Heart Ventricles; Hydralazine; Imidazoles; Integrin alphaV; Integrin beta Chains; Integrin beta1; Integrin beta3; Integrins; Irbesartan; Laminin; Losartan; Myocardium; Phosphorylation; Platelet Membrane Glycoproteins; Protein-Tyrosine Kinases; Pyridines; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; RNA, Messenger; Tetrazoles; Up-Regulation; Vitronectin | 2000 |
The brain renin-angiotensin system modulates angiotensin II-induced hypertension and cardiac hypertrophy.
Topics: Angiotensin II; Angiotensinogen; Animals; Animals, Genetically Modified; Atrial Natriuretic Factor; Blood Pressure; Brain Chemistry; Cardiomegaly; Collagen; Gene Expression; Heart Ventricles; Hypertension, Renal; Male; Myocardium; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System; RNA, Messenger | 2000 |
Myosin light chain kinase mediates sarcomere organization during cardiac hypertrophy in vitro.
Topics: Angiotensin II; Animals; Cardiomegaly; Cells, Cultured; Myosin-Light-Chain Kinase; Phenotype; Phenylephrine; Phosphorylation; Rats; Rats, Wistar; Sarcomeres | 2000 |
Targeted inhibition of calcineurin prevents agonist-induced cardiomyocyte hypertrophy.
Topics: Adenoviridae; Angiotensin II; Animals; Apoptosis Regulatory Proteins; Atrial Natriuretic Factor; Calcineurin; Calcineurin Inhibitors; Cardiomegaly; Carrier Proteins; Cattle; Cells, Cultured; DNA-Binding Proteins; Fetal Blood; Gene Expression Regulation; Genes; Genetic Therapy; Genetic Vectors; Hypertrophy; Myocardium; NFATC Transcription Factors; Nuclear Proteins; Phenylephrine; Rats; Reverse Transcriptase Polymerase Chain Reaction; Transcription Factors; Transfection | 2000 |
Blood pressure-independent effects in rats with human renin and angiotensinogen genes.
Topics: Albuminuria; Angiotensin II; Angiotensinogen; Animals; Animals, Genetically Modified; Antihypertensive Agents; Blood Pressure; Cardiomegaly; Diuresis; Glomerular Filtration Rate; Humans; Hydralazine; Hydrochlorothiazide; Ki-67 Antigen; Kidney; Male; Myocardium; Natriuresis; Protease Inhibitors; Rats; Rats, Sprague-Dawley; Renal Circulation; Renin; Reserpine; Sodium; Transgenes | 2000 |
Chronic antisense therapy for angiotensinogen on cardiac hypertrophy in spontaneously hypertensive rats.
Topics: Analysis of Variance; Angiotensin II; Angiotensinogen; Animals; Cardiomegaly; Gene Expression; Genetic Therapy; Injections, Intravenous; Liver; Male; Myocardium; Oligodeoxyribonucleotides, Antisense; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; RNA, Messenger; Ventricular Remodeling | 1999 |
Specific role of the extracellular signal-regulated kinase pathway in angiotensin II-induced cardiac hypertrophy in vitro.
Topics: Angiotensin II; Animals; Animals, Newborn; Cardiomegaly; Cells, Cultured; Enzyme Inhibitors; Heart; Heart Ventricles; Imidazoles; JNK Mitogen-Activated Protein Kinases; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Models, Cardiovascular; Myocardium; p38 Mitogen-Activated Protein Kinases; Phenylephrine; Protein Serine-Threonine Kinases; Pyridines; Rats; Rats, Wistar; Recombinant Proteins; Signal Transduction; Transfection | 2000 |
Sodium-induced cardiac aldosterone synthesis causes cardiac hypertrophy.
Topics: Aldosterone; Angiotensin II; Animals; Cardiomegaly; Cytochrome P-450 CYP11B2; Heart; Male; Myocardium; Rats; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; RNA, Messenger; Sodium | 2000 |
Expression profiling reveals distinct sets of genes altered during induction and regression of cardiac hypertrophy.
Topics: Angiotensin II; Animals; Cardiomegaly; Gene Expression Profiling; Gene Expression Regulation; Isoproterenol; Male; Mice; Oligonucleotide Array Sequence Analysis; Reverse Transcriptase Polymerase Chain Reaction | 2000 |
Interleukin-6 family of cytokines mediate angiotensin II-induced cardiac hypertrophy in rodent cardiomyocytes.
Topics: Angiotensin II; Animals; Cardiomegaly; Cells, Cultured; Cytokines; Fibroblasts; Growth Inhibitors; Interleukin-6; Leukemia Inhibitory Factor; Lymphokines; Mice; Mice, Inbred ICR; Myocardium; Rats; Rats, Wistar; Vasoconstrictor Agents | 2000 |
Inability to induce hypertension in normotensive rat expressing AT(1) receptor antisense.
Topics: Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Dose-Response Relationship, Drug; Drinking; Female; Gene Transfer Techniques; Hypertension; Oligonucleotides, Antisense; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Reference Values; Renal Circulation; Time Factors; Vasoconstriction | 2000 |
Angiotensin II stimulates hypertrophic growth of cultured neonatal rat ventricular myocytes: roles of PKC and PGF2alpha.
Topics: Angiotensin II; Animals; Cardiomegaly; Cell Fractionation; Cells, Cultured; Dinoprost; Enzyme Activation; Enzyme Inhibitors; Heart Ventricles; Myocardium; Phorbol 12,13-Dibutyrate; Protein Kinase C; Rats | 2000 |
Reverse remodeling of cardiac myocyte hypertrophy in hypertension and failure by targeting of the renin-angiotensin system.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Cardiomegaly; Echocardiography; Enalapril; Female; Heart Failure; Hypertension, Renal; Imidazoles; Muscle Fibers, Skeletal; Myocardium; Organ Size; Rats; Rats, Inbred Strains; Renin-Angiotensin System; Tetrazoles; Ventricular Remodeling | 2000 |
Involvement of calcineurin in angiotensin II-induced cardiomyocyte hypertrophy and cardiac fibroblast hyperplasia of rats.
Topics: Angiotensin II; Animals; Animals, Newborn; Atrial Natriuretic Factor; Calcineurin; Calcineurin Inhibitors; Calcium; Cardiomegaly; Cell Division; Cells, Cultured; Cyclosporine; DNA; Fibroblasts; Fura-2; Hyperplasia; Losartan; Myocardium; Protein Kinase C; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; RNA, Messenger; Signal Transduction | 1999 |
Effect of bosentan on NF-kappaB, inflammation, and tissue factor in angiotensin II-induced end-organ damage.
Topics: Albuminuria; Angiotensin II; Angiotensinogen; Animals; Animals, Genetically Modified; Antihypertensive Agents; Blood Pressure; Bosentan; Cardiomegaly; Fibronectins; Heart; Humans; Hydralazine; Immunohistochemistry; Inflammation; Intercellular Adhesion Molecule-1; Kidney; Macrophages; Male; NF-kappa B; Rats; Rats, Sprague-Dawley; Renin; Sulfonamides; Thromboplastin; Transcription Factor AP-1; Vascular Cell Adhesion Molecule-1 | 2000 |
G1 cyclins are involved in the mechanism of cardiac myocyte hypertrophy induced by angiotensin II.
Topics: Angiotensin II; Animals; Cardiomegaly; Cell Cycle Proteins; Cells, Cultured; Cyclin G; Cyclin G1; Cyclin-Dependent Kinase Inhibitor p16; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinases; Cyclins; Myocardium; p21-Activated Kinases; Phosphorylation; Protein Serine-Threonine Kinases; Rats; Rats, Wistar; Retinoblastoma Protein; Signal Transduction | 2000 |
Taurine attenuates hypertrophy induced by angiotensin II in cultured neonatal rat cardiac myocytes.
Topics: Angiotensin II; Animals; Blotting, Northern; Cardiomegaly; Cell Size; Cells, Cultured; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Myocardium; Protein Kinase C; Rats; Rats, Wistar; RNA, Messenger; Taurine; Vasoconstrictor Agents | 2000 |
Unchanged cardiac angiotensin II levels accompany losartan-sensitive cardiac injury due to nitric oxide synthase inhibition.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Blood Pressure; Cardiomegaly; Dose-Response Relationship, Drug; Enzyme Inhibitors; Heart; Losartan; Male; Myocardial Infarction; Myocardium; Nitric Oxide Synthase; Nitroarginine; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Vasculitis | 2000 |
[Cardiac and vascular hypertrophy in hypertension due to angiotensin II. Effect of losartan and bosentan].
Topics: Analysis of Variance; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Blood Pressure; Body Weight; Bosentan; Cardiomegaly; Carotid Arteries; Endothelin Receptor Antagonists; Endothelins; Follow-Up Studies; Hypertension; Hypertrophy; Losartan; Male; Organ Size; Rats; Rats, Sprague-Dawley; Sulfonamides | 2000 |
Early sequence of cardiac adaptations and growth factor formation in pressure- and volume-overload hypertrophy.
Topics: Adaptation, Physiological; Angiotensin II; Animals; Blood Pressure; Cardiac Volume; Cardiomegaly; Disease Models, Animal; Echocardiography; Endothelin-1; Female; Hemodynamics; In Situ Hybridization; Insulin-Like Growth Factor I; Male; Myocardium; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Swine | 2000 |
Angiotensin II-induced cardiac hypertrophy is associated with different mitogen-activated protein kinase activation in normotensive and hypertensive mice.
Topics: Angiotensin II; Angiotensinogen; Animals; Blood Pressure; Cardiomegaly; Cells, Cultured; Enzyme Activation; Female; Hypertension; In Vitro Techniques; JNK Mitogen-Activated Protein Kinases; Male; MAP Kinase Kinase 4; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mitogen-Activated Protein Kinase Kinases; Mitogen-Activated Protein Kinases; Myocardium; Myosin Heavy Chains; p38 Mitogen-Activated Protein Kinases; Promoter Regions, Genetic; Renin; Stress, Mechanical; Transgenes; Vasoconstrictor Agents | 2000 |
Cardiac hypertrophy and cardiac renin-angiotensin system in Dahl rats on high salt intake.
Topics: Angiotensin I; Angiotensin II; Animals; Blood Pressure; Brain Chemistry; Cardiomegaly; Gene Expression; Heart Ventricles; Immunoglobulin Fab Fragments; Male; Myocardium; Organ Size; Ouabain; Peptidyl-Dipeptidase A; Rats; Rats, Inbred Dahl; Renin; Renin-Angiotensin System; RNA, Messenger; Sodium, Dietary; Sympathetic Nervous System | 2000 |
Calcineurin blockade prevents cardiac mitogen-activated protein kinase activation and hypertrophy in renovascular hypertension.
Topics: Angiotensin II; Animals; Calcineurin; Calcineurin Inhibitors; Cardiomegaly; Cyclosporine; Enzyme Activation; Hypertension, Renovascular; Male; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinases; Myocardium; Protein Kinase C | 2000 |
Cardiac aldosterone production in genetically hypertensive rats.
Topics: Adrenalectomy; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiomegaly; Corticosterone; Cytochrome P-450 CYP11B2; Heart Ventricles; Hypertension; In Vitro Techniques; Mineralocorticoid Receptor Antagonists; Myocardium; Organ Size; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Renin; RNA, Messenger; Spironolactone | 2000 |
Important role of angiotensin II-mediated c-Jun NH(2)-terminal kinase activation in cardiac hypertrophy in hypertensive rats.
Topics: Acute Disease; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Binding, Competitive; Blood Pressure; Cardiomegaly; Chronic Disease; DNA; Heart Rate; Hypertension; Isoenzymes; JNK Mitogen-Activated Protein Kinases; Male; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Organ Size; p38 Mitogen-Activated Protein Kinases; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Transcription Factor AP-1 | 2000 |
Congestive heart failure: fifty years of progress.
Topics: Angiotensin II; Apoptosis; Calcium; Cardiomegaly; Cardiomyopathies; Cytokines; Heart Failure; History, 20th Century; Humans; Models, Cardiovascular; Myocardial Contraction; Myocardial Ischemia; Signal Transduction | 2000 |
Interaction between angiotensin II and Smad proteins in fibroblasts in failing heart and in vitro.
Topics: Active Transport, Cell Nucleus; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Cardiomegaly; Cell Nucleus; Cells, Cultured; Collagen; Cytosol; DNA-Binding Proteins; Fibroblasts; Heart Failure; In Vitro Techniques; Losartan; Male; Myocardial Infarction; Myocardium; Phosphorylation; Rats; Rats, Sprague-Dawley; Receptor Cross-Talk; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Smad2 Protein; Smad4 Protein; Trans-Activators; Transforming Growth Factor beta; Vimentin | 2000 |
Rho plays an important role in angiotensin II-induced hypertrophic responses in cardiac myocytes.
Topics: Actins; Angiotensin II; Animals; Animals, Newborn; Cardiomegaly; Cells, Cultured; Enzyme Activation; Gene Expression Regulation; Genes, fos; Heart; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinases; Myocardium; Promoter Regions, Genetic; Rats; Rats, Wistar; Recombinant Proteins; rho GTP-Binding Proteins; Transfection | 2000 |
Myocardial cell death in human diabetes.
Topics: Angiotensin II; Apoptosis; Cardiomegaly; Diabetes Mellitus, Type 2; Female; Heart Failure; Humans; Hypertension; Male; Middle Aged; Oxidative Stress; Reactive Oxygen Species; Renin-Angiotensin System; Tyrosine | 2000 |
Gene expression of brain natriuretic peptide in isolated atrial and ventricular human myocardium: influence of angiotensin II and diastolic fiber length.
Topics: Angiotensin II; Blotting, Northern; Cardiomegaly; Diastole; Heart Atria; Heart Ventricles; Humans; In Vitro Techniques; Isometric Contraction; Muscle Fibers, Skeletal; Myocardial Contraction; Myocardium; Natriuretic Peptide, Brain; RNA, Messenger; Stress, Mechanical | 2000 |
The effects of sarpogrelate on cardiomyocyte hypertrophy.
Topics: Angiotensin II; Animals; Animals, Newborn; Cardiomegaly; Cells, Cultured; Endothelin-1; Fibroblasts; Heart Ventricles; Leucine; Myocardium; Rats; Rats, Wistar; Serotonin; Serotonin Antagonists; Succinates; Tritium | 2000 |
Genetic variation in angiotensin-converting enzyme does not prevent development of cardiac hypertrophy or upregulation of angiotensin II in response to aortocaval fistula.
Topics: Angiotensin II; Animals; Aorta; Arteriovenous Fistula; Cardiomegaly; Chymases; Disease Models, Animal; Genetic Variation; Male; Mice; Mice, Knockout; Myocardium; Organ Size; Peptidyl-Dipeptidase A; Renin-Angiotensin System; Serine Endopeptidases; Up-Regulation; Vena Cava, Inferior; Ventricular Dysfunction, Left | 2001 |
Temporary treatment of prepubescent rats with angiotensin inhibitors suppresses the development of hypertensive nephrosclerosis.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Angiotensins; Animals; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Cardiomegaly; Gene Expression; Genetic Predisposition to Disease; Hydralazine; Hypertension; Indans; Kidney; Male; Nephrosclerosis; Proteinuria; Rats; Rats, Inbred SHR; Renin; Stroke; Tetrazoles; Time Factors; Vasodilator Agents | 2001 |
The role of angiotensin II, endothelin-1 and transforming growth factor-beta as autocrine/paracrine mediators of stretch-induced cardiomyocyte hypertrophy.
Topics: Angiotensin II; Animals; Cardiomegaly; Cells, Cultured; Culture Media, Conditioned; Endothelin-1; Endothelium, Vascular; Fibroblasts; Gene Expression; Genes, fos; Muscle, Smooth, Vascular; Myocardium; Rats; Rats, Wistar; RNA, Messenger; Stress, Mechanical; Transforming Growth Factor beta; Vasoconstrictor Agents | 2001 |
[Changes of mitogen-activated protein kinase activity in cardiac tissues, Ang II and cardiac hypertrophy in spontaneously hypertensive rats].
Topics: Angiotensin II; Animals; Cardiomegaly; Hypertension; In Vitro Techniques; Male; Mitogen-Activated Protein Kinases; Myocardium; Rats; Rats, Inbred SHR; Rats, Inbred WKY | 1998 |
Activation of NF-kappa B is required for hypertrophic growth of primary rat neonatal ventricular cardiomyocytes.
Topics: Angiotensin II; Animals; Animals, Newborn; Atrial Natriuretic Factor; Cardiomegaly; Cells, Cultured; DNA-Binding Proteins; I-kappa B Proteins; NF-kappa B; NF-KappaB Inhibitor alpha; Phenylephrine; Rats; Rats, Sprague-Dawley | 2001 |
AT(2), judgment day: which angiotensin receptor is the culprit in cardiac hypertrophy?
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiomegaly; GTP-Binding Proteins; Humans; Mice; Mice, Knockout; Myocardium; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Signal Transduction; Up-Regulation | 2001 |
[The role of nitric oxide in the angiotensin II-induced hypertrophy of cardiac myocytes].
Topics: Angiotensin II; Animals; Animals, Newborn; Cardiomegaly; Cells, Cultured; Myocardium; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Rats; Rats, Sprague-Dawley | 1999 |
[Involvement of calcineurin-dependent signal pathway in the angiotensin II-induced cardiac myocyte hypertrophy].
Topics: Angiotensin II; Animals; Calcineurin; Cardiomegaly; Cells, Cultured; Cyclosporine; Myocardium; Rats; Signal Transduction | 1999 |
Redox-sensitive intermediates mediate angiotensin II-induced p38 MAP kinase activation, AP-1 binding activity, and TGF-beta expression in adult ventricular cardiomyocytes.
Topics: Angiotensin II; Animals; Cardiomegaly; Cells, Cultured; Enzyme Activation; Heart Ventricles; MAP Kinase Signaling System; Mitogen-Activated Protein Kinases; Models, Biological; Myocardium; Oxidation-Reduction; p38 Mitogen-Activated Protein Kinases; RNA, Messenger; Transcription Factor AP-1; Transcriptional Activation; Transforming Growth Factor beta | 2001 |
Persistent cardiovascular effects of chronic renin-angiotensin system inhibition following withdrawal in adult spontaneously hypertensive rats.
Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Blood Vessels; Cardiomegaly; Cardiovascular System; Drug Administration Schedule; Heart Rate; Hydralazine; Hypertension; Kidney; Male; Motor Activity; Perindopril; Rats; Rats, Inbred SHR; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Tetrazoles; Vasodilator Agents | 2001 |
Effect of chronic angiotensin II inhibition on the nitric oxide synthase in the normal rat during aging.
Topics: Aging; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Aorta; Blood Pressure; Cardiomegaly; Enalapril; Losartan; Male; NADPH Dehydrogenase; Nitrates; Nitric Oxide Synthase; Nitrites; Rats; Rats, Wistar; Reference Values; Time Factors | 2001 |
Peroxisome proliferator-activated receptor gamma activators inhibit cardiac hypertrophy in cardiac myocytes.
Topics: Angiotensin II; Animals; Animals, Newborn; Biological Transport; Cardiomegaly; Cells, Cultured; Chromans; Heart; Leucine; Myocardium; Natriuretic Peptide, Brain; NF-kappa B; Phenylephrine; Prostaglandin D2; Rats; Receptors, Cytoplasmic and Nuclear; RNA, Messenger; Stress, Mechanical; Thiazoles; Thiazolidinediones; Transcription Factors; Troglitazone | 2001 |
Interaction between sodium intake, angiotensin II, and blood pressure as a cause of cardiac hypertrophy.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Captopril; Cardiomegaly; Circadian Rhythm; Cross-Over Studies; Disease Models, Animal; France; Heart; Hypertension, Renovascular; Kidney; Losartan; Models, Cardiovascular; Organ Size; Rats; Rats, Wistar; Renin; Sodium, Dietary; Telemetry | 2001 |
Overexpression of the human angiotensin II type 1 receptor in the rat heart augments load induced cardiac hypertrophy.
Topics: Angiotensin II; Animals; Animals, Genetically Modified; Animals, Newborn; Binding, Competitive; Blood Pressure; Calcium; Cardiomegaly; Disease Models, Animal; Dose-Response Relationship, Drug; Gene Expression Regulation; Heart Ventricles; Hemodynamics; Humans; Membranes; Myocardium; Organ Size; Perfusion; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; RNA, Messenger; Time Factors; Transgenes | 2001 |
Angiotensin II in cardiac pressure-overload hypertrophy in fetal sheep.
Topics: Adrenal Glands; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Blood Pressure; Brain; Cardiomegaly; Female; Gestational Age; Heart; Imidazoles; Kidney; Lung; Organ Size; Phenylephrine; Pregnancy; Pulmonary Artery; Pyridines; Receptor, Angiotensin, Type 2; Sheep | 2001 |
Isoproterenol-induced cardiac hypertrophy: role of circulatory versus cardiac renin-angiotensin system.
Topics: Adrenergic beta-Agonists; Angiotensin I; Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Cardiomegaly; Collagen; Coronary Circulation; Heart Rate; Isoproterenol; Isoquinolines; Losartan; Male; Myocardium; Organ Size; Peptidyl-Dipeptidase A; Quinapril; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Renin; Renin-Angiotensin System; Tetrahydroisoquinolines | 2001 |
Statins as antioxidant therapy for preventing cardiac myocyte hypertrophy.
Topics: Angiotensin II; Animals; Antioxidants; Atrial Natriuretic Factor; Cardiomegaly; Cells, Cultured; Heart; Mice; Myocardium; Oxidation-Reduction; Promoter Regions, Genetic; rac1 GTP-Binding Protein; Rats; Rats, Sprague-Dawley; Simvastatin; Superoxides | 2001 |
Dilated cardiomyopathy and impaired cardiac hypertrophic response to angiotensin II in mice lacking FGF-2.
Topics: Angiotensin II; Animals; Cardiomegaly; Cardiomyopathy, Dilated; Cells, Cultured; Enzyme Activation; Fibroblast Growth Factor 2; Male; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinases; Myocardium | 2001 |
Inhibitory effect of quercetin on cultured neonatal rat cardiomyocytes hypertrophy induced by angiotensin.
Topics: Angiotensin II; Animals; Animals, Newborn; Cardiomegaly; Cells, Cultured; Hypertrophy; Myocardium; Myocytes, Cardiac; Protein Kinase C; Protein-Tyrosine Kinases; Quercetin; Rats; Rats, Wistar | 2001 |
Effects of adrenomedullin on hypertrophic responses induced by angiotensin II, endothelin-1 and phenylephrine.
Topics: Adrenomedullin; Angiotensin II; Animals; Atrial Natriuretic Factor; Cardiomegaly; Cyclic AMP; Cyclic GMP; Drug Interactions; Endothelin-1; Gene Expression; Heart; Heart Ventricles; In Vitro Techniques; Myocardium; Natriuretic Peptide, Brain; Peptides; Phenylephrine; Rats; Sarcomeres | 2001 |
Angiotensin II induced cardiac hypertrophy in vivo is inhibited by cyclosporin A in adult rats.
Topics: Angiotensin II; Animals; Blotting, Northern; Body Weight; Calcineurin; Calcium; Cardiomegaly; Cyclosporine; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Hypertrophy; Myocardium; Organ Size; Rats; Rats, Wistar; RNA; Signal Transduction; Up-Regulation | 2001 |
Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: metalloproteinase inhibitors as a new therapy.
Topics: ADAM Proteins; ADAM12 Protein; Angiotensin II; Animals; Aorta, Thoracic; Cardiomegaly; Disease Models, Animal; Disintegrins; Epidermal Growth Factor; ErbB Receptors; Glycine; GTP-Binding Proteins; Heart Ventricles; Heparin-binding EGF-like Growth Factor; Hydroxamic Acids; Hypertension; Intercellular Signaling Peptides and Proteins; Male; Membrane Proteins; Metalloendopeptidases; Phenylephrine; Protease Inhibitors; Protein Processing, Post-Translational; Rats; Signal Transduction; Systole; Transcriptional Activation | 2002 |
Downregulation of ANG II receptor is associated with compensated pressure-overload hypertrophy in the young dog.
Topics: Adaptation, Physiological; Age Factors; Angiotensin II; Animals; Aorta; Arrhythmias, Cardiac; Blood Pressure; Cardiac Volume; Cardiomegaly; Disease Models, Animal; Dogs; Down-Regulation; Electrophysiology; Gene Expression; Muscle Fibers, Skeletal; Myocardium; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Renin-Angiotensin System; RNA, Messenger; Ventricular Function, Left | 2002 |
[Simvastatin attenuates cardiovascular effects and oxidative stress induced by angiotensin II].
Topics: Angiotensin II; Animals; Anticholesteremic Agents; Blood Pressure; Cardiomegaly; Hypertension; Lipid Peroxidation; Male; Oxidative Stress; Rats; Rats, Sprague-Dawley; Simvastatin | 2001 |
Pivotal role of a gp91(phox)-containing NADPH oxidase in angiotensin II-induced cardiac hypertrophy in mice.
Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Blood Pressure; Cardiomegaly; Collagen; Membrane Glycoproteins; Mice; Mice, Knockout; Myocardium; Myosin Heavy Chains; NADPH Oxidase 2; NADPH Oxidases; Organ Size; RNA, Messenger; Superoxides | 2002 |
Specific role for the extracellular signal-regulated kinase pathway in angiotensin II- but not phenylephrine-induced cardiac hypertrophy in vitro.
Topics: Angiotensin II; Animals; Carbon Radioisotopes; Cardiomegaly; Cells, Cultured; Heart Ventricles; In Vitro Techniques; Male; MAP Kinase Signaling System; Mitogen-Activated Protein Kinases; Muscle Fibers, Skeletal; Myocardium; Phenylalanine; Phenylephrine; Protein Kinase C; Rats; Rats, Wistar; Ribosomal Protein S6 Kinases; Vasoconstrictor Agents | 2002 |
Treatment of heart failure: state of the art and prospectives.
Topics: Adrenergic beta-Antagonists; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Cardiomegaly; Drug Therapy; Endothelins; Heart Failure; Humans; Norepinephrine; Review Literature as Topic; Spironolactone; Tumor Necrosis Factor-alpha; Ventricular Dysfunction, Left | 2001 |
Apoptosis signal-regulating kinase/nuclear factor-kappaB: a novel signaling pathway regulates cardiomyocyte hypertrophy.
Topics: Angiotensin II; Animals; Cardiomegaly; Cytokines; Endothelin-1; GTP-Binding Protein alpha Subunits, Gq-G11; Heterotrimeric GTP-Binding Proteins; MAP Kinase Kinase Kinase 5; MAP Kinase Kinase Kinases; NF-kappa B; Phenylephrine; Reactive Oxygen Species; Signal Transduction | 2002 |
Involvement of nuclear factor-kappaB and apoptosis signal-regulating kinase 1 in G-protein-coupled receptor agonist-induced cardiomyocyte hypertrophy.
Topics: Angiotensin II; Animals; Cardiomegaly; Cell Size; Cells, Cultured; Dose-Response Relationship, Drug; Endothelin-1; Heterotrimeric GTP-Binding Proteins; I-kappa B Proteins; Kinetics; MAP Kinase Kinase Kinase 5; MAP Kinase Kinase Kinases; Mutation; Myocardium; NF-kappa B; Phenylephrine; Rats; Rats, Wistar; Reactive Oxygen Species; Receptors, Cell Surface; Sarcomeres | 2002 |
Protective effect of Salvia miltiorrhiza on angiotensin II-induced hypertrophic responses in neonatal rat cardiac cells.
Topics: Angiotensin II; Animals; Animals, Newborn; Blotting, Northern; Cardiomegaly; Cell Count; Cell Size; Cell Survival; Cells, Cultured; Chromatography, High Pressure Liquid; DNA; Myocardium; Plant Extracts; Plant Roots; Rats; Rats, Wistar; RNA, Messenger; Salvia | 2001 |
Angiotensin II induced inflammation in the kidney and in the heart of double transgenic rats.
Topics: Angiotensin II; Angiotensinogen; Animals; Animals, Genetically Modified; Cardiomegaly; Electrophoretic Mobility Shift Assay; Enzyme Inhibitors; Heart; Humans; Intercellular Adhesion Molecule-1; Kidney; Models, Animal; Myocarditis; Necrosis; Nephritis; NF-kappa B; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Oxidative Stress; Proline; Rats; Rats, Sprague-Dawley; Renin; Thiocarbamates; Vascular Cell Adhesion Molecule-1 | 2002 |
Decoy oligonucleotide characterization of GATA-4 transcription factor in hypertrophic agonist induced responses of cardiac myocytes.
Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Binding Sites; Cardiomegaly; DNA-Binding Proteins; Endothelin-1; GATA4 Transcription Factor; Gene Expression Regulation; Myocardium; Natriuretic Peptide, Brain; Oligodeoxyribonucleotides; Phenylephrine; Promoter Regions, Genetic; Protein Binding; Rats; Transcription Factors | 2002 |
Peroxisome proliferator-activated receptor gamma plays a critical role in inhibition of cardiac hypertrophy in vitro and in vivo.
Topics: Actins; Angiotensin II; Animals; Atrial Natriuretic Factor; Body Weight; Cardiomegaly; Cell Size; Cells, Cultured; Chromans; Disease Models, Animal; Gene Expression; Heart; Heterozygote; Hypoglycemic Agents; Ligands; Mice; Mice, Knockout; Myocardium; Organ Size; Pioglitazone; Rats; Rats, Wistar; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Thiazoles; Thiazolidinediones; Transcription Factors; Troglitazone | 2002 |
Serial killer: angiotensin drives cardiac hypertrophy via TGF-beta1.
Topics: Angiotensin II; Animals; Cardiomegaly; Gene Expression Regulation; Humans; Myocardium; Signal Transduction; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2002 |
TGF-beta1 mediates the hypertrophic cardiomyocyte growth induced by angiotensin II.
Topics: Angiotensin II; Animals; Cardiomegaly; Cell Size; Echocardiography; Heart; Hemodynamics; Mice; Mice, Inbred Strains; Mice, Knockout; Myocardium; Myosin Heavy Chains; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2002 |
Interactions between sodium and angiotensin.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Cardiomegaly; Drug Interactions; Rats; Rats, Inbred SHR; Rats, Sprague-Dawley; Renin; Renin-Angiotensin System; Sodium Chloride; Water-Electrolyte Imbalance | 2001 |
Tissue Angiotensin-converting enzyme activity plays an important role in pressure overload-induced cardiac fibrosis in rats.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Cardiomegaly; Collagen Type I; Constriction, Pathologic; Dose-Response Relationship, Drug; Endomyocardial Fibrosis; Imidazoles; Imidazolidines; Male; Myocardium; Peptidyl-Dipeptidase A; Rats; Rats, Sprague-Dawley; Tissue Distribution; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2002 |
Impact of HMG CoA reductase inhibition on small GTPases in the heart.
Topics: Angiotensin II; Animals; Atorvastatin; Atrial Natriuretic Factor; Cardiac Myosins; Cardiomegaly; Cell Membrane; Cells, Cultured; Gene Expression Regulation; GTP Phosphohydrolases; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; JNK Mitogen-Activated Protein Kinases; Male; MAP Kinase Kinase 4; Mitogen-Activated Protein Kinase Kinases; Myocardium; Myosin Light Chains; Pyrroles; rac1 GTP-Binding Protein; Rats; Rats, Sprague-Dawley; rhoA GTP-Binding Protein; RNA, Messenger; Simvastatin | 2002 |
Cardiovascular influences of alpha1b-adrenergic receptor defect in mice.
Topics: Angiotensin II; Animals; Aorta; Arterioles; Atrial Natriuretic Factor; Blood Pressure; Cardiomegaly; Cardiovascular System; Echocardiography; Heart Rate; Heart Ventricles; Hypertension; Male; Mesentery; Mice; Mice, Transgenic; Norepinephrine; Organ Size; Phenylephrine; Receptors, Adrenergic, alpha-1; RNA, Messenger; Vasoconstrictor Agents; Ventricular Remodeling | 2002 |
[MKP-1 regulates the cardiomyocyte hypertrophic responses induced by angiotensin II].
Topics: Angiotensin II; Animals; Animals, Newborn; Cardiomegaly; Cell Cycle Proteins; Cells, Cultured; Dual Specificity Phosphatase 1; Immediate-Early Proteins; Mitogen-Activated Protein Kinases; Myocytes, Cardiac; Phosphoprotein Phosphatases; Protein Phosphatase 1; Protein Tyrosine Phosphatases; Rats; Rats, Sprague-Dawley | 2000 |
Effects of all-trans retinoic acid on angiotensin II-induced myocyte hypertrophy.
Topics: Angiotensin II; Animals; Animals, Newborn; Calcium; Cardiomegaly; Cell Count; Cell Division; Cells, Cultured; Dose-Response Relationship, Drug; Fibroblasts; Golgi Apparatus; Hyperplasia; Intracellular Fluid; Myocardium; Proteins; Rats; Rats, Wistar; Sarcomeres; Tretinoin | 2002 |
Angiotensin II binding and extracellular matrix remodelling in a rat model of myocardial infarction.
Topics: Angiotensin II; Animals; Biomarkers; Cardiomegaly; Cicatrix; Coronary Circulation; Extracellular Matrix; Female; Kinetics; Myocardial Infarction; Myocardium; Perfusion; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Time Factors; Tissue Distribution | 2000 |
Effects of long-term enalapril and losartan therapy of heart failure on cardiovascular aldosterone.
Topics: Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiac Output, Low; Cardiomegaly; Cardiovascular System; Chronic Disease; Enalapril; Losartan; Male; Mesenteric Arteries; Myocardial Infarction; Rats; Rats, Wistar | 2002 |
[Molecular mechanism of nitric oxide in preventing cardiomyocytes from hypertrophic response induced by angiotensin II].
Topics: Angiotensin II; Animals; Animals, Newborn; Arginine; Cardiomegaly; Fungal Proteins; In Vitro Techniques; Mitogen-Activated Protein Kinases; Myocytes, Cardiac; Nitric Oxide; Rats; Rats, Sprague-Dawley; Signal Transduction | 2002 |
Humoral regulation of vascular resistance after 30 days of pulmonary artery constriction.
Topics: Angiotensin II; Animals; Cardiomegaly; Catecholamines; Dopamine; Epinephrine; Guinea Pigs; Heart Failure; Norepinephrine; Papaverine; Phentolamine; Phenylephrine; Saralasin; Sympathetic Nervous System; Tyrosine 3-Monooxygenase; Vascular Resistance | 1979 |
Diastolic compliance of the left ventricle in man.
Topics: Adolescent; Adult; Aged; Angina Pectoris; Angiotensin II; Aortic Valve Stenosis; Blood Pressure; Cardiac Catheterization; Cardiac Output; Cardiac Volume; Cardiomegaly; Cineangiography; Coronary Disease; Female; Heart; Heart Diseases; Heart Function Tests; Heart Rate; Heart Ventricles; Hemodynamics; Humans; Male; Mathematics; Middle Aged; Myocardial Contraction; Prognosis | 1975 |
Differences in the regulation of vascular resistance in guinea pigs with right and left heart failure.
Topics: Angiotensin II; Animals; Aorta; Arterial Occlusive Diseases; Blood Gas Analysis; Cardiomegaly; Electric Stimulation; Guinea Pigs; Heart Failure; Heart Ventricles; Hemodynamics; Hindlimb; Male; Norepinephrine; Papaverine; Pulmonary Artery; Sympathectomy; Vascular Resistance; Vasomotor System | 1977 |
U vectorcardiograms in left ventricular overloading.
Topics: Adult; Angiotensin II; Aortic Valve Insufficiency; Cardiomegaly; Electrocardiography; Female; Humans; Hypertension; Male; Middle Aged; Vectorcardiography | 1978 |
Pulmonary vascular reactivity in the spontaneously hypertensive rat.
Topics: Altitude; Angiotensin II; Animals; Blood Pressure; Body Weight; Cardiomegaly; Heart; Hematocrit; Hypertension, Pulmonary; Hypoxia; Lung; Male; Organ Size; Prostaglandins F; Rats; Vascular Resistance | 1979 |
Cardiac effects of angiotensin antagonists in normotensive rats.
Topics: Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Catecholamines; Rats; Saralasin | 1979 |
[Endothelin-1 as an autocrine factor in hypertrophy of cardiomyocytes].
Topics: Angiotensin II; Animals; Cardiomegaly; Cell Division; Cell Size; Endothelins; Gene Expression; In Vitro Techniques; Myocardium; Peptides, Cyclic; Protein Kinase C; Rats | 1992 |
Cardiac angiotensin converting enzyme and diastolic function of the heart.
Topics: Angiotensin I; Angiotensin II; Animals; Cardiomegaly; Diastole; Enalaprilat; Heart; In Vitro Techniques; Male; Myocardium; Peptidyl-Dipeptidase A; Rats; Rats, Wistar; Reference Values; RNA, Messenger; Ventricular Function, Left | 1992 |
Effects of losartan, a nonpeptide angiotensin II receptor antagonist, on cardiac hypertrophy and the tissue angiotensin II content in spontaneously hypertensive rats.
Topics: Analysis of Variance; Angiotensin II; Animals; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Body Weight; Cardiomegaly; Heart Rate; Heart Ventricles; Hypertension; Imidazoles; Losartan; Male; Organ Size; Radioimmunoassay; Rats; Rats, Inbred SHR; Renin; Tetrazoles | 1992 |
Long-term angiotensin II antagonism in spontaneously hypertensive rats: effects on blood pressure and cardiovascular amplifiers.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Biphenyl Compounds; Blood Pressure; Cardiomegaly; Cardiovascular Agents; Cardiovascular Physiological Phenomena; Cardiovascular System; Hindlimb; Hypertension; Imidazoles; Losartan; Male; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Tetrazoles; Time Factors | 1992 |
Reactive and reparative myocardial fibrosis in arterial hypertension in the rat.
Topics: Aldosterone; Angiotensin II; Animals; Cardiomegaly; Collagen; Disease Models, Animal; Fibrosis; Hypertension, Renovascular; Male; Myocardium; Rats; Rats, Sprague-Dawley; Sodium, Dietary; Spironolactone | 1992 |
Angiotensin II-induced protein phosphorylation in the hypertrophic heart of the Dahl rat.
Topics: Angiotensin II; Animals; Calcimycin; Cardiomegaly; Cell Separation; Drug Resistance; Electrophoresis; Ionomycin; Methionine; Muscle Proteins; Myocardium; Phosphoproteins; Phosphorylation; Rats; Rats, Inbred Strains; Sodium Chloride; Tetradecanoylphorbol Acetate | 1992 |
Angiotensin II stimulation of left ventricular hypertrophy in adult rat heart. Mediation by the AT1 receptor.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Biphenyl Compounds; Blood Pressure; Cardiomegaly; Imidazoles; Infusion Pumps; Losartan; Male; Organ Size; Rats; Rats, Inbred Strains; Receptors, Angiotensin; Tetrazoles | 1992 |
[Vasoactive substances and growth].
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiomegaly; Cell Division; Heart Failure; Humans | 1992 |
Role of cardiac angiotensin II in isoproterenol-induced left ventricular hypertrophy.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Body Weight; Cardiomegaly; Heart Rate; Hydralazine; Indoles; Isoproterenol; Male; Myocardium; Nephrectomy; Rats; Rats, Inbred Strains; Renin | 1992 |
Converting enzyme inhibitors regressed cardiac hypertrophy and reduced tissue angiotensin II in spontaneously hypertensive rats.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Cardiomegaly; Enalapril; Heart Atria; Heart Ventricles; Indoles; Male; Myocardium; Organ Size; Rats; Rats, Inbred SHR; Renin-Angiotensin System | 1991 |
Reversal of angiotensin II effect on the cyclic adenosine 3',5' monophosphate response to isoprenaline in cardiac hypertrophy.
Topics: Angiotensin II; Animals; Cardiomegaly; Cells, Cultured; Cyclic AMP; Heart; Isoproterenol; Male; Myocardium; Rats; Rats, Inbred Strains; Stimulation, Chemical | 1991 |
Cardiac and renal hypertrophy is independent of tissue angiotensin converting enzyme and circulating angiotensin II in hypertensive rats.
Topics: Angiotensin II; Animals; Cardiomegaly; Desoxycorticosterone; Hypertension; Hypertension, Renovascular; Hypertrophy; Kidney; Myocardium; Peptidyl-Dipeptidase A; Rats; Rats, Inbred Strains; Sodium Chloride | 1991 |
Remodeling of the rat right and left ventricles in experimental hypertension.
Topics: Aldosterone; Angiotensin II; Animals; Cardiomegaly; Collagen; Fibrosis; Heart Ventricles; Hemodynamics; Hypertension; Hypertension, Renovascular; Male; Rats; Rats, Inbred Strains; Staining and Labeling | 1990 |
Cardiac remodelling and myocardial contractility in patients with congestive heart failure treated with furosemide and enalapril.
Topics: Aged; Angiotensin II; Cardiomegaly; Drug Therapy, Combination; Enalapril; Furosemide; Heart Failure; Humans; Male; Middle Aged; Myocardial Contraction | 1991 |
Cardiac myocyte necrosis induced by angiotensin II.
Topics: Angiotensin II; Animals; Aorta, Abdominal; Blood Pressure; Captopril; Cardiomegaly; DNA; Fibrosis; Heart; Ligation; Male; Myocardium; Necrosis; Rats; Rats, Inbred Strains; Sympatholytics; Vasoconstriction | 1991 |
Effects of tryptophan on the development of deoxycorticosterone acetate (DOCA)-induced hypertension in rats.
Topics: Angiotensin II; Animals; Blood Pressure; Body Weight; Cardiomegaly; Desoxycorticosterone; Diencephalon; Drinking; Eating; Female; Hypertension; Nephrectomy; Protein Binding; Rats; Rats, Inbred Strains; Serotonin; Sodium Chloride; Tryptophan | 1991 |
Regression of left ventricular hypertrophy by angiotensin converting enzyme inhibitor in reduced renal mass hypertensive rats.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Cardiomegaly; Heart Ventricles; Hypertension, Renal; Indoles; Male; Nephrectomy; Organ Size; Perindopril; Rats; Rats, Inbred Strains; Renin | 1991 |
Role of angiotensin II receptor antagonism and converting enzyme inhibition in the progression and regression of cardiac hypertrophy in rats.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta, Abdominal; Biphenyl Compounds; Bridged Bicyclo Compounds; Cardiomegaly; Constriction; Hypertension; Imidazoles; Losartan; Male; Ramipril; Rats; Rats, Inbred Strains; Receptors, Angiotensin; Tetrazoles | 1991 |
Isolated myocardial cells: a new tool for the investigation of hypertensive heart disease.
Topics: Angiotensin II; Animals; Cardiomegaly; Cells, Cultured; Heart Rate; Hypertension; Isoproterenol; Myocardial Contraction; Myocardium; Rats; Rats, Inbred Strains | 1990 |
Excitation-contraction coupling in hypertrophied myocardium.
Topics: Age Factors; Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Epinephrine; Heart; Hypertension; Hypertension, Renal; Male; Myocardial Contraction; Myocardium; Prazosin; Protein Kinases; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta | 1985 |
Converting enzyme inhibition specifically prevents the development and induces regression of cardiac hypertrophy in rats.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Bridged Bicyclo Compounds; Cardiomegaly; Dihydralazine; Hypertension; Male; Nifedipine; Ramipril; Rats; Rats, Inbred Strains | 1989 |
Study of cardiac hypertrophy--humoral factors that stimulate protein metabolism of cultured rat heart cells.
Topics: Angiotensin II; Animals; Biological Factors; Cardiomegaly; Cells, Cultured; Chromatography, High Pressure Liquid; Dogs; Isoproterenol; Male; Myocardium; Norepinephrine; Proteins; Rats; Rats, Inbred WKY; Tissue Extracts | 1989 |
Study of the pathogenesis of cardiac hypertrophy--biochemical differences of cultured heart cells from normotensive and spontaneously hypertensive rats.
Topics: Angiotensin II; Animals; Cardiomegaly; Cells, Cultured; Hypertension; Isoproterenol; Leucine; Myocardium; Protein Biosynthesis; Proteins; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Stimulation, Chemical; Uridine | 1989 |
Impaired relaxation of the hypertrophied myocardium is potentiated by angiotensin II.
Topics: Angiotensin II; Animals; Cardiomegaly; Cells, Cultured; Myocardial Contraction; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Stimulation, Chemical | 1989 |
Isoform-specific modulation of Na+, K+-ATPase alpha-subunit gene expression in hypertension.
Topics: Angiotensin II; Animals; Cardiomegaly; Desoxycorticosterone; Heart Ventricles; Hypertension; Isoenzymes; Rats; RNA, Messenger; Sodium-Potassium-Exchanging ATPase | 1988 |
Monocrotaline pyrrole-induced cardiopulmonary toxicity is not altered by metergoline or ketanserin.
Topics: Angiotensin II; Animals; Blood Platelets; Blood Pressure; Cardiomegaly; Ergolines; Ketanserin; Lung; Male; Metergoline; Monocrotaline; Organ Size; Piperidines; Pyrrolizidine Alkaloids; Rats; Receptors, Serotonin; Serotonin | 1986 |
Vascular hyperresponsiveness in perfused lungs from monocrotaline-treated rats.
Topics: Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Hydrogen-Ion Concentration; Hypertension, Pulmonary; Hypoxia; Male; Monocrotaline; Perfusion; Pulmonary Artery; Pulmonary Circulation; Pulmonary Edema; Pyrrolizidine Alkaloids; Rats; Rats, Inbred Strains; Vasoconstriction | 1986 |
Chronic treatment with L-5-hydroxytryptophan prevents the development of DOCA-salt-induced hypertension in rats.
Topics: 5-Hydroxytryptophan; Administration, Cutaneous; Angiotensin II; Animals; Cardiomegaly; Catecholamines; Desoxycorticosterone; Female; Hypertension; Infusion Pumps; Kidney Concentrating Ability; Nephrectomy; Rats; Rats, Inbred Strains; Sodium, Dietary | 1987 |
Beta-adrenergic receptors in rat myocardium during the development and reversal of hypertrophy and following chronic infusions of angiotensin II and epinephrine.
Topics: Aging; Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Dihydroalprenolol; Epinephrine; In Vitro Techniques; Male; Membranes; Myocardium; Nephrectomy; Nucleotidases; Organ Size; Rats; Rats, Inbred SHR; Rats, Inbred Strains; Rats, Inbred WKY; Receptors, Adrenergic, beta; Time Factors | 1985 |
[Clinical study of cardiac asthma].
Topics: Aged; Angiotensin II; Blood Pressure; Bradycardia; Cardiac Output; Cardiomegaly; Circadian Rhythm; Dyspnea, Paroxysmal; Epinephrine; Exercise Test; Female; Heart Failure; Heart Valve Diseases; Hemodynamics; Humans; Hypertension; Infusions, Parenteral; Male; Middle Aged; Norepinephrine; Posture; Pulmonary Circulation; Serum Albumin, Radio-Iodinated | 1967 |
Left ventricular function in children studied by increasing peripheral resistance with angiotensin.
Topics: Adolescent; Angiotensin II; Blood Pressure; Cardiac Catheterization; Cardiomegaly; Child; Child, Preschool; Chlorpromazine; Endocardial Fibroelastosis; Female; Glycogen Storage Disease; Heart Valves; Heart Ventricles; Humans; Infant; Male; Meperidine; Mitral Valve Insufficiency; Mucopolysaccharidosis II; Promethazine; Ventricular Function | 1968 |
Effects of cortisone on renal sodium excretion in rabbits.
Topics: Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Cortisone; Desoxycorticosterone; Edema; Female; Glomerular Filtration Rate; Hematocrit; Kidney; Male; Pleural Effusion; Potassium; Pulmonary Edema; Rabbits; Sodium; Vena Cava, Inferior; Water-Electrolyte Balance | 1968 |
Myocardial function in patients with coronary artery disease.
Topics: Adolescent; Adult; Aged; Angiocardiography; Angiotensin II; Arteriosclerosis; Cardiomegaly; Cineangiography; Coronary Disease; Female; Heart; Heart Function Tests; Heart Ventricles; Humans; Male; Middle Aged; Stress, Physiological | 1969 |
The production of sustained hypertension in dogs by a single transient anoxic episode.
Topics: Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Dogs; Hypertension; Kidney; Models, Biological; Photomicrography; Renal Artery; Renal Artery Obstruction; Renin; Time Factors | 1969 |
[Clinical considerations and hemodynamic studies in some cases of dynamic hypertrophic stenosis of the left ventricle].
Topics: Adolescent; Adult; Angiotensin II; Blood Pressure; Butylamines; Cardiac Catheterization; Cardiomegaly; Electrocardiography; Epinephrine; Female; Heart; Heart Diseases; Heart Ventricles; Hemodynamics; Humans; Kinetocardiography; Male; Middle Aged; Nitrites; Norepinephrine; Phonocardiography; Radiography, Thoracic; Strophanthins; Sympatholytics | 1970 |
Left ventricular function in chronic obstructive lung disease.
Topics: Angiotensin II; Blood Pressure; Bronchitis; Carbon Dioxide; Cardiac Catheterization; Cardiac Output; Cardiomegaly; Cineangiography; Coronary Angiography; Heart Failure; Heart Function Tests; Heart Ventricles; Hemodynamics; Humans; Hypercapnia; Lung Diseases; Lung Diseases, Obstructive; Oxygen; Pulmonary Emphysema; Spirometry | 1971 |
[The epidermolysis syndrome (Lyell) from the viewpoint of internal medicine].
Topics: Acute Disease; Aged; Angiotensin II; Cardiomegaly; Cholangitis; Chronic Disease; Diabetes Complications; Glomerulonephritis; Humans; Liver Cirrhosis; Male; Methicillin; Middle Aged; Pancreatic Diseases; Potassium; Prednisolone; Prognosis; Stevens-Johnson Syndrome | 1970 |
Cardiac hypertrophy in spontaneously hypertensive rats.
Topics: Age Factors; Angiotensin II; Animals; Cardiomegaly; DNA; Heart Ventricles; Hydralazine; Hypertension; Methyldopa; Organ Size; Rats; Rats, Inbred Strains; Renin | 1974 |
Characteristics of hypertension in the black population.
Topics: Adult; Angiotensin II; Animals; Black or African American; Cardiomegaly; Cerebrovascular Disorders; Chlorthalidone; Coronary Disease; Drug Therapy, Combination; Female; Guanethidine; Heart Ventricles; Humans; Hydralazine; Hypertension; Male; Methyldopa; Middle Aged; New York City; Rabbits; Radioimmunoassay; Renin; Sodium; Spironolactone | 1974 |
The relation of plasma renin activity to left ventricular hypertrophy and retinopathy in patients with arterial hypertension.
Topics: Adolescent; Adult; Aged; Angiotensin II; Cardiomegaly; Heart Ventricles; Humans; Hyperaldosteronism; Hypertension; Kidney Diseases; Middle Aged; Radioimmunoassay; Renin; Retinal Diseases; Sodium Chloride | 1974 |